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Abstract 
The carbohydrate 7-aminosialic acid (5) is a non-natural analogue of the sialic acid 
Neu5Ac (1) and represents a potential precursor to a new-generation of anti-influenza 
drugs. Consequently, there is a significant need for the development of effective 
methods for the synthesis of this compound and various congeners. As such, the aims 
of the present work were to exploit the previous research results obtained within the 
Banwell laboratories in the establishment of an effective and flexible route to target 5. 
In particular, it was anticipated that the diol 33 (X = Cl), which is readily obtained by 
microbial dihydroxylation of chlorobenzene, could be elaborated to target 5 using the 
same sort of protocols as employed by De Savi and Banwell in their synthesis of 
Neu5Ac (1) from the same precursor. 
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During the course of developing a synthesis of the compound 53, a potential precursor 
to target 5, a number of interesting compounds were produced that offered the 
possibility of gaining efficient access to various naturally occurring but unusual 
carbohydrates such as D-talose (92), DMJ (105) and Rha-DMJ (116) . The total 
syntheses of all three of these compounds are detailed in the thesis. 
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The thesis starts (Chapter 1) with a brief introduction to the chemistry of sialic acids, 
the biological significance of these compounds and their derivatives, and the reasons 
for selecting compound 5 as a synthetic target. This is followed by a general 
description of previously reported approaches to such systems that are relevant to the 
current work. A discussion of the utility of cis-1,2-dihydrocatechols 33 as precursors 
to carbohydrates is also presented. 
Chapter 2 details efforts of the author directed towards the synthesis of compound 53 
and using cis-1,2-dihydrocatechol 33 (X = Cl) as starting material. In this connection, 
an investigation into the origins of the unexpected compound 77 is detailed. Such 
studies led to the establishment of efficient routes to target 53. 
Chapter 3 describes methods for the preparation of differentially protected D-talose 
derivatives from epoxide 60 which was readily obtained in three steps from cis-1 ,2-
dihydrocatechol 33 (X = Cl). The relative ease of access to such derivatives should aid 
general investigations into the chemical and biological properties of this rare type of 
D-aldohexose. 
Chapter 4 details the establishment of a total synthesis of DMJ (105) by two routes. 
The first exploits compounds 72 and 77 as precursors while the second involves a 
slightly different synthetic strategy but still uses cis-1,2-dihydrocatechol 33 (X = Cl) 
as starting material. To some extent, the latter route can be considered a more efficient 
and flexible variation of the former one. 
V 
Chapter 5 details the first total synthesis of Rha-DMJ (116) from derivatives 71 and 
112 of diol 33 (X = Cl). Evaluation of the glycosidase inhibitory activity of compound 
116 is also reported. Indeed, it was found that the synthetic material was 5-10 times 
less active towards a-L-fucosidase than the naturally-derived material and the reason 
for this can probably be attributed to contamination of the latter sample with a more 
powerful inhibitor like P-L-homofuconojirimycin. Such work serves to highlight the 
value of cis-1,2-dihydrocatechol 33 (X = Cl) as a non-carbohydrate precursor in the 
synthesis of complex carbohydrates. Since various disaccharide derivatives of DMJ 
have been identified as potential cancer remedies, the present work should provide 
useful methods for accessing this pharmacologically interesting class of compound . 
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Chapter One 2 
1.1 Overview 
N-Acetylneuraminic acid [1, a.k.a. (-)-Neu5Ac and (-)-5-acetamido-3,5-dideoxy-D-
glycero-D-galacto-non-2-ulosonic acid] is a nine-carbon-containing carbohydrate. 
This compound was first isolated[!] in the 1930's and is the most prominent member 
of a class of ca. thirty-six carbohydrates collectively known as the sialic acids. [lJ 
Neu5Ac (1) as well as certain other family members are abundant in nature, especially 
in the animal kingdom and are normally found as a-glycosidically-linked terminal 
residues of glycoproteins and glycolipids. They are also found attached at different 
positions of various monosaccharide residues and thus forming sialyl-containing 
o ligosaccharides. 
HO 
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2,3-Dehydro-2,4-dideoxy-4-guanidino-N-acetyl-neuraminic acid (2, a.k.a. Relenza™, 
zanamivir, 4-guanidino-N eu5Ac2en and GG 167i31 is a prominent example of a 
modified sialic acid which has found pharmaceutical utility. This compound, which is 
derived by substitution of the hydroxy group at the C-4 position within Neu5Ac (1) 
with a guanidino group as well as dehydration across the 2,3-positions, is now used 
for the treatment of influenza. Furthermore, functionalization at the C-7 position 
within compound 2 has provided a series of carbamate derivatives and alkoxy 
derivatives, 3[4J and 4[5] respectively, most of these are also potent inhibitors of 
influenza NA. This recent discovery has led to the identification of the C-7 aminated 
sialic acid (5) as a potentially important scaffold for the construction of a new-
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generation of anti-influenza agents. Developing effective methods for the construction 
of such systems was, therefore, an important initial objective of the work described in 
this thesis. 
1.2 Biological Significance of Sialic Acids and their Analogues 
Neu5Ac (1) has been implicated in many important biological processes, including 
cell adhesion and differentiation, immune responses, tumour metastasis and the 
development of neural cells. [2b] This compound can be cleaved from the terminal 
position of a-glycosidically-linked glycoproteins, glycolipids and oligosaccarides by 
sialidase (also called N-neuraminidase or NA) which is one of the two membrane-
associated glycoproteins situated on the surface of influenza viruses, the other being 
hemagglutinin ( or HA). The former enzyme is thought to be important for the release 
of virons from the host cell surface and may also enhance infectivity by allowing 
movement of the virus through the mucins lining the respiratory tract. [6] As a 
consequence, it has long been recognised that inhibition of sialidase should restrict the 
establishment and progression of infection by the influenza virus. 
Studies on the interactions between sialidase and Neu5Ac (1) have facilitated the 
search for potent inhibitors of this enzyme. [7] Indeed, analysis of the X-ray crystal 
structure derived from complexation of these species indicated that the sialidase active 
site possessed a hydrophilic pocket which was not completely filled by the sialic acid 
moiety. Such knowledge led to the design and then the synthesis of novel sialic acid-
based inhibitors. As a consequence of such endeavours, 4-guanidino-Neu5Ac2en (2, 
a.k.a. Relenza™) was identified as a potent and highly selective inhibitor of influenza 
NA and is now used worldwide for the treatment of flu. [3d] 
Subsequent to the discovery of Relenza™ (2), considerable attention has been focused 
on the modification of the hydroxy group at the C-7 position within compound 2. The 
X-ray crystal structural studies of Neu5Ac (1) and Relenza™ (2) bound to influenza 
NA revealed that the 7-hydroxy group has no close interactions with the enzyme and, 
in fact, points directly out of and away from the active site. [BJ Based on this 
observation, Andrews and co-workers[4J prepared a series of 7-carbamates, 3, of 
Relenza™ (2) and found that such compounds retain high affinity for influenza NA 
and many also possess good anti-viral properties. It is worth noting that, like 
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Relenza™ (2) itself, compounds of the general type 3 don't show any selectivity 
between influenza A and B viruses. In contrast, derivatives of Relenza ™ with altered 
glycerol sidechains[9J are selective inhibitors of influenza A. 
In view of the remarkably high NA inhibitory activity of the 7-carbamates 3, chemists 
at Biota Holdings Ltd [the Australian Company involved in the development of 
Relenza™ (2)] explored the possibility of using tethered carbamate derivatives of 
Relenza™ to selectively capture influenza virons onto a surface. Thus, the series of 
compounds 6a-d, which consist of a Relenza™ "core" attached through a C-7 linker to 
a biotin moiety, can be used to capture flu virions on a streptavidin surface and thus 
providing a relatively simple method for diagnosing influenza infection in man_[IOJ 
HO 
H6 
\ 
AcHN j C02H X 
HN j R )-~ 
H2N H 
6a X=bond 
6b X = (COCH2NH)3 
6c X = [COCH2)5NH]4 
6d X = C02[CH2CH20J?oCH2CH2NH 
R= 
Recently, Japanese chemists have shown that certain 7-alkoxy derivatives, 4, [5J of 
Relenza™ (2) are highly potent inhibitors of influenza. This interesting discovery 
suggests that further investigations into novel 7-substituted sialic acid analogues are 
warranted. In this connection, the little known[IIJ 7-aminosialic acid (5) is of great 
interest and ready access to such a novel sialic acid scaffold may provide a new-
generation of anti-influenza agents. As a consequence, a major focus of the early 
stages of the work described in this thesis was the development of efficient routes to 
compound 5 and various congeners. 
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1.3 Synthetic Routes to Neu5Ac (1) and Its Analogues 
1.3.1 Neu5Ac (1) 
Two distinct routes to Neu5Ac (1) have been developed in the last four decades or so, 
viz. those involving enzymatic procedures and those using chemical methods. The 
enzymatic procedures[12J employ, as the key step, a reversible aldol condensation 
between N-acetyl-D-mannosamine (or ManNAc, 7) and pyruvic acid (8) in the 
presence of Neu5Ac aldolase (Scheme 1.1). Studies on the substrate specificity of 
Neu5Ac aldolase have shown that only pyruvic acid (8) is accepted as the 3-carbon 
OH 
Neu5Ac aldolase 
+ 
1 
Scheme 1.1: Enzymatic Syntheses of (-)-Neu5Ac (1) 
"donor" synthon[13J while ManNAc (7i14J is one of the few naturally-occurring 
"acceptor" substrates for the enzyme. Thus, N-acetyl-D-glucosamine ( or GlcNAc, 9), 
for example, is not processed by the enzyme. [l 3a,I 4J 
The chemical syntheses ofNeu5Ac (1) can be divided into three basic types: 
(i) aldol condensation of an aldohexose with a pyruvate or equivalent three-carbon 
homologating unit; 
(ii) addition of a two-carbon homologating unit to a seven-carbon sugar halide;[I 5J 
(iii) syntheses using non-carbohydrate precursors. [l 6J 
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The first type ( often referred to as "3 + 6" approach) is highly developed and, 
therefore, widely used in the synthesis of N eu5Ac (1) while the other two are of little 
practical value due to difficulties in manipulation, poor yields and/or the lengthy 
nature of the reaction sequences involved. Because of its general utility as well as its 
specific relevance to the work described in this thesis, a detailed discussion of the first 
type is presented here. Clearly, it mimics the enzymatic approach described in 
Scheme 1.1. The readily available ManNAc (7) constitutes the six-carbon unit while 
pyruvic acid (8) or an equivalent provides the remaining three carbons of the target 1. 
A key challenge is to control the stereoselectivity of the nucleophilic addition of the 
three-carbon "donor" to the C-1 of the aldohexose "acceptor" so as to establish the 
correct configuration at the C-4 in the resulting sialic acid derivative or precursor. [2bJ 
Early attempts at direct combination of these two pieces failed to provide Neu5Ac (1) 
because of the facile polymerisation of the pyruvic acid (8). [1 7J Successful coupling 
could be achieved with 3-fluoropyruvate, 3-bromopyruvate and 3-hydroxypyruvate 
although these approaches proved unreliable.[2b,I 7J In 1957, Cornforth and co-
workers[18J explored a coupling process involving the more reactive oxobutanedioic 
acid 10 as a replacement for pyruvic acid (8) and thereby established the first robust 
chemical synthesis of Neu5Ac (1) (Scheme 1.2). Thus, this synthesis involved 
reaction of GlcNAc (9) (the six-carbon synthon) with keto-acid 10 (the three-carbon 
synthon) at pH 9-11, to give, after decarboxylation, Neu5Ac (1) in ca. 2% yield. 
OH 
pH9-11 ~ HO + 
HO OH 
9 7 \_ __ _ 
y 
j 
(-)-Neu5Ac (1) 
4-epi-(-)-Neu5Ac (11) 
Scheme 1.2: First Reliable Chemical Synthesis ofNeu5Ac (1) 
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Further optimization of the reaction conditions and using the potassium salt of di-tert-
butyl oxobutanedioate led to an increased yield of ca. 34%.[I 9] 
In a more recent development, Vasella and co-workers[20J have employed tert-butyl a-
(bromomethyl)acrylate (12) as a masked pyruvate in this type of approach to N eu5Ac 
(1) (Scheme 1.3). The key step involves reaction of a protected form of ManNAc, viz. 
labile aldehyde 13 (which was prepared in seven steps from commercially available 8-
gluconolactone) with the organozinc reagent derived from precursor 12. A 1 : 4 
mixture of erythro- and threo-adducts 14a and 14b was thereby obtained in a 
combined yield of 80%. Treatment of the chromatographically separable product 14b 
with aqueous acid then gave the fully deprotected y-hydroxy-a-methylene-acid and 
exposure of the latter species to ozone resulted in alkene cleavage and (presumably 
after a reductive workup) unmasking of the a-keto acid 15 which spontaneously 
cyclised to provide target 1 in 40% yield. Although this approach offers effective 
access to N eu5Ac (1 ), it was originally restricted by the need to use the highly 
+ 1 
13 
Neu5Ac (1) --- HO 
Scheme 1.3: Vasella's Approach to Neu5Ac (1) 
14a 
14b l ii-iii 
OH 
OH NHAc 
15 
Reagents: (i) Zn/ Ag on K-activated graphite; (ii) HCl then NaOH; (iii) 0 3. 
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reactive Zn/Ag couple on potassium-activated graphite in order to generate the 
requisite organometallic species from tert-butyl a-(bromomethyl)acrylate (12). More 
recently, however, indium[2IJ has provided a suitable substitute for this purpose in that 
indium-mediated condensation of a-(bromomethyl)acrylic acid (12) ( or an ester 
derivative thereof) with ManNAc (7) in aqueous media proceeds smoothly and a 3 : 1 
mixture of threo- and erythro-adducts 16a and 16b (Scheme 1.4) was obtained in 
good yield. Subjection of this inseparable mixture to treatment with ozone led to (-)-
N eu5Ac (1) which could be separated from 4-epi-(-)-Neu5Ac (11) using fractional 
recrystallization techniques. The ratio of the former product to the latter was 3 : 1. 
12 
+ 
OH OH 0 (YYH 
OH OH NHAc 
7 
In 
IR= H, Me, Et, But I 
OH OH OH OH QH 9H 
~ ~ 
\ 16a 16b J 
"-------- ____ _/ y 
(-)-Neu5Ac (1) 4-epi-(-)-Neu5Ac (11) 
Scheme 1.4: Indium-mediated Coupling of Acrylic Acid (12) with ManNAc (7) 
Very recently, Banwell and De Savi have succeeded in using zinc dust[22J as the 
reductive coupling agent in a related synthesis of Neu5Ac (1). Due to its particular 
relevance to the present work a detailed discussion of this synthesis is presented later 
in this chapter [see Section 1.4.2 (a)]. 
1.3.2 Analogues of Neu5Ac (1) 
Most syntheses of Neu5Ac analogues employ this sialic acid as starting material with 
the most notable example being that leading to the preparation of Relenza™ (2). Thus, 
von Itzstein and co-workers[23J have reported the synthesis of compound 2 using the 
protected sialic acid derivative 17 as "precursor" (Scheme 1.5). A key challenge in 
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this synthesis was the stereoselective introduction of nitrogen to the C-4 position 
within precursor 17. This was ultimately achieved by conversion of compound 17 into 
derivative 18, the allylic oxazoline group of which is susceptible to stereoselective 
nucleophilic displacement by azide ( at C-4) thereby affording the desired product 19. 
Elaboration of this last species into target 2 involved sequential treatment with, (i) 
hydrogen using 10% palladium on carbon (Pd/C) as catalyst (thus forming compound 
20), (ii) Amberlite JRA-400 (OH-) resin then Dowex-S0W x 8 (H+) resin (to give 
intermediate 21) and, (iii) aminoiminomethanesulfonic acid in the presence of 
aqueous potassium carbonate (to deliver target 2). A similar approach to Relenza™ (2) 
based on the same precursor (17) has also been described in a more recent European 
Patent filing. [Z4 J 
AcO AcO AcO 
Acd 1 Acd 11 
CO2Me CO2Me CO2Me 
Acd 
_, 
" ~ N3 
17 18 19 j iii 
HO HO AcO 
Hd V 
-· 
Hd IV 
AcHN O2H CO2Na CO2Me 
HN $ 4 ~· $ >- ~ " " N ~ ~ H2N H2N 
\ 
H2N H 
2 21 20 
Scheme 1.5: von Itzstein's Synthesis ofRelenza™ (2) from Compound 17 
Reagents: (i) BF3·Et2O, MeOH; (ii) LiN3, Dowex-50W x 8 (Hl resin; (iii) H2 (1 atm), 10% Pd/C; (iv) 
Amberlite IRA-400 (Oir) resin then Dowex-50W x 8 (Hl resin; (v) H2N(NH=)CSO3H, K2CO3 . 
The synthesis of a series of 7-carbamate derivatives, 3, of Relenza™ (2) (Scheme 1.6) 
reported by Andrews and co-workers, [4bJ and using the known methyl ester 22 as 
starting material, represents another example of the derivatisation of sialic acids. The 
most significant aspect of this synthesis is the formation of a C-7 carbamate linker by 
a simple two-step process. Thus, treatment of precursor 22 with 4-nitrophenyl 
chloroformate resulted in generation of the active ester 23 which led, upon reaction 
with the appropriate primary and secondary amines, to various 7-carbamates of the 
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general type 24. These last species were converted into C-4 amines, 25, by treatment 
with triphenylphosphine then aqueous triethylamine. Guanidinylation of compounds 
25 with N,N(.bis-t-butoxycarbonyl-lH-pyrazole-1-carboxarnidine (BisBocPCH) then 
provided the protected guanidines 26 which reacted with TF A to afford the desired 
products 3. 
HO 
V 
AcHN 
4 
;} CO2H 
HN 1 }-~ 
H2N H 
3 
(a) R1 = R2 = substituents; 
(b) R 1 = H, R2 = substituents; 
(c) R1 = substituents, R2 = H. 
HO 
HO 
BocN 1 4 }-N 
BocHN H 
26 
< 
N~ 
24 
lll 
IV 
25 
Scheme 1.6: Andrews' Synthesis of 7-Carbarnate Derivatives, 3, of Relenza™ (2) 
Reagents: (i) p-N02C6H40COC1, DMAP; (ii) R1R2NH, DMAP; (iii) PPh3 then Et3N, H20; (iv) 
Bis(Boc)PCH, Et3N; (v) TFA. 
Of particular relevance to the present work is Honda's report[I IJ on the synthesis of 
various 4-guanidino-7-substituted Neu5Ac2en derivatives including compound 27, an 
analogue of 7-arninosialic acid (5) (Scheme 1.7). The key step in the synthesis 
involved an aldol condensation of 4-azido-N-acetyl-D-mannosamine 29 (prepared 
from precursor 28 in three steps) with sodium pyruvate in the presence of Neu5Ac 
aldolase. By such means the desired 7-azido-Neu5Ac 30 was obtained in 80% yield. 
The conversion of compound 30 into target 27 was achieved in eight steps. This is the 
only reported approach to such systems and since it involves an enzyme-catalyzed 
coupling process it is anticipitated that there would be some significant restrictions on 
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its broad application. As a consequence, the development of strictly chemical methods 
for the synthesis of 7-amino-Neu5Ac (5) appears warranted. Work pertinent to the 
development of such methods is outlined in the following sections. 
HO 
VNHAc 
HO Hd 
7 
1-lll lV OH 
N,j'',,,,·· AcHN ·•,,.~ NHAc 
~C02H 
OH Hd 
28 29 30 l v-x 
HO HO HO 
< 7 
Hd Xll Xl 
AcHN C02H C02Me 02Me 
HN -< BocN -< BocN $ 
>-~ >-~ >-~ H2N H BocHN H BocHN H 
27 32 31 
Scheme 1.7: Honda's Synthesis of 7-Aminosialic Acid Derivative 27 
Reagents: (i) NaN3, Dowex-50W (Ir); (ii) TFA, Ac2O then 3 N HCl; (iii) NaOAc, Ac2O; (iv) Neu5Ac 
aldolase, sodium pyruvate, pH 7.5; (v) MeOH, Dowex-50W (Ir); (vi) Ac2O, HOAc, H2SO4 (cat.); (vii) 
NaN3, Dowex-50W (Ir); (viii) H2, Lindlar catalyst; (ix) Bis(Boc)PCH; (x) NaOMe, MeOH; (xi) H2, 
Lindlar catalyst; (xii) NaOH then TFA. 
1.4 Application of cis-1,2-Dihydrocatechols 33 to the Synthesis 
of Carbohydrates 
1.4.1 Production and General Utility of cis-1,2-Dihydrocatechols 33 
There are two maJor advantages to usmg cis-1,2-dihydrocatechols 33 as starting 
materials in the synthesis of rare and complex carbohydrates. The first is that these 
"diols" are readily available in essentially enantiopure form (> 99% e.e.) and large 
quantity by biocatalytic oxidation of the corresponding arenes using the genetically-
engineered micro-organism Escherichia coli JM109 (pDTG60l).[25J Thus, one litre of 
the appropriate fermentation broth can provide up to 35 g of the desired metabolite 
(Scheme 1.8). The absolute stereochemistry of diols 33 generated in this manner has 
been confirmed through various chemical correlation studies as well as single-crystal 
X-ray analyses of certain derived Diels-Alder adducts.[26] 
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9 X E.coli JM109 (pDTG601) 
I X = Cl, Br, I, CN, Me etc. I 
9 .. ,DH .,,,,,,OH X 
33 
12 
Scheme 1.8: Biotransformation of Arenes to Diols 33 with E. coli JMl 09 (pDTG601) 
The second attraction to employing these diols in the synthesis of carbohydrates is 
that they can engage in a wide range of chemical reactions and without the need to 
employ complex protecting group strategies (Figure 1.1). This happy circumstance 
arises because the two hydroxy groups within these compounds are in sterically 
distinct environments and can, therefore, be manipulated in a selective manner. The 
cis-vicinal-diol moiety within these compounds also has great influence on the facial 
selectivity associated with the addition of reactants to the carbon-carbon double bonds 
of the adjacent cyclohexadienyl unit. Furthermore, this diene unit can engage in 
various chemical transformations in a diastereo- and/ or regio-controlled manner as 
determined by the nature of the X substituent and/or whether or not the cis-vicinal-
diol moiety is present in either a free or protected form. In addition, the X substituent 
offers the possibility for derivatisation as, for example, via cross-coupling chemistry 
(when X = halogen). Finally, the use of readily available isotopically labelled versions 
of the cis-1,2-dihydrocatechols 33 allows for access to labelled carbohydrates 
incorporating 2H-, 13C- and/or 170- at specific positions. As such, cis-l ,2-
chemically more sterically more 
_r_ea_c_ti_ve __ ___, ~ { accessible 
site of regioselective 
cycloaddi tion { 9 ,,,\OH } · 11 d' · _ ··· _ stenca y rrectmg ::,..., .,,, element ~ ~H ------~ 
X 
L 1) sterically directing element 2) good leaving group (if X = halogen) 
3) derivable group 
(ifX = CH3 or CN) 
Figure 1.1: Reactivity Patterns Associated with cis-1,2-Dihydrocatechols 33 
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dihydrocatechols 33 are, indeed, well-suited for the synthesis of many carbohydrates 
as exemplified by the work detailed in the following section. 
1.4.2 Relevant Synthetic Applications of cis-1,2-Dihydrocatechols 33 
cis-1,2-Dihydrocatechols 33 have already provided access to a wide range of 
carbohydrates and structurally related cyclitols. Examples of target molecules include 
(±)-pinitol/27J aldo-tetroses, -pentoses and -hexoses/28] sialic acids/22,29J 
mannojirimycin and ( + )-kifunensine,[30J 17O-labelled aldohexoses,[3IJ 2H-labelled D-
mannose. [32J Among them, N eu5Ac (1) and mannojirimycin are of particular 
relevance to the present work. Consequently, and in order to put the author's own 
work in appropriate context, a detailed description of these syntheses is now 
presented. 
(a) Neu5Ac (1) 
A diastereoselective synthesis of Neu5Ac (1) from cis-1,2-dihydrocatechol 33 (X = 
Cl) (Scheme 1.9) has recently been completed by Banwell and De Savi. [22J In essence, 
the synthetic strategy adopted is based upon the "3 + 6" approach as detailed earlier, 
and wherein ethyl a-(bromomethyl)acrylate (12) is employed as the three-carbon 
pyruvate anion equivalent while aldehyde 41 [a derivative of ManNAc (7)] serves as 
the required six-carbon synthon. There were two key challenges involved in this 
synthesis. One came from the preparation of a configurationally stable D-
mannosamine derivative, viz. 41, from diol 33 (X = Cl), and the other from the 
diastereoselective condensation of such a derivative with acrylate 12. The elaboration 
of precursor 33 (X = Cl) into compound 41, which highlights the diverse reactivity 
patterns associated with the former compound, followed the early steps of Hudlicky' s 
total synthesis of the six-carbon azasugar mannojirimycin[30J (see Scheme 1.10). Thus, 
the acetonide derivative, 34, of diol 33 was converted into the cis-azido-alcohol 35 by 
the established procedures. O-Benzylation of compound 35 under the conventional 
conditions then gave the benzyl-ether 36 which was subjected to ozonolytic cleavage 
and reductive workup with sodium borohydride to afford the diol 37. Hydrogenolysis 
of compound 37 using 10% Pd/C as catalyst resulted in the formation of aminotriol 38 
which was immediately treated with benzyl bromide to give the dibenzylated amine 
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39. Treatment of this last species with acetone in the presence of TfOH as catalyst 
afforded the bis-acetonide 40 which led, via Swem oxidation, to the desired aldehyde 
41. The coupling of the three-carbon unit 12 with the six-carbon unit 41 was achieved 
Bn2N 
9·"'''°H .. ,,,,,OH
X 
33 
(X = Cl) 
40 
41 
AcO 
Accf 
I 
Vll 
~ 
Ac6 
47 
.. ,,,,,Q N3 .,,,,,Q 
,,,,,j< 11 .. ,,,,j< ~ 
···c35R=H 
m 36 R = Bn 
j iv 
OH 
R2N .. ,,,,,0 N3 
""'ox 
.,,,,~ 
V 
-.,,,,,o 
. r---- 38 R= H 
VIL- 39 R= Bn 
12 
IX 
... r- 42X=CH2,R=OH,R1 =H 
Vlll L- 43 X=CH RR1 = 0 ----2, ' J X 
. r---- 44 X = CH2, R = H, R1 = OTMS 
XI L- 45 X = 0 R = H R 1 = OTMS 
Xlll 
' ' 
AcO 
Accf 
j xii 
Accf 
46 
Scheme 1.9: Total Synthesis of (-)-Neu5Ac Derivative 47 from Diol 33 (X = Cl) 
Reagents and conditions: (i) see reference 33; (ii) see reference 34; (iii) NaH then BnBr; (iv) 0 3, -78 
~C, then NaBH4; (v) H2 (50 psi), 10% Pd/C; (vi) BnBr, K2CO3; (vii) Me2CO, TfOH (cat.); (viii) 
(COCl)i, DMSO, -78~0 °C, then Et3N; (ix) Zn dust, sat. aq. NH4Cl; (x) NaBH4 then TMSCl, HMDS; 
(xi) AD-mix-a then Pb(OAc)4; (xii) 6% w/v HCl in MeOH then Ac2O, DMAP (trace); (xiii) Pd black 
then Ac2O, DMAP (trace). 
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using zinc dust and the anti-addition product 42 (85% at 90% conversion) was 
obtained as the essentially exclusive product of the reaction. Swem oxidation of the 
latter material then provided the highly unstable ketone 43 which was immediately 
reduced, in a diastereoselective manner, with N aBH4• The resulting alcohol was 
protected as the corresponding TMS-ether 44. Since ozonolysis of the C-C double 
bond within compound 44 resulted in competing oxidation of the N,N-dibenzyl 
moiety, the required a-keto unit was unmasked by a two-step procedure involving 
initial reaction with AD-mix-a then cleavage of the glycol so-formed with lead 
tetraacetate. In this manner, the unstable ketone 45 was formed. Treatment of 
compound 45 with methanolic hydrochloric acid followed by acetylation then 
afforded the nonulosonic acid derivative 46. Debenzylation of this last compound was 
readily achieved using formic acid-palladium black and the ensuing amine was then 
acetylated to deliver the sialic acid derivative 47 in reasonable overall yield. 
(b) Mannojirimycin 
Mannojirimycin (52) is an endo-nitrogenous six-carbon azasugar which inhibits 
certain carbohydrate processing enzymes. An ingenious route to this compound from 
cis-1,2-dihydrocatechol 33 (X = Cl) has been established by Hudlicky and his co-
workers[30J (Scheme 1.10) and exploits various significant reactivity patterns 
associated with cis-1,2-dihydrocatechols 33. Thus, the diene unit within this starting 
material could be manipulated in a regio- and diastereo-controlled manner through 
initial formation of epoxide 48. The three-membered ring within compound 48 allows 
for attachment of a wide variety of substituents (i.e. NH2, H, F, R etc.) to the 
cyclohexene ring and, thereby, access to amino-, desoxy- or fluoro-derivatives of the 
aldohexoses and cyclitols. For example, and as seen in Hudlicky's work, ring-opening 
of epoxide 48 with lithium chloride in the presence of ethyl acetoacetate (EAA) gave 
a trans-chlorohydrin which was converted to the cis-azido-alcohol 35 via a SN2 
displacement reaction with lithium azide. The key step in the synthesis involved 
ozonolytic cleavage of the chloroalkene moiety within compound 35 and, in this 
manner, the hydroperoxy intermediate 49 was obtained. Treatment of the latter with 
sodium cyanoborohydride then gave the y-lactone 50 which was converted, upon 
reaction with DIBAL-H, into the lactol 51. Exposure of this last species to 
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trimethylphosphine then water (Staudinger reduction) resulted in the formation of a 
1 °-amine which underwent rearrangement to give, after appropriate deprotection, 
mannojirimycin (52). 
H 
48 
OH 
52 
1-11 
Vl-Vll 
35 
~3 
HO~H 
6~ 
51 
111 
V 
Scheme 1.10: Hudlicky's Synthesis of Mannojirimycin (52) 
49 
~3 
o~OH 
6xb 
50 
Reagents: (i) LiCl, EAA; (ii) NaN3; (iii) 0 3, MeOH, H2O, NaHCO3; (iv) NaBH3CN, pH 3; (v) DIBAL-
H, -78 °C; (vi) PMe3, THF, H2O; (vii) TFA, H2O. 
1.5 Aims of the Research Work Described in this Thesis 
The aims of the research work described in this thesis are summarized in Figure 1.2. 
The first was to establish an effective route from enantiopure cis-1,2-dihydrocatechol 
33 (X = Cl) to ketone 53 which was viewed as a potential precursor to 7-aminosialic 
acid (5). The second aim, which followed from unexpected outcomes involved in 
pursuing the first, was to establish efficient and flexible methods for the preparation 
of D-talose (92), DMJ (105) and Rha-DMJ (116) from cis-1,2-dihydrocatechol 33 (X 
= Cl). 
On the basis of the foregoing, Chapter 2 describes the elaboration, in a regio- and 
stereo-controlled fashion, of ketone 53 from cis-1,2-dihydrocatechol 33 (X = Cl). 
Chapter 3 describes exploitation of epoxide 60 [ formed in the course of converting 
cis-1,2-dihydrocatechol 33 (X = Cl) into ketone 53] in the synthesis of differentially 
protected derivatives of D-talose (92). 
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Chapters 4 and 5 detail the syntheses of two biologically important and naturally-
occurring azasugars, viz. 1-deoxymannojirimycin (DMJ, 105) and 6-0-a-L-
rhamnopyranosyl-DMJ (Rha-DMJ, 116) from cis-1,2-dihydrocatechol 33 (X = Cl). 
The ready access to the targeted compounds provided by the routes described in the 
following chapters should assist in exploration of the therapeutic potential of these 
novel carbohydrates. 
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Figure 1.2: Summary of the Research Objectives and Outcomes Presented in the 
Following Chapters 
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2.1 Overview 
As noted earlier, sialic acid analogues such as Relenza™ (2i1J and a series of 7-
carbamate derivatives, 3, (2J of the latter have been used as agents for the treatment 
and/or detection of influenza. Furthermore, 7-alkoxy derivatives, 4/3J of Relenza™ (2) 
are also potent inhibitors of the influenza viruses. In this connection, there is 
considerable interest in accessing novel sialic acid analogues such as the little 
known[4J 7-aminosialic acid (5). 
HO 
NH 
G- ~ 
HN NH2 
~-
d d 
2 3 
Alkyl\._ 
HO 0 HO 
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As shown in Figure 2.1, our synthetic approach to 7-aminosialic acid (5) exploits key 
elements of the previously reported "3 + 6" method for constructing Neu5Ac (ti5J 
from cis-1,2-dihydrocatechol 33 (X = Cl). Thus, it was envisaged that target 5 could 
be accessed in a similar way from the three-carbon pyruvate anion equivalent ethyl a-
(bromomethyl)acrylate (12) and the diaminated 6C unit 54 (a D-mannosamine 
derivative). Given that the 3 C unit is readily available, elaboration of diol 33 into the 
required 6C unit represented the key challenge associated with the present work. 
Since it was anticipated that this latter fragment could be prepared from the 
corresponding ketone 53 via a reductive amination process, the key aspect of the 
present work was the development of an effective synthesis of compound 53. 
Consequently, this chapter details successful efforts directed towards the preparation 
of compound 53 from diol 33 (X = Cl). As the two hydroxy moieties within diol 33 
are destined to undergo distinct transformations in the course of the proposed 
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synthesis of target 53, implementation of selective and differential protection regimes 
represents a crucial aspect of the initial stages of the synthesis, details of which are 
provided in the following section. 
OMOM 
y··"'°H BocHN 5 6 .. ,, 6 2 
''''OH MEMO i •-,~o 
X 0~ 
33 
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!J nOEt 
HO OMOM 
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-- 0~ Hd 
5 54 
Figure 2.1: Proposed Synthetic Approach to Target 5 and Identification of Ketone 53 
as a Key Intermediate 
2.2 Early Stages of Synthesis: Unexpected Formation of Piperidinone 77 
2.2.1 Synthesis of cis-Azido-alcohol Derivative 69 
The synthetic pathways leading to derivatives of trans-chlorohydrin 62 from cis-1,2-
dihydrocatechol 33 (X = Cl) are shown in Scheme 2.1 and start with the selective 
mono-protection of diol 33 using tert-butyldiphenylsilylchloride (TBDPS-Cl). Thus, 
in keeping with the earlier work on its iodo-congener, [6] treatment of diol 33 (X = Cl) 
with TBDPS-Cl in the presence of imidazole as base led to the selective mono-
protection of the less sterically hindered C-3 hydroxy group thus forming the mono-
TBDPS-ether 55 together with small amounts of its regio-isomer 56. This unstable 
mixture was immediately O-acetylated under standard conditions to afford the 
differentially protected diol 57 (78% from 33) which could be readily separated from 
its co-produced regioisomer 58 (16% from 33) by flash chromatography. Like the 
mono-protected counterparts 55 and 56, compound 57 was particularly prone to 
9 ... ,,,,0H ··,,,,,,OH 
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Scheme 2.1: Pathways to Derivatives of trans-Chlorohydrin 62 
24 
Reagents and conditions: (i) TBDPS-Cl (1. 1 mol equiv.), imidazole (2.7 mol equiv.), CH2Cl2, 18 °C, 1 
h; (ii) Ac2O (2.0 mol equiv.), DMAP (cat.), py, 18 °C, 2 h; (iii) m-CPBA (1.0 mol equiv.) , CH2Ch, 0-
18 °C, 18 h; (iv) Method A: LiCl (5.0 mol equiv.), EAA (3.0 mol equiv.) , THF, 44-46 °C, 86 h; 
Method B: LiCl (5.0 mol equiv.), HOAc (3.0 mol equiv.), THF, 18 °C, 70 h; (v) LiN3 (3.2 mol equiv.) , 
DMF, 18 °C, 64 h; (vi) Ac2O, DMAP (cat.), py, 18 °C, 2 h; (vii) NH4OH, THF, 18 °C, 20 h then Ac2O, 
PY, 18 °C, 24 h; (viii) LiN3 (3.0 mol equiv.), DMF, 18 °C_, 96 h. 
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elimination processes (leading to aromatic products) so it was immediately subjected 
to the next step of the reaction sequence, namely selective epoxidation of the non-
chlorinated double bond using m-CPBA. In this manner, two diastereoisomeric 
epoxides 59 (58%) and 60 (18%) were obtained after separation by flash 
chromatography, with the predominance of the former product being dictated by the 
sterically demanding TBDPS and (to a lesser extent) acetyl moieties directing 
epoxidation to the less congested ~-face of the non-chlorinated double bond within 
substrate 57. The appearance of three additional signals (relative to the eighteen seen 
in isomer 59) in the low-field region of the APT 13C NMR spectrum of the minor 
isomer 60 is attributed to the restricted rotation of the aromatic rings associated with 
the TBDPS group in this highly congested 'all-cis' substituted cyclohexene. 
Confirmation of the structure of products 59 and 60 follows from a single-crystal X-
ray analysis of the latter (see Figure 2.2, Experimental section 6.2 and Appendix A 
2.1). 
After the epoxidation, the next task was to prepare trans-chlorohydrin 62. This could 
be achieved through the diastereo- and regio-controlled 'ring-opening' of epoxide 59 
with LiCl in the presence of EAA[7J or HOAcJ81 EAA functions as a solvent capable 
of dissolving both the substrate 59 and LiCl thereby promoting formation of the 
solubilized lithium ion (Li+) which acts as the catalyst. Both conditions gave high 
yields of the desired product 62 (88% with EAA and 86% with HO Ac) and small 
amounts of diastereoisomer 61 (8% with EAA and 3% with HOAc). Fortunately, like 
epoxide 60, cis-chlorohydrin 61 could be readily crystallized and this permitted a 
single-crystal X-ray analysis to be undertaken (see Figure 2.3, Experimental section 
6.2 and Appendix A 2.2). 
With compound 62 in hand, attention was focused on the conversion of this material 
into cis-azido-alcohol 63 (Scheme 2.1) then to protect the free OH group in the latter, 
probably as a methoxymethyl (MOM) ether. A common way to prepare an azido-
alcohol like compound 63 involves displacement of the chloride moiety within a 
halohydrin (halogen = Cl, Br or I) by azide ion (N3-) via a SN2 reaction, a process 
often facilitated by using DMF as solvent. However, when compound 62 was 
subjected to treatment with LiN3 three new products were formed as evidenced by 
TLC analysis. After separation by flash chromatography, the first was identified as the 
expected compound 63 (37%) while the other two proved to be the TBDPS-migration 
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Figure 2.2: ADEP (with 50% Probability Ellipsoids) of Compound 60 Derived from 
X-ray Crystallographic Data 
(This analysis was conducted by Dr A. J. Edwards at The Australian National University) 
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Figure 2.3: ADEP (with 50% Probability Ellipsoids) of cis-Chlorohydrin 61 Derived 
from X-ray Crystallographic Data 
(This analysis was conducted by Dr A. C. Willis at The Australian National University) 
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products 64 and 65. The structure of compound 65 was confirmed through a single-
crystal X-ray analysis of the corresponding O-acetyl derivative 67 (see Figure 2.4 and 
Appendix A 2.3). Compound 67 could also be prepared by reaction of precursor 62 
with aqueous ammonia in THF, and presumably by a process which involves mono-ol 
65 as intermediate, followed by O-acetylation under the usual conditions. Treatment 
of the diacetate 67 with LiN3 led, in a completely stereo-controlled fashion, to the 
azide 66 (94%) which was identical, in all respects, with the O-acetylated derivative 
66 derived from compound 64. As a result, the structure of compound 64 was 
confirmed. 
Based on the foregoing, it seemed clear that direct conversion of the trans-
chlorohydrin 62 into the cis-azido-alcohol 63 was not as efficient as expected due to 
the propensity of the TBDPS group to migrate under the reaction conditions 
employed. However, the ready conversion of the diacetate 67 into the azide 66 
indicated that the required azido-alcohol derivative 69 (Scheme 2.2) could be 
prepared in an alternative way from the MOM-protected chlorohydrin 68. Indeed, this 
latter pathway to target 69 proved remarkably successful. Thus, substrate 62 was 
treated with dimethoxymethane in the presence of P2O5. [9J Under such conditions 
acetal 68 was obtained as the exclusive reaction product and in excellent yield (90% ). 
Following this protection step, treatment of chloride 68 with LiN3 resulted in the 
formation of the desired cis-azido-alcohol derivative 69 (93%) which was obtained as 
a clear, colourless oil. All of the physical, analytical and spectroscopic data obtained 
on compound 69 were in full accord with the assigned structure. An accurate mass 
measurement on the prominent fragment ion (M-C4H9·)+ observed at m/z 472 in the 70 
e V EI mass spectrum suggested the molecular formula for this compound is 
C26H32ClN3O5Si. The infrared (IR) spectrum established the presence of the azide 
OH OMOM OMOM 
Cl,,,,,, 
,., ,,. 
,,,,OTBDPS 
1 
Cl11,,,, 
••. 
,,,,OTBDPS 
,,., N3 ,,, OTBDPS 
.•• 
11 
.. ,,,,,OAc .. ,,,,OAc ··,,,,,OAc 
Scheme 2.2: Elaboration of trans-Chlorohydrin 62 to Compound 69 
Reagents and conditions: (i) CHi(OMe)2, P2O5, 18 °C, 0.5 h; (ii) LiN3 (3.0 mol equiv.) , DMF, 18 °C, 
96 h. 
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Figure 2.4: ADEP (with 50% Probability Ellipsoids) of Compound 67 Derived from 
X-ray Crystallographic Data 
(This analysis was conducted by Dr A. J. Edwards· at The Australian National University) 
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group by virtue of the appearance of a strong absorption band at 2101 cm-1. The 75 
MHz APT 13C NMR spectrum (Figure 2.5) displays the expected twenty signals. The 
five quaternary and sp2-hybridised carbons resonate at 8 169.6, 133.0, 132.5, 132.4 
and 19.3, whilst the protonated aromatic carbons are observed in the expected region 
(at 8 135.9, 135.6, 130.1, 129.8, 127.8 and 127.4). The signal at 8 123.8 is assigned to 
the protonated olefinic carbon while the signals at 8 77.2, 70.7, 69.5 and 55.8 are 
attributed to the methine carbons, C-4, C-2, C-3 and C-5, respectively. The resonances 
associated with the methoxy and methyl groups could be discerned at 8 57 .4 (OCH3), 
26.7 (three overlapping signals arising from the three methyl carbons associated with 
the tert-butyl moiety) and 20.4 ( corresponding to the acetate methyl moiety) whilst 
the remaining signal, at 8 97 .5, is ascribed to the dioxygenated methylene carbon 
associated with the MOM group. All of the required thirty-two proton resonances are 
observed in the 1H NMR spectrum (see Experimental section 6.2) thus providing 
further support for the assigned structure. 
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Figure 2.5: 75 MHz APT 13C NMR Spectrum of Compound 69 
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2.2.2 Proceeding to Compound 77 
With the azide 69 in hand, the next challenge was to effect ozonolytic cleavage of the 
chloroalkene moiety and thereby generate, after reductive workup, the hydroxyester 
71 (Scheme 2.3). To such ends, a methanolic solution of substrate 69 was ozonolyzed 
in the presence of pyridine to give the hydroperoxy hemiacetal 70 which was 
obtained, after purification by flash chromatography on silica, as a clear, colourless 
oil. All analytical, physical and spectroscopic data acquired on compound 70 were 
completely consistent with the assigned structure. For example, the APT 13C NMR 
spectrum displayed the expected twenty-one signals with the most diagnostic one 
appearing at 8 106.6 which is assigned to the methine carbon bearing the hydroperoxy 
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Scheme 2.3: Reaction Sequence Leading to Piperidinone 77 
Reagents and conditions: (i) 0 3, py (10.0 mol equiv.) , MeOH, -78 °C, 1 h; (ii) Nal (6.1 mol equiv.), -
78~0 °C, 1 h then NaBH4 (15.7 mol equiv.), 0 °C, 4 h; (iii) MEM-Cl (8.1 mol equiv.) , DIPEA (10.0 
mol equiv.), CH2Ch, 18 °C, 16 h; (iv) L~ (8.2 mol equiv.), THF, -78 °c , 6 h; (v) 2,2-DMP, p-
TsOH (cat.), 18 °C, 3 h; (vi) H2 (1 atm), (Boc)20 (21.3 mol equiv.), 5% Pd/C, EtOAc, 18 °C, 20 h; (vii) 
TBAF (1.5 mol equiv.), THF, 18 °C, 0.75 h; (viii) DMP (3.0 mol equiv.), CH2Ch, 18 °C, 24 h. 
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and methoxy moieties. The appearance of a proton resonance at 8 9 .18 (br s) in the 1 H 
NMR spectrum provided further support for the presence of the hydroperoxy moiety 
in the assigned structure. Interestingly, when the above-mentioned conversion was 
conducted in the absence of pyridine the reaction was much slower (12 h vs. 1 h). 
Treatment of compound 70 in situ with sodium iodide is presumed to generate the 
corresponding aldehyde and this species was then reduced by the added N aBH4 to 
give the originally sought-after hydroxyester 71 in 49% yield. 
In the next step of the reaction sequence, protection of the OH group within 
compound 71 was required since this function would otherwise complicate the 
anticipated conversion of the TBDPS-masked OH moiety into the corresponding and 
targeted ketone unit. In this connection, then, compound 71 was treated with 2-
methoxyethoxymethylchloride (MEM-Cl) using DIPEA[IOJ as base and the MEM-
ether 72 was thereby obtained as a clear, colourless oil and in 87% yield. 
As a result, the final target, viz. ketone 53, seemed within sight. However, treatment 
of compound 72 with lithium aluminium hydride in THF at -78 °C afforded not the 
desired diol but, unexpectedly, product 73 which was formed via a 1,3-shift[llJ of the 
TBDPS group. Presumably the driving force for this process, which most likely 
occurs intramolecularly via a six-centered transition state, is the relocation of the 
bulky TBDPS group to the sterically less-congested terminal position of the 
polyhydroxylated carbon framework. Compound 73 was readily converted into the 
acetonide derivative 74 under standard conditions[12J and hydrogenolysis[ 13J of the 
latter species using 5% Pd/C as catalyst resulted in the formation of an amine 
intermediate which reacted with the added di-tert-butyldicarbonate [(Boc)2O] thereby 
giving the Boe-protected amine 75 in excellent yield (95%). Exposure of the last 
compound to TBAF[14J gave rise to the primary alcohol 76 (92%) which led, upon 
treatment with Dess-Martin periodinane (DMP)/15] to unexpected product 77 (92%). 
All physical, analytical and spectroscopic data obtained on compound 77 were fully 
consistent with the proposed structure. For instance, the 70 eV EI mass spectrum 
showed an intense molecular ion M+· at m/z 449 and an accurate mass measurement 
on this species established the molecular formula as C20H35NO10. The 75 MHz APT 
13C NMR spectrum (Figure 2.6) displayed all of the expected seventeen resonances 
with the most diagnostic signals being located at 8 167 .4 (being assigned to the Boe 
carbonyl) and 152.3 (assigned to the carbonyl carbon of the lactam ring). The 
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presence of the two carbonyl moieties was, in tum, confirmed by the two intense 
absorption maxima observed at 1775 and 1727 cm-1 in the IR spectrum. 
The likely pathway leading from compound 76 to piperidinone 77 is shown in Figure 
2. 7. Some support for this proposal follows from oxidation of the former compound 
with pyridine-buffered DMP[16J which delivered two chromatographically separable 
products, viz. 77 and 79 (Scheme 2.4). The latter product, which was obtained as a 
mixture of epimers as judged by 13C NMR analysis, could be converted into the 
former product by reaction with DMP in the absence of pyridine. Furthermore, 
treatment of compound 77 with NaBH4 in methanol afforded alcohol 76 which was 
identical, in all respects, with an authentic sample. 
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Reagents and conditions: (i) DMP (4.1 mol equiv.) , py (excess) , CH2Ch, 18 °C, 2 h; (ii) DMP (4.9 mol 
equiv.), CH2Ch, 18 °C, 2 h; (iii) NaBJLi (excess), MeOH, 18 °C, 24 h. 
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It is interesting to note that hydrogenolysis of azide 72, by the same means as 
employed in the conversion 74~75, afforded products 80 and 81 (Scheme 2.5), with 
the latter presumably arising via nucleophilic attack of the newly revealed amine 
moiety at the methyl ester unit. Treatment of a methanolic solution of compound 80 
with N aBH4 gave three chromatographically separable products, 82, 83 and 84. The 
first, 82, proved to be a de-acetyl derivative of compound 80 while the other two, 83 
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OMOM 
,,,\OTBDPS 
·•' 
.,,,,,,OAc 
OMe 
72 
·•' 
,,,\OTBDPS 
.,,,,,,OH 
OMe 
82 
1 
+ 
BocHN 
BocHN 
BocHN 
OMOM 
,,,\OTBDPS 
·•' 
OMe 
80 j ii 
,,,\OH 
·•' 
.,,,,,,OH 
TBDPS 
83 l iii 
OMOM 
.,,,\\\\0 
.. ,,;;< 
TBDPS 
75 
Boe 
+ 
N !'OH 
MEM~ 
MoMO o+ 
87 
0 
OAc 
+ 
OTBDPS 
MEMO OMOM 
81 
OMOM 
BocHN ,,,\OH 
·•' 
MEMO 
.,,,,,,OTBD PS 
j iv 
OMOM 
BocHN .,,,Dt 
0 MEMO I 
TBDPS 
85 
VI 
BocHN 
86 
Reagents and conditions: (i) H2 (1 attn), 5% Pd/C, (Boc)20 (3.0 mol equiv.), EtOAc, 18 °C, 36 h; (ii) 
NaBH4 (excess), MeOH, 18 °C, 20 h; (iii), (iv) 2,2-DMP,p-TsOH (cat.), 18 °C, 5 h; (v) TBAF (1.4 mol 
equiv.), THF, 18 °C, 2 h; (vi) DMP (5.1 mol equiv.), CH2Cli, 18 °C, 6 h. 
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and 84, were the TBDPS-migration products. The 70 eV EI mass spectra of both 
compounds 83 and 84 displayed intense fragment ions (M-C4H9OH-C4H9·)+ at m/z 
520 and accurate mass measurements on these species established the expected 
elemental composition of both as C33H53NO10Si. However, final confirmation of the 
structures of compounds 83 and 84 was achieved through derivatisation studies. Thus, 
treatment of compound 83 with 2,2-DMP under standard conditions resulted in the 
formation of the acetonide derivative 75 which was identical, in all respects, with the 
material prepared from compound 74 (see Scheme 2.3). This led to the identification 
of compound 83 as that formed via a 1,3-shift of the TBDPS group. In a similar way, 
regioisomer 84 was converted into the acetonide derivative 85 (92%) which afforded, 
upon reaction with TBAF, the alcohol 86 (93 % ). Further oxidation of compound 86 
with DMP resulted in the conversion of the C-OH moiety into the carbonyl (C=O) 
which cyclised spontaneously with the Boe-amine function and in this way, product 
87 (80%) was obtained as a clear, colourless oil. All physical, analytical and 
spectroscopic data obtained on compound 87 supported the proposed structure. For 
example, the intense absorption maxima observed at 3467 and 1697 cm-1 in the IR 
spectrum supported the presence of both the OH and the C=O moieties. The APT 13C 
NMR spectrum displayed the expected eighteen signals with the most diagnostic one 
being located at 8 89.7 and assigned to the carbon carrying the free OH group. An 
accurate mass measurement on the fragment ion (M-OH·)+ observed at m/z 434 in the 
low-resolution mass spectrum confirmed the molecular formula C20H37NO10. With the 
structural confirmation of compound 87, the constitutions of compounds 84, 85 and 
86 were thereby established. Clearly, compound 84 was formed via a 1,2-shift[l IJ of 
the TBDPS group during the reduction of compound 80. 
2.3 Targeting Ketone 53 
With an awareness of the facility with which the TBDPS group migration can occur 
during reduction of compounds 72 and 80, a new approach to target 53 had to be 
devised. One option was to remove the TBDPS group after the reduction process then 
to re-order the acetonide formation and oxidation steps. As such, two routes to 
compound 53 were pursued (Scheme 2.6). The first (path a) employed compound 80 
as starting material and the initial step involved its treatment with N aBH4 then TBAF. 
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As a result, triol 88 was obtained as a clear, colourless oil and in 52% yield. Reaction 
of this last species with 2,2-DMP in the presence of p-TsOH afforded mono-ol 89 
(82%) which was different from the previously observed two regioisomers 76 and 86 
as judged by comparison of the relevant 1 H NMR spectral data ( see Experimental 
section 6.2). Furthermore, and as anticipated, oxidation of the alcohol 89 with DMP 
delivered the by now long sought-after ketone 53 in excellent yield (96%). All 
physical, analytical and spectroscopic data obtained on compound 53 were in full 
accord with the assigned structure. For instance, the 75 MHz APT 13C NMR spectrum 
(Figure 2.8) showed the expected eighteen signals with the most diagnostic one 
appearing at 8 206.0 and being assigned to the carbon of the ketone moiety. The 
resonance appearing at 8 155.1 is assigned to the carbonyl carbon associated with the 
Boe-amine moiety. The appearance of a one-proton doublet (8 5.19, J 9.1 Hz) in the 
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Scheme 2.6: Two Routes to Compound 53 
Reagents and conditions: (i) NaBRi (excess), MeOH, 18 °C, 30 h; (ii) TBAF (1.1 mol equiv.), THF, 18 
°C, 1 h; (iii) 2,2-DMP, p-TsOH (cat.), 18 °C, 2 h; (iv) DMP (5.0 mol equiv.), CH2Ch, 18 °C, 2 h; (v) 
TBAF (1.2 mol equiv.) , THF, 18 °C, 0.5 h; (vi) 2,2-DMP, p-TsOH ( cat.), 18 °C, 0.5 h; (vii) H2 (1 atm), 
5% Pd/C, (Boc)20 (1.3 mol equiv.), EtOAc, 18 °C, 13 h. 
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low-field region of the 300 MHz 1H NMR spectrum is attributed to the proton 
associated with the BocNH unit, a feature absent in the 1H NMR spectra of 
compounds 77 and 87. The IR spectrum of compound 53 showed only one intense 
absorption band which appeared at 1716 cm-1• The 70 eV EI mass spectrum displayed 
a protonated molecular ion (M+H)+ at m/z 452 and an accurate mass measurement on 
this species established the molecular formula as C20H37NO10. 
The second and slightly more effecient route (path b) to compound 53 employed the 
diol 73 as precursor. Thus, treatment of the latter material with TBAF afforded triol 
90 (81 % ) which was readily converted into the acetonide derivative 91 (83 % ) by 
reaction with 2,2-DMP using p-TsOH as catalyst. Hydrogenolysis of this last species 
with 5% Pd/C in the presence of (Boe )20 resulted in the formation of the Boe-amine 
derivative 89 (89%) which was identical, in all respects, with the material prepared 
from the triol 88. 
2.4 Conclusions 
The work detailed in this chapter has established methods for converting cis-1 ,2-
dihydrocatechol 33 (X = Cl) into the novel Boe-protected amino-ketone derivative 53. 
The availability of this key compound should now facilitate access to the originally 
targeted 7-aminosialic acid (5). Moreover, several of the compounds produced in the 
course of this work would serve, vide infra, as effective precursors to novel sugars or 
azasugars such as D-talose (92), DMJ (105) and Rha-DMJ (116). Indeed, the pursuit 
of the latter types of target molecules became the major focus of the work described in 
the remaining chapters of this thesis whist the conversion of compound 53 into the 
originally targeted 7-aminosialic acid (5) is the subject of ongoing studies in the 
Banwell group. 
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3.1 Overview 
D-Talose [D-talo-hexose, (92)], one of the rarer D-aldohexoses, as well as certain 
deoxy-derivatives, represent key residues associated with a range of biologically 
significant entities. The first reported occurrence of this hexose was by Hesse who, in 
1902, described the isolation of a hydrate as a hydrolysis product of cocacitrin. [lJ 
More recently, D-talose has been identified[2J as the central motif associated with the 
aminoglycoside hygromycin B (produced by S. hygroscopicus) which acts as a broad 
spectrum antibiotic and is used in veterinary medicine as an anthelmintic, especially 
against acaridsJ3J 6-Deoxy-D-talose (D-talomethylose) is obtained by hydrolysis of the 
capsular polysaccharide of Gram-negative bacteria_[4J It has also been identified in an 
extracellular polysaccharide produced by the ruminal bacterium Butyrivibrio 
fibrisolvens X6C6 l [5] and in the serotype c polysaccharide antigen from Actinbacillus 
actinomycetemocomitans.[6] An O-acetylated homopolysaccharide of 6-deoxy-D-
talose (6-deoxy-a-D-talan polymer) has recently been isolated from Burkholderia 
(Pseudomonas) plantarii DSM 65357 while 3-O-methyl-6-deoxy-D-talose has been 
identified in lipopolysaccharides of Rhodopseudomonas palustris. [7J D-Talose has 
found use as a bulking and/or browning agent in food preparation. [SJ Further, since it 
also has the same natural taste as sucrose, D-talose can be used as a low-calorie 
sweetening agent.[9J The 'all-cis' arrangement of the non-anomeric hydroxy groups in 
the pyranose form of compound 92 has a number of useful implications in molecular 
recognition processes[IOJ and may be responsible for the capacity of this sugar to 
reduce molybdenum inhibition of the growth of the yeast Saccharomyces 
cerevisiae. [ 11 J 
Given the foregoing, it is not surprising that some effort has been directed to the 
preparation of the title compound and various derivatives. The most common and 
perhaps obvious route to D-talose has been by C-2 epimerization of the more abundant 
D-galactose, a conversion that can be achieved directly through the agency of various 
molybdenum species/12J or by multi-step sequences. [l 3J A practical and recently 
reported synthesis of D-talose involves a stannylene acetal-mediated epimerization 
process. [l4J The dihydroxylation of D-galactal provides another route to target 92. [l 5J 
Paulsen has also reported[16J a simple synthesis of D-talose by acetoxonium 
rearrangement of D-galactose. In related work, 1,6-anhydro-~-D-talopyranose has 
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been prepared from the C-2 epimeric 1,6-anhydro-~-D-galactopyranose by an 
oxidation/reduction sequence. [I 7] 
A concise synthesis of D-talose has recently been developed by O'Doherty[ISJ and 
involves the asymmetric dihydroxylation of furfural. * The synthesis of differentially 
protected D-talose derivatives has also been the subject of some effort with the work 
just described providing access to such species en route to the final target, i.e. 92. Not 
surprisingly, the selective manipulation of D-talose itself has also provided methods 
for accessing useful derivatives/21 J while regimes involving manipulations (including 
inversion at C-2) of a galactose derivative have also been reported. [22J Chain-
extension approaches employing the Henry reaction of D-lyxose and its derivatives 
have provided efficient syntheses of various amino-deoxy-D-talose derivatives. [23J 
CHO CHO 
H 
H 9--·'"0H ,,,,OTBDPS ·•' H H OH 
.,,,,,,OH ··,,,,,,OAc H OH H OH 
X H2OH H2OH 
33 92 93 
(X = Cl) 
For some time now, the Banwell group has been engaged in a program directed 
towards the synthesis of novel and/or rare carbohydrates from non-carbohydrate 
precursors. Two types of precursors have been exploited in this work, namely ring-
fused gem-dibromocyclopropanes [24J and 3-halo-cis-1,2-dihydrocatechols 33 (X = 
halogen). [25J Both types of compounds are available in either enantiomeric form, the 
first by resolution of the racemate, and the second through whole-cell 
biotransformation of the appropriate aromatic precursor. A key chemical step in the 
elaboration of each of these precursors to the target carbohydrate is the ozonolytic 
cleavage of the corresponding halocycloalkene followed by reductive workup, a 
strategy pioneered by Hudlicky and co-workers in their seminal studies on the 
conversion of 3-halo-cis-1,2-dihydrocatechols 33 (X = halogen) into various 
* The concise synthesis of L-talose from non-carbohydrate sources was achieved using asymmetric 
epoxidation methodology (see reference 19 and references therein). More recent syntheses of the same 
L-aldohexose have been reported by Vogel, Marshall, and Ogasawara (see reference 20). 
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aldohexoses, particularly derivatives of D-mannose 93. [26'271* As part of the Banwell 
group's efforts in this general area the preparation of a range of previously unreported 
and differentially protected D-talose derivatives from the epoxide derivative, 60, of 
diol 33 (X = Cl), is now reported. The relative ease of access to such compounds 
afforded by the present work should assist in general investigations into the chemical 
and biological properties of this rare type of D-aldohexose. Further, since 2H-, 13C-
and/or 17 O-labelled cis-dihydrocatechols 33 are rather easily produced, the 
correspondingly labelled D-talose derivatives will also be readily available by the 
pathway described here. t 
3.2 Conversion of Epoxide 60 into y-Lactone Acetonide 97 
The synthetic pathway leading to y-lactone acetonide 97, a D-talose derivative, from 
epoxide 60 is shown in Scheme 3.1. With compound 60 becoming available in large 
quantity during studies detailed in the preceding chapter, the first goal was to prepare 
the corresponding trans-diol from this precursor by appropriate opening of the 
epoxide ring. [281 However, the choice of acid catalyst for this conversion was critical. 
When phosphoric acid was employed as catalyst target 95 predominated (71 % ), 
although significant amounts (20%) of the by-product, 94, incorporating the elements 
of THF, were obtained. The latter compound could be formed via a similar pathway to 
that leading to compound 95, viz. through nucleophilic attack at the three-membered 
ring within substrate 60 by the solvent THF (Figure 3.1). In contrast, when 
hydrochloric acid in aqueous THF was employed, only minor amounts (12%) of the 
required compound, 95, was obtained with the predominant product being the 
corresponding and crystalline trans-chlorohydrin 98 (55%) (Scheme 3.2). 
Confirmation of the structure of the latter followed from a single-crystal X-ray 
analysis (see Figure 3.2, Experimental section 6.3 and Appendix A 2.4). 
* For a very useful review on the synthesis of monosaccharides from non-carbohydrate sources see 
reference 27b. 
t For useful discussions on the value of carbohydrates incorporating such labels see reference 25d. 
9.,,,,,,0H ··,,,,,,OH 
X 
33 
(X = Cl) 
I 3 steps 
+ (see Scheme 2.1) 
,,,,OTBDPS 
.••' 
., ,,,,OAc 
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Scheme 3.1: Conversion of Epoxide 60 into y-Lactone Acetonide 97 
47 
Reagents and conditions: (i) H3PO4 ( cat.), 3 : 1 v/v THF/ H2O, 18 °C, 40 h; (ii) 0 3, py, MeOH, -78 °C, 
1 h then Nal (3.1 mol equiv.), -78~-66 °C, 3 h then NaBH4 (19.8 mol equiv.) , -60~-40 °C, 6 h; (iii) 2,2-
DMP, p-TsOH (cat.), 18 °C, 3 h. 
0111,, 
h ,,,,, ,OTBDPS _+_H_+_ 
y ·,,,~'OAc 0 
Cl 
60 
OH 
-
--HO(CH2)40Y' ,,,,,,,OTBDPS 
-H+ 
~ .,,,,,10Ac 
Cl 
94 
Figure 3.1: Mechanism of Formation of the THF-incorporated Product 94 from 
Epoxide 60 
OH OH 
,,,,OTBDPS 
.,, ,,,OTBDPS 
,,, 
Cl 
+ 
.,,,,~OAc 
Scheme 3.2: The Ring-opening of Epoxide 60 with Hydrochloric Acid 
Reagents and conditions: (i) HCl (ca. 1.0 mol equiv.), 3 : 1 v/v THF/H2O, 18 °C, 24 h. 
,,, 
,,,,OTBDPS 
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Figure 3.2: ADEP (with 50% Probability Ellipsoids) of Compound 98 Derived from 
X-ray Crystallographic Data 
(This analysis was conducted by Dr A. J. Edwards at The Australian National University) 
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With sufficient quantities of compound 95 available by the methods just described, 
the key chemical step could be investigated (Scheme 3.1). Thus, the manipulation of 
the alkene moiety within this substrate through ozonolysis and reductive workup so as 
to deliver D-talonic acid y-lactone 96 was pursued. Compound 95 was subjected to 
reaction with ozone at -78 °C in the presence of pyridine and the intermediate 
hydroperoxy species[2Se] then treated, sequentially, with sodium iodide then N aBH4 
during which time the reaction temperature was maintained between -66 °C and -40 
°C. In this way, the required compound 96 was obtained, after isolation by flash 
chromatography, in 54% yield. This last species was readily converted, by standard 
methods, into the corresponding and more easily handled y-lactone acetonide 97 
(82%). All physical, analytical and spectroscopic data obtained on this last material 
were fully consistent with the assigned structure. The appearance of two intense 
absorption maxima observed at 1803 and 1752 cm-1 in the IR spectrum indicated the 
presence of the two carbonyl units with one being incorporated in the y-lactone ring 
and the other associated with the acetyl group. The 75 MHz APT 13C NMR spectrum 
(Figure 3.3) displayed the expected twenty signals with the resonance due to the 
carbonyl carbon of the lactone appearing at 8 172.3. The signals attributed to the 
TBDPS moiety appear at 8 135.9, 135.7, 132.9, 132.1, 130.5, 128.2, 128.1, 26.7 and 
19 .4 while those due to the acetyl group are observed at 8 169 .9 and 20.6, and those 
due to the acetonide unit at 8 110.6, 25.6 and 25.5. The signal arising from the only 
methylene carbon is visible at 8 65.2. The remaining four resonances, at 8 83.6, 74.2, 
71.9 and 69.2, correspond to c ·-4, C-2, C-3 and C-5, respectively. The signals in the 
1H NMR spectrum (Figure 3.4) were well-resolved and could be completely assigned. 
For instance, the doublet (J 5.5 Hz) resonating at 8 5.58 is assigned to the oxymethine 
proton on the carbon (C-2) bearing the acetate moiety and this is coupled to the 
adjacent oxymethine proton on the C-3 which appears as a one-proton doublet (J 5.5 
Hz) at 8 4.62. Interestingly, the remaining oxymethine proton, at the C-4, in the 
lactone ring is observed as a singlet at 8 4.06. The low-resolution (70 eV) EI mass 
spectrum of compound 97 displayed a fragment ion (M-CH3·)+ at m/z 483 and a high-
resolution mass measurement on this species, together with the microanalytical data, 
established the molecular formula as C27H3407Si. 
o~~ \_J -,,/H 
~ .. ~· \~ 
AcO bTBDPS 
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Figure 3.3: 75 MHz APT 13C NMR Spectrum of Compound 97 
(Spectrum recorded in CDC13 solution) 
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3.3 Preparation of Differentially Protected D-Talose Derivatives 
The reaction sequence employed for elaboration of the y-lactone derivative 97 into 
differentially protected D-talose derivatives is shown in Scheme 3.3. The first step 
required reduction of the lactone carbonyl and after several unsuccessful attempts 
using NaBHi291 and DIBAL-H/25d] the desired outcome was achieved using 
diisoamylborane[30J and in this manner, lactol 99 was obtained as a ca. 2 : 3 mixture of 
the a- and ~-anomers and in good yield (83%). Treatment of this mixture with TBAF 
resulted in the removal of the TBDPS group and the ensuing material was 
immediately subjected to exhaustive acetylation under standard conditions. The 
resulting triacetates 100 ( 40%) and 101 ( 4 7%) could be separated by flash 
chromatography on silica. All the spectral data obtained on the separated samples of 
compounds 100 and 101 indicated that they were anomers. The 300 MHz 1H NMR 
spectra of both showed anomeric protons resonating as doublets, with compound 100 
giving rise to a signal at 8 6.18 (J 1.8 Hz) and its counterpart in 101 appearing at 8 
6.43 (J 4.5 Hz). In the 75 MHz APT 13C NMR spectrum of compound 100 the 
expected anomeric carbon resonance could be seen at 8 98.1 while the equivalent 
signal for anomer 101 appeared at 8 94.4. The 70 eV EI mass spectra of these 
0~ o✓P \_J ·,qH 
Ac(f ,~~OTBDPS 
97 
P-k 
HOJ~O 
u ·,, /,,H 
Ac6.· 
0
\-0TBDPS 
99 
11 
+ 
P-k 0 _, 0 
AcO,,,, .. ey:;v, 
,,, 
"H 
AcO-· "%-OAc 
101 
Scheme 3.3: Preparation of Differentially Protected D-Talose Derivatives 
Reagents and conditions: (i) diisoamylborane (8.7 mol equiv.), THF, 0-18 °C, 72 h; (ii) TBAF (1.2 mol 
equiv.), 18 °C, 0.5 h then Ac20, DMAP (cat.), py, 18 °C, 14 h. 
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anomers displayed significant fragment ions (M-CH3 ·) + at m/z 3 31 which are 
attributed to loss of a methyl radical from the molecular ion. Accurate mass 
measurements on these species established that both had the expected composition, 
viz. C15H22O9• Such data were fully consistent with the microanalytical data obtained 
on compound 100 (see Experimental section 6.3). However, the final confirmation of 
the stereochemistries of compounds 100 and 101 followed from a single-crystal X-ray 
analysis of the former (see Figure 3.5 and Appendix A 2.5) which also established 
that the three D-talose derivatives 99, 100 and 101 exist in furanose form. 
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Figure 3.5: ADEP (with 50% Probability Ellipsoids) of Compound 100 Derived from 
X-ray Crystallographic Data 
(This analysis was conducted by Dr A. J. Edwards at The Australian National University) 
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3.4 Structural Confirmation 
With access to the differentially protected D-talose derivatives 100 and 101 from cis-
1,2-dihydrocatechol 33 (X = Cl) now established, efforts were made to chemically 
correlate these two carbohydrates with material derived from the authentic sample of 
D-talose (92) (Scheme 3.4). To such ends, a mixture of compounds 100 and 101 was 
treated with aq. TF A so as to effect global deprotection and thereby generate D-talose 
itself. The products of this process proved extremely difficult to handle in terms of the 
analytical and spectroscopic characterization because of the ready interconversion of 
a- and ~-anomers in both the furanose and pyranose forms. Therefore, the material 
was exhaustively acetylated under standard conditions. TLC analysis of the resulting 
mixture revealed the presence of at least three fractions with two able to be isolated by 
flash chromatographic techniques. One fraction (the less mobile) contained a ca. 2: 1 
mixture of two penta-0-acetates 102 and 103 (53% combined yield) as judged by the 
1H NMR spectral analysis, whilst the other provided a single compound 104 (22%) of 
the same composition. Two of these three compounds were presumed to correspond to 
r-k 
Aco'-<0 ~
0 
LJ .'"'H 
AcO,_. "<-~OAc 
100 
0Ac 
A O 
~
0 ; 0Ac C ~,,,,,. ., 
,,✓• 
"H 
AcO_.. ·-%-OAc 
Ac0 
102 
+ 
0Ac 
103 
+ 
0Ac 
QAc 
AcO'-("O~OAc 
LJ .'"'H 
AcO,. -~~OAc 
104 
D-Talose (92) 
11 
Scheme 3.4: Structural Confirmation via Known Derivatives of D-Talose (92) 
Reagents and conditions: (i) TFA, 4 : 1 v/v THF/H20, 0-18 °C, 20 h then Ac20 , DMAP (cat.), py, 0-18 
°C, 23 h; (ii) Ac20, py, 0-18 °C, 18 h. 
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the a-forms of penta-O-acetyl-D-talopyranose 103 and penta-O-acetyl-D-talofuranose 
104, respectively, while the remaining one was thought to be the isomeric penta-O-
acetyl-~-D-talofuranose 102 based on, inter alia, the 1H NMR chemical shift (8 6.42) 
and coupling ( d, J 4.5 Hz) observed for the anomeric proton in this material. The 
above conclusions were confirmed through generation of authentic samples of 
compounds 103[311 and 104 by exhaustive O-acetylation of authentic D-talose (92) 
under standard conditions. The 1H and 13C NMR spectral data associated with 
compound 103 derived from authentic D-talose (92) were in full accord with those 
obtained from the minor component of the 2 : 1 mixture of two penta-O-acetates 102 
and 103, thus establishing that the minor component in this mixture was the penta-O-
acetyl-a-D-talopyranose 103 while the major one was the penta-O-acetyl-P-D-
talofuranose 102. Compound 104 derived from authentic D-talose (92) proved 
identical to the synthetically-derived material. Confirmation of the C-1 configuration 
of the two penta-O-acetyl-D-talofuranoses 102 and 104 follows from comparison of 
the C-1 proton and carbon resonances arising from these compounds with those due to 
their counterparts in the well-established two triacetates 100 and 101 (Table 3.1). 
Obviously, the C-1 proton and carbon chemical shifts of a-anomers 100 and 104 were 
quite similar and such similarity was also observed for the P-anomers 101 and 102. In 
contrast, the C-1 proton and carbon chemical shifts of anomers 100 and 104 were 
significantly different from their counterparts 101 and 102. On this basis, compound 
102 was confirmed as the ~-configured penta-O-acetyl-D-talofuranose and compound 
104 as the a-configured penta-O-acetyl-D-talofuranose. 
Table 3.1: Comparison of the C-1 Proton and Carbon Resonances Observed for 
Compounds 100 - 102, 104 
1H (8) 13c (8) 
100 6 .18 ( d, J l. 8 Hz) 98.1 
a-anomers 
104 6.12 (s) 97.7 
101 6.43 ( d, J 4.5 Hz) 94.4 
~-anomers 
102 6.42 ( d, J 4.5 Hz) 93.9 
The 300 MHz 1H NMR spectra of compounds 103 and 104 are presented in Figure 3.6 
while the corresponding 75 MHz APT 13C NMR spectra are shown in Figure 3.7. 
OAc 
.,,,,,,H 
AcO''''··· ··,,,,,1OAc 
OAc 
103 
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Figure 3.6: 300 MHz 1H NMR Spectra of Compounds 103 and 104 
(Spectra recorded in Cl)Cl3 solution) 
180 
180 
0Ac 
AcO''''··· ··,,,,,,OAc 
OAc 
103 
160 140 
OAc 
AcO""-<O~OAc \_J ·,qH 
~ .. -- ·-:.~ 
AcO bAc 
104 
160 140 
120 
120 
Chapter Three 
100 80 
\ 
100 80 
CDC13 
I 
60 
40 
40 
20 
20 
Figure 3.7: 75 MHz APT 13C NMR Spectra of Compounds 103 and 104 
(Spectra recorded in CDCh solution) 
58 
ppm 
ppm 
Chapter Three 59 
3.5 Conclusions 
The work detailed above has established a unique approach to a range of previously 
unreported and differentially protected D-talose derivatives using the readily available 
epoxide 60 derived from the cis-1,2-dihydrocatechol 33 (X = Cl) as starting material. 
The relative ease of access to such derivatives afforded by the present work should 
assist in general investigations into the chemical and biological properties of this rare 
type of D-aldohexose. Moreover, since 2H-, 13C- and/or 17O-labelled cis-1,2-
dihydrocatechols are rather easily prepared the correspondingly labelled D-talose 
derivatives will also be readily available by the pathway described here. 
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4.1 Overview 
The alkaloid 1-deoxymannojirimycin (DMJ, 105) has been isolated from the seeds of 
Lonchocarpus sericeus[I] and L. costaricensis (Leguminosaei2J as well as from 
cultures of Streptomycese lavendulae. [3] Like a number of other naturally occurring 
polyhydroxylated piperidines/4J DMJ displays various rather important biological 
properties. In particular, it is a potent inhibitor of several a-mannosidases. [5J Given 
the therapeutic potential arising from a capacity to control glycosidation, [6] DMJ and 
its derivatives have attracted attention as agents for the treatment of, inter alia, cancer, 
diabetes, arthritis and viral infections (HIV, flu). [6,7] As a result, various ingenious 
synthetic routes to polyhydroxylated piperidines, including DMJ (105), have been 
developed. [4,SJ One of the most elegant and effective methods has been established by 
Hudlicky and co-workers[9J who were able to convert the cis-1,2-dihydrocatechol 33 
(X = Cl) into various endo-nitrogenous azasugars such as ( + )-kifunensine and 
mannojirimycin (52). A great attraction of this approach is that compound 33 (X = 
c1i10J is available in large quantity and enantiomerically pure form via microbial 
oxidation of chlorobenzene and it can be readily elaborated into various differentially 
protected and, therefore, synthetically valuable forms of several azasugars. As 
detailed in the introductory chapter, this approach could be adapted to the preparation 
of target 105. 
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Given the foregoing and based on the unexpected generation of piperidinone 77 from 
diol 33 (X = Cl) as detailed in Chapter Two, the development of a simple synthesis of 
DMJ (105) and its derivatives seemed possible. Obviously, compound 77 embodies 
Chapter Four 64 
all the essential elements required for target 105. Furthermore, the related compound 
72 might also serve as an effective precursor to DMJ (105). As such, this chapter 
describes two different synthetic approaches to DMJ (105) with the first employing 
compounds 72 and 77 as precursors and the second ( and more direct) being based on 
an alternative approach but still involving diol 33 (X = Cl) as the ultimate starting 
material. 
4.2 The First Approach to DMJ (105) 
The initial efforts directed towards the synthesis of DMJ (105) were focused on the 
elaboration of precursor 77 into the protected DMJ derivative 106 since the latter 
should be readily converted into target 105 via global deprotection (Scheme 4.1). Two 
possible means for effecting conversion 77-+ 106 appeared possible. The first would 
involve direct removal of the lactam carbonyl within compound 77 so as to form 
compound 106. In this regard, LiA1Hi11 J and BH3-DMS[12J were investigated. 
However, neither was effective in carrying out the desired transformation. The second 
means for effecting conversion 77-+ 106 would involve a stepwise reduction with 
hemiaminal 79 as an intermediate. Although treatment of lactam 77 with lithium 
triethylborohydride[l 3J at -78 °C did give the required hemiaminal 79 ( as a mixture of 
"anomers"), the latter could not be further reduced to the corresponding (and targeted) 
piperidine 106. Since it was anticipated that the Boe protecting group could exert an 
MEMO 
0 
OMOM 
77 
111 
1 or 11 
x--
MEM 
°x 0 
MEMO OMOM 
79 
OMOM 
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········• 
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HO OH 
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Scheme 4.1: Early Studies on the Conversion of Substrate 77 into Compound 106 
Reagents and conditions: (i) LiA1H4, AlC13, THF, 0 °C or 18 °C; (ii) BH3-DMS, THF, 18 °C; (iii) 
LiEt3BH, THF, -78 °C; (iv) Et3SiH/BF3·Et2O, THF, -78~0 °C. 
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adverse effect on the required reduction steps efforts were re-directed towards initial 
removal of this group. This would then be followed by deoxygenation and global 
deprotection as defined in the ultimately successful route to target 105 (Scheme 4.2). 
In the event, treatment of compound 77 with TF A resulted in the formation of lactam 
107 (74%). All of the expected fifteen carbon resonances were observed in the APT 
13C NMR spectrum of this material while the 70 eV EI mass spectrum displayed a 
protonated molecular ion (M+H)+ at m/z 350 and an accurate mass measurement on 
this species established the molecular formula as C1sH27NOg. 
11 
0 0 
°x 1 °x 0 0 
MEM OMOM MEMO OMOM 
77 107 
lll 
HC10:~ 
HO OH 
lV ;t;c:>< 
MEMO OMOM 
105a 108 
Scheme 4.2: The First Synthetic Approach to DMJ·HCl (105a) 
Reagents and conditions: (i) TFA, CH2Ch, 0 °C, 3 h; (ii) (Boc)20 (1.5 mol equiv.) , DMAP (cat.), 
MeCN, 18 °C, 1 h; (iii) LiA1H4 (5.0 mol equiv.), THF, 18 °C, 24 h; (iv) 2.0 M HCl/MeOH, 18 °C, 7 h. 
Deoxygenation of the carbonyl unit within compound 107 was attempted using 
LiAlH4 and, indeed, the desired piperidine derivative 108 was obtained in excellent 
yield (88%). All physical, analytical and spectroscopic data acquired on compound 
108 supported the assigned structure. The APT 13C NMR spectrum of this material 
displayed the expected fifteen carbon signals with the most diagnostic one appearing 
at 8 45.6 and being attributed to the methylene moiety adjacent to the nitrogen atom. 
The absence of an absorption band in the 1600-1800 cm-1 region of the IR spectrum 
and the presence of two additional proton resonances at 8 2.94 (dd, J 14.8 and 2.8 Hz, 
lH) and 2.52 (m, lH) in the 1H NMR spectrum clearly indicated that deoxygenation 
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had been successful. The intense signal appearing at m/z 3 3 6 in the 7 0 e V EI mass 
spectrum was consistent with the protonated molecular ion (M+H)+ and an accurate 
mass measurement on this species, in association with the elemental analysis data (see 
Experimental section 6.4), confirmed the molecular formula C15H29NO7. 
The global deprotection of compound 108 was achieved by treatment of this material 
with a 2.0 M solution of hydrochloric acid in methanol at 18 °C and in this way, the 
HCl salt of DMJ (105ai 12aJ was obtained as a light-yellow solid and in quantitative 
yield. The low-resolution (ESI) mass spectrum displayed a significant protonated 
molecular ion (M+H)+ at mlz 164 and a high-resolution (FAB) mass measurement on 
this species confirmed the molecular formula C6H13NO4• The 300 MHz 1H NMR 
spectrum (Figure 4.1) and the 75 MHz 13C NMR spectrum (Figure 4.2) of the 
synthetic sample of DMJ·HCl (105a) were identical, in all respects, with those derived 
from the authentic sample purchased from Sigma™. 
With the successful conversion of compound 77 into DMJ·HCl (105a), attention was 
focused on the establishment of more efficient routes to this target. One such route 
(Scheme 4.3) started with hydrogenolysis of substrate 72 under the usual conditions 
and in this manner, lactam 81 was obtained in 87% yield. With this latter species in 
hand, the next challenge was to unmask the cis-vicinal-diol moiety and then protect 
this as an acetonide. Indeed, treatment of lactam 81 with TBAF resulted in the 
formation of diol 109 (89%) as a white, crystalline solid. All physical, analytical and 
spectroscopic data acquired on compound 109 were in full accord with the assigned 
structure. For instance, the signal appearing at 8 1 71. 9 in the APT 13 C NMR spectrum 
and the presence of a strong absorption band at 1673 cm-1 in the corresponding IR 
spectrum provided evidence for the presence of the carbonyl moiety. The one-proton 
singlet appearing at 8 6.89 in the 1H NMR spectrum was assigned to the amine unit 
while the two intense three-proton singlets at 8 3.34(4) and 3.33(9) were attributed to 
the two methoxy residues associated with the MEM and the MOM moieties. The 70 
eV EI mass spectrum displayed a protonated ion (M+H)+ at m/z 310 and an accurate 
mass measurement on this species established the molecular formula as C12H23NO8 
which was completely consistent with the elemental analysis data obtained from the 
same material. 
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Figure 4.1: 300 MHz 1H NMR Spectrum of Synthetic DMJ·HCI (105a) 
(Spectrum recorded in D2O solution) 
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Treatment of diol 109 with 2,2-DMP in the presence of p-TsOH afforded product, 107 
(92 % ), which proved identical to the material prepared from compound 77. 
Furthermore, and following the same procedures as outlined in Scheme 4.2, lactam 
107 was converted into DMJ·HCl (105a). 
0 0 
N3 ,,,,OTB DPS 
·•' OAc 
1 11 
.• ,,,,10Ac OTBDPS 
OMe MEM OMOM MEMO OMOM 
72 81 109 
l iii 
0 HCMOH P,J< °>< V IV = OH 0 
HO OH MEMO OMOM MEMO OMOM 
105a 108 107 
Scheme 4.3: An Alternative Version of the First Synthetic Approach to DMJ·HCl 
(105a) 
Reagents and conditions: (i) H2 (1 atin), 5% Pd/C, EtOAc, 18 °C, 18 h; (ii) TBAF (3.4 mol equiv.) , 
THF, 18 °C, 18 h; (iii) 2,2-DMP, p-TsOH (cat.), 18 °C, 2 h; (iv) LiAlH4 (5.0 mol equiv.) , THF, 18 °C, 
24 h; (v) 2.0 M HCl/MeOH, 18 °C, 7 h; 
Thus, two routes have been developed for the synthesis of DMJ·HCl (105a) from diol 
33 (X = Cl). The latter route (Scheme 4.3) is more efficient than the former one 
(Scheme 4.2) in that fewer steps are involved (13 vs. 16) and the overall yield is 
superior (9% vs. 3%). 
The success, as described above, in obtaining DMJ (105) from derivatives 72 and 77, 
of diol 33 (X = Cl), offers the capacity to establish even more efficient routes to target 
105. Details of efforts directed towards these ends are presented in the following 
section. 
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4.3 The Second Approach to DMJ (105) 
The new approach to DMJ (105) is shown in Scheme 4.4 and once again exploits diol 
33 (X = Cl) as "ultimate" precursor. It follows the early stages of Hudlicky' s 
synthesis of mannojirimycin (52) and involves immediate installation of an acetonide 
moiety for protection of the cis-vicinal-diol moiety. Thus, treatment of precursor 33 
9"'"0H .,,,,,Q Y"'"o 1 ... ,,,,;}< 11 .. ,,,,;}< .. ,, ,,OH 
X Cl 
33 48 
(X = Cl) j iii 
OH 
N3 ... ,,,,Q N3,,,,, .. ... ,,,,Q Cl,,,,,. .. ,,,,0 ., .
"'W;J< .. ,,,;}< lV .. ,, ,;}< + ~ ~ 
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111 110 j V 
OBn OBn OBn 
N3 ... ,,,,Q N3 ... ,,,,Q N3 .,,,,,0 
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j viii 
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Scheme 4.4: The Second Synthetic Approach to DMJ·TFA (105b) 
Reagents and conditions: (i) 2,2-DMP, p-TsOH (cat.) , 18 °C, 1 h; (ii) m-CPBA (1.0 mol equiv.), 
CH2Ch, 0-18 °C, 18 h; (iii) HOAc (3.0 mol equiv.) , LiCl (5.0 mol equiv.), THF, 18 °C, 19 h; (iv) LiN3 (3.0 mol equiv.) , DMF, 18 °C, 72 h; (v) BnBr (3.0 mol equiv.), NaH (1.6 mol equiv.), KI (cat. ), THF, 
0-18 °C, 24 h; (vi) 0 3, py (4.9 mol equiv.) , MeOH, -78 °C, 1 h then NaBH4 (11.0 mol equiv.), -1 0 °C, 3 
h; (vii) TBS-Cl (1.5 mol equiv.), imidazole (5.0 mol equiv.), CH2Ch, 18 °C, 2 h; (viii) H2 (1 atm), 5% 
Pd/C, EtOAc, 18 °C, 36 h; (ix) BHrDMS (10.0 mol equiv.), THF, 18 °C, 4.5 h then 10% Pd/C, MeOH, 
18 °C, 38 h; (x) 80% v/v TFA/H20 , 18 °C, 20 h. 
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(X = Cl) with 2,2-DMP under standard conditions afforded the well-known acetonide 
34[9] which was immediately subjected to epoxidation with m-CPBA to give the 
previously reported epoxide 4g[9J (80% from diol 33). This last species was then 
converted, in a completely regio- and diastereo-selective fashion, into trans-
chlorohydrin 110 (98%) upon reaction with LiCl in the presence of HOAc. Treatment 
of the last compound with LiN3 in DMF resulted in an SN2-type displacement and 
formation of the previously reported cis-azido-alcohol 35[9] (91 %) together with a 
small amount of diastereoisomer 111 [9J (5%). The latter product could be formed by a 
process involving a ring-closure and re-opening pathway as shown in Figure 4.3 and 
with epoxide 48 as intermediate. 
OH 
ring-closure nng-opemng 
N 31,,,,.. ..,,,,,0 
¾,__ ... ,,,,;;<-
Cl 
110 111 
Figure 4.3: Proposed Pathway to Compound 111 from trans-Chlorohydrin 110 
The free OH within compound 35 now needed to be masked in order to allow for the 
formation of lactam 114 (rather than an isomeric y-lactone) which should be readily 
converted into piperidine 115. To this end, substrate 35 was O-benzylated under 
standard conditions to give the expected ether 36[ 141 in quantitative yield. Subjection 
of the latter species to ozonolytic cleavage followed by reductive workup with N aBH4 
then afforded the alcohol 112 ( 45%). All of the physical, analytical and spectroscopic 
data obtained on compound 112 were fully consistent with the assigned structure. The 
70 eV EI mass spectrum exhibited the expected fragment ion (M-CH3·)+ at m/z 350 
which is attributed to the loss of a methyl radical from the molecular ion and an 
accurate mass measurement on this species established that it had the anticipated 
elemental composition, viz. C17H23N3O6. The most diagnostic features in the APT 13C 
NMR spectrum were the resonances appearing at 8 170.2, 61.8 and 52.2 which 
correspond to the carbonyl, the terminal oxymethylene and the methoxy moieties, 
respectively. The infrared spectrum showed strong absorption maxima at 3506, 2101 
and 1731 cm-1 corresponding to the hydroxy, azide and ester carbonyl moieties, 
respectively. In the 1H NMR spectrum the absence of a signal in the olefinic region 
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and the presence of an intense three-proton singlet at 8 3.57 provided convincing 
evidence that the ozonolytic cleavage of compound 36 had occurred to form, in an 
exclusive manner, the alcohol 112. 
The next step of the reaction sequence involved treatment of compound 112 with tert-
butyldimethylsilylchloride (TBS-Cl) under standard conditions and thus led to the 
azido-TBS-ether 113 (89%) which was obtained as a clear, colourless oil. The 
presence of an intense nine-proton singlet at 8 0.93 and a six-proton singlet at 8 0.09 
in the 1 H NMR spectrum of compound 113 provided clear evidence for the successful 
incorporation of the TBS group. 
With compound 113 in hand, the next task was to construct the lactam ring and 
remove the benzyl group. Such transformations could be achieved simultaneously by 
two-fold hydrogenolysis of substrate 113 using 5% Pd/C as catalyst. In this manner, 
the desired product 114[lla] was obtained as a white, crystalline solid and in good 
yield (86% ). All physical, analytical and spectroscopic data obtained on compound 
114 were fully consistent with the proposed structure. The 70 eV EI mass spectrum 
displayed an intense protonated molecular ion (M+H)+ at mlz 332 and an accurate 
mass measurement on this species confirmed the molecular formula C15H29NO5Si. A 
fragment ion corresponding to the loss of a methyl radical from the molecular ion was 
also observed at m/z 316. The 75 MHz APT 13C NMR spectrum displayed all of the 
expected eleven carbon resonances with the most diagnostic one being located at 8 
168.2 which is assigned to the carbonyl unit. The absence of an absorption band due 
to an azide moiety in the region 2000-2200 cm-1 of the IR spectrum as well as a three-
proton singlet due to the methoxy group in the 1 H NMR spectrum implied that the 
formation of the lactam ring had taken place. The absence of a five-proton multiplet 
due to the aromatic moiety in the low-field region of the 1 H NMR spectrum confirmed 
that the benzyl group had also been removed during the conversion 113~ 114. 
In keeping with earlier observations,[llaJ subjection of compound 114 to reaction with 
BH3-DMS followed by cleavage of the resulting borane-amine complex with 
methanol in the presence of 10% Pd/C[ISJ as catalyst afforded the corresponding 
piperidine 115 (73%). The 70 eV EI mass spectrum of compound 115 exhibited a 
molecular ion M+· at m/z 317 and an accurate mass measurement on this species 
established that it had the anticipated empirical formula, viz. C15H31NO4Si. The 
absence of a carbonyl signal and the presence of a resonance due to a methylene 
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carbon (at 8 45.8) adjacent to the amine unit in the 75 MHz APT 13C NMR spectrum 
clearly indicated that the reduction of the carbonyl moiety to the corresponding 
methylene had been successful. 
In the final step of the synthesis compound 115 was treated with 80% v/v TF A/H20 
and in this manner target 105, in the form of TF A salt (105b ), was obtained in 
quantitative yield. The 75 MHz 13C NMR spectral data obtained on compound 105b 
were consistent with the assigned structure while the 300 MHz 1H NMR spectrum 
(Figure 4.4) perfectly matched that derived from authentic samples of DMJ·HCl 
(105a) either purchased from Sigma™ or synthesized via the first approach as detailed 
in the preceding section. 
In summary, the second approach to DMJ·TFA (105b) described in this section 
involves a ten-step reaction sequence. Clearly, it is even shorter than the previously 
reported routes (see Section 4.2) and proceeds in an overall yield of 18%. As such, the 
second approach is much more concise and efficient. 
4.4 Conclusions 
The work detailed above has resulted in the establishment of two distinct synthetic 
approaches to DMJ (105), both of which proceed in a completely stereocontrolled 
manner and start from the same precursor, namely cis-1,2-dihydrocatechol 33 (X = 
Cl). The first approach has highlighted the utility of the chemistry established in 
Chapter Two, while the second approach has extended the methodologies for 
accessing this type of unusual carbohydrate. Indeed, the ready access to various 
differentially protected DMJ derivatives provided by the work just described has 
assisted in the synthesis of biologically significant disaccharide derivatives of DMJ, in 
particular, Rha-DMJ (116). Such work is detailed in the following chapter. 
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Figure 4.4: 300 MHz 1H NMR Spectrum of Synthetic DMJ·TFA (105b) 
(Spectrum recorded in D2O solution) 
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5.1 Overview 
The pseuda-disaccharide 6-O-a-L-rhamnopyranosyl-DMJ (Rha-DMJ, 116i1J was first 
isolated in 2001 from the bark of Anglyocalyx pynaertii (Leguminosae) along with 
fourteen other polyhydroxylated alkaloids including DMJ (105). The former 
compound has been identified as the first naturally-occurring glycoside of DMJ and it 
has been claimed as a significantly more potent inhibitor of a-L-fucosidase than DMJ 
itself. Hitherto, there have been no reports on the synthesis of such a compound. On 
this basis, the development of effective routes to target 116 is a topic of considerable 
interest. 
The synthetic strategy employed by the author in obtaining compound 116 is shown in 
Figure 5.1. Thus, it was envisaged that target 116 should be accessible via 
glycosidation of the bromide 118 with the glycosyl acceptors 119 or 120 followed by 
removal of all the protecting groups from the resulting conjugate. The bromide 118 
should be readily prepared from L-rhamnose 117 by known methods[2J while the 1 °-
alcohols 119 and 120 could be accessed from cis-1,2-dihydrocatechol 33 (X = Cl) 
using the newly established routes to DMJ (105) as described in Chapter Four. This 
chapter details efforts to implement such ideas which have culminated in the first total 
synthesis of Rha-DMJ (116). 
Me,,.,.0OH 
HO~·-,,,,,OH 
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··,,,,,,OAc 
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Figure 5.1: Strategy Employed for the Synthesis ofRha-DMJ (116) 
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5.2 Preparation of Bromide 118 
The simple two-step synthesis of bromide 118 used in the present work is shown in 
Scheme 5.1 and follows the procedure of Bebault et al. [2J Thus, exhaustive O-
acetylation of L-rhamnose monohydrate 117 under standard conditions afforded a 
chromatographically separable mixture of the peracetate 121 [2J (71 %) and its ~-
anomer 122[3] (23%). All physical, analytical and spectroscopic data acquired on 
compounds 121 and 122 were in full accord with their assigned structures (see 
Experimental section 6.5). Development of the chemistry necessary to deliver 
bromide 118 was first investigated with a-anomer 121. In the event, when compound 
121 was treated with a solution of 45% HBr in HOAc the required bromide 118 was 
obtained in quantitative yield. The 1H NMR spectral data obtained on this material 
were consistent with those reported in the literature. [2J When ~-anomer 122 was 
subjected to bromination under the same reaction conditions, the resulting product 
(94%) proved identical to the bromide 118 generated from a-anomer 121. This result 
clearly implied that the C-2 acetoxy group within the substrates 121 and 122 provides 
anchimeric assistance, in the form of acetoxonium ion 123, and thus ensures the 
observed and required a-bromide 118 is formed stereoselectively. 
2 + 
Me/,XX"" 0 .. , OH 
HO i ''''OH 
OH 
AcO = ··,,,,110Ac 
Me"D'" 0 
2 
::,,DAc 
AcO = ''1tOAc 
OAc 
117 
M&.XX""·· 0 .. , Br 
AcO = ''1tOAc 
OAc 
118 
OAc 
"'- 121 
Scheme 5.1: Preparation of Bromide 118 
122 ; ___ _/ 
y 
j ii 
"B -
MeXJl,,,,.. 0 c; · r 
@)-Me 
.,,,,,,6 
AcO i 
OAc 
123 
Reagents and conditions: (i) ) Ac2O, py, 18 °C, 24 h; (ii) 45% HBr/HOAc, HOAc, 18 °C, 1 h. 
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5.3 The First Approach to Rha-DMJ (116) 
5.3.1 Towards the Synthesis of 1 °-Alcohol 119 
With the glycosyl donor 118 available, efforts were next directed towards the 
construction of the glycosyl acceptor 119. At the outset, it was expected that target 
119 could be prepared from compound 108 [which itself was generated in 12 steps 
from diol 33 (X = Cl) as depicted in Chapters Two and Four] through a two-step 
transformation. As shown in Scheme 5.2, the first step involved N-benzylation[4J and 
under the relevant conditions substrate 108 was converted into the expected benzyl-
amine 124 in 92% yield. However, the next step, namely selective deprotection of the 
MEM protecting group within compound 124 so as to give 119, was unsuccessful. 
Although various reagents such as TiC14/ 5J ZnBr2,[5J LhZnBr4/ 6J and CeCb[7J were 
employed in efforts to effect this transformation, none proved useful. 
ox ox 11 BHo 1 
i j< X .. 0 0 
MEM OMOM MEM OMOM HO OMOM 
108 124 119 
Scheme 5.2: An Earlier Approach to 1 °-Alcohol 119 
Reagents and conditions: (i) BnBr (1.3 mol equiv.), K2CO3 (1.5 mol equiv.) , MeCN, 18 °C, 18 h; (ii) 
(a) TiC4, CH2Ch, -10~0 °C; or (b) ZnBr2, CH2Ch; or (c) Li2ZnBr4, Et2O; or (d) MgBr2, Et2O; or (e) 
CeCh, MeCN. 
The failure to achieve selective removal of the MEM unit suggested that replacement 
of such functionality with a more labile protecting group was necessary. In this 
regard, the methoxyisopropyl (MIP) moiety was selected and thus led to the 
establishment of an effective route to target 119 (Scheme 5.3). This started with 
hydrogenolysis of the hydroxyester 71 [ derived from diol 33 (X = Cl) in 7 steps] 
using 5% Pd/C as catalyst. The ensuing lactam 125 (96%) was subjected to reaction 
with 2-methoxypropene in the presence of phosphoryl trichloride[8J as catalyst thereby 
giving the MIP-ether 126 in 99% yield. All of the physical, analytical and 
spectroscopic data obtained on compound 126 were in full accord with the assigned 
structure. For instance, the 70 eV EI mass spectrum showed a significant fragment ion 
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(M-CH3O·)+ at mlz 542, which corresponds to loss of a methoxy radical from the 
molecular ion and an accurate mass measurement on this species established that it 
had the anticipated composition, viz. C30H43NO8Si. The APT 13C NMR spectrum 
displayed the expected twenty-four signals with the most diagnostic one appearing at 
8 100.5 and being assigned to the dioxygenated carbon associated with the MIP unit. 
The intense three-proton resonances observed in the 1 H NMR spectrum at 8 3 .16 and 
3.17 are served to confirm the presence of MIP and MOM groups. 
9 ... ,,,0H ··,,,,,,OH 
X 
33 
(X = Cl) 
0 
ox 
0 
MIPO OMOM 
129 
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.. 
+ 
71 
°x 
0 
HO OMOM 
128 
VI BP,'N O 
- · X 
. 0 
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131 
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lV 
Vll 
Scheme 5.3: Synthesis of 1 °-Alcohol 119 from Precursor 71 
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MIPO OMOM 
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Bn,~10 
rr:J<-
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Reagents and conditions: (i) H2 (1 atm), 5% Pd/C, EtOAc, 18 °C, 18 h; (ii) CH2=C(OMe)Me, POC13 (cat.), CH2Ch, 18 °C, 8 h; (iii) TBAF (4.1 mol equiv.), THF, 18 °C, 20 h; (iv) 2,2-DMP, p-TsOH (cat.) , 
0 °C, 1 h; (v) LiA1H4 (2.4 mol equiv.), THF, 18 °C, 20 h; (vi) BnBr (1.3 mol equiv.), K2CO3 (1.5 mol 
equiv.), MeCN, 18 °C, 16 h; (vii) PPTS (0.6 mol equiv.), MeOH, 18 °C, 36 h. 
Deprotection of both the acetyl and the TBDPS groups within compound 126 was 
achieved using TBAF and a white, crystalline product, 127, was obtained in excellent 
yield (96% ). In the next step of the reaction sequence this diol was treated with 2,2-
DMP under the usual conditions thus affording the desired acetonide derivative 129 
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(67%) as well as the by-product 128 (15%). With ready access to compound 129 now 
assured, the next task was to prepare the piperidine 130. To such ends, treatment of 
substrate 129 with LiAlH4 resulted in the formation of the expected product 130 
(86%) which was N-benzylated under the usual conditions to give the benzyl-amine 
131 in 94% yield. The final step in the synthesis of the 1 °-alcohol 119 involved the 
removal of the MIP protecting group and pyridiniump-toluenesulfonate (PPTSi9J was 
employed for this purpose. In this manner, target 119 was obtained as a clear, 
colourless oil and in excellent yield (96%). All physical, analytical and spectroscopic 
data acquired on compound 119 were fully consistent with the assigned structure. For 
example, the expected sixteen signals were observed in the APT 13C NMR spectrum 
with the diagnostic resonances being located at 8 109.3 (-OCO-), 96.6 (-OCH2O-), 
60.3 (PhCH2-), 57.2 (-OCH2-), 49.4 (-NCH2CH-). The presence of an absorption 
maximum at 3469 cm-1 in the IR spectrum confirmed the presence of the OH moiety 
within compound 119. An intense fragment ion (M-CH3·)+ was observed at m/z 322 in 
the 70 e V EI mass spectrum and an accurate mass measurement on this species 
established that it had the expected composition, viz. C18H27NOs. 
5.3.2 Formation of Rha-DMJ (116) from 1 °-Alcohol 119 
The reaction sequence leading to Rha-DMJ (116) from bromide 118 and 1 °-alcohol 
119 is shown in Scheme 5.4. The first step involved reaction of the glycosyl donor 
(bromide 118) with the glycosyl acceptor (1 °-alcohol 119). Thus, treatment of an 
equimolar mixture of these compounds with silver trifluoromethanesulfonate[IOJ 
resulted in the formation of disaccharide 132 (63%) which was obtained as a clear, 
colourless oil that solidified upon standing. All physical, analytical and spectroscopic 
data obtained on this material supported the assigned structure. The APT 13C NMR 
spectrum displayed the expected twenty-eight carbon resonances with the diagnostic 
signals appearing at 8 170.1 (C=O), 170.0 (C=O), 169.8 (C=O), 109.1 (-OCO-), 97.5 
(-OCHO-), 96.0 (-OCH2O-), 66.8 (PhCH2O-), 56.0 (-OCH3), 49.5 (-NCH2CH-), 17.6 
(-CHCH3). The strong absorption band observed at 1750 cm-1 in the IR spectrum 
confirmed the presence of the three carbonyl groups. The 70 e V EI mass spectrum 
showed an intense molecular ion ~ - at m/z 609 and an accurate mass measurement 
on this species established the molecular formula as C30H43NO12. An intense fragment 
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ion, at m/z 594, derived from the loss of a methyl radical was also observed. The 
stereochemistry established at the anomeric carbon center was presumed to involve 
the a-configuration and final confirmation of this followed from the successful 
conversion of compound 132 into Rha-DMJ (116) (vide infra). 
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Scheme 5.4: Formation of Rha-DMJ (116) from Bromide 118 and 1 °-Alcohol 119 
Reagents and conditions: (i) AgOTf (0.9 mol equiv., calculation based on bromide 118), PhMe, MS 
4A., CH2Ch, -10 °c, 0.5 h; (ii) 1 : 3 v/v TFA/CH2Ch, 18 °C, 32 h; (iii) 0.2 M NaOMe in MeOH, 18 °C, 
2 h; (iv) H2 (1 atm), 5% Pd/C, MeOH, 18 °C, 24 h. 
In fact, removal of the protecting groups within compound 132 so as to form the final 
product Rha-DMJ (116) was achieved in a stepwise fashion. Thus, treatment of 
substrate 132 with TF A in dichloromethane resulted in cleavage of both the acetonide 
and MOM groups thereby affording the triol 133 (72%) which was obtained as a 
white, crystalline solid. The 75 MHz APT 13C NMR spectrum of the latter material 
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displayed the anticipated twenty-three carbon signals and the absence of the 
resonances associated with the MOM moiety and the acetonide unit clearly indicated 
that these two groups had been removed. The intense absorption maxima observed at 
1749 and 343 lcm-1 in the IR spectrum provided evidence for the presence of the 
acetyl and the hydroxy groups, respectively. The mass spectral data obtained on 
compound 133 were also consistent with the assigned structure. Thus, the fragment 
ion due to (M-OH·)+ was observed at m/z 508 in the 70 eV EI mass spectrum and an 
accurate mass measurement on this species confirmed the molecular formula 
C2sH3sNO11. 
Treatment of compound 133 with a 0.2 M solution of sodium methoxide in methanol 
resulted in the removal of all the three acetyl groups thereby providing product 134 
(84%) which led, after debenzylation/11J to the by now long sought-after Rha-DMJ 
(116i1] in 95% yield. The ESI mass spectrum of compound 116 showed an intense 
protonated molecular ion (M+H)+ at mlz 310 and an accurate mass measurement on 
this species established the molecular formula as C12H23NO8. The 500 MHz 1H and 
the 125 MHz APT 13C NMR spectra (Figures 5.2 and 5.3) of the synthetic samples 
proved identical to those derived from the authentic samples of Rha-DMJ (116) and 
thereby established that the glycosidation reaction led to compound 132 with the 
required . a-configuration. The specific rotation { [ a ]n} of the synthetic sample [-43. 8 
(c 0.5, H2O)] was also in good match with that derived from the natural product [-
42.6 (c 0.33, H20)].[1J 
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Figure 5.2: 500 MHz 1H NMR Spectnun of Synthetic Rha-DMJ (116) 
(Spectrum recorded in D2O solution) 
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5.4 The Second Approach to Rha-DMJ (116) 
5.4.1 Synthesis of 1 °-Alcohol 120 
Based on the work described in the preceding section, it was anticipated that the 
pivotal glycosyl acceptor could be prepared in a more efficient way from compound 
112. Consequently, a second approach to Rha-DMJ (116) was pursued and involved 
the initial preparation of 1 °-alcohol 120. 
The elaboration of precursor 112 into the 1 °-alcohol 120 could be achieved by either 
of two routes as illustrated in Scheme 5.5. The first (path a) started with N- and O-
benzylation of compound 115 (available in just three steps from the hydroxyester 112) 
under standard conditions and this led to a fully protected product 135 in 89% yield. 
The TBS-ether moiety within the latter species was then cleaved with TBAF to give 
OBn 0 9··""0H N3 .,,,,,,Q °x 6 steps ,,,,,j< 111 
.• ,,,10H 
path 0 
X b HO OBn 
33 136 
(X = Cl) l 3 steps j iv 
0 Bxxo ;t;x:>< i ;;< 1 path 
TBSO OBn a TBSO OH MIPO OBn 
135 115 137 l ii j V 
B100 Bxxo ;ye:>< i ;;< V11 i j< Vl 
HO OBn MIPO OBn MIPO OBn 
120 139 138 
Scheme 5.5: Synthetic Pathways to 1 °-Alcohol 120 from Precursor 112 
Reagents and conditions: (i) BnBr (4.3 mol equiv.), NaH (6.8 mol equiv.), KI (0.5 mol equiv.) , THF, 0-
18 °C, 36 h; (ii) TBAF (1.2 mol equiv.), THF, 18 °C, 2 h; (iii) PPh3 (1.5 mol equiv.), THF, H2O, 18 °C, 
24 h; (iv) CH2=C(OMe)Me, POCh (cat.), CH2Ch, 18 °C, 3 h; (v) LiA1H4 (2.4 mol equiv.), THF, 18 °C, 
9 h; (vi) BnBr (1.3 mol equiv.), K2CO3 (1.5 mol equiv.), MeCN, 18 °C, 16 h; (vii) PPTS (0.6 mol 
equiv.), MeOH, 18 °C, 20 h. 
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target 120[13] (99%) which was obtained as a clear, colourless oil after purification by 
flash chromatography on silica. All physical, analytical and spectroscopic data 
obtained on compound 120 were in full accord with the assigned structure. For 
instance, the presence of an intense absorption maximum observed at 3468 cm-1 in the 
IR spectrum established the presence of the hydroxy group. The APT 13C NMR 
spectrum displayed the expected eighteen carbon signals while the 70 e V EI mass 
spectrum showed a deprotonated molecular ion (M-H ·) + at m/z 3 82 and an accurate 
mass measurement on this species confirmed the molecular formula C23H29NO4. 
The second . route (path b) to the 1 °-alcohol 120 from precursor 112 involved initial 
formation of lactam 136 (92%) by reaction of azide 112 with triphenylphosphine.[ 14J 
Treatment of compound 136 thus formed with 2-methoxypropene in the same way as 
employed with compound 125 (see Scheme 5.3) led to the MIP-ether 137 (97%) 
which was readily converted, upon reaction with LiAlH4, into the anticipated 
piperidine 138 (81 %). This last material was N-benzylated under standard conditions 
to provide the benzyl-amine 139 in quantitative yield. Removal of the MIP moiety 
within compound 139 with PPTS in methanol then afforded the desired product 120 
(94%) which proved identical to the material derived from the first route. 
5.4.2 Formation of Rha-DMJ (116) from 1 °-Alcohol 120 
The formation of Rha-DMJ (116) from bromide 118 and 1 °-alcohol 120 is illustrated 
in Scheme 5.6 and followed the previously established protocols (see Scheme 5.4). 
Thus, reaction of the glycosyl donor 118 with the glycosyl acceptor 120 under the 
previously defined conditions afforded product 140 (92% at 94% conversion) as a 
white foam. Treatment of the latter material with TF A resulted in the removal of the 
acetonide group thereby giving diol 141 (91 %) which was subsequently deacetylated 
under standard conditions to provide product 142 (88%). Debenzylation of this last 
species under the established conditions (see above) delivered the desired product 116 
which proved identical to the material derived from the first approach to target 116. 
On the basis of the foregoing, two different approaches to Rha-DMJ (116) have been 
developed with the first involving an eighteen-step reaction sequence and the second 
fifteen steps. The overall yield of the former is 5 times lower (3% vs. 15%) than the 
latter. Clearly, the latter approach is much more efficient. 
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Scheme 5.6: Formation ofRha-DMJ (116) from Bromide 118 and 1 °-Alcohol 120 
Reagents and conditions: (i) AgOTf (0.9 mol equiv., calculation based on bromide 118), PhMe, MS 
4A, CH2Cl2, -10 °C, 0.5 h; (ii) 1 : 9 v/v TFA/CH2Ch, 18 °C, 24 h; (iii) 0.2 M NaOMe in MeOH, 18 °C, 
2 h; (iv) H2 (1 atm), 5% Pd/C, MeOH, 18 °C, 24 h. 
5.5 Biological Evaluation of Synthetic Rha-DMJ (116) 
The synthetic Rha-DMJ (116) produced as detailed above was evaluated for its 
glycosidase inhibitory activity (Table 5.1) and shown to be 5-10 times less active than 
the naturally-derived material. These results call into question the previously reported 
glycosidase inhibitory activity of the naturally occurring Rha-DMJ (116) which may 
have been compromised by contamination of the assay sample with a more powerful 
inhibitor like ~-L-homofuconojirimycin. 
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Table 5.1: Comparison of the Enzymatic Inhibitory Properties of Synthetic and 
Natural Samples ofRha-DMJ (116ia,b] 
Enzyme 
a-L-Fucosidase 
bovine epididymis 
human placenta 
rat epididymis 
a-Mannosidase 
rat epididymis 
a-L-Rhamnosidase 
penicillium decumbens 
Synthetic 116 
2.8 
23 
28 
>1000 
not tested 
ICso (µM) 
Natural 116 
0.5 
4.6 
3.2 
460 
740 
[a] The a-L-fucosidase enzymes derived from bovine epididymis and human placenta, and a-L-
rhamnosidase from penicillium decumbens were purchased from Sigma Chemical Co. The rat 
epididymal fluid prepared from rat epididymis according to the method of Skudlarek et al. [l 2J was used 
as the enzyme source of rat epididymis glycosidases. The glycosidase activities were determined using 
an appropriate p-nitrophenyl glycoside as substrate at the optimum pH of each enzyme. The reaction 
was stopped by adding 400 mM Na2CO3. The released p-nitrophenol was measured spectrometrically 
at 400 nm. 
[b] These assays were conducted by Professor N. Asano and his co-workers at Hokuriku University, 
Kanazawa, Japan. 
5.6 Conclusions 
The work detailed in this chapter has resulted in the establishment, for the first time, 
of two efficient and flexible approaches to Rha-DMJ (116) from the enantiopure cis-
1,2-dihydrocatechol 33 (X = Cl). As testimony to the effectiveness of such 
procedures, more than 100 mg of compound 116 was obtained in optically pure form. 
Since various disaccharide derivatives of DMJ have been identified as potential 
cancer remedies, the methods developed here for the construction of Rha-DMJ (116) 
should offer useful means for accessing other members of this interesting class of 
pseudo-trisaccharide. Work directed towards such ends are now underway in these 
laboratories. 
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6.1 General Protocols 
Unless otherwise indicated, proton (1H) and carbon (13C) NMR spectra were recorded 
on a Varian Gemini 3 00 spectrometer operating at 3 00 MHz for proton and 7 5 MHz 
for carbon, respectively. Chemical shifts were recorded as a values in parts per 
million (ppm). Deuterochloroform (CDCh, Cambridge Isotope Laboratories, Inc.) was 
normally used as solvent. For proton spectra, the reference peak was sited at 8 7.26 
while for carbon spectra the reference peak was defined as the central peak (8 77 .1 6) 
of the CDCl3 triplet. For those proton spectra recorded in CDCh containing 
tetramethylsilane (CDCh/TMS, Aldrich Chemical Company Inc.), TMS (8 0.00) was 
used as the internal reference. For proton spectra recorded in deuterium oxide (D2O), 
the reference peak was located at 8 4.79 while for carbon spectra recorded in D2O, 
dimethyl-d6 sulfoxide (DMSO-d6, Cambridge Isotope Laboratories, Inc.) was used as 
the internal reference with the reference peak being located at 8 39.52. Data were 
recorded as follows: chemical shift (B), multiplicity (s: singlet, d: doublet, t: triplet, q: 
quartet, m: multiplet, dd: doublet of doublets etc., hr: broad), coupling constant(s) (J 
Hz), relative integral (for proton spectra) and assignment (where possible). The digital 
resolution within spectra varied slightly depending on the selection of spectral width 
and number of data points allocated. However, in all cases this was, at worst, of the 
order of 0.4 Hz/point for one-dimensional spectra. The attached proton test (APT) 
technique was often employed for the assignment of NMR spectra. APT 13C NMR 
spectral data are reported in the following format: chemical shift (B) and protonicity 
(C = quaternary, CH = methine, CH2 = methylene, CH3 = methyl, C/CH2 = quaternary 
or methylene, CH/CH3 = methine or methyl). Protonicities were determined by the 
phase of the resonance relative to the solvent signal, viz. C and CH2 were of the same 
phase as the CDCh triplet, whilst CH and CH3 resonances were of the opposite phase. 
The anomeric configurations of the various pyranosides reported herein were 
established by nuclear Overhauser enhancement (n.O.e.) experiments. 
Infrared (IR) spectra (vmax) were recorded on either a Perkin-Elmer 983G infrared 
spectrophotometer or a Perkin-Elmer 1800 Series FTIR instrument. Samples were 
analyzed either as thin films on sodium chloride plates (for liquids) or as potassium 
bromide discs (for solids). 
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Low- and high-resolution electron-impact mass spectra (LREI-MS) (m/z) were 
recorded at 70 eV on either a VG Micromass 7070F mass spectrometer or a JEOL 
AX-505H mass spectrometer. Chemical ionisation (CI) mass spectra were recorded on 
an AUTOSPEC spectrometer using ammonia (NH3) as the reactant gas. Mass spectral 
data were listed as mass-to-charge ratio (m/z), assignment (where possible) and 
relative intensity(% of base peak). 
Optical rotations were measured (unless otherwise specified) with a Perkin-Elmer 241 
polarimeter at the sodium D line (589 nm) using spectroscopic grade chloroform 
(CHCb, Merck) as solvent at T = 18 °C and the concentration (c) (g/100 mL) 
indicated. Specific rotations {[a]0 T} were calculated using the equation [a]0 = 
(100.a)/(c.l) and are given in units of 10-1.deg.cm2.g-1• 
Melting points were recorded with a Kofler hot stage apparatus and are uncorrected. 
Microanalyses were performed by the Microanalytical Services Unit of the Australian 
National University, Canberra, Australia. 
Ozonolyses were performed using a Wallace and Tieman Ozonator with the oxygen 
flow rate and power adjusted to approximately 25 L/h and 200 V, respectively. 
Analytical thin-layer chromatography (TLC) was conducted on aluminium-backed 0.2 
mm thick silica gel 60 GF254 plates (Merck) and the chromatograms were visualised 
under a 254 nm UV lamp and/or by treatment with a reagent solution [ either 
anisaldehyde/sulfuric acid/ethanol (2 : 5 : 93) dip, phosphomolybdic acid/ethanol (8 g 
: 200 mL) dip or phosphomolybdic acid/eerie (IV) sulfate/sulfuric acid/water (37.5 g : 
7.5 g : 37.5 mL : 720 mL) dip] followed by heating. Flash chromatography was 
conducted according to the method of Still and coworkers[IJ using the analytical 
reagent (AR) grade solvents indicated. 
High performance liquid chromatography (HPLC) was conducted on a Waters µ-
Porasil™ semi-preparative silica column (7.8 x 300 mm) using the HPLC grade 
solvents indicated and connected to an ISCO Model 2350 pump. The peaks were 
detected using an ERMA ERC-7512 refractive index detector connected to a Spectra-
Physics SP4270 reporting integrator. 
Gas chromatography (GC) was performed on either a Varian 3400 Gas 
Chromatograph fitted with a SGE Cydex-B chiral capillary column (25 m x 0.22 mm 
internal diameter, film thickness = 25 micron) or a Varian Vista Series Gas 
Chromatograph fitted with a SGE BPX5 silica capillary column (25 m x 0.22 mm 
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internal diameter, film thickness = 25 micron). The carrier gas (helium) flow rate was 
ca. 35 cm/sec, a standard temperature program [involving an initial temperature of 
100 °C (10 mins), ramp rate of 10 °C/10 mins, and a final temperature of 270 °C] was 
employed. The peaks were detected using a flame-ionisation detector. 
All cis-1,2-dihydrocatechols were generously provided by Dr Gregg Whited of 
Genencor International Inc. (Palo Alto, CA) and used as obtained. 
Many reagents were available from the Aldrich Chemical Company and were used as 
supplied. Drying agents and other inorganic salts were purchased from AJAX or BDH 
Chemicals. Reaction solvents and reagents were purified according to established 
procedures. [2J Tetrahydrofuran (THF) and diethyl ether (EtiO, ether) were distilled 
under nitrogen from sodium benzophenone ketyl, while methanol (MeOH) was 
distilled from magnesium methoxide. Dichloromethane (CH2Ch) was distilled from 
calcium hydride and toluene from sodium. DMF was dried with calcium hydride then 
filtered and distilled. Pyridine and diisopropylethylamine (DIPEA, Hiinig' s base) 
were both distilled from and stored over potassium hydroxide pellets. 
Reactions employing air- and/or moisture-sensitive reagents were carried out under an 
atmosphere of dry and oxygen-free nitrogen in oven- or flame-dried apparatus. 
Organic solutions obtained from workup of reaction mixtures were dried with 
magnesium sulphate (MgSO4) unless otherwise specified. Solutions were 
concentrated under reduced pressure on a rotary evaporator with the water bath 
temperature generally not exceeding 40 °C. When reactions were conducted at, or 
below, 0 °C then the internal temperature was monitored using an alcohol 
thermometer. 
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( 1 S, 6S)-6-0-tert-Butyldiphenylsilyl-2-chloro-2,4-cyclohexadien-1-ol Acetate ( 57) 
and (JS,6S)-6-0-tert-Butyldiphenylsilyl-5-chloro-2,4-cyclohexadien-1-ol Acetate 
(58) 
(!""'OH 
y··,,,,,OH 
Cl 
33 
i) TBDPS-Cl 
imidazole 
CH2Cl2, 18 °C 
ii) Ac20, py 
DMAP, 18 °C 
(l:::"•OTBDPS + y ''''OAc 
Cl 
57 
(!""'OAc 
Y:'""'OTBDPS 
Cl 
58 
tert-Butyldiphenylsilylchloride (TBDPS-Cl) (32.5 mL, 124.2 mmol) was added, 
dropwise over a period of 0.5 h, to a magnetically stirred solution of diol 33 (17.0 g, 
116.0 mmol) and imidazole (21.0 g, 308.5 mmol) in dry dichloromethane (100 mL) 
maintained at 18 °C under a nitrogen atmosphere. After stirring for 1 h, the reaction 
mixture was treated with water (500 mL) and the separated aqueous phase was 
extracted with dichloromethane (3 x 100 mL). The combined organic phases were 
washed with brine (2 x 150 mL) then dried (MgSO4), filtered and concentrated under 
reduced pressure to give a ca. 4 : 1 mixture (as judged by 1H NMR analysis) of two 
regioisomeric mono-TBDPS-ethers which was obtained as a clear, colourless oil. This 
unstable mixture was immediately dissolved in pyridine (30 mL) and the resulting 
solution treated with acetic anhydride (22 mL, 23 3 .2 mmol) and 4-(N,N-
dimethylamino )pyridine (DMAP) (1.40 g, 11.6 mmol). After stirring at 18 °C for 2 h, 
the reaction mixture was concentrated under reduced pressure and the residue thus 
obtained was subjected to flash chromatography (silica, gradient elution using 1.25 to 
1.5% v/v ethyl acetate/hexane) thereby affording two fractions, A and B. 
Concentration of fraction A [R1 0.5 in 2 : 12 : 9 v/v/v ethyl acetate/hexane/petroleum 
spirit (60-80 °C)] afforded compound 57 (38.54 g, 78%) as a clear, colourless oil. 
1H NMR (CDCb, 300 MHz) 8 7.75-7.70 (complex m, 4H), 7.50-7.38 (complex m, 
6H), 6.17 (d, J 5.9 Hz, lH), 5.75 (ddd, J 9.7, 5.9 and 2.4 Hz, lH), 5.61 (dd, J 9.7 and 
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2.5 Hz, lH), 5.56 (d, J6.6 Hz, lH), 4.72 (dt, J6.4 and 2.5 Hz, lH), 2.15 (s, 3H), 1.09 
(s, 9H). 
13C NMR (CDCh, 75 MHz) 8 170.2 (C), 136.0 (CH), 135.9 (CH), 133.7 (C), 132.8 
(C), 130.7 (C), 130.4 (CH), 130.1 (CH), 130.1 (CH), 128.0 (CH), 127.9 (CH), 125.3 
(CH), 121.9 (CH), 71.1 (CH), 70.5 (CH), 26.8 (CH3), 21.0 (CH3), 19.2 (C). 
IR (KBr) Vmax2958, 2932, 2858, 1747, 1427, 1226, 1112, 868,821,702,506 cm-1. 
EI MS m/z (70 eV) 428 (M+, 2%) and 426 (5), 386 (13) and 384 (33), 84 (100). 
HRMS Found: M+, 426.1421. C24H2l 5ClO3Si requires: M+·, 426.1418. 
Specific Rotation [a]n -107.4 (c 1.75, CHCh). 
Concentration of fraction B [R10.4 in 2 : 12 : 9 v/v/v ethyl acetate/hexane/petroleum 
spirit (60-80 °C)] afforded compound 58 (7.90 g, 16%) as a clear, colourless oil. 
1H NMR (CDCh, 300 MHz) 8 7.77-7.70 (complex m, 4H), 7.45-7.37 (complex m, 
6H), 6.18 (d, J 5.2 Hz, lH), 5.95 (ddd, J 9.7, 5.7 and 3.1 Hz, lH), 5.81 (ddm, J 9.7 
and 3.1 Hz, lH), 5.28 (m, lH), 4.26 (d, J5.7 Hz, lH), 1.77 (s, 3H), 1.08 (s, 9H). 
13C NMR (CDCh, 75 MHz) 8 170.2 (C), 136.2 (CH), 136.2 (CH), 135.3 (C), 133.6 
(C), 132.7 (C), 130.0 (CH), 129.8 (CH), 127.7 (CH), 127.5 (CH), 126.1 (CH), 124.0 
(CH), 123.3 (CH), 72.5 (CH), 71.4 (CH), 26.9 (CH3), 21.9 (CH3), 19.9 (C). 
IR (KBr) Vmax 2931, 2857, 1738, 1427, 1369, 1233, 1112, 1049, 702, 505 cm-1. 
El MS m/z (70 eV) 428 (M+, 4%) and 426 (11), 386 (1) and 384 (2), 199 (100). 
HRMS Found: M+, 426.1417. C24H2l 5ClO3Si requires: M+·, 426.1418. 
Specific Rotation [a]n +5.3 (c 1.03, CHCh). 
[JS-(la,2a,3a,6a)]-2-O-tert-Butyldiphenylsilyl-4-chloro-7-oxabicyclo[4.1.0]hept-
4-en-3-ol Acetate (59) and [JR-(la,2p,3p,6a)]-2-O-tert-Butyldiphenylsilyl-4-
chloro-7-oxabicyclo[4.1.0]hept-4-en-3-ol Acetate (60) 
~ ::·""OTBDPS 
Y'''lfOAc 
Cl 
57 
m-CPBA 
CH2Cl2, 0-18 °C 
Cl 
59 
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A magnetically stirred solution of compound 57 (2.08 g, 4.87 mmol) 1n 
dichloromethane (25 mL) maintained at ca. 0 °C (ice-bath) was treated, in one 
portion, with m-chloroperbenzoic acid (m-CPBA) (ca. 70% peracid, 1.26 g, 5.1 1 
mmol). Stirring was continued overnight during which time the ice bath and the 
reaction mixture were allowed to warm to ca. 18 °C. The resulting mixture was 
washed with sodium sulfite (Na2SO3) (3 x 60 mL of a 15% w/v aq. solution), 
NaHCO3 (1 x 60 mL of a saturated aq. solution) and water (1 x 60 mL) then dried 
(MgSO4), filtered and concentrated under reduced pressure. The ensuing crude oil was 
subjected to flash chromatography (silica, gradient elution using 2 to 3% v/v ethyl 
acetate/hexane) thereby affording two fractions, A and B. 
Concentration of fraction A [R10.5 in 3 : 12 : 9 v/v/v ethyl acetate/hexane/petroleum 
spirit (60-80 °C)] afforded compound 59 (1.25 g, 58%) as a clear, colourless oil. 
1H NMR (CDCb, 300 MHz) 8 7.75-7.65 (complex m, 4H), 7.50-7.40 (complex m, 
6H), 6.30 ( dd, J 4.1 and 2.2 Hz, 1 H), 5 .3 8 (m, 1 H), 4.55 (m, 1 H), 3 .41 (m, 1 H), 3 .3 5 
(m, lH) 1.94 (s, 3H), 1.11 (s, 9H). 
13C NMR (CDCb, 75 MHz) 8 170.1 (C), 136.4 (CH), 136.3 (CH), 135.9 (C), 133.6 
(C), 133.3 (C), 130.7 (CH), 130.5 (CH), 128.4 (CH), 128.1 (CH), 122.8 (CH), 69.4 
(CH), 68.4 (CH), 53.7 (CH), 48.6 (CH), 27.3 (CH3), 21.0 (CH3), 20 (C). 
IR (KBr) Vmax2957, 2932, 2858, 1751, 1427, 1369, 1225, 1112, 703, 506 cm-1. 
EI MS m/z (70 eV) 444 (M+·, 1 %) and 442 (4), 387 (4) and 385 (11), 241 (100). 
HRMS Found: M+, 442.1363. C24H2l 5ClO4Si requires: M+, 442.1367. 
Specific Rotation [a]0 +34.6 (c 1.1, CHCb). 
Concentration of fraction B [R1 0.3 in 3 : 12 : 9 v/v/v ethyl acetate/hexane/petroleum 
spirit (60-80 °C)] afforded compound 60 (0.38 g, 18%) as a white, crystalline solid, 
m.p. 156-158 °C. 
1 H NMR (CDCh, 300 MHz) 8 7.81 (m, 2H), 7.77 (m, 2H), 7.50-7.37 (complex m, 
6H), 6.25 (d, J 4.4 Hz, lH), 5.86 (dd, J 5.7 and 1.9 Hz, lH), 4.31 (dd, J 5.7 and 1.2 
Hz, lH), 3.17 (t, J 4.2, lH), 3.03 (m, lH), 2.24 (s, 3H), 1.09 (s, 9H). 
13C NMR (CDCh, 75 MHz) 8 170.7 (C), 135.9 (CH), 135.8 (CH), 134.9 (CH), 134.7 
(C), 133.3 (C), 132.1 (C), 130.3 (CH), 130.2 (CH), 129.6 (CH), 128.1 (CH), 128.0 
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(CH), 127.7 (CH), 126.7 (CH), 70.6 (CH), 70.0 (CH), 54.9 (CH), 47.8 (CH), 26.7 
(CH3), 21.2 (CH3), 19.2 (C). 
IR (KBr) Vmax 2931, 2858, 1743, 1427, 1370, 1233, 1112, 706, 507 cm-1. 
EI MS m/z (70 eV) 444 and 442 (M+·, both< 1 %), 387 (2) and 385 (5), 199 (100). 
HRMS Found: (M-C4H9·)\ 385.0663. C24H2l5ClO4Si requires: (M-C4H9·)\ 
385.0663. 
Microanalysis Found: C, 64.8; H, 6.1; Cl, 7.9; C24H27ClO3Si requires: C, 65.1; H, 
6.1; Cl, 8.0%. 
Specific Rotation [a]0 -156.9 (c 1.1, CHCb). 
(JS,2S,3S,6R)-2-0-tert-Butyldiphenylsilyl-4,6-dichloro-4-cyclohexene-1,3-diol 3-
Acetate ( 61) and (1S,2S,3S, 6S)-2-0-tert-Butyldiphenylsilyl-4,6-dichloro-4-
cyclohexene-1,3-diol 3-Acetate (62) 
Method A: OH OH 
.. ,,,,,,OTBD PS LiCl, EAA Cl .. ,,,,,,OTBD PS Cl1,,,,, 
_.,, ,~OTBDPS 
'·· THF, 44-46 °C 
+ 
,,,,,,10Ac 
MethodB: 
··,,,,,,OAc ··,,,,,,OAc 
Cl LiCl, HOAc Cl Cl 
59 THF, 18 °C 61 62 
Method A: A magnetically stirred mixture of epoxide 59 (2.90 g, 6.55 mmol), 
lithium chloride (LiCl) (1.39 g, 32.79 mmol) and ethyl acetoacetate (2.5 mL, 19.61 
mmol) in dry THF (25 mL) was maintained at 44-46 °C (oil-bath). After stirring for 86 
h, the reaction mixture was treated with NH4Cl (30 mL of a saturated aq. solution) and 
brine (30 mL). The separated aq. phase was extracted with dichloromethane (3 x 20 
mL) and the combined organic phases were washed with brine (2 x 50 mL) then dried 
(MgSO4), filtered and concentrated under reduced pressure. Subjection of the ensuing 
residue to flash chromatography (silica, gradient elution using 2 to 4% v/v ethyl 
acetate/hexane) afforded two fractions, A and B. 
Concentration of fraction A [R1 0.3 in 5 : 12 : 9 v/v/v ethyl acetate/hexane/petroleum 
spirit (60-80 °C)] afforded cis-chlorohydrin 61 (0.25 g, 8%) as a white, crystalline 
solid, m.p. 117-119 °C. 
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1H NMR (CDCh, 300 MHz) 8 7.75-7.65 (complex m, 4H), 7.55-7.36 (complex m, 
6H), 6.04 (d, J 4.4 Hz, lH), 5.82 (d, J 3.9 Hz, lH), 4.80 (t, J 3.9 Hz, lH), 4.37 (dd, J 
8.1 and 3.9 Hz, lH), 4.08 (dd, J 8.1 and 3.7 Hz, lH), 2.01 (s, 3H), 1.84 (br s, lH), 
1.11 (s, 9H). 
13C NMR (CDCh, 75 MHz) 8 169.8 (C), 136.1 (CH), 135.9 (CH), 133.2 (C), 133.1 
(C), 132.8 (C), 130.3 (CH), 130.1 (CH), 128.1 (CH), 127.8 (CH), 127.0 (CH), 71.1 
(CH), 70.4 (CH), 68.8 (CH), 59.0 (CH), 26.9 (CH3), 20.7 (CH3), 19.4 (C). 
IR (KBr) Vmax 3549, 2931, 2858, 1751, 1427, 1368, 1226, 1113, 910, 703, 508 cm-1. 
EI MS mlz (70 eV) 425 [(M-C4H9·)\ 3%] and 423 (13) and 421 (18), 241 (100). 
HRMS Found: (M-C4H9·)\ 421.0430. C24H2s35ChO4Si requires: (M-C4H9·)\ 
421.0430. 
Microanalysis Found: C, 59.81; H, 5.74; Cl, 14.89; C24H2gChO4Si requires: C, 60.12; 
H, 5.89; Cl, 14.79%. 
Specific Rotation [a]0 -107.8 (c 0.6, CHCh). 
Concentration of fraction B [R_r 0.4 in 5 : 12 : 9 v/v/v ethyl acetate/hexane/petroleum 
spirit (60-80 °C)] afforded trans-chlorohydrin 62 (2.78 g, 88%) as a white foam. 
1H NMR (CDCh, 300 MHz) 8 7.80-7.65 (complex m, 4H), 7.55-7.35 (complex m, 
6H), 5.92 (d, J 2.5 Hz, lH), 5.64 (d, J 4.0 Hz, lH), 4.18 (dd, J 7.8 and 2.5 Hz, lH), 
4.12 (dd, J9.6 and 7.8 Hz, lH), 3.84 (dd, J9.6 and 4.0 Hz, lH), 2.25 (br s, lH), 2.19 
(s, 3H), 1.08 (s, 9H). 
13C NMR (CDCh, 75 MHz) 8 169.7 (C), 136.4 (CH), 135.5 (CH), 133.8 (C), 131.7 
(C), 130.6 (C), 130.4 (CH), 130.2 (CH), 129.4 (CH), 128.2 (CH), 128.0 (CH), 73.7 
(CH), 72.5 (CH), 71.8 (CH), 59.0 (CH), 26.8 (CH3), 21.0 (CH3), 19.4 (C). 
IR (KBr) Vmax 3567, 2932, 2858, 1752, 1427, 1370, 1225, 1113, 911, 703 , 506 cm-1. 
EI MS m/z (70 eV) 425 [(M-C4H9·)\ 3%] and 423 (15) and 421 (20), 241 (100) . 
HRMS Found: (M-C4H9·)\ 421.0425. C24H2s3 5ChO4Si requires: (M-C4H9·)\ 
421.0430. 
Microanalysis Found: C, 60.18; H, 5.92; Cl, 14.85; C24H2gChO4Si requires: C, 60.12; 
H, 5.89; Cl, 14.79%. 
Specific Rotation [a]0 -56.0 (c 0.6, CHCh). 
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Method B: Glacial acetic acid (11.4 mL, 197.85 mmol) was added to a 
magnetically stirred solution of epoxide 59 (29.2 g, 65.91 mmol) and LiCl (14.0 g, 
330.27 mmol) in dry THF (220 mL) maintained at 18 °C under a nitrogen atmosphere. 
After 70 h the reaction mixture was concentrated under reduced pressure. The residue 
so formed was dissolved in ethyl acetate ( 400 mL) and the resulting mixture washed 
with NaHCO3 (2 x 400 mL of a saturated aq. solution) and water (1 x 400 mL) then 
dried (MgSO4), filtered and concentrated under reduced pressure. Subjection of the 
ensuing residue to flash chromatography (silica, gradient elution using 2 to 4% v/v 
ethyl acetate/hexane) afforded two fractions, A and B. 
Concentration of fraction A [R_r0.3 in 5 : 12 : 9 v/v/v ethyl acetate/hexane/petroleum 
spirit (60-80 °C)] afforded cis-chlorohydrin 61 (0.94 g, 3%) which proved identical, 
in all respects, to the material obtained by Method A. 
Concentration of fraction B [R1 0.4 in 5 : 12 : 9 v/v/v ethyl acetate/hexane/petroleum 
spirit ( 60-80 °C)] afforded trans-chlorohydrin 62 (27 .28 g, 86%) which proved 
identical, in all respects, to the material obtained by Method A. 
( 1 S,2S,3S, 6S)-6-Azido-2-0-tert-butyldiphenylsilyl-4-chloro-4-cyclohexene-1,3-diol 
3-Acetate (63) 
A magnetically stirred solution of trans-chlorohydrin 62 ( 600 mg, 1.25 mmol) in dry 
DMF (30 mL) maintained at 18 °C under a nitrogen atmosphere was treated with 
lithium azide (LiN3) (198 mg, 4.04 mmol). After 64 h the reaction mixture was treated 
with sodium thiosulfate (Na2S2O3) (20 mL of 10% w/v aq. solution) and diethyl ether 
(60 mL). The separated aq. phase was extracted with ether (3 x 25 mL) and the 
combined organic phases were washed with brine (1 x 20 mL) then dried (MgSO4), 
filtered and concentrated under reduced pressure. Subjection of the ensuing residue to 
flash chromatography (silica, gradient elution using 4 to 6% v/v ethyl acetate/hexane) 
afforded two fractions, A and B. 
Cl 
63 
,,,,OTBDPS 
.. ,, 
+ 
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Concentration of fraction A (Rt 0.4 m 1 : 2.5 : 5.5 v/v/v ethyl 
acetate/dichloromethane/hexane) afforded cis-azido-alcohol 63 (225 mg, 37%) as a 
clear, light-yellow oil. 
1H NMR (CDCb, 300 MHz) 8 7.73-7.64 (complex m, 4H), 7.51-7.37 (complex m, 
6H), 5.96 (d, J 4.4 Hz, lH), 5.72 (d, J 3.4 Hz, lH), 4.28 (dd, J 8.0 and 3.9 Hz, 2H), 
4.08 (q, J 4.0 Hz, lH), 1.97 (s, 3H), 1.88 (br s, lH), 1.08 (s, 9H). 
13C NMR (CDCb, 75 MHz) 8 169.9 (C), 136.2 (CH), 135.8 (CH), 133.8 (C), 133 .2 
(C), 132.5 (C), 130.4 (CH), 130.2 (CH), 128.2 (CH), 127.8 (CH), 124.3 (CH), 70.8 
(CH), 70.6 (CH), 70.0 (CH), 59.4 (CH), 26.9 (CH3), 20.7 (CH3), 19.4 (C). 
IR (KBr) Vmax3482, 2931, 2858, 2104, 1750, 1427, 1368, 1226, 1114, 703 , 508 cm-1. 
EI MS mlz (70 eV) 430 [(M-C4H9·)\ 4%] and 428 (10), 327 (26) and 325 (53), 241 
(82), 199 (100). 
HRMS Found: (M-C4H9·)\ 428.0843. C24H2335ClN3O4Si requires: (M-C4H9·)\ 
428.0833. 
Specific Rotation [a]n -106.5 (c 0.6, CHCb). 
Concentration of fraction B (Rt 0.3 in 1 : 2.5 : 5.5 v/v/v ethyl 
acetate/dichloromethane/hexane) afforded a ca. 4 : 1 mixture of two compounds (250 
mg, 41 % combined yield) tentatively identified as 64 and 65. 
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(JR,2S,5S,6S)-6-0-tert-Butyldiphenylsilyl-3,5-dichloro-3-cyclohexene-1,2-diol l,2-
Diacetate ( 67) 
Cl,,,,, 
,, .. 
OH 
Cl 
62 
.. ,,,,,OAc 
i) NH40H, THF, 18 °C 
ii) Ac20, py, 18 °C 
OTBDPS 
Cl 
67 
... ,,,,,OAc 
Ammonia (1 mL of a 12% aq. solution) was added to a magnetically stirred solution 
of trans-chlorohydrin 62 (70 mg, 0.15 mmol) in THF (5 mL). After stirring the 
resulting mixture at 18 °C for 20 h it was treated with ethyl acetate (10 mL) and 
NH4Cl (10 mL of a saturated aq. solution). The separated organic phase was washed 
with NH4Cl (1 x 10 mL of a saturated aq. solution) and brine (1 x 10 mL) then dried 
(MgSO4), filtered and concentrated under reduced pressure. The ensuing residue was 
dissolved in pyridine (3 mL) and then treated with acetic anhydride (0.5 mL). Stirring 
was continued at 18 °C for 24 h and then the reaction mixture was treated with ethyl 
acetate (20 mL) and NaHCO3 (30 mL of a saturated aq. solution). The separated 
organic phase was washed with NaHCO3 (1 x 30 mL of a saturated aq. solution) and 
NH4Cl (1 x 30 mL of a saturated aq. solution) then dried (MgSO4), filtered and 
concentrated under reduced pressure. Subjection of the residue so formed to flash 
chromatography (silica, 2% v/v ethyl acetate/hexane elution) and concentration of the 
appropriate fractions (R_r0.5) afforded the title compound 67 ( 45 mg, 59%) as a white, 
crystalline solid, m.p. 137.5-139 °C. 
1H NMR (CDCh, 300 MHz) B 7.85-7.80 (m, 2H), 7.61-7.56 (m, 2H), 7.48-7.34 
(complex m, 6H), 6.04 (d, J 2.9 Hz, lH), 5.60 (d, J 3.8 Hz, lH), 4.99 (dd, J 10.6 and 
3.8 Hz, lH), 4.62 (dd, J7.2 and 2.9 Hz, lH), 4.18 (dd, J 10.6 and 7.2 Hz, lH), 1.75 (s, 
3H), 1.12 (s, 3H), 1.06 (s, 9H). 
13C NMR (CDCh, 75 MHz) B 170.1 (C), 169.8 (C), 136.6 (CH), 135.5 (CH), 134.2 
(C), 131.4 (C), 130.2 (CH), 130.0 (CH), 129.6 (CH), 129.5 (C), 127.8 (CH), 127.7 
(CH), 72.3 (CH), 71.4 (CH), 69.8 (CH), 59.9 (CH), 27.0 (CH3), 20.3 (CH3), 20.0 
(CH3), 19.9 (C). 
IR (KBr) Vmax2932, 2859, 1755, 1428, 1371, 1233, 1210, 1113, 1043, 707, 513 cm-1. 
Chapter Six 104 
EI MS m/z (70 eV) 467 [(M-C4H9·)\ 10%] and 465 (47) and 463 (65), 241 (89), 199 
(100), 57 (17). 
HRMS Found: (M-C4H9·)\ 463.0541. C26H3a35ChO5Si requires: (M-C4H9·)\ 
463.0535. 
Microanalysis Found: C, 59.69; H, 6.01; Cl, 13.71; C26H30ChO5Si requires: C, 59.88; 
H, 5.80; Cl, 13.60%. 
Specific Rotation [a]0 -37.6 (c 1.27, CHCh). 
( 1 R,2S, 5R, 6R)-5-Azido-3-chloro-6-0-tert-bu tyldiphenylsilyl-3-cyclohexene-1,2-
diol l ,2-Diacetate (66) 
Cl4,,, 
,, .. 
OTBDPS 
Cl 
67 
.. ,,,,,OAc 
LiN3, DMF, 18 °C 
OTBDPS 
Cl 
66 
A magnetically stirred solution of compound 67 (510 mg, 0.98 mmol) in dry DMF (10 
mL) maintained at 18 °C under a nitrogen atmosphere was treated with LiN3 (144 mg, 
2.94 mmol). After stirring for 96 h, the reaction mixture was treated with Na2S2O3 (30 
mL of 10% w/v aq. solution) and ethyl acetate (30 mL). The separated organic phase 
was washed with NH4Cl (3 x 25 mL of a saturated aq. solution) then dried (MgSO4), 
filtered and concentrated under reduced pressure. The ensuing residue was subjected 
to flash chromatography (silica, 3% v/v ethyl acetate/hexane elution) thereby 
affording, after concentration of the appropriate fractions (R1 0.3), the title compound 
66 (485 mg, 94%) as a white, crystalline solid, m.p. 126-128 °C. 
1 H NMR (CDCh, 300 MHz) 8 7.80-7.73 (m, 2H), 7.71-7.65 (m, 2H), 7.52-7.36 
(complex m, 6H), 5.96 (d, J 5.9 Hz, lH), 5.61 (d, J 4.l Hz, lH), 5.31 (dd, J 10.4 and 
4.1 Hz, lH), 4.37 (dd, J 10.4 and 4.2 Hz, lH), 4.18 (dd, J5.7 and 4.2 Hz, lH), 1.84 (s, 
3H), 1.51 (s, 3H), 1.09 (s, 9H). 
13C NMR (CDCh, 75 MHz) 8 169.8 (C), 169.7 (C), 136.3 (CH), 135.8 (CH), 133.4 
(C), 132.6 (C), 130.4 (C), 130.3 (CH), 129.9 (CH), 128.0 (CH), 127.8 (CH), 126.5 
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(CH), 70.4 (CH), 68. 7 (CH), 68.3 (CH), 60.0 (CH), 26.9 (CH3), 20.4 (CH3), 20.4 
(CH3), 19.4 (C). 
IR (KBr) Vmax2932, 2858, 2113, 1754, 1428, 1371, 1232, 1114, 1045, 703,510 cm-1. 
EI MS m/z (70 eV) 472 [(M-C4H9·)\ 15%] and 470 (36), 327 (29) and 325 (51), 241 
(72), 199 (100), 57 (23). 
HRMS Found: (M-C4H9·)\ 470.0941. C26H3a35ClN3O5Si requires: (M-C4H9·)\ 
470.0939. 
Microanalysis Found: C, 59.12; H, 5.75; N, 7.97, Cl, 6.76; C26H30ClN3O5Si requires: 
C, 59.14; H, 5.73; N, 7.96, Cl, 6.71 %. 
Specific Rotation [a]o -106.2 (c 1.2, CHCb). 
(1 S,4S, 5S, 6S)-6-0-tert-Butyldiphenylsilyl-2,4-dichloro-5-0-methoxymethyl-2-
cyclohexene-1-ol Acetate ( 68) 
Cl,,,,, 
'••. 
OH 
Cl 
62 
,,,,OTBDPS 
··'' 
.. ,,,"OAc 
Cl,,,,, 
,., . 
OMOM 
_.,,,,,,OTBDPS 
Cl 
68 
Phosphorus pentoxide (30 g) was added, in portions over 0.25 h, to a magnetically 
stirred solution of trans-chlorohydrin 62 (27.0 g, 56.31 mmol) in dimethoxymethane 
(200 mL) maintained at 18 °C. When TLC analysis indicated no starting material 
remained (ca. 0.5 h), the reaction mixture was treated with ice (100 g) and then ether 
(400 mL). The separated aqueous phase was extracted with ether (3 x 150 mL) and 
the combined organic phases were washed with NaHCO3 (2 x 200 mL of a saturated 
aq. solution) followed by brine (2 x 200 mL) then dried (MgSO4), filtered and 
concentrated under reduced pressure. The residue thus obtained was subjected to flash 
chromatography (silica, 3% v/v ethyl acetate/hexane elution) to provide, after 
concentration of the appropriate fractions (Rt 0.5), the title compound 68 (26.5 g, 
90%) as a clear, colourless oil. 
1H NMR (CDCb, 300 MHz) 8 7.76-7.64 (complex m, 4H), 7.50-7.35 (complex m, 
6H), 5.95 (d, J 3.4 Hz, lH), 5.31 (d, J 3.9 Hz, lH), 4.86 (d, J 6.9 Hz, lH), 4.53 (d, J 
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6.9 Hz, lH), 4.00 (dd, J 5.6 and 3.4 Hz, lH), 4.17 (dd, J 8.5 and 5.6 Hz, lH), 4.10 
(dd, J 8.4 and 3.4 Hz, lH), 3.38 (s, 3H), 1.98 (s, 3H), 1.09 (s, 9H). 
13C NMR (CDCh, 75 MHz) 8 169.6 (C), 136.2 (CH), 136.1 (CH), 133.0 (C), 132.9 
(C), 131.2 (C), 130.1 (CH), 130.1 (CH), 128.2 (CH), 127.8 (CH), 127.7 (CH), 97.7 
(CH2), 78.4 (CH), 72.0 (CH), 71.0 (CH), 56.9 (CH), 56.3 (CH3), 27.0 (CH3), 20.8 
(CH3), 19.4 (C). 
IR (KBr) Vmax 2933, 2859, 1752, 1427, 1369, 1223, 1113, 1052, 741, 702, 506 cm-1. 
EI MS m/z (70 eV) 469 [(M-C4H9·)\ 2%] and 467 (12) and 465 (18), 241 (100). 
HRMS Found: (M-C4H9·)\ 465.0691. C26H3/5ChOsSi requires: (M-C4H9·)\ 
465.0692. 
Specific Rotation [a]n + 16.2 (c 1.05, CHCh). 
(JS,4R,5R,6S)-4-Azido-6-0-tert-butyldiphenylsilyl-2-chloro-5-0-methoxymethyl-
2-cyclohexene-1-ol Acetate ( 69) 
OMOM 
,,,,OTBDPS 
··'' 
Cl 
68 
LiN3, DMF, 18 °C 
OMOM 
Cl 
69 
.. ,,,,,,OTB DPS 
A magnetically stirred solution of compound 68 (9.09 g, 17.36 rnrnol) in dry DMF (75 
mL) maintained at 18 °C under a nitrogen atmosphere was treated with LiN3 (2.55 g, 
52.08 rnrnol). After stirring for 96 h, the reaction mixture was treated with Na2S2O3 
(150 mL of 10% w/v aq. solution) and ether (150 mL). The separated aq. phase was 
extracted with ether (3 x 100 mL) and the combined organic phases were washed with 
brine (1 x 200 mL) then dried (MgSO4), filtered and concentrated under reduced 
pressure. Purification of the ensuing residue by flash chromatography (silica, 3% v/v 
ethyl acetate/hexane elution) afforded, after concentration of the appropriate fractions 
(R10.4), the title compound 69 (8.57 g, 93%) as a clear, colourless oil. 
1H NMR (CDCh, 300 MHz) 8 7.72-7.60 (complex m, 4H), 7.50-7.36 (complex m, 
6H), 6.03 (m, lH), 5.69 (m, lH), 4.56 (dd, J 11.2 and 6.8 Hz, 2H), 4.38 (dd, J 6.0 and 
3.5 Hz, lH), 4.22 (m, lH), 3.93 (m, lH), 3.26 (s, 3H), 1.79 (s, 3H), 1.06 (s, 9H). 
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13C NMR (CDCh, 75 MHz) 8 169.6 (C), 135.9 (CH), 135.6 (CH), 133.0 (C), 132.5 
(C), 132.4 (C), 130.1 (CH), 129.8 (CH), 127.8 (CH), 127.4 (CH), 123.8 (CH), 97.5 
(CH2), 77.2 (CH), 70.7 (CH), 69.5 (CH), 57.4 (CH), 55.8 (CH3), 26.7 (CH3), 20.4 
(CH3), 19.3 (C). 
IR (KBr) Vmax2932, 2858, 2101, 1749, 1427, 1367, 1222, 1113, 1039, 702, 508 cm-1. 
EI MS mlz (70 eV) 474 [(M-C4H9·)\ 4%] and 472 (10), 241 (100), 199 (82). 
HRMS Found: (M-C4H9·)\ 472.1092. C26H3/5ClN3O5Si requires: (M-C4H9·)\ 
472.1096. 
Specific Rotation [a]o -103.1 (c 0.98, CHCh). 
Methyl 2-O-Acetyl-5-azido-3-O-tert-butyldiphenylsilyl-5-deoxy-6-hydroperoxy-6-
O-methyl-4-O-methoxymethyl-D-mannonate (70) 
OMOM 
,,,,OTBDPS 
.... , 
Cl 
69 
03, MeOH, py, -78 °C 
OMOM 
,,,,OTB DPS 
,,, 
.,,,,,,OAc 
OMe 
70 
A magnetically stirred solution of compound 69 (1.58 g, 2.98 mmol) and pyridine (1.2 
mL, 14.84 mmol) in methanol (MeOH) (25 mL) was cooled to -78 °C (acetone/dry ice 
bath) and then treated with a stream of ozone (03) (ca. 40% 0 3 in oxygen). When 
TLC analysis indicated no starting material remained (ca. 1 h), the reaction mixture 
was purged with nitrogen for ca. 0.66 hand then concentrated under reduced pressure. 
The residue thus obtained was partitioned between ethyl acetate (20 mL) and brine 
(20 mL). The separated aq. phase was extracted with ethyl acetate (3 x 20 mL) and 
the combined organic phases were then dried (MgSO4), filtered and concentrated 
under reduced pressure. The ensuing residue was purified by flash chromatography 
(silica, 25% v/v ethyl acetate/hexane elution) to give, after concentration of the 
appropriate fractions (RJ 0.2), the title compound 70 (0.66 g, 37%) as a clear, 
colourless oil. 
1H NMR (CDCh, 300 MHz) 8 9.18 (br s, lH), 7.78-7.64 (complex m, 4H), 7.53-7.33 
(complex m, 6H), 5.12 (d, J 2.6 Hz, lH), 4.93 (d, J 4.5 Hz, lH), 4.64 (d, J 6.7 Hz, 
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lH), 4.33 (dd, J 5.6 and 2.6 Hz, lH), 4.29 (d, J 6.7 Hz, lH), 4.12 (t, J 4.5 Hz, lH), 
3.78 (t, J 5.2 Hz, lH), 3.65 (s, 3H), 3.56 (s, 3H), 3.20 (s, 3H), 2.17 (s, 3H), 1.08 (s, 
9H). 
13C NMR (CDCh, 75 MHz) 8 170.2 (C), 168.2 (C), 136.1 (CH), 136.0 (CH), 133.0 
(C), 132.6 (C), 130.2 (CH), 130.0 (CH), 127.8 (CH), 106.6 (CH), 98.0 (CH2), 78.2 
(CH), 73.9 (CH), 72.6 (CH), 63.0 (CH), 57.6 (CH3), 56.2 (CH3), 52.4 (CH3), 26.9 
(CH3), 20.7 (CH3), 19.5 (C). 
IR (KBr) Vmax 3368, 2954, 2858, 2110, 1752, 1428, 1220, 1112, 1027, 703, 506 cm-1. 
EI MS m/z (70 eV) 556 [(M-H2O-CH3·)\ 7%], 460 (82), 311 (100), 199 (92). 
HRMS Found: (M-H2O-CH3·)\ 556.2116. C2sH39N3O10Si requires: (M-H2O-CH3·)\ 
556.2115. 
Specific Rotation [a]n +23.0 (c 1.0, CHCh). 
Methyl 2-0-Acetyl-5-azido-3-0-tert-butyldiphenylsilyl-5-deoxy-4-0-
methoxymethyl-D-mannonate (71) 
Cl 
69 
,,,,OTBDPS 
.... , 
i) 03, MeOH, py, -78 °C 
ii) Nal, -78~0 °C 
iii) NaBH4, 18 °C 
OMOM 
,,,,OTBDPS 
,•\' 
OMe 
71 
A magnetically stirred solution of compound 69 (3.2 g, 6.04 mmol) and pyridine (4.88 
rn.L, 60.34 mmol) in MeOH (70 mL) maintained at -78 °C (acetone/dry ice bath) was 
treated with a stream of ozone (03) (ca. 40% 0 3 in oxygen). When TLC analysis 
indicated no starting material remained (ca. 1 h), the reaction mixture was purged 
with nitrogen for ca. 0.66 h and then treated with sodium iodide (Nal) (5.5 g, 36.69 
mmol). After 1 h the by now red-brown reaction mixture was warmed to O °C and 
then treated with sodium borohydride (NaBH4) (ca. 3.58 g, 94.63 mmol). The reaction 
mixture was maintained at O °C (ice-bath) with stirring for 4 hand then treated with 
hydrochloric acid (2.0 M solution in MeOH) so as to reduce the pH to ca. 4. The 
ensuing mixture was concentrated under reduced pressure and the residue partitioned 
between ethyl acetate (50 rn.L) and brine (50 rn.L). The separated aqueous phase was 
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extracted with ethyl acetate (2 x 50 mL) and the combined organic phases were dried 
(MgSO4), filtered and concentrated under reduced pressure. Subjection of the 
resulting light-yellow oil to flash chromatography (silica, 25% v/v ethyl 
acetate/hexane elution) and concentration of the appropriate fractions (R1 0.4) then 
gave the title compound 71 (1.64 g, 49%) as a clear, colourless oil. 
1H NMR (CDCh, 300 MHz) 8 7.75-7.65 (complex m, 4H), 7.50-7.35 (complex m, 
6H), 5.12 (d, J 3.2 Hz, lH), 4.37 (s, 2H), 4.30 (dd, J 4.3 and 3.2 Hz, lH), 3.90-3.72 
(complex m, 3H), 4.64 (dd, J 7.0 and 4.3 Hz, lH), 3.61 (s, 3H), 3.25 (s, 3H), 2.43 (br 
s, lH), 2.18 (s, 3H), 1.08 (s, 9H). 
13C NMR (CDCh, 75 MHz) 8 169.6 (C), 167.6 (C), 135.7 (CH), 135.6 (CH), 132.2 
(C), 132.1 (C), 129.9 (CH), 129.9 (CH), 127.5 (CH), 127.5 (CH), 97.3 (CH2), 77.1 
(CH), 73.6 (CH), 71.4 (CH), 62.6 (CH), 62.1 (CH2), 55.9 (CH3), 52.0 (CH3), 26.5 
(CH3), 20.4 (CH3), 19.0 (C). 
IR (KBr) Vmax3488, 2953, 2858, 2103, 1752, 1428, 1224, 1112, 1026, 703,505 cm-1. 
EI MS m/z (70 eV) 502 [(M-C4H9·)\ 4%], 470 (54), 341 (42), 241 (58), 199 (100). 
HRMS Found: (M-C4H9·)\ 502.1645. C27H37N3OgSi requires: (M-C4H9·)\ 502.1646. 
Specific Rotation [a]n +31.0 (c 1.01, CHCh). 
Methyl 2-0-Acetyl-5-azido-3-0-tert-butyldiphenylsilyl-5-deoxy-6-0-(2-
methoxyethoxy)methyl-4-0-methoxymethyl-D-mannonate (72) 
OMOM 
,,,,OTBDPS 
··\' 
71 
MEM-Cl, DIPEA 
CH2Cl2, 18 °C 
OMOM 
,,~OTBDPS 
··'' 
OMe 
72 
2-Methoxyethoxymethylchloride (MEM-Cl) (5.0 mL, 43.91 mmol) was added, 
dropwise, to a magnetically stirred solution of compound 71 (3.04 g, 5.43 mmol) and 
DIPEA (9.5 mL, 54.54 mmol) in dichloromethane (15 mL) maintained at 18 °C under 
a nitrogen atmosphere. After stirring for ca. 16 h, the reaction mixture was 
concentrated under reduced pressure and the residue partitioned between ethyl acetate 
(50 mL) and NH4Cl (50 mL of a saturated aq. solution). The separated organic layer 
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was washed with NH4Cl (2 x 50 mL of a saturated aq. solution) and water (1 x 50 
mL) then dried (MgSO4), filtered and concentrated under reduced pressure. 
Purification of the ensuing residue by flash chromatography (silica, 15% v/v ethyl 
acetate/hexane elution) gave, after concentration of the appropriate fractions (R1 0.5), 
the title compound 72 (3.05 g, 87%) as a clear, colourless oil. 
1H NMR (CDCb, 300 MHz) 3 7.73-7.65 (complex m, 4H), 7.46-7.30 (complex m, 
6H), 5.12 (d, J 3.0 Hz, lH), 4.73 (s, 2H), 4.31 (m, 3H), 4.05 (m, lH), 3.93 (m, lH), 
3.72 (m, 2H), 3.64 (m, lH), 3.59 (s, 3H), 3.55 (m, 3H), 3.37 (s, 3H), 3.17 (s, 3H), 2.15 
(s, 3H), 1.07 (s, 9H). 
13C NMR (CDCb, 75 MHz) 3 169.8 (C), 167.7 (C), 136.0 (CH), 132.6 (C), 132.5 (C), 
130.2 (CH), 127.8 (CH), 127.8 (CH), 97.1 (CH2), 95.7 (CH2), 77.8 (CH), 73.5 (CH), 
71.8 (CH), 71.7 (CH2), 68.3 (CH2), 67.0 (CH2), 61.7 (CH), 59.0 (CH3), 56.1 (CH3), 
52.2 (CH3), 26.8 (CH3), 20.6 (CH3), 19.3 (C). 
IR(KBr)vmax2933,2859,2101, 1753, 1428, 1225, 1112, 1028,824, 704,506cm-1. 
EI MS m/z (70 eV) 588 [(M-C2H5NO·)\ 14%], 470 (64), 311 (100), 199 (52). 
HRMS Found: (M-C2H5NO·)\ 588.2495. C31H45N3O10Si requires: (M-C2HsNO·)\ 
588.2503. 
Specific Rotation [a]0 +31.6 (c 1.05, CHCb). 
5-Azido-1-0-tert-butyldiphenylsilyl-5-deoxy-6-0-(2-methoxyethoxy)methyl-4-0-
methoxymethyl-D-mannitol (73) 
OMOM 
.. ,,,,,,OTBD PS 
72 
LiAlH4, THF, -78 °C 
OMOM 
OTBDPS 
73 
Lithium aluminium hydride (LiAlH4) (14.0 mL of 1.0 M solution in THF, 14.00 
mmol) was added, dropwise, to a magnetically stirred solution of compound 72 (1.11 
g, 1.71 mmol) in dry THF (20 mL) maintained at -78 °C (acetone/dry ice bath) under 
a nitrogen atmosphere. After stirring for ca. 6 h, ethyl acetate (100 mL) then water (5 
mL) were added and the resulting mixture was allowed to warm to 18 °C. After 
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filtration and concentration of the filtrate, the residue was partitioned between ethyl 
acetate (25 mL) and brine (25 mL). The separated aq. phase was extracted with ethyl 
acetate (3 x 20 mL) and the combined organic phases were dried (MgSO4), filtered 
and concentrated under reduced pressure. The light-yellow oil thus obtained was 
purified by flash chromatography (silica, 35% v/v ethyl acetate/hexane elution) to 
give, after concentration of the appropriate fractions (R1 0.3), the title compound 73 
(0.52 g, 53%) as a clear, colourless oil. 
1H NMR (CDCb, 300 MHz) 8 7.71-7.65 (complex m, 4H), 7.45-7.35 (complex m, 
6H), 4.79 (d, J 6.9 Hz, 2H), 4.76 (s, 2H), 3.99-3.81 (complex m, 4H), 3.79-3 .62 
(complex m, 4H), 3.56 (m, 3H), 3.42 (s, 3H), 3.39 (m, lH), 3.39 (s, 3H), 2.75 (br s, 
2H), 1.07 (s, 9H). 
13C NMR (CDCb, 75 MHz) 8 136.7 (CH), 136.6 (CH), 132.9 (C), 132.8 (C), 130.0 
(CH), 127.9 (CH), 127.9 (CH), 98.6 (CH2), 95.8 (CH2), 77.0 (CH), 71.8 (CH2), 71.8 
(CH), 70.5 (CH), 67.4 (CH2), 67.2 (CH2), 65.9 (CH2), 62.0 (CH), 59.1 (CH3), 56.6 
(CH3), 26.9 (CH3), 19.3 (C). 
IR (KBr) Vmax3468, 2931, 2859, 2098, 1428, 1268, 1112, 1026, 741,703,505 cm-1. 
Specific Rotation [a]0 -24.0 (c 0.5, CHCb). 
5-Azido-1-0-tert-butyldiphenylsilyl-5-deoxy-2,3-0-isopropylidene-6-0-(2-
methoxyethoxy)methyl-4-0-methoxymethyl-D-mannitol (7 4) 
OMOM 
OTBDPS 
73 
2,2-DMP,p-TsOH, 18 °C 
MEMO 
OMOM 
OTBDPS 
74 
p-Toluenesulfonic acid (p-TsOH) (50.9 mg, 0.27 mmol) was added to a magnetically 
stirred solution of compound 73 (520 mg, 0.90 mmol) in 2,2-dimethoxypropane (2,2-
DMP) (30 mL) maintained at 18 °C. After 3 h the reaction mixture was treated with 
triethylamine (0.5 mL) and then concentrated under reduced pressure. The residue so 
obtained was dissolved in ethyl acetate (25 mL) and the resulting mixture washed 
with NH4Cl (1 x 25 mL of a saturated aq. solution) and brine (2 x 25 mL) then dried 
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(MgSO4), filtered and concentrated under reduced pressure. The ensuing residue was 
purified by flash chromatography (silica, 15% v/v ethyl acetate/hexane elution) 
thereby affording, after concentration of the appropriate fractions (R1 0.4), the title 
compound 74 (416 mg, 75%) as a clear, colourless oil. 
1H NMR (CDCb, 300 MHz) 8 7.73-7.67 (complex m, 4H), 7.47-7.35 (complex m, 
6H), 4.76 (m, 3H), 4.67 (d, J 6.6 Hz, lH), 4.26 (m, 2H), 3.98 (m, 2H), 3.87 (m, 2H), 
3.74 (m, 4H), 3.56 (m, 2H), 3.40 (s, 3H), 3.39 (s, 3H), 1.40 (s, 3H), 1.34 (s, 3H), 1.08 
(s, 9H). 
13C NMR (CDCb, 75 MHz) 8 135.7 (CH), 135.7 (CH), 133.1 (C), 133.0 (C), 129.9 
(CH), 129.9 (CH), 127.9 (CH), 108.5 (C), 97.5 (CH2), 95.7 (CH2), 77.7 (CH), 77.6 
(CH), 75.0 (CH), 71.8 (CH2), 67.1 (CH2), 67.0 (CH2), 62.9 (CH2), 62.3 (CH), 59.1 
(CH3), 56.2 (CH3), 27.4 (CH3), 26.9 (CH3), 25.6 (CH3), 19.2 (C). 
IR(KBr)Vmax2932,2889,2098, 1428, 1369, 1217, 1112, 1028, 704,505 cm-1. 
EI MS m/z (70 eV) 602 [(M-CH3·)\ 7%], 560 (31), 412 (12), 311 (11), 241 (59), 199 
( 4 7), 89 (95), 59 (100). 
HRMS Found: (M-CH3·)\ 602.2903. C31H47N3O8Si requires: (M-CH3·)\ 602.2898. 
Specific Rotation [a]0 + 15.3 (c 0.6, CHCb). 
5-tert-Butoxycarbonylamino-1-0-tert-butyldiphenylsilyl-5-deoxy-2,3-0-
isopropylidene-6-0-(2-methoxyethoxy)methyl-4-0-methoxymethyl-D-mannitol 
(75) 
OMOM 
OTBDPS 
74 
Method A: 
5% Pd/C, (Boe )iO 
H2, EtOAc, 18 °C 
OMOM 
Boe H N ,,,1110 
: .. ,,,,;;< 
OTBDPS 
75 
Method A: A magnetically stirred mixture of compound 74 (153 mg, 0.25 mmol), 
di-tert-butyldicarbonate [(Boc)2O] (116 mg, 5.32 mmol) and 5% Pd/C (85 mg) in 
ethyl acetate (10 mL) was exposed to a balloon of hydrogen gas. After stirring at 18 
°C for 20 h, the reaction mixture was filtered through a short pad of Celite™ and the 
filtrate was concentrated under reduced pressure. The residue so formed was purified 
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by flash chromatography (silica, 20% v/v ethyl acetate/hexane elution) to give, after 
concentration of the appropriate fractions (Rt 0.3), the title compound 75 (162 mg, 
95%) as a clear, colourless oil. 
1H NMR (CDCb, 300 MHz) o 7.71-7.66 (complex m, 4H), 7.49-7.33 (complex m, 
6H), 5.74 (d, J 8.1 Hz, lH), 4.63 (m, 4H), 4.39 (t, J 5.5 Hz, lH), 4.28 (dd, J 11.4 and 
5.9 Hz, lH), 4.03 (m, 2H), 3.89 (dd, J 10.7 and 6.7 Hz, lH), 3.81-3.58 (complex m, 
5H), 3.52 (m, 2H), 3.37 (s, 3H), 3.32 (s, 3H), 1.42 (s, 9H), 1.38 (s, 3H), 1.33 (s, 3H), 
1.06 (s, 9H). 
13C NMR (CDCb, 75 MHz) o 155.7 (C), 135.8 (CH), 135.7 (CH), 133.3 (C), 133.0 
(C), 129.9 (CH), 129.9 (CH), 127.8 (CH), 127.8 (CH), 108.4 (C), 97.3 (CH2), 95.7 
(CH2), 79.1 (C), 77.9 (CH), 77.8 (CH), 75.1 (CH), 71.8 (CH2), 67.0 (CH2), 67.0 
(CH2), 63.1 (CH2), 59.1 (CH3), 56.3 (CH3), 52.2 (CH), 28.5 (CH3), 27.2 (CH3), 27.0 
(CH3), 25.7 (CH3), 19.3 (C). 
IR (KBr) Vmax 3422, 2932, 2888, 1715, 1504, 1366, 1218, 1112, 1044, 704, 505 cm-1. 
EI MS m/z (70 eV) 676 [(M-CH3·)\ 15%], 634 (10), 414 (37), 241 (39), 199 (57), 89 
(99), 57 (100). 
HRMS Found: (M-CH3·)\ 676.3522. C36H57NO10Si requires: (M-CH3·)\ 676.3517. 
Specific Rotation [a]n + 12.0 (c 0.5, CHCb). 
BocHN 
OMOM 
.. ,,,,,OH 
OTBDPS 
83 
MethodB: 
2,2-DMP,p-TsOH, 18 °C 
BocHN 
MEMO 
OMOM 
... ,,1110 
,,,,,,;;< 
OTBDPS 
75 
Method B: p-TsOH (19 mg, 0.10 mmol) was added to a magnetically stirred 
solution of compound 83 (50 mg, 0.08 mmol) in 2,2-DMP (6 mL) maintained at 18 
°C. After 5 h the reaction mixture was treated with triethylamine (0.1 mL) and then 
concentrated under reduced pressure. The residue so formed was dissolved in ethyl 
acetate (10 mL) and the resulting solution washed with NaHCO3 (2 x 10 mL of a 
saturated aq. solution) then dried (MgSO4), filtered and concentrated under reduced 
pressure. The ensuing residue was subjected to flash chromatography (silica, 20% v/v 
ethyl acetate/hexane elution) to give, after conce_ntration of the appropriate fractions 
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(R10.3), the title compound 75 (36 mg, 68%) which proved identical, in all respects, 
to the material obtained by Method A. 
5-tert-Butoxycarbonylamino-5-deoxy-2,3-0-isopropylidene-6-0-(2-
methoxyethoxy)methyl-4-0-methoxymethyl-D-mannitol (7 6) 
OMOM OMOM 
BocHN 
.. ,,,,1,0 
.. ,,,,;;< 
OTBDPS 
75 
Method A: 
TBAF, THF, 18 °C 
BocHN 
OH 
76 
.. ,,,,110 
.,,,,,;;< 
Method A: A magnetically stirred solution of compound 75 (155 mg, 0.25 mmol) 
in THF (5 mL) was treated with tetra-n-butylammonium fluoride (TBAF) (380 µL of 
a 1.0 M solution in THF, 0.38 mmol). After stirring at 18 °C for 0.75 h, 
dichloromethane (10 mL) was added. The resulting mixture was washed with water (2 
x 10 mL) then dried (MgSO4), filtered and concentrated under reduced pressure. 
Subjection of the ensuing residue to flash chromatography (silica, 1 : 1 v/v ethyl 
acetate/hexane elution) led, after concentration of the appropriate fractions (R1 0.2), to 
the title compound 76 (105 mg, 92%) as a clear, colourless oil. 
1 H NMR (CDCh, 300 MHz) 8 5.44 (d, J7.8 Hz, lH), 4.83 (d, J 6.7 Hz, lH), 4.69 (sd, 
J 6.7 Hz, 3H), 4.32 (dd, J 7.9 and 5.4 Hz, lH), 4.16 (m, lH), 4.03 (m, 2H), 3.85 (dd, J 
11.7 and 6.6 Hz, lH), 3.69 (m, 4H), 3.60 (m, lH), 3.56 (m, 3H), 3.41 (s, 3H), 3.39 (s, 
3H), 1.43 (s, 12H), 1.34 (s, 3H). 
13C NMR (CDCh, 75 MHz) 8 156.1 (C), 108.1 (C), 97.6 (CH2), 95.6 (CH2), 78.0 (C), 
77.9 (CH), 77.8 (CH), 75.7 (CH), 71.9 (CH2), 67.2 (CH2), 66.3 (CH2), 61.5 (CH2), 
59.2 (CH3), 56.3 (CH3), 52.0 (CH), 28.6 (CH3), 28.2 (CH3), 25.8 (CH3). 
IR (KBr) Vmax3417, 2932, 2884, 1712, 1513, 1369, 1246, 1167, 1046, 854 cm-1. 
EI MS m/z (70 eV) 454 [(M+H)\ 23%], 438 (8), 246 (31), 192 (44), 89 (91), 59 
(100). 
HRMS Found: (M-CH3·)\ 438.2339. C20H39NO10 requires: (M-CH3·)\ 438.2339. 
Specific Rotation [a]0 +57.0 (c 0.3, CHCh). 
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MethodB: 
NaBH4, MeOH, 18 °C 
MEMO OMOM 
77 
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OMOM 
OH 
76 
.. ,,,,,0 
. .,,,,;;< 
115 
Method B: A magnetically stirred solution of compound 77 (67 mg, 0.15 mmol) in 
MeOH (5 mL) maintained at 18 °C was treated with NaBH4 (650 mg, 17.18 mmol). 
When TLC analysis indicated no starting material remained (ca. 24 h), the reaction 
mixture was concentrated under reduced pressure. The residue thus obtained was 
partitioned between ethyl acetate (20 mL) and NaHCO3 (30 mL of a saturated aq. 
solution). The separated aqueous phase was extracted with ethyl acetate (1 x 10 mL) 
and the combined organic phases were dried (MgSO4), filtered and concentrated 
under reduced pressure. The resulting residue was subjected to flash chromatography 
(silica, 1 : 1 v/v ethyl acetate/hexane elution) to afford, after concentration of the 
appropriate fractions (R1 0.2), the title compound 76 (59 mg, 87%) which proved 
identical, in all respects, to the material obtained by Method A. 
N-tert-Butoxycarbonyl-5-deoxy-2,3-0-isopropylidene-6-0-(2-
methoxyethoxy)methyl-4-0-methoxymethyl-D-mannolactam (77) 
BocHN 
OMOM 
OH 
76 
Method A: 
DMP, CH2Cl2, 18 °C 
0 
ox 
0 
MEMO OMOM 
77 
Method A: A solution of compound 76 (102 mg, 0.22 mmol) 1n dry 
dichloromethane (5 mL) was added to a magnetically stirred suspension of Dess-
Martin periodinane (DMP) (279 mg, 0.66 mmol) in dry dichloromethane (5 mL) 
maintained at 18 °C under a nitrogen atmosphere. The resulting mixture was stirred 
for a further 24 h at 18 °C then ethyl acetate (20 mL) and brine (20 mL) were added. 
The separated aqueous phase was extracted with ethyl acetate (2 x 10 mL) and the 
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combined organic phases were dried (MgS04), filtered and concentrated under 
reduced pressure. The ensuing residue was purified by flash chromatography (silica, 
50% v/v ethyl acetate/hexane elution) to give, after concentration of the appropriate 
fractions (R1O.4), the title compound 77 (93 mg, 92%) as a clear, colourless oil. 
1H NMR (CDCb, 300 MHz) 8 4.71 (m, 5H), 4.61 (d, J 6.9 Hz, lH), 4.47 (m, lH), 
4.26 (t, J 2.4 Hz, lH), 3.81 (m, 2H), 3.67 (dd, J 8.8 and 4.2 Hz, 2H), 3.53 (m, 2H), 
3.37 (s, 3H), 3.37 (s, 3H), 1.51 (s, 12H), 1.34 (s, 3H). 
13C NMR (CDCb, 75 MHz) 8 167.4 (C), 152.3 (C), 110.6 (C), 95.7 (CH2), 95.5 
(CH2), 83.7 (C), 75.9 (CH), 75.3 (CH), 71.8 (CH2), 69.6 (CH), 67.0 (CH2), 59.1 
(CH3), 58.4 (CH), 56.1 (CH3), 28.0 (CH3), 26.0 (CH3), 23.9 (CH3). 
IR (KBr) Vmax2935, 2891, 1775, 1727, 1369, 1209, 1155, 1035, 852 cm-1. 
EI MS m/z (70 eV) 449 (M+, 9%), 434 (14), 334 (53), 198 (50), 89 (100), 59 (92). 
HRMS Found: M+·, 449.2253. C20H35N010 requires: M+·, 449.2261. 
Specific Rotation [a]0 +15.0 (c 0.2, CHCb). 
OH 
°x 
0 
Method B: 
DMP, CH2Cl2, 18 °C 
MEMO OMOM 
79 
0 
MEMO OMOM 
77 
Method B: Following the same procedure as described immediately above, 
compound 79 (63 mg, 0.14 mmol) (a mixture of anomers) was converted into the title 
compound 77 (53 mg, 85%) which proved identical, in all respects, to the material 
obtained by Methods A and C. 
0 
0 ;;<-
MEMO OMOM 
107 
Method C: 
(Boc)iO, DMAP 
MeCN, 18 °C 
0 
MEMO OMOM 
77 
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Method C: A magnetically stirred solution of compound 107 (112 mg, 0.32 mmol) 
in acetonitrile (MeCN) (8 mL) was treated with (Boc)2O (104 mg, 0.48 mmol) and 
DMAP (8 mg). After stirring at 18 °C for 1 h, the reaction mixture was concentrated 
under reduced pressure. Subjection of the ensuing residue to flash chromatography 
(silica, 50% v/v ethyl acetate/hexane elution) and concentration of the relevant 
fractions (R1 0.4) delivered the title compound 77 (138 mg, 96%) which proved 
identical, in all respects, to the material obtained by Methods A and B. 
N-tert-Butoxycarbonyl-5-deoxy-2,3-O-isopropylidene-6-O-(2-
methoxyethoxy)methyl-4-O-methoxymethyl-D-mannolactam (77) and 
(2R,3S,4S,5S)-N-tert-Butoxycarbonyl-6-hydroxy-4,5-O-isopropylidene-2-{[(2-
methoxyethoxy)methoxy]methyl] }-3-O-methoxymethylpiperidine (79) 
BocHN 
MEMO 
OMOM 
OH 
76 
0 DMP, py 
··"'" X _c_H2_C_I2_, _I8_0_c_ 
.. ,,,,,a 
0 
ox+ 
0 
MEMO OMOM 
77 
OH 
MEMO OMOM 
79 
A solution of compound 76 (88 mg, 0.19 mmol) in dry dichloromethane (5 mL) was 
added to a magnetically stirred suspension of DMP (327 mg, 0. 77 mmol) in dry 
dichloromethane (5 mL) and pyridine (0.3 mL) maintained at 18 °C under a nitrogen 
atmosphere. After 2 h ethyl acetate ( 15 mL) and brine ( 15 mL) were added to the 
reaction mixture. The separated aq. phase was extracted with ethyl acetate (2 x 10 
mL) and the combined organic phases were dried (MgSO4), filtered and concentrated 
under reduced pressure. The residue so formed was subjected to flash chromatography 
( silica, gradient elution using 45 to 60% v/v ethyl acetate/hexane) thus affording two 
fractions, A and B. 
Concentration of fraction A (R1 0.4 1n 8 2.5 5.5 v/v/v ethyl 
acetate/dichloromethane/hexane) afforded compound 77 (47 mg, 54%) which proved 
identical, in all respects, to the material obtained as described immediately above. 
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Concentration of fraction B (R1 0.3 in 8 : 2.5 : 5.5 v/v/v ethyl 
acetate/dichloromethane/hexane) afforded compound 79 (15 mg, 17%) as a mixture of 
anomers. 
13C NMR (CDCh, 75 MHz) 8 155.7 (C), 110.2 (C), 108.7 (C), 96.9 (CH2), 95.9 
(CH2), 95.7 (CH2), 95.6 (CH2), 81.3 (C), 81.2 (C), 78.2 (CH), 75.2 (CH), 74.5 (CH), 
71.8 (CH2), 71.7 (CH2), 71.6 (CH), 67.2 (CH2), 66.9 (CH2), 59.2 (CH), 59.1 (CH3), 
56.3 (CH3), 28.5 (CH3), 28.4 (CH3), 26.7 (CH3), 25.1 (CH3), 24.9 (CH3), 23.1 (CH3). 
IR(KBr) Vmax3469, 2932, 1703, 1371, 1209, 1165, 1053, 1025, 866 cm-1. 
EI MS mlz (70 eV) 434 [(M-OH·)\ 31 %], 393 (13), 214 (36), 89 (71), 57 (100). 
HRMS Found: (M-OH·)\ 434.2386. C20H37NO10 requires: (M-OH·)\ 434.2390. 
Methyl 2-0-Acetyl-5-tert-butoxycarbonylamino-3-0-tert-butyldiphenylsilyl-5-
deoxy-6-0-(2-methoxyethoxy)methyl-4-0-methoxymethyl-D-mannonate (80) and 
2-0-Acetyl-3-0-tert-butyldiphenylsilyl-5-deoxy-6-0-(2-methoxyethoxy)methyl)-4-
0-methoxymethyl-D-mannolactam (81) 
OMOM 5% Pd/C, H2 
N3 ,,,,OTB DPS 
··\' 
(Boc)iO BocHN 
EtOAc, 18 °C 
MEMO 0 
···,,,,,OAc 
OMe 
72 
OMOM 
_.,,,,,,OTB DPS 
···,,,,,OAc 
OMe 
80 
+ 
MEMO 
0 
OAc 
OTBDPS 
OMOM 
81 
A magnetically stirred mixture of compound 72 ( 4.09 g, 6.31 mmol), (Boe )20 ( 4.13 g, 
18.92 mmol) and 5% Pd/C (2.5 g) in ethyl acetate (10 mL) was exposed to a balloon 
of hydrogen gas. After stirring at 18 °C for 36 h, the reaction mixture was filtered 
through a short pad of Celite™ and the filtrate was concentrated under reduced 
pressure. The ensuing residue was purified by flash chromatography (silica, gradient 
elution using 30 to 80% v/v ethyl acetate/hexane) to provide two fractions, A and B. 
Concentration of fraction A (Rt 0.4 in 4 : 2.5 : 5.5 v/v/v ethyl 
acetate/dichloromethane/hexane) afforded compound 80 (2.62 g, 58%) as a clear, 
colourless oil. 
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1H NMR (CDCb, 300 MHz) 8 7.74-7.57 (complex m, 4H), 7.45-7.30 (complex m, 
6H), 5.92 (d, J 7.5 Hz, lH), 5.20 (d, J l.9 Hz, lH), 4.47 (dd, J 12.8 and 6.6 Hz, 2H), 
4.30 (dt, J 7.0 and 6.5 Hz, 2H), 4.08 (m, 2H), 3.86 (m, lH), 3.67 (s, 3H), 3.50 (m, 
6H), 3.36 (s, 3H), 3.16 (s, 3H), 2.06 (s, 3H), 1.42 (s, 9H), 1.06 (s, 9H). 
13C NMR (CDCb, 75 MHz) 8 169.7 (C), 167.6 (C), 155.2 (C), 136.2 (CH), 135.9 
(CH), 133.3 (C), 132.4 (C), 129.9 (CH), 129.8 (CH), 127.5 (CH), 127.5 (CH), 98.6 
(CH2), 95.5 (CH2), 82.0 (CH), 78.9 (C), 74.4 (CH), 73.8 (CH), 71.8 (CH2), 66.7 
(CH2), 66.1 (CH2), 59.0 (CH3), 56.0 (CH3), 52.2 (CH3), 51.3 (CH), 28 .6 (CH3), 27.0 
(CH3), 20.7 (CH3), 19.6 (C). 
IR (KBr) Vmax 3412, 2933, 2891, 1751, 1716, 1511, 1231, 1113, 1028, 705, 508 cm-1. 
EI MS m/z (70 eV) 664 [(M-C4H9-)\ 6%], 532 (16), 444 (32), 241 (24), 199 (54), 89 
(100), 59 (100). 
HRMS Found: (M-C4H9·)\ 664.2785. C36HssNO12Si requires: (M-C4H9·)\ 664.2789. 
Specific Rotation [a]0 +31.8 (c 0.5, CHCb). 
Concentration of fraction B (R1 0.3 1n 16 : 2.5 : 5.5 v/v/v ethyl 
acetate/dichloromethane/hexane) afforded compound 81 (1.05 g, 28%) as a clear, 
colourless oil. 
1H NMR (CDCb, 300 MHz) 8 7.70-7.60 ( complex m, 4H), 7.43-7.31 ( complex m, 
6H), 6.35 (s, lH), 5.44 (d, J 2.5 Hz, lH), 4.68 (dd, J 11.8 and 7.0 Hz, 2H), 4.36 (d, J 
6.9 Hz, lH), 4.25 (t, J 2.5 Hz, lH), 4.15 (d, J 6.9 Hz, lH), 3.72-3.56 (complex m, 
SH), 3.51 (m, 3H), 3.38 (s, 3H), 3.14 (s, 3H), 1.93 (s, 3H), 1.06 (s, 9H). 
13C NMR (CDCb, 75 MHz) 8 169.8 (C), 166.5 (C), 136.1 (CH), 135.9 (CH), 132.7 
(C), 132.5 (C), 130.1 (CH), 129.8 (CH), 127.8 (CH), 127.4 (CH), 95.8 (CH2), 95.6 
(CH2), 74.6 (CH), 72.4 (CH), 71.7 (CH2), 69.9 (CH), 69.4 (CH2), 67.4 (CH2), 59.0 
(CH3), 56.2 (CH3), 55.8 (CH), 27.0 (CH3), 20.7 (CH3), 19.6 (C). 
IR (KBr) Vmax 3290, 2933, 2891, 1752, 1700, 1371 , 1228, 1034, 705, 508 cm-1. 
EI MS m/z (70 eV) 590 [(M+H)\ 4%], 574 (4), 532 (22), 490 (100), 199 (60), 89 
(91). 
HRMS Found: (M+H)\ 590.2788. C30H43NO9Si requires (M+H)\ 590.2785. 
Specific Rotation [a]0 +20.2 (c 0.5, CHCb). 
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Methyl 5-tert-Butoxycarbonylamino-2-O-tert-butyldiphenylsilyl-5-deoxy-6-O-(2-
methoxyethoxy)methyl-4-O-methoxymethyl-D-mannonate (82), 5-tert-
Butoxycarbonylamino-1-O-tert-butyldiphenylsilyl-5-deoxy-6-O-(2-
methoxyethoxy)methyl-4-O-methoxymethyl-D-mannitol (83) and 5-tert-
Butoxycarbonylamino-2-O-tert-butyldiphenylsilyl-5-deoxy-6-O-(2-
methoxyethoxy)methyl-4-O-methoxymethyl-D-mannitol (84) 
BocHN 
OMOM 
BocHN .. ,,,,,,OTBDPS BocHN 
+ 
82 
OMOM 
,,,,OTBDPS 
.~'' 
... ,,,ijOAc 
OMe 
80 j NaBH4, MeOH, 18 °C 
OMOM 
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BocHN 
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A magnetically stirred solution of compound 80 (2.02 g, 2.80 mmol) in MeOH (50 
mL) maintained at 18 °C was treated with NaBH4 (2.31 g, 61.06 mmol). After stirring 
for 20 h, the reaction mixture was concentrated under reduced pressure and the 
ensuing residue was partitioned between ethyl acetate (100 mL) and NaHCO3 (150 
mL of a saturated aq. solution). The separated aqueous phase was extracted with ethyl 
acetate (3 x 50 mL) and the combined organic phases were then dried (MgSO4), 
filtered and concentrated under reduced pressure. The residue thus obtained was 
subjected to flash chromatography (silica, gradient elution using 25 to 60% v/v ethyl 
acetate/hexane) thereby affording three fractions, A, Band C. 
Concentration of fraction A (R1 0.5 m 8 2.5 5.5 v/v/v ethyl 
acetate/dichloromethane/hexane) afforded compound 82 (0.17 g, 9%) as a clear, 
colourless oil. 
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1H NMR (CDCb, 300 MHz) 8 7.73-7.62 (complex m, 4H), 7.45-7.31 (complex m, 
6H), 5.57 (d, J 8.5 Hz, lH), 4.69 (s, 2H), 4.41 (s, 2H), 4.25 (d, J 8.1 Hz, lH), 4.01 (m, 
2H), 3.82 (dm, J 6.7 Hz, 2H), 3.68 (m, 2H), 3.57 (m, 3H), 3.39 (m, 4H), 3.38 (s, 3H), 
3.26 (s, 3H), 1.44 (s, 9H), 1.08 (s, 9H). 
13C NMR (CDCb, 75 MHz) 8 171.7 (C), 156.1 (C), 136.0 (CH), 135.9 (CH), 135.7 
(CH), 135.7 (CH), 132.7 (C), 132.4 (C), 130.0 (CH), 129.9 (CH), 127.8 (CH), 127.7 
(CH), 127.6 (CH), 127.4 (CH), 97.8 (CH2), 95.8 (CH2), 79.7 (C), 76.7 (CH), 73.5 
(CH), 72.6 (CH), 71.8 (CH2), 67.2 (CH2), 67.1 (CH2), 59.1 (CH3), 56.2 (CH3), 51.8 
(CH3), 51.5 (CH), 28.5 (CH3), 27.0 (CH3), 20.7 (CH3), 19.6 (C). 
IR (KBr) Vmax 3423, 2932, 2892, 1749, 1713, 1505, 1428, 1366, 1113, 705, 507 cm-1. 
EI MS m/z (70 eV) 548 [(M-C4H9OH-C4H9·)\ 4%], 490 (24), 199 (100), 89 (85). 
HRMS Found: (M-C4H9OH-C4H9·)\ 548.1956. C34H53NO11Si requires: (M-C4H9OH-
C4H9·)\ 548.1952. 
Specific Rotation [a] 0 -0.8 (c 0.5, CHCb). 
Concentration of fraction B (R1 0.4 1n 8 : 2.5 : 5.5 v/v/v ethyl 
acetate/dichloromethane/hexane) afforded compound 83 (0.3 l g, 17%) as a clear, 
colourless oil. 
1H NMR (CDCh, 300 MHz) 8 7.70-7.61 (complex m, 4H), 7.45-7.33 (complex m, 
6H), 5.49 (d, J 7.8 Hz, lH), 4.80 (s, 2H), 4.73 (s, 2H), 3.95 (m, SH), 3.71 (m, 4H), 
3.56 (m, 3H), 3.44 (s, 3H), 3.37 (m, 4H), 3.18 (m, lH), 1.39 (s, 9H), 1.06 (s, 9H). 
13C NMR (CDCh, 75 MHz) 8 156.9 (C), 135.6 (CH), 135.5 (CH), 133.2 (C), 129.7 
(CH), 129.7 (CH), 127.8 (CH), 127.7 (CH), 98.7 (CH2), 96.2 (CH2), 80.2 (C), 77.8 
(CH), 71.8 (CH2), 71.8 (CH2), 70.5 (CH), 70.4 (CH), 67.6 (CH2), 65.6 (CH2), 59.2 
(CH3), 56.7 (CH3), 50.9 (CH), 28.5 (CH3), 27.1 (CH3), 19.5 (C). 
IR (KBr) Vmax3443, 2931, 1712, 1691, 1505, 1428, 1366, 1112, 1044, 704,506 cm-1. 
EI MS m/z (70 eV) 520 [(M-C4H9OH-C4H9·)\ 66%], 241 (26), 199 (71), 89 (100). 
HRMS Found: (M-C4H9OH-C4H9·)\ 520.2005. C33Hs3NO10Si requires: (M-C4H9OH-
C4H9-)\ 520.2003. 
Specific Rotation [a] 0 -8.2 (c 0.5, CHCh). 
Concentration of fraction C (R1 0.3 1n 8 : 2.5 : 5.5 v/v/v ethyl 
acetate/dichloromethane/hexane) afforded compound 84 (0.64 g, 35%) as a clear, 
colourless oil. 
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1H NMR (CDCh, 300 MHz) 8 7.73-7.61 (complex m, 4H), 7.46-7.32 (complex m, 
6H), 5.54 (d, J 7.5 Hz, lH), 4.70 (s, 2H), 4.46 (s, 2H), 4.01-3.77 (complex m, 6H), 
3.69 (m, 3H), 3.58 (m, 3H), 3.40 (s, 3H), 3.27 (s, 3H), 2.61 (br s, lH), 1.71 (br s, lH), 
1.46 (s, 9H), 1.06 (s, 9H). 
13C NMR (CDCh, 75 MHz) 8 156.5 (C), 135.9 (CH), 135.6 (CH), 134.1 (C), 133.0 
(C), 130.0 (CH), 129.9 (CH), 127.8 (CH), 127.7 (CH), 98.0 (CH2), 95.9 (CH2), 80.0 
(C), 77.6 (CH), 74.3 (CH), 72.7 (CH), 71.8 (CH2), 67.3 (CH2), 67.0 (CH2), 65.5 
(CH2), 59.2 (CH3), 56.2 (CH3), 51.5 (CH), 28.5 (CH3), 27.2 (CH3), 19.5 (C). 
IR (KBr) Vmax 3414, 2932, 1712, 1505, 1428, 1366, 1247, 1171, 1111, 705, 507 cm-1. 
EI MS m/z (70 eV) 520 [(M-C4H9OH-C4H9·)\ 25%], 241 (11), 199 (46), 59 (100). 
HRMS Found: (M-C4H9OH-C4H9·)\ 520.2003. C33H53NO10Si requires: (M-C4H9OH-
C4H9·)\ 520.2003. 
Specific Rotation [a]n + 13.2 (c 0.5, CHCh). 
5-tert-Butoxycarbonylamino-2-0-tert-butyldiphenylsilyl-5-deoxy-1,3-0-
isopropylidene-6-0-(2-methoxyethoxy)methyl-4-0-methoxymethyl-D-mannitol 
(85) 
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OMOM 
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p-TsOH ( 40 mg, 0.21 mmol) was added to a magnetically stirred solution of 
compound 84 (124 mg, 0.19 mmol) in 2,2-DMP (10 mL) maintained at 18 °C. After 5 
h the reaction mixture was treated with triethylamine (0.1 mL) and then concentrated 
under reduced pressure. The ensuing residue was subjected to flash chromatography 
(silica, 35% v/v ethyl acetate/hexane elution) to give, after concentration of the 
appropriate fractions (R1 0.2), the title compound 85 (122 mg, 92%) as a clear, 
colourless oil. 
1H NMR (CDCh, 300 MHz) 8 7.69-7.61 (complex m, 4H), 7.46-7.32 (complex m, 
6H), 5.57 (d, J 8.6 Hz, lH), 4.74 (s, 2H), 4.43 (s, 2H), 4.25 (m, lH), 4.04 (m, 3H), 
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3.73 (m, 3H), 3.59 (m, 5H), 3.41 (s, 3H), 3.26 (s, 3H), 1.45 (s, 3H), 1.42 (s, 9H), 1.34 
(s, 3H), 1.04 (s, 9H). 
13C NMR (CDCh, 75 MHz) 8 155.6 (C), 135.8 (CH), 135.7 (CH), 134.1 (C), 133.0 
(C), 130.0 (CH), 129.9 (CH), 127.8 (CH), 127.7 (CH), 99.0 (C), 98.0 (CH2), 95.9 
(CH2), 78.9 (C), 74.7 (CH), 74.3 (CH), 71.9 (CH2), 67.8 (CH2), 67.3 (CH2), 65.2 
(CH), 65.1 (CH2), 59.2 (CH3), 56.0 (CH3), 52.1 (CH), 28.6 (CH3), 28.2 (CH3), 27.1 
(CH3), 19.8 (CH3), 19.4 (C). 
IR (KBr) Vmax 3436, 2932, 2889, 1716, 1500, 1428, 1366, 1171, 1111, 705, 508 cm-1. 
EI MS m/z (70 eV) 676 [(M-CH3·)\ 3%], 602 (21), 241 (6), 199 (22), 59 (100). 
HRMS Found: (M-CH3·)\ 676.3518. C36H57NO10Si requires: (M-CH3·)\ 676.3517. 
Specific Rotation [a]n -3.0 (c 0.5, CHCh). 
5-tert-Butoxycarbonylamino-5-deoxy-1,3-0-isopropylidene-6-0-(2-
methoxyethoxy)methyl-4-0-methoxymethyl-D-mannitol (86) 
BocHN 
a 
I 
TBDPS 
85 
TBAF, THF, 18 °C BocHN 
MEMO 
86 
A magnetically stirred solution of compound 85 (154 mg, 0.22 mmol) in THF (6 mL) 
was treated with TBAF (0.3 mL of a 1.0 M solution in THF, 0.30 mmol). After 
stirring at 18 °C for 2 h, the reaction mixture was concentrated under reduced 
pressure. Subjection of the residue so formed to flash chromatography (silica, 1.5 : 1 
v/v ethyl acetate/hexane elution) yielded, after concentration of the appropriate 
fractions (R1 0.4), the title compound 86 (94 mg, 93%) as a clear, colourless oil. 
1H NMR (CDCh, 300 MHz) 8 5.36 (d, J 9.l Hz, lH), 4.75 (dm, J 6.7 Hz, 4H), 4.18 
(m, lH), 3.96-3.81 (complex m, 4H), 3.78-3 .50 (complex m, 7H), 3.43 (s, 3H), 3.36 
(s, 3H), 3.32 (d, J 5. l Hz, lH), 1.43 (s, 3H), 1.40 (s, 3H), 1.39 (s, 9H). 
13C NMR (CDCh, 75 MHz) 8 155.4 (C), 99.2 (C), 98.1 (CH2), 95.9 (CH2), 79.2 (C), 
74.5 (CH), 74.0 (CH), 71.9 (CH2), 67.7 (CH2), 67.4 (CH2), 64.6 (CH2), 62.9 (CH), 
59 .1 (CH3), 56.5 (CH3), 50.4 (CH), 28. 7 (CH3), 28.5 (CH3), 19 .2 (CH3). 
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IR (KBr) Vmax3432, 2936, 2889, 1714, 1505, 1456, 1367, 1169, 1029, 890 cm-1. 
EI MS m/z (70 eV) 454 [(M+H)\ < 1 %], 438 (< 1), 382 (5), 192 (45), 89 (100), 59 
(88), 57 (83). 
HRMS Found: (M+H)\ 454.2656. C20H39NO10 requires: (M+H)\ 454.2652. 
Specific Rotation [a]n -51.0 (c 0.5, CHCh). 
(2R,3S,4S,5S)-N-tert-Butoxycarbonyl-5-hydroxy-4,6-0-isopropylidene-2-{[(2-
methoxyethoxy)methoxy] methyl}-3-0-methoxymethylpyrrolidine (87) 
BocHN 
86 
MEMO 
MOMcf' 
87 
A solution of compound 86 (60 mg, 0.13 mmol) in dry dichloromethane (4 mL) was 
added to a magnetically stirred suspension of DMP (280 mg, 0.66 mmol) in dry 
dichloromethane ( 4 mL) maintained at 18 °C under a nitrogen atmosphere. After 
stirring for 6 h, dichloromethane (15 mL) and NaHCO3 (15 mL of a saturated aq. 
solution) were added. The separated organic phase was washed with N aHCO3 (2 x 15 
mL of a saturated aq. solution) then dried (MgSO4), filtered and concentrated under 
reduced pressure. The ensuing residue was purified by flash chromatography (silica, 
70% v/v ethyl acetate/hexane elution) to give, after concentration of the appropriate 
fractions (R1 0.3), the title compound 87 (48 mg, 80%) as a clear, colourless oil. 
1H NMR (CDCh, 300 MHz) c> 4.71 (m, 4H), 4.07 (m, 6H), 3.78 (m, lH), 3.68 (m, 
2H), 3.53 (m, 3H), 3.38 (s, 3H), 3.36 (s, 3H), 1.46 (s, 9H), 1.42 (s, 3H), 1.32 (s, 3H). 
13C NMR (CDCh, 75 MHz) c> 154.5 (C), 99.8 (C), 95.5 (CH2), 95.5 (CH2), 89.7 (C), 
81.4 (C), 79.5 (CH), 77.4 (CH), 71.8 (CH2), 67.7 (CH2), 67.1 (CH2), 66.8 (CH2), 65.8 
(CH), 59.1 (CH3), 55.8 (CH3), 28.5 (CH3), 25.6 (CH3), 21.9 (CH3). 
IR (KBr) Vmax3467, 2936, 2889, 1697, 1456, 1381, 1225, 1154, 1043, 856 cm-1. 
EI MS m/z (70 eV) 434 [(M-OH·)\ 13%], 420 (18), 320 (100), 232 (63), 89 (73). 
HRMS Found: (M-OH·)\ 434.2390. C20H37NO10 requires: (M-OH·)+, 434.2390. 
Specific Rotation [a]n -23.8 (c 0.5, CHCh). 
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5-tert-Butoxycarbonylamino-5-deoxy-6-O-(2-methoxyethoxy)methyl-4-O-
methoxymethyl-D-mannitol (88) 
BocHN 
OMOM 
,,,,,OTBD PS 
··' 
.,,,,,,OAc 
OMe 
80 
BocHN 
i) NaBH4, MeOH, 18 °C 
ii) TBAF, THF, 18 °C MEMO 
OMOM 
OH 
88 
125 
A magnetically stirred solution of compound 80 (2.61 g, 3.62 mmol) in MeOH (60 
mL) maintained at 18 °C was treated in portions with NaBH4 (3.14 g, 83.00 mmol). 
After stirring for ca. 30 h, the reaction mixture was concentrated under reduced 
pressure and the ensuing residue was partitioned between ethyl acetate (100 mL) and 
NaHCO3 (150 mL of a saturated aq. solution). The separated aq. phase was extracted 
with ethyl acetate (3 x 50 mL) and the combined organic phases were then dried 
(MgSO4), filtered and concentrated under reduced pressure. The resulting material 
(comprising a mixture of regioisomers 83 and 84) was dissolved in THF (30 mL) and 
then treated with TBAF (4.0 mL of a 1.0 M solution in THF, 4.00 mmol). After 
stirring at 18 °C for 1 h, the reaction mixture was concentrated under reduced 
pressure. The residue thus obtained was purified by flash chromatography (silica, 3% 
v/v methanol/ethyl acetate elution) to give, after concentration of the appropriate 
fractions (R10.4), the title compound 88 (0.78 g, 52%) as a clear, colourless oil. 
1 H NMR (CDCb, 300 MHz) 8 5.50 (d, J 8.9 Hz, lH), 4.81 (d, J 6.6 Hz, lH), 4.71 (m, 
3H), 4.3 8 ( d, J 4. 7 Hz, 1 H), 4.00 (br s, 1 H), 3 .89 (m, 3H), 3 .83-3 .59 ( complex m, 6H), 
3.54 (m, 3H), 3.47 (s, 3H), 3.37 (s, 3H), 2.72 (br s, lH), 1.42 (s, 9H). 
13C NMR (CDCb, 75 MHz) 8 157.1 (C), 98.8 (CH2), 96.3 (CH2), 80.7 (C), 78.2 (CH), 
71.8 (CH2), 71.2 (CH), 70.3 (CH), 67.9 (CH2), 67.8 (CH2), 65.2 (CH2), 59.2 (CH3), 
57.0 (CH3), 50.4 (CH), 28.5 (CH3). 
IR (KBr) Vmax 3410, 2931, 1690, 1512, 1455, 1367, 1249, 1170, 1042, 852, 587 cm-1. 
EI MS m/z (70 eV) 414 [(M+H)\ 10%], 340 (7), 248 (23), 192 (42), 57 (100). 
HRMS Found: (M+H)\ 414.2338. C17H35NO10 requires: (M+H)\ 414.2339. 
Specific Rotation [a]0 -29.0 (c 0.5, CHCb). 
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5-tert-Butoxycarbonylamino-5-deoxy-1,2-0-isopropylidene-6-0-(2-
methoxyethoxy)methyl-4-0-methoxymethyl-D-mannitol (89) 
OMOM 
BocH N ,,,,OH 
·•'' 
OH 
88 
Method A: 
2,2-DMP,p-TsOH, 18 °C 
OMOM 
BocHN ,,,,,OH 
.•• 
89 
126 
Method A: p-TsOH (99 mg, 0.52 mmol) was added to a magnetically stirred 
solution of compound 88 (357 mg, 0.86 mmol) in 2,2-DMP (15 mL) maintained at 18 
°C. After stirring for 2 h, the reaction mixture was treated with triethylamine (1 mL) 
and then concentrated under reduced pressure. The ensuing residue was subjected to 
flash chromatography (silica, 85% v/v ethyl acetate/hexane elution) to provide, after 
concentration of the appropriate fractions (Rt 0.5), the title compound 89 (323 mg, 
82%) as a clear, colourless oil. 
1H NMR (CDCh, 300 MHz) <i 5.45 (d, J 8.2 Hz, lH), 4.74 (m, 4H), 4.13 (m, lH), 
4.04 (m, 2H), 3.89 (m, 3H), 3.80-3.62 (complex m, 4H), 3.54 (m, 2H), 3.47 (m, lH), 
3.40 (s, 3H), 3.36 (s, 3H), 1.42 (s, 9H), 1.36 (s, 3H), 1.31 (s, 3H). 
13C NMR (CDCh, 75 MHz) <i 156.8 (C), 109.2 (C), 98.4 (CH2), 96.1 (CH2), 80.3 (C), 
77.6 (CH), 74.6 (CH), 72.3 (CH), 71.8 (CH2), 68.4 (CH2), 67.4 (CH2), 67.2 (CH2), 
59.1 (CH3), 56.6 (CH3), 50.8 (CH), 28.5 (CH3), 27.1 (CH3), 25.5 (CH3). 
IR (KBr) Vmax 3409, 2932, 1713, 1504, 1368, 1249, 1166, 1038, 854, 515 cm-1. 
EI MS m/z (70 eV) 454 [(M+H)\ 13%], 438 (2), 380 (15), 192 (41), 89 (100). 
HRMS Found: (M+H)\ 454.2649. C2oH39N010 requires: (M+H)\ 454.2652. 
Specific Rotation [a]0 -51.0 (c 0.5, CHCh). 
OMOM Method B: OMOM 
N3 ,,,,OH 5% Pd/C, (Boe )20 BocHN ,,,,OH ... , 
.,,, 
H2, EtOAc, 18 °C 
,,.,~ 
MEMO 
•,,.,~ 1/0 1/0 01' 01' 
91 89 
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Method B: A magnetically stirred mixture of compound 91 (69 mg, 0.18 mmol), 
(Boc)2O (50 mg, 0.23 mmol) and 5% Pd/C (50 mg) in ethyl acetate (2 mL) was 
exposed to a balloon of hydrogen gas. After stirring at 18 °C for 13 h, the reaction 
mixture was filtered through a short pad of Celite™ and the filtrate was concentrated 
under reduced pressure. The ensuing residue was purified by flash chromatography to 
give, after concentration of the appropriate fractions (R1 0.5), the title compound 89 
(73 mg, 89%) which proved identical, in all respects, to the material obtained by 
Method A. 
5-Azido-5-deoxy-6-O-(2-methoxyethoxy)methyl-4-O-methoxymethyl-D-mannitol 
(90) 
OMOM 
..• ,,,,10H 
OTBDPS 
73 
TBAF, THF, 18 °c 
OMOM 
OH 
90 
A magnetically stirred solution of compound 73 (162 mg, 0.28 mmol) in THF (3 mL) 
was treated with TBAF (350 µL of a 1.0 M solution in THF, 0.35 mmol). After 
stirring at 18 °C for 0.5 h, the reaction mixture was concentrated under reduced 
pressure. The residue so obtained was subjected to flash chromatography (silica, 40% 
v/v methanol/ethyl acetate elution) thereby providing, after concentration of the 
appropriate fractions (R10.4), the title compound 90 (77 mg, 81 %) as a clear, light-
yellow oil. 
1H NMR (CDCb, 300 MHz) 8 4.74 (m, 4H), 3.98-3.80 (complex m, 4H), 3.72 
(complex m, 6H), 3.56 (m, 3H), 3.43 (s, 3H), 3.37 (s, 3H), 3.27 (br s, lH), 3.18 (d, J 
7.5 Hz, lH). 
13C NMR (CDCb, 75 MHz) 8 98.5 (CH2), 95.7 (CH2), 77.2 (CH), 71.8 (CH2), 71.1 
(CH), 71.0 (CH), 67.3 (CH2), 67.2 (CH2), 64.1 (CH2), 61.9 (CH), 59.1 (CH3), 56.7 
(CH3). 
IR (KBr) Vmax 3429, 2932, 2893, 2099, 1455, 1367, 1272, 1027, 849 cm-1. 
ESI MS mlz (70 eV) 362 [(M+Na)\ 100%]. 
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HRMS (FAB) Found: (M+Na)\ 362.1529. C12H25N3O8Na requires: (M+Na)\ 
362.1534. 
Specific Rotation [a]n -69.8 (c 0.5, CHCb). 
5-Azido-5-deoxy-1,2-0-isopropylidene-6-0-(2-methoxyethoxy)methyl-4-0-
methoxymethyl-D-mannitol (91) 
OMOM 
OH 
90 
2,2-DMP, p-TsOH, 18 °C 
OMOM 
,,,,,OH 
..• 
91 
p-TsOH (20 mg, 0.10 mmol) was added to a magnetically stirred solution of 
compound 90 (74 mg, 0.20 mmol) in 2,2-DMP (3 mL) maintained at 18 °C. After 0.5 
h the reaction mixture was treated with triethylamine (0.2 mL) and then concentrated 
under reduced pressure. Subjection of the residue to flash chromatography (silica, 1 : 
1 v/v ethyl acetate/hexane elution) and concentration of the appropriate fractions (R1 
0.3) afforded the title compound 91 (69 mg, 83%) as a clear, colourless oil. 
1H NMR (CDCb, 300 MHz) 8 4.75 (m, 4H), 4.11 (m, lH), 4.02-3.90 (complex m, 
3H), 3.89-3.79 (complex m, 2H), 3.72 (m, 3H), 3.55 (m, 3H), 3.42 (s, 3H), 3.38 (s, 
3H), 2.68 (d, J7.5 Hz, lH), 1.37 (s, 3H), 1.31 (s, 3H). 
13C NMR (CDCb, 75 MHz) 8 109.5 (C), 98.2 (CH2), 95.8 (CH2), 77.0 (CH), 75.1 
(CH), 72.3 (CH), 71.8 (CH2), 67.7 (CH2), 67.6 (CH2), 67.2 (CH2), 62.4 (CH), 59.1 
(CH3), 56.6 (CH3), 27.0 (CH3), 25.5 (CH3). 
IR (KBr) Vmax3452, 2936, 2889, 2098, 1455, 1371, 1259, 1067, 1027, 849 cm-1. 
EI MS m/z (70 eV) 364 [(M-CH3·)\ 10%], 290 (3), 248 (37), 216 (49), 115 (40), 89 
(82), 59 (100). 
HRMS Found: (M-CH3·)\ 364.1719. C15H29N3Os requires: (M-CH3·)\ 364.1720. 
Specific Rotation [a]n -19.4 (c 0.5, CHCb). 
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5-tert-Butoxycarbonylamino-5-deoxy-1,2-0-isopropylidene-6-0-(2-
methoxyethoxy)methyl-4-0-methoxymethyl-3-keto-D-mannitol (53) 
OMOM 
BocHN ,,,,,OH 
..• 
89 53 
129 
DMP (1. 72 g, 4.05 mmol) was added to a magnetically stirred solution of compound 
89 (367 mg, 0.81 mmol) in dry dichloromethane (30 mL) maintained at 18 °C under a 
nitrogen atmosphere. After stirring for 2 h, the reaction mixture was treated with 
dichloromethane (30 mL) and NaHCO3 (30 mL of a saturated aq. solution). The 
separated organic phase was washed with NaHCO3 (2 x 30 mL of a saturated aq. 
solution) then dried (MgSO4), filtered and concentrated under reduced pressure. The 
resulting residue was subjected to flash chromatography (silica, 70% v/v ethyl 
acetate/hexane elution) thereby affording, after concentration of the appropriate 
fractions (R1 0.4), the title compound 53 (350 mg, 96%) as a clear, colourless oil. 
1H NMR (CDCb, 300 MHz) o 5.19 (d, J 9.l Hz, lH), 4.76 (m, lH), 4.65 (m, 4H), 
4.40 (d, J 5.7 Hz, lH), 4.19 (m, 2H), 4.05 (dd, J 8.5 and 6.3 Hz, lH), 3.65 (m, 3H), 
3.52 (m, 3H), 3.35 (s, 3H), 3.34 (s, 3H), 1.46 (s, 3H), 1.39 (s, 9H), 1.36 (s, 3H). 
13C NMR (CDCb, 75 MHz) o 206.0 (C), 155.1 (C), 110.8 (C), 97.4 (CH2), 95.6 
(CH2), 79.8 (C), 79.5 (CH), 78.0 (CH), 71.8 (CH2), 67.2 (CH2), 66.2 (CH2), 66.1 
(CH2), 59.1 (CH3), 56.4 (CH3), 51.3 (CH), 28.5 (CH3), 26.0 (CH3), 25.4 (CH3). 
IR (KBr) Vmax3351, 2935, 2892, 1716, 1505, 1368, 1247, 1155, 1042, 848 cm-1. 
EI MS m/z (70 eV) 452 [(M+H)\ 6%], 380 (32), 320 (37), 192 (41), 89 (100). 
HRMS Found: (M+H)\ 452.2492. C20H37NO10 requires: (M+H)\ 452.2496. 
Specific Rotation [a]n -9.0 (c 0.5, CHCb). 
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6.3 Experimental Procedures Associated with 
Work Described in Chapter Three 
(JS,2S,3S,6R)-2-O-tert-Butyldiphenylsilyl-4-chloro-6-O-(4-hydroxybutyl)-4-
cyclohexene-1,3-diol 3-Acetate (94) and (JR,2S,3S,4S)-3-0-tert-
Butyldiphenylsilyl-5-chloro-5-cyclohexene-1,2,4-triol 4-Acetate (95) 
130 
g,,,, 
h·"•''°TBDPS H3P04, H20 
THF, 18 °C 
y··,,,~OAc ------
OH 
HO~··"'DTBDPS 
Cl 
y ·•·,,,,10Ac 
Cl 
60 95 
A magnetically stirred solution of epoxide 60 (1.08 g, 2.44 mmol) in THF (15 mL) 
and water (5 mL) was treated with phosphoric acid (0.5 mL of a 93% aq. solution). 
After stirring at 18 °C for 40 h, the reaction mixture was concentrated under reduced 
pressure and the ensuing residue was partitioned between ethyl acetate (3 0 mL) and 
brine (30 mL). The separated aqueous phase was extracted with ethyl acetate (3 x 30 
mL) and the combined organic phases were then dried (MgSO4), filtered and 
concentrated under reduced pressure. The resulting crude oil was subjected to flash 
chromatography (silica, gradient elution using 30 to 50% v/v ethyl acetate/hexane) 
thus affording two fractions, A and B. 
Concentration of fraction A (R1 0.5 in 8 : 2.5 : 5.5 v/v/v ethyl 
acetate/dichloromethane/hexane) afforded compound 94 (265 mg, 20%) as a clear, 
light-yellow oil. 
1H NMR (CDCb, 300 MHz) 8 7.75-7.70 (complex m, 4H), 7.45-7.38 (complex m, 
6H), 6.07 (br d, J 4.0 Hz, lH), 5.61 (br d, J 4.0 Hz, lH), 4.28 (m, lH), 4.03 (br t, J 4.0 
Hz, lH), 3.64-3.54 (complex m, 3H), 3.41 (m, lH), 3.25 (m, lH), 2.43 (s, 2H), 1.88 
(s, 3H), 1.52 (m, 4H), 1.08 (s, 9H). 
13C NMR (CDCb, 75 MHz) 8 169.8 (C), 136.1 (CH), 136.0 (CH), 132.9 (C), 132.8 
(C), 131.7 (C), 130.2 (CH), 129.9 (CH), 127.9 (CH), 127.7 (CH), 126.5 (CH), 77.4 
(CH), 70.8 (CH), 70.5 (CH), 69.9 (CH2), 62.5 (CH2), 29.5 (CH2) 26.9 (CH3), 26.5 
(CH2), 20.7 (CH3), 19.5 (C). 
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IR (KBr) Vmax 3429, 2932, 2858, 1747, 1427, 1370, 1228, 1112, 1045, 704, 507 cm-1. 
EI MS m/z (70 eV) 477 [(M-C4H9·)\ 1 %] and 475 (2), 241 (78), 199 (100), 181 (47). 
HRMS Found: (M-C4H9·)\ 475.1345. C2sH3/5ClO6Si requires: (M-C4H9·)\ 
475.1344. 
Specific Rotation [a]0 -87.2 (c 1.0, CHCh). 
Concentration of fraction B (R1 0.7 1n 8 : 2.5 : 5.5 v/v/v ethyl 
acetate/dichloromethane/hexane) afforded trans-dial 95 (795 mg, 71 %) as a clear, 
colourless oil. 
1H NMR (CDCh, 300 MHz) 8 7.75-7.65 (complex m, 4H), 7.50-7.38 (complex m, 
6H), 6.02 (m, lH), 5.48 (m, lH), 4.50 (m, lH), 4.30 (m, lH), 3.51 (dd, J 6.5 and 1.6 
Hz, lH), 2.74 (s, 2H), 1.69 (s, 3H), 1.08 (s, 9H). 
13C NMR (CDCh, 75 MHz) 8 170.0 (C), 136.2 (CH), 136.1 (CH), 132.9 (C), 132.5 
(C), 130.9 (C), 130.3 (CH), 129.8 (CH), 128.5 (CH), 128.0 (CH), 127.5, 77.4 (CH), 
72.3 (CH), 70.8 (CH), 70.4 (CH), 27.0 (CH3), 20.5 (CH3), 19.8 (C). 
IR (KBr) Vmax3432, 2931, 2857, 1747, 1427, 1372, 1228, 1159, 1112, 704,508 cm-1. 
EI MS m/z (70 eV) 405 [(M-C4H9·)\ 2%] and 403 (7), 241 (60), 199 (100). 
HRMS Found: (M-C4H9·)\ 403.0763. C24H2l5ClOsSi requires: (M-C4H9·)+, 
403.0769. 
Specific Rotation [a]0 -59.1 (c 1.0, CHCh). 
(JR,2S,3S,4S)-3-O-tert-Butyldiphenylsilyl-5-chloro-5-cyclohexene-1,2,4-triol 4-
Acetate (95) and (JS,2S,3S,6R)-2-O-tert-Butyldiphenylsilyl-4,6-dichloro-4-
cyclohexene-1,3-diol 3-Acetate (98) 
g,,,,,. 
[1··""'0TBDPS 
y··,,,,,OAc 
Cl 
60 
HCI, H20 
THF, 18 °C 
QH 
HO!l···"~OTBDPS + 
y ···,,,,,,OAc 
Cl 
95 
QH 
Cl'rl .. ""OTBDPS 
y ··,,,,10Ac 
Cl 
98 
A magnetically stirred solution of epoxide 60 (457 mg, 1.03 mmol) in THF (6 mL) 
and water (2 mL) was treated with HCl (1 mL of a 1.0 M aq. solution). After stirring 
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at 18 °C for 24 h, the reaction mixture was treated with dichloromethane (10 mL) and 
then sodium hydroxide (NaOH) (2.5 mL of a 1.0 N aq. solution). The separated 
aqueous phase was extracted with dichloromethane (3 x 8 mL) and the combined 
organic phases were washed with brine (1 x 10 mL) then dried (MgSO4), filtered and 
concentrated under reduced pressure. Subjection of the ensuing light-yellow oil to 
flash chromatography (silica, gradient elution using 3 to 30% v/v ethyl 
acetate/hexane) afforded three fractions, A, Band C. 
Concentration of fraction A (R1 0.6 in 1 2.5 5.5 v/v/v ethyl 
acetate/dichloromethane/hexane) afforded the starting material 60 (68 mg, 15% 
recovery) which proved identical, in all respects, to the authentic material. 
Concentration of fraction B (R1 0.7 in 8 : 2.5 : 5.5 v/v/v ethyl 
acetate/dichloromethane/hexane) afforded trans-dial 95 (50 mg, 10% at 85% 
conversion) which proved identical, in all respects, to the material obtained as 
described immediately above. 
Concentration of fraction C (R1 0.5 1n 1 : 2.5 5.5 v/v/v ethyl 
acetate/dichloromethane/hexane) afforded compound 98 (231 mg, 47% at 85% 
conversion), as a white, crystalline solid, m.p. 135.5-137 °C. 
1H NMR (CDCh, 300 MHz) 8 7.75-7.65 (complex m, 4H), 7.50-7.38 (complex m, 
6H), 6.07 (d, J 4.4 Hz, lH), 5.70 (d, J 4.4 Hz, lH), 4.56 (m, lH), 4.37 (m, lH), 3.72 
(m, lH), 2.70 (br s, lH), 1.98 (s, 3H), 1.09 (s, 9H). 
13C NMR (CDCh, 75 MHz) 8 169.5 (C), 136.1 (CH), 136.0 (CH), 132.6 (C), 132.5 
(C), 132.4 (C), 130.4 (CH), 130.2 (CH), 128.1 (CH), 127.9 (CH), 126.8 (CH), 73.4 
(CH), 70.2 (CH), 69.2 (CH), 56.6 (CH), 27.0 (CH3), 20.7 (CH3), 19.5 (C). 
IR (KBr) Vmax 3567, 2932, 2858, 1751, 1647, 1427, 1371, 1226, 1113, 702, 508 cm-1. 
EI MS m/z (70 eV) 425 [(M-C4H9·)\ < 1 %], 423 (2) and 421 (4), 241 (88), 199 (100). 
HRMS Found: (M-C4H9·)+, 421.0427. C24H2l5ChO4Si requires: (M-C4H9·)+, 
421.0430. 
Microanalysis Found: C, 59.6; H, 5.8; Cl, 14.7; C24H2sChO4Si requires: C, 60.1; H, 
5.9; Cl, 14.8%. 
Specific Rotation [a]0 -131.4 (c 0.9, CHCh). 
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3-0-tert-Butyldiphenylsilyl-D-talonic acid y-Lactone 2-Acetate (96) 
QH 
HO~_,.,.OTBDPS 
y··,,,,,OAc 
Cl 
95 
i) 03, MeOH, py, -78 °C 
ii) Nal, -78~-66 °C 
iii) NaBH4, -66~-40 °C 
OH 
o~O ··,  = OH 
,~/ 
H 
.. ~ "'; 
Accf %-OTBDPS 
96 
133 
A magnetically stirred solution of trans-diol 95 (830 mg, 1.80 mmol) and pyridine (2 
mL) in MeOH (35 mL) maintained at -78 °C (acetone/dry ice bath) was treated with a 
stream of ozone (03) (ca. 40% 0 3 in oxygen). When TLC analysis indicated no 
starting material remained (ca. 1 h), the reaction mixture was purged with nitrogen for 
1 h and then treated with Nal (840 mg, 5.60 mmol). After 3 h the by now red-brown 
reaction mixture was warmed to -66 °C and treated with NaBH4 (1.35 g, 35.69 mmol). 
The reaction mixture was maintained between -60 and -40 °C for 6 h and then treated 
with HCl (2.0 M solution in MeOH) so as to reduce the pH to ca. 3.5. The ensuing 
mixture was concentrated under reduced pressure and the residue partitioned between 
ethyl acetate (25 mL) and brine (25 mL). The separated aq. phase was extracted with 
ethyl acetate (3 x 20 mL) and the combined organic phases were then dried (MgSO4), 
filtered and concentrated under reduced pressure. Subjection of the residue so 
obtained to flash chromatography (silica, 60% v/v ethyl acetate/hexane elution) and 
concentration of the appropriate fractions (R1 0.4) afforded lactone 96 (450 mg, 54%) 
as a clear, colourless oil. 
1H NMR (CDCb, 300 MHz) 8 7.62-7.58 (complex m, 4H), 7.50-7.37 (complex m, 
6H), 5.62 (d, J 5.6 Hz, lH), 4.61 (d, J 5.6 Hz, lH), 4.13 (br s, lH), 3.42 (dd, J l l.3 
and 8.0 Hz, lH), 3.31 (dd, J l l.3 and 4.1 Hz, lH), 3.15 (m, lH), 2.55 (br s, 2H), 2.10 
(s, 3H), 1.07 (s, 9H). 
13C NMR (CDCb, 75 MHz) 8 172.8 (C), 170.2 (C), 135.8 (CH), 135.7 (CH), 132.9 
(C), 132.2 (C), 130.5 (CH), 130.5 (CH), 128.2 (CH), 128.1 (CH), 86.3 (CH), 71.8 
(CH), 70.5 (CH), 69.2 (CH), 63.1 (CH2), 26.8 (CH3), 20.6 (CH3), 19.4 (C). 
IR (KBr) Vmax 3467, 2930, 2857, 1796, 1753, 1375, 1232, 1113, 703, 508 cm-1. 
EI MS mlz (70 eV) 401 [(M-C4H9·)\ 15%], 323 (12), 295 (18), 241 (26), 199 (100), 
77 (20). 
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HRMS Found: (M-C4H9·)\ 401.1041. C24H30O1Si requires: (M-C4H9·)\ 401.1057. 
Specific Rotation [ a ]n + 19 .1 ( c 0.6, CHCl3). 
3-0-tert-Butyldiphenylsilyl-5,6-0-isopropylidene-D-talonic acid y-Lactone 2-
Acetate (97) 
QH 
o~O ., ' OH 
I¼'/ 
H 
Accf.. \~OTBDPS 
96 
2,2-DMP, p-TsOH, 18 °C 
P-k 
0~oY"vo 
\_J ''q1H 
Ac•-- \~OTBDPS 
97 
p-TsOH (25 mg, 0.13 mmol) was added to a magnetically stirred solution of 
compound 96 (100 mg, 0.22 mmol) in 2,2-DMP (7 mL) maintained at 18 °C. After 
stirring for 3 h, the reaction mixture was treated with triethylamine (2 mL) and then 
concentrated under reduced pressure. Purification of the ensuing residue by flash 
chromatography (silica, 15% v/v ethyl acetate/hexane elution) and concentration of 
the appropriate fractions (R_r 0.4) provided the title compound 97 (90 mg, 82%) as a 
white, crystalline solid, m.p. 106-107.5 °C. 
1H NMR (CDCh, 300 MHz) 8 7.70-7.60 (complex m, 4H), 7.55-7.38 (complex m, 
6H), 5.58 (d, J 5.5 Hz, lH), 4.62 (d, J 5.5 Hz, lH), 4.06 (s, lH), 3.72 (m, 2H), 3.45 (t, 
J7.3 Hz, lH), 2.15 (s, 3H), 1.25 (s, 3H), 1.23 (s, 3H), 1.07 (s, 9H). 
13C NMR (CDCh, 75 MHz) 8 172.3 (C), 169.9 (C), 135.9 (CH), 135.7 (CH), 132.9 
(C), 132.1 (C), 130.5 (CH), 128.2 (CH), 128.1 (CH), 110.6 (C), 83.6 (CH), 74.2 (CH), 
71.9 (CH), 69.2 (CH), 65.2 (CH2), 26.7 (CH3), 25.6 (CH3), 25.5 (CH3), 20.6 (CH3), 
19.4 (C). 
IR(KBr)vmax2933,2859, 1803, 1752, 1373, 1225, 1137, 1113, 703,507cm-1. 
EI MS m/z (70 eV) 483 [(M-CH3·)\ 30%], 441 (33), 383 (100), 341 (48), 241 (80), 
199 (93), 77 (25). 
HRMS Found: (M-CH3·)\ 483.1839. C27H34O7Si requires: (M-CH3·)\ 483.1839. 
Microanalysis Found: C, 63.2; H, 6.5; C27H34O7Si requires: C, 65.0; H, 6.9%. 
Specific Rotation [a]0 + 16.0 (c 1.0, CHCh). 
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3-0-tert-Butyldiphenylsilyl-5,6-0-isopropylidene-D-talo-furanose 2-Acetate (99) 
r-k 
o r O 
0~ 
Ace!' \~OTBDPS 
97 
diisoamylborane 
THF, 0-18 °C 
r-k 
HO~o~O LJ ''~1H 
Ac6 _ . \.~OTBDPS 
99 
A solution of diisoamylborane in THF was prepared by treatment ofBH3-DMS (2 mL 
of a 2.0 M solution in THF, 4.00 mmol) with 2-methylbut-2-ene (4 mL of a 2.0 M 
solution in THF, 8.00 mmol) maintained at 0 °C (ice-bath) under a nitrogen 
atmosphere. After stirring the ensuing mixture at 0 °C for 3 h, it was treated with a 
solution of lactone 97 (231 mg, 0.46 mmol) in THF ( 5 mL ). After stirring at 18 °C for 
3 days, the reaction mixture was treated with water (1 mL), NaHCO3 (10 mL of a 
saturated aq. solution) and then hydrogen peroxide (0.5 mL of a 30% aq. solution). 
The resulting mixture was concentrated under reduced pressure and the residue 
partitioned between dichloromethane (20 mL) and water (20 mL). The separated 
aqueous phase was extracted with dichloromethane (3 x 20 mL) and the combined 
organic phases were dried (MgSO4), filtered and concentrated under reduced pressure 
to afford a light-yellow oil. Subjection of this material to flash chromatography 
( silica, 15% v/v ethyl acetate/hexane elution) and concentration of the appropriate 
fractions (R1 0.3) then yielded a ca. 2 : 3 mixture of the a- and ~-forms of lactol 99 
(192 mg, 83%) as a clear, colourless oil. 
13C NMR (CDCb, 75 MHz) 8 170.0 (C), 169.9 (C), 136.0 (CH), 135.9 (CH), 135.8 
(CH), 135.7 (CH), 133.4 (C), 132.6 (C), 132.4 (C), 131.9 (C), 130.5 (CH), 130.3 
(CH), 130.2 (CH), 128.1 (CH), 128.0 (CH), 128.0 (CH), 127.9 (CH), 109. (C), 109.6 
(C), 100.0 (CH), 96.4 (CH), 83.4 (CH), 82.0 (CH), 77.5 (CH), 75.2 (CH), 74.3 (CH), 
74.0 (CH), 72.6 (CH), 72.4 (CH), 66.0 (CH2), 65.2 (CH2), 30.0 (CH3), 27.1 (CH3), 
27.0 (CH3), 26.1 (CH3), 26.0 (CH3), 25. 7 (CH3), 22.1 (CH3), 21.3 (CH3), 21.2 (CH3), 
21.0 (CH3), 19.4 (C), 19.3 (C). 
IR (KBr) Vmax 3443, 2933, 2859, 1748, 1428, 1371, 1235, 1113, 1062, 703 , 505 cm-1. 
EI MS m/z (70 eV) 485 [(M-CH3·)\ 23%], 443 (38), 341 (50), 241 (68), 199 (100). 
HRMS Found: (M-C4H9·)\ 443.1523. C27H36O7Si requires: (M-C4H9·)\ 443.1526. 
Specific Rotation [a]0 -30.2 (c 0.5, CHCb). 
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5,6-O-Isopropylidene-a-D-talofuranose Triacetate (100) and 5,6-O-
Isopropylidene-P-D-talofuranose Triacetate (101) 
i) TBAF, THF, 18 °c 
ii) Ac20, py 
DMAP, 18 °C 
9~ 
AcO~o~O \_J '/q1H 
Ac6__. \-~OAc 
100 
136 
Method A: A magnetically stirred solution of compound 99 (67 mg, 0.13 mmol) in 
THF (4 mL) maintained at 18 °C under a nitrogen atmosphere was treated with TBAF 
( 150 µL of a 1.0 M solution in THF, 0.15 mmol). After 0.5 h the reaction mixture was 
treated with pyridine (6 mL), acetic anhydride (0.5 mL) and DMAP (13 mg, 0.11 
mmol). Stirring was continued at 18 °C for 14 h and then the resulting light-yellow oil 
was treated with NH4Cl (20 mL of a saturated aq. solution) and ethyl acetate (15 mL). 
The separated aq. phase was extracted with ethyl acetate (2 x 10 mL) and the 
combined organic phases were washed with brine (1 x 15 mL) then dried (MgSO4) , 
filtered and concentrated under reduced pressure. The residue so obtained was 
subjected to flash chromatography (silica, gradient elution using 20 to 25% v/v ethyl 
acetate/hexane) to afford two fractions, A and B. 
Concentration of fraction A (R1 0.5 1n 4 : 2.5 : 5.5 v/v/v ethyl 
acetate/dichloromethane/hexane) afforded compound 100 (18 mg, 40%) as a light-
yellow, crystalline solid, m.p. 96-98 °C. 
1H NMR (CDCh, 300 MHz) 8 6.18 (d, J 1.8 Hz, lH), 5.44-5.32 (complex m, 2H), 
4.26-4.14 (complex m, 2H), 4.03 (m, lH), 3.84 (m, lH), 2.12 (s, 3H), 2.09 (s, 3H), 
2.08 (s, 3H), 1.40 (s, 3H), 1.38 (s, 3H). 
13C NMR (CDCh, 75 MHz) 8 169.7 (C), 169.4 (C), 169.2 (C), 110.0 (C), 98.1 (CH), 
80.9 (CH), 75.3 (CH), 74.3 (CH), 71.1 (CH), 65.2 (CH2), 26.3 (CH3), 25.8 (CH3), 21.3 
(CH3), 21.8 (CH3), 20.8 (C). 
IR (KBr) Vmax 2988, 2925, 1752, 1372, 1219, 1062, 970 cm-1. 
EI MS m/z (70 eV) 331 [(M-CH3·)\ 53%], 287 (12), 169 (57), 127 (40), 101 (100). 
HRMS Found: (M-CH3·)\ 331.1029. C1sH22O9 requires: (M-CH3·)\ 331.1030. 
Microanalysis Found: C, 52.0; H, 6.1; C1sH22O9 requires: C, 52.0; H, 6.4%. 
Chapter Six 137 
Specific Rotation [a]n + 11.2 (c 0.25, CHCb). 
Concentration of fraction B (R1 0.4 in 4 : 2.5 : 5.5 v/v/v ethyl 
acetate/dichloromethane/hexane) afforded compound 101 (22 mg, 47%) as a clear, 
colourless oil. 
1H NMR (CDCb, 300 MHz) 8 6.43 (d, J 4.5 Hz, lH), 5.34 (dd, J 5.5 and 2.1 Hz, lH), 
5.28 (m, lH), 4.30 (m, lH), 4.24 (m, lH), 4.02 (t, J 6.7 Hz, lH), 3.91 (m, lH), 2.13 
(s, 3H), 2.11 (s, 3H), 2.07 (s, 3H), 1.39 (s, 3H), 1.36 (s, 3H). 
13C NMR (CDCb, 75 MHz) 8 170.3 (C), 169.7 (C), 169.3 (C), 110.1 (C), 94.4 (CH), 
83.2 (CH), 75.3 (CH), 71.1 (CH), 70.3 (CH), 65.2 (CH2), 26.2 (CH3), 25.8 (CH3), 21.3 
(CH3), 21.0 (CH3), 20.6 (C). 
IR (lffir) Vmax 2988, 2925, 1750, 1372, 1222, 1111, 939 cm-1. 
EI MS m/z (70 eV) 331 [(M-CH3·)\ 80%], 287 (15), 169 (60), 127 (29), 101 (100). 
HRMS Found: (M-CH3·)\ 331.1029. C1 5H22O9 requires: (M-CH3·)\ 331.1029. 
Specific Rotation [a]n -54.0 (c 0.25, CHCb). 
P-k 
HO~o~O 
\_J ''~1H 
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i) Ac20, py 
DMAP, 18 °C 
ii) TBAF, THF, 18 °C 
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Method B: A magnetically stirred solution of compound 99 (51 mg, 0.10 mmol) 
and DMAP (15 mg, 0.12 mmol) in pyridine (2.5 mL) maintained at 18 °C was treated 
with acetic anhydride (0.5 mL). After 3 h dichloromethane (8 mL) and NH4Cl (15 mL 
of a saturated aq. solution) were added. The separated organic phase was washed with 
NH4Cl (1 x 15 mL of a saturated aq. solution) and brine (1 x 15 mL) then dried 
(MgSO4), filtered and concentrated under reduced pressure to give a light-yellow oil. 
This material was dissolved in THF (2.5 mL) and the resulting solution treated with 
TBAF (90 µL of a 1.0 M solution in THF, 0.09 mmol). After 0.5 h the reaction 
mixture was treated with pyridine (4 mL), acetic anhydride (0.5 mL) and DMAP (6 
mg, 0.05 mmol) then maintained at 18 °C, with stirring, for 14 h. The resulting light-
yellow solution was treated with NaHCO3 (15 mL of a saturated aq. solution) and 
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ethyl acetate (10 mL). The separated aq. phase was extracted with ethyl acetate (3 x 5 
mL) and the combined organic phases were washed with brine (1 x 15 mL) then dried 
(MgSO4), filtered and concentrated under reduced pressure. Subjection of the ensuing 
residue to flash chromatography (silica, gradient elution using 20 to 25% v/v ethyl 
acetate/hexane) afforded two fractions, A and B. 
Concentration of fraction A (Rf 0.5 1n 4 2.5 5.5 v/v/v ethyl 
acetate/dichloromethane/hexane) afforded compound 100 (22 mg, 63%) which proved 
identical, in all respects, to the chromatographically less mobile product obtained by 
Method A as described immediately above. 
Concentration of fraction B (Rf 0.4 1n 4 2.5 5.5 v/v/v ethyl 
acetate/ dichloromethane/hexane) afforded compound 101 ( 6 mg, 1 7%) which proved 
identical, in all respects, to the chromatographically more mobile product obtained by 
Method A as described immediately above. 
Penta-O-acetyl-a-D-talopyranose (103) and Penta-O-acetyl-a-D-talofuranose 
(104) 
D-Talose (92) 
Ac20, py 
DMAP, 0-18 °C 
OAc 
103 
OAc OAc 
+ AcO~O~OAc \_J .,,,,1H 
Ac6 __ . \✓,,OAc 
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Method A: A magnetically stirred solution of authentic D-talose (92) (153 mg, 
0.85 mmol) in pyridine ( 4 mL) was cooled to 0 °C (ice-bath) and then treated with 
acetic anhydride (2 mL). After stirring at 0-18 °C for 18 h, the reaction mixture was 
treated with NaHCO3 (20 mL of a saturated aq. solution) and ethyl acetate (20 mL). 
The separated aq. phase was washed with NaHCO3 (1 x 20 mL of a saturated aq. 
solution) and NH4Cl (2 x 20 mL of a saturated aq. solution) then dried (MgSO4), 
filtered and concentrated under reduced pressure. Subjection of the ensuing residue to 
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flash chromatography (silica, gradient elution using 25 to 35% v/v ethyl 
acetate/hexane) afforded two fractions, A and B. 
Concentration of fraction A (R_r 0.26 in 4 : 2.5 : 5.5 v/v/v ethyl 
acetate/dichloromethane/hexane) afforded compound 103[3] (259 mg, 78%) as a light-
yellow, crystalline solid, m.p. 104-106 °C (lit. [3J 107 °C). 
1H NMR (CDCb, 300 MHz) 8 6.08 (br s, lH), 5.30 (br s, lH), 5.25 (t, J 3.7 Hz, lH), 
5.05 (m, lH), 4.26 (br t, J 6.9 Hz, lH), 4.10 (m, 2H), 2.10 (s, 3H), 2.10 (s, 3H), 2.09 
(s, 3H), 1.98 (s, 3H), 1.95 (s, 3H). 
13C NMR (CDCb, 75 MHz) 8 170.2 (C), 169.9 (C), 169.5 (C), 169.5 (C), 167.9 (C), 
91.4 (CH), 68.8 (CH), 66.3 (CH), 65.3 (CH), 65.1 (CH), 61.5 (CH2), 21.0 (CH3), 20.9 
(CH3), 20.8 (CH3), 20.7 (CH3), 20.6 (C). 
IR (KBr) Vmax 2974, 1749, 1433, 1372, 1226, 1143, 1002, 732 cm-1. 
EI MS m/z (70 eV) 347 [(M-CH3CO·)\ 11 %] , 331 (24), 245 (8), 157 (77), 115 (100), 
73 (18). 
HRMS Found: (M-CH3CO·)\ 347.0969. C16H22O11 requires: (M-CH3CO·)\ 
347.0978. 
Microanalysis Found: C, 49.3; H, 5.3; C16H22O11 requires: C, 49.2; H, 5.7%. 
Specific Rotation [a]0 +74.8 (c 0.5, CHCb) (lit.[3J +70.2 in CHCb). 
Concentration of fraction B (R1 0.32 in 4 : 2.5 : 5.5 v/v/v ethyl 
acetate/dichloromethane/hexane) afforded compound 104 (40 mg, 12%) as a clear, 
colourless oil. 
1H NMR (CDCb, 300 MHz) 8 6.12 (s, lH), 5.31 (m, 2H), 5.18 (m, lH), 4.34 (m, lH), 
4.27 (dd, J 11.9 and 4.5 Hz, lH), 4.14 (dd, J 11.9 and 6.6 Hz, lH), 2.12 (s, 3H), 2.11 
(s, 3H), 2.10 (s, 3H), 2.05 (s, 6H). 
13C NMR (CDCb, 75 MHz) 8 170.4 (C), 169.9 (C), 169.5 (C), 169.4 (C), 168.8 (C), 
97.7 (CH), 79.3 (CH), 74.0 (CH), 70.0 (CH), 69.7 (CH), 62.5 (CH2), 21.2 (CH3), 21.0 
(CH3), 20.9 (CH3), 20.7 (CH3), 20.6 (C). 
IR (KBr) Vmax 1749, 1372, 1219, 1045, 967, 895, 602 cm-1. 
EI MS m/z (70 eV) 347 [(M-CH3CO·)\ 2%], 331 (30), 245 (100), 157 (28), 143 (92), 
73 (18). 
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HRMS Found: (M-CH3CO·)\ 347.0969. C16H22O11 requires: (M-CH3CO·)\ 
347.0978. 
Specific Rotation [a]0 +38.6 (c 0.5, CHCh). 
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Method B: A magnetically stirred solution of compounds 100 and 101 ( 40 mg, 
0.12 mmol, obtained by either one of the two methods described immediately above) 
in THF/water (4 mL of a 1 : 1 v/v mixture) maintained at O °C (ice-bath) was treated 
with TF A (0.4 mL ). Stirring was continued at 0-18 °C for 20 h before the reaction 
mixture was concentrated under reduced pressure. The ensuing light-yellow oil was 
dissolved in pyridine ( 4 mL), the resulting solution cooled to ca. 0 °C (ice-bath) and 
then treated with acetic anhydride (1 mL) and DMAP (7 mg, 0.06 mmol). After 
stirring at O °C for 1 h and then at 18 °C for 23 h, the reaction mixture was poured 
into a mixture of ethyl acetate (10 mL) and NH4Cl (15 mL of a saturated aq. solution). 
The separated organic phase was washed with NH4Cl (2 x 15 mL of a saturated aq. 
solution) then dried (MgSO4), filtered and concentrated under reduced pressure. 
Purification of the residue thus-obtained by flash chromatography (silica, gradient 
elution using 25 to 35% v/v ethyl acetate/hexane) afforded two fractions, A and B. 
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Concentration of fraction A (R1 0.26 in 4 : 2.5 : 5.5 v/v/v ethyl 
acetate/dichloromethane/hexane) afforded a ca. 2 : 1 mixture of penta-O-acetyl-~-D-
talofuranose 102 and compound 103 (24 mg, 53% combined yield) as a light-yellow 
oil which solidified on standing. Comparison of the 1H and 13C NMR data derived 
from this material with those derived from compound 103 prepared from the authentic 
D-talose (92) provided a good match. The following additional signals, attributed to 
the penta-O-acetyl-B-D-talofuranose 102, were observed: 1H NMR (CDCh, 300 MHz) 
c> 6.42 (d, J 4.5 Hz, lH), 5.30 (m, partially obscured, lH), 5.23 (m, lH), 5.15 (m, lH), 
4.46 (t, J2.9 Hz, lH), 4.31 (dd, J 11.7 and 4.8 Hz, lH), 4.16 (m, lH) (signals due to 
acetate methyl groups overlapping with those arising from equivalent groups in 
compound 103). 13C NMR (CDCh, 75 MHz) c> 170.4, 169.9, 169.8, 169.7, 169.3, 
93.9, 82.0, 77.4, 69.9, 69.8, 62.1, 29.9, 21.3, 21.1, 20.5 (one signal obscured or 
overlapping). 
Concentration of fraction B (R1 0.32 in 4 : 2.5 : 5.5 v/v/v ethyl 
acetate/dichloromethane/hexane) afforded compound 104 (10 mg, 22%) as a clear, 
colourless oil. This material was identical, in all respects, to the material prepared as 
described above from D-talose (92). 
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2-0-Acetyl-3-0-tert-butyldiphenylsilyl-5-deoxy-6-0-(2-methoxyethoxy)methyl-4-
0-methoxymethyl-D-mannolactam (81) 
OMOM 
__ ,,,,,,OTBD PS 
5% Pd/C, H2, EtOAc, 18 °C 
72 
0 
OTBDPS 
MEMO OMOM 
81 
A magnetically stirred mixture of compound 72 (1.98 g, 3 .06 mmol) and 5% Pd/C 
(565 mg) in ethyl acetate (5 mL) was exposed to a balloon of hydrogen gas. After 
stirring at 18 °C for 18 h, the reaction mixture was filtered through a short pad of 
Celite TM and the filtrate was concentrated under reduced pressure. Subjection of the 
ensuing residue to flash chromatography (silica, 80% v/v ethyl acetate/hexane elution) 
and concentration of the appropriate fractions (R1 0.3) afforded the title compound 81 
(1.56 g, 87%) as a clear, colourless oil. 
1H NMR (CDCh, 300 MHz) 8 7.70-7.60 (complex m, 4H), 7.43-7.31 (complex m, 
6H), 6.35 (s, lH), 5.44 (d, J 2.5 Hz, lH), 4.68 (dd, J 11.8 and 7.0 Hz, 2H), 4.36 (d, J 
6.9 Hz, lH), 4.25 (t, J 2.5 Hz, lH), 4.15 (d, J 6.9 Hz, lH), 3.72-3 .56 (complex m, 
SH), 3.51 (m, 3H), 3.38 (s, 3H), 3.14 (s, 3H), 1.93 (s, 3H), 1.06 (s, 9H). 
13C NMR (CDCh, 75 MHz) 8 169.8 (C), 166.5 (C), 136.1 (CH), 135.9 (CH), 132.7 
(C), 132.5 (C), 130.1 (CH), 129.8 (CH), 127.8 (CH), 127.4 (CH), 95.8 (CH2), 95 .6 
(CH2), 74.6 (CH), 72.4 (CH), 71.7 (CH2), 69.9 (CH), 69.4 (CH2), 67.4 (CH2), 59.0 
(CH3), 56.2 (CH3), 55.8 (CH), 27.0 (CH3), 20.7 (CH3), 19.6 (C). 
IR (KBr) Vmax 3290, 2933, 2891, 1752, 1700, 1371 , 1228, 1034, 705, 508 cm-1. 
EI MS mlz (70 eV) 590 [(M+H)\ 4%], 574 (4), 532 (22), 490 (100), 199 (60), 89 
(91). 
HRMS Found: (M+H)\ 590.2788. C3ofLnNO9Si requires (M+H)\ 590.2785. 
Specific Rotation [a]n +20.2 (c 0.5, CHCh). 
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5-Deoxy-6-O-(2-methoxyethoxy)methyl-4-O-methoxymethyl-D-mannolactam 
(109) 
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TBAF, THF, 18 °C 
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A magnetically stirred solution of compound 81 (1.20 g, 2.03 mmol) in THF (12 mL) 
was treated with TBAF (7 mL of a 1.0 M solution in THF, 7.00 mmol). After stirring 
at 18 °C for 18 h, triethylamine (1 mL) was added and the resulting mixture was 
concentrated under reduced pressure. The residue thus obtained was purified by flash 
chromatography (silica, 2% v/v methanol/ethyl acetate elution) thereby providing, 
after concentration of the appropriate fractions (R1 0.3), the title compound 109 (0.56 
g, 89%) as a white, crystalline solid, m.p. 70-71 °C. 
1H NMR (CDCh, 300 MHz) 8 6.89 (s, lH), 4.72 (d, J6.9 Hz, lH), 4.67 (dd, J9.l and 
6.9 Hz, 2H), 4.63 (d, J6.9 Hz, lH), 4.26 (d, J3.4 Hz, lH), 4.21 (br s, 2H), 4.18 (t, J 
3.1 Hz, lH), 3.75 (m, 2H), 3.67 (m, 3H), 3.51 (m, 3H), 3.34(4) (s, 3H), 3.33(9) (s, 
3H). 
13C NMR (CDCh, 75 MHz) 8 171.9 (C), 95.9 (CH2), 95.5 (CH2), 74.4 (CH), 71.7 
(CH2), 70.9 (CH), 68.6 (CH2), 68.3 (CH), 67.3 (CH2), 58.9 (CH), 56.0 (CH3), 55.4 
(CH3). 
IR (KBr) Vmax 3388, 2933, 2884, 1673, 1456, 1304, 1214, 1103, 1039, 918, 850, 705, 
555 cm-1. 
EI MS m/z (70 eV) 310 [(M+H)\ 4%], 280 (4), 250 (11), 234 (17), 202 (26), 143 
( 45), 89 (95), 59 (100). 
HRMS Found: (M+H)\ 310.1494. C12H23NO8 requires: (M+H)\ 310.1502. 
Microanalysis Found: C, 47.30; H, 7.46; N, 4.26; C12H23NOs requires: C, 46.6; H, 
7.49; N, 4.53%. 
Specific Rotation [a]n +38.4 (c 0.5, CHCl3). 
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5-Deoxy-2,3-O-isopropylidene-6-O-(2-methoxyethoxy)methyl-4-O-
methoxymethyl-D-mannolactam (107) 
0 
OH Method A: 
2,2-DMP,p-TsOH, 18 °C 
0 
°x 
0 OH 
MEMO OMOM MEMO OMOM 
109 107 
144 
Method A: p-TsOH (150 mg, 0. 77 mmol) was added to a magnetically stirred 
solution of compound 109 (514 mg, 1.66 mmol) in 2,2-DMP (20 mL) maintained at 
18 °C. After stirring for ca. 2 h, the reaction mixture was treated with triethylamine (1 
mL) then concentrated under reduced pressure. Subjection of the residue so formed to 
flash chromatography (silica, 2 % v/v methanol/ethyl acetate elution) and 
concentration of the appropriate fractions (R1 0.5) afforded the title compound 107 
(533 mg, 92%) as a clear, colourless oil. 
1H NMR (CDCh, 300 MHz) 8 6.87 (s, lH), 4.78 (d, J 6.6 Hz, lH), 4.64-4.52 (m, 3H), 
4.45 (d, J 7.6 Hz, lH), 4.31 (dd, J 7.5 and 6.2 Hz, lH), 3.78 (dd, J 9.9 and 3.4 Hz, 
lH), 3.72-3.49 (m, 4H), 3.44 (m, 3H), 3.28 (s, 3H), 3.28 (s, 3H), 1.38 (s, 3H), 1.27 (s, 
3H). 
13C NMR (CDCh, 75 MHz) 8 168.4 (C), 110.5 (C), 95.7 (CH2), 95.3 (CH2), 78.1 
(CH), 73.2 (CH), 72.7 (CH), 71.6 (CH2), 67.1 (CH2), 66.8 (CH2), 58.7 (CH), 55.9 
(CH3), 52.8 (CH3), 26.8 (CH3), 25.0 (CH3). 
IR (KBr) Vmax 3333, 2936, 2884, 1687, 1456, 1381 , 1214, 1106, 1035, 857 cm-1. 
EI MS m/z (70 eV) 350 [(M+H)\ 7%], 334 (2), 290 (27), 200 (32), 89 (99), 59 (100). 
HRMS Found: (M+H)\ 350.1811. C15H27NOs requires: (M+H)\ 350.1815. 
Specific Rotation [a]n +57.6 (c 0.5, CHCh). 
0 
ox 
0 
MEMO OMOM 
77 
Method B: 
TF A, CH2Cl2, 0 °C 
0 
0 ;;;< 
MEMO OMOM 
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Method B: TFA (50 µL) was added to a magnetically stirred solution of 
compound 77 (19 mg, 0.04 mmol) in dry dichloromethane (6 mL) maintained at 0 °C 
(ice-bath) under a nitrogen atmosphere. After stirring for 3 h, triethylamine (0.5 mL) 
was added and the resulting mixture concentrated under reduced pressure. The residue 
thus obtained was subjected to flash chromatography (silica, 2% v/v methanol/ethyl 
acetate elution) to give, after concentration of the appropriate fractions (R_r 0.5), the 
title compound 107 (11 mg, 74%) which proved identical, in all respects, to the 
material obtained by Method A. 
1,5-Dideoxy-1,5-imino-2,3-O-isopropylidene-6-O-(2-methoxyethoxy)methyl-4-O-
methoxymethyl-D-mannitol (108) 
0 
°x 0 
MEMO OMOM 
107 
LiAlH4, THF, 18 °C 
0 )< 
MEMO OMOM 
108 
LiAlH4 ( 4.4 mL of a 1.0 M solution in THF, 4.40 mmol) was added, dropwise, to a 
magnetically stirred solution of compound 107 (406 mg, 0.88 mmol) in dry THF (12 
mL) maintained at 18 °C under a nitrogen atmosphere. The reaction mixture was 
stirred at 18 °C for 24 h then treated with NaOH (20 mL of a 2.0 N aq. solution) and 
ethyl acetate (30 mL). The separated aq. phase was extracted with ethyl acetate (3 x 
20 mL) and the combined organic phases were then dried (MgSO4), filtered and 
concentrated under reduced pressure. Purification of the ensuing residue by flash 
chromatography (silica, 12% v/v methanol/ethyl acetate elution) and concentration of 
the appropriate fractions (R1 0.2) delivered the title compound 108 (342 mg, 88%) as a 
clear, colourless oil. 
1H NMR (CDCh, 300 MHz) 8 4.89 (d, J 6.4 Hz, lH), 4.72 (dd, J 10.4 and 6.6 Hz, 
2H), 4.69 (d, J6.3 Hz, lH), 4.12 (m, lH), 4.00 (dd, J7.0 and 5.3 Hz, lH), 3.79 (dd, J 
9.5 and 2.9 Hz, lH), 3.72-3.56 (m, 3H), 3.52 (m, 3H), 3.37 (s, 3H), 3.36 (m, lH), 3.36 
(s, 3H), 2.94 (dd, J 14.8 and 2.8 Hz, lH), 2.52 (m, lH), 1.89 (br s, lH), 1.52 (s, 3H), 
1.34 (s, 3H). 
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13C NMR (CDCb, 75 MHz) 8 108.7 (C), 96.1 (CH2), 95.7 (CH2), 80.1 (CH), 75.6 
(CH), 74.1 (CH), 71.6 (CH2), 67.9 (CH2), 66.7 (CH2), 58.8 (CH), 57.5 (CH3), 55.8 
(CH3), 45.6 (CH2), 28.0 (CH3), 26.5 (CH3). 
IR (KBr) Vmax 3339, 2933, 2886, 1455, 1381, 1241, 1103, 1050, 850, 518 cm-1. 
EI MS m/z (70 eV) 336 [(M+H)\ 8%], 320 (24), 216 (100), 184 (32), 89 (17), 59 
(34). 
HRMS Found: (M+H)\ 336.2023. C15H29NO7 requires: (M+H)\ 336.2022. 
Microanalysis Found: C, 53.47; H, 8.86; N, 4.20; C15H29NO7 requires: C, 53.72; H, 
8.71; N, 4.18%. 
Specific Rotation [a]0 -32.6 (c 0.5, CHCb). 
1,5-Dideoxy-1,5-imino-D-mannitol Hydrochloride (105a) 
X 0 HCl/MeOH, 18 °C 
OH 
OH 
MEMO OMOM HO OH 
108 105a 
Amine 108 (152 mg, 0.45 mmol) was dissolved in HCl (15 mL of 2.0 M solution in 
MeOH) and the resulting mixture was maintained, with stirring, at 18 °C for 7 h then 
concentrated under reduced pressure. The residue so formed was dissolved in water 
(15 mL) and washed with dichloromethane (3 x 8 mL) then filtered through a short 
pad of cotton. The collected filtrate was freeze-dried thus providing DMJ·HCl 
(105ai4J (90 mg, 100%) as a light-yellow solid, m.p. 178-186 °C (lit. [4J 175-180 °C). 
This material was identical, in all respects, with the authentic sample of DMJ·HCl 
purchased from Sigma™. 
1H NMR (D2O, 300 MHz) 8 4.21 (m, lH), 3.96 (dd, J 12.6 and 3.4 Hz, lH), 3.81 (m, 
2H), 3.65 (dd, J 9.5 and 3.1 Hz, lH), 3.38 (dd, J 13.5 and 3.1 Hz, lH), 3.21 (br d, J 
13.5 Hz, lH), 3.12 (m, lH). 
13C NMR (D2O/DMSO-d6, 75 MHz) 8 72.7 (CH), 66.0 (CH), 65.6 (CH), 61.0 (CH), 
57.9 (CH2), 47.2 (CH2). 
ESI MS mlz (70 eV) 164 [(M+H)\ 100%]. 
HRMS (FAB) Found: (M+H)\ 164.0920. C6H13NO4 requires: (M+H)\ 164.0917. 
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Specific Rotation [a]0 -17.5 (c 0.4, H2O) [lit.[4J -10.9 (c 0.3, H2O)]. 
(JR,4S,5S,6R)-3-Chloro-4,5-O-isopropylidene-7-oxabicyclo[4.1.0]hept-2-ene-4,5-
diol (48) 
(r···~•OH 
y··,,,,,OH 
Cl 
33 
i) 2,2-DMP,p-TsOH, 18 °c 
ii) m-CPBA, CH2Cl2, 0-18 °C 
Cl 
48 
.,,,,,,0 
.,,,,,)'< 
p-TsOH (210 mg, 1.08 mmol) was added to a magnetically stirred solution of diol 33 
(10.10 g, 68.91 mmol) in 2,2-DMP (60 mL) maintained at 18 °C. After stirring for 1 
h, the reaction mixture was treated with triethylamine (1.5 mL) and then concentrated 
under reduced pressure. The residue so obtained was dissolved in diethyl ether (250 
mL), washed with NaHCO3 (2 x 100 mL of a saturated aq. solution) and water (1 x 
100 mL) then dried (MgSO4), filtered and concentrated under reduced pressure to give 
the acetonide 34[5] (12.58 g, 98%) as a clear, colourless syrup. This material was 
subsequently dissolved in dichloromethane (250 mL) and cooled to O °C (ice-bath). 
After addition of m-CPBA ( ca. 70% peracid, 16.10 g, 65 .31 mmol), the resulting 
mixture was allowed to warm to 18 °C and after 18 h, it was treated with Na2SO3 (250 
mL of a 15% w/v aq. solution). The separated organic phase was washed with 
NaHCO3 (1 x 250 mL of a saturated aq. solution) and water (1 x 250 mL) then dried 
(MgSO4), filtered, and concentrated under reduced pressure. Purification of the 
ensuing residue by flash chromatography (silica, 8% v/v ethyl acetate/hexane elution) 
and concentration of the appropriate fractions (R1 0.5) delivered the title epoxide 48[5] 
(11.24 g, 82%) as a white, crystalline solid, m.p. 63-64 °C (lit.[5J 59-60 °C). 
1H NMR (CDCh, 300 MHz) 8 6.19 (dd, J 4.4 and 1.0 Hz, lH), 4.84 (m, lH), 4.34 
(dd, J 6.9 and 1.0 Hz, lH), 3.55 (dd, J 3.7 and 1.9 Hz, lH), 3.36 (complex m, lH), 
1.42 (s, 3H), 1.40 (s, 3H). 
13C NMR (CDCb, 75 MHz) 8 137.8 (C), 122.3 (CH), 111.4 (C), 73.2 (CH), 72.7 
(CH), 49.7 (CH), 48.0 (CH), 27.6 (CH3), 26.0 (CH3). 
IR (KBr) Vmax2990, 2936, 1643, 1372, 1242, 1074, 860, 590 cm-1. 
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EI MS m/z (70 eV) 204 (M+·, 9%) and 202 (28), 189 (47) and 187 (90), 115 (100). 
HRMS Found: M+·, 202.0396. C9H11 35ClO3 requires: M+, 202.0397. 
Specific Rotation [a]o +79.0 (c 0.5, CHCh). 
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(3S,4S,5S,6S)-1,3-Dichloro-5,6-O-isopropylidene-1-cyclohexene-4,5,6-triol (110) 
Cl 
48 
"""°>< 
'''''''0 
HOAc, LiCl, THF, 18 °C 
OH 
CI,,,,,, .. _ .. ,,,,\,0 
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Cl 
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Glacial acetic acid (9.5 mL, 164.88 mmol) was added to a magnetically stirred 
solution of epoxide 48 (11.24 g, 55.47 mmol) and LiCl (11.8 g, 275.58 mmol) in dry 
THF (180 mL) maintained at 18 °C. After stirring for 19 h, the reaction mixture was 
treated with ethyl acetate (200 mL) and NaHCO3 (250 mL of a saturated aq. solution). 
The separated aqueous phase was extracted with ethyl acetate (3 x 50 mL) and the 
combined organic phases were then dried (MgSO4), filtered, and concentrated under 
reduced pressure. Subjection of the resulting crude oil to flash chromatography (silica, 
25% v/v ethyl acetate/hexane elution) afforded, after concentration of the appropriate 
fractions (R_r0.3), trans-chlorohydrin 110[5] (12.97 g, 98%) as a clear, colourless oil. 
1H NMR (CDCh, 300 MHz) o 5.98 (d, J2.3 Hz, lH), 4.59 (dd, J 6.3 and 0.9 Hz, lH), 
4.36 (ddd, J 8.2, 2.2 and 1.2 Hz, lH), 4.15 (dd, J 8.3 and 6.3 Hz, lH), 3.78 (dt, J 8.3 
and 3.4 Hz, lH), 3.57 (d, J3.4 Hz, lH), 1.51 (s, 3H), 1.39 (s, 3H). 
13C NMR (CDCh, 75 MHz) o 130.3 (C), 128.5 (CH), 111.4 (C), 77.5 (CH), 75.5 
(CH), 73.9 (CH), 58.0 (CH), 28.1 (CH3), 26.0 (CH3). 
IR (KBr) Vmax 3447, 2989, 2936, 1648, 1383, 1219, 1079, 868, 739 cm-1. 
EI MS m/z (70 eV) 241 [(M+H)\ 7%], 239 (12) and 237 (3), 227 (26), 225 (71) and 
223 (100), 59 ( 49). 
HRMS Found: (M+H)\ 239.0249. C9H1/ 5ChO3 requires: (M+H)+, 239.0242. 
Specific Rotation [a]0 -6.6 (c 0.5, CHCh) [lit.[SJ -7.3 (c 2.08, CHCh)]. 
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(3R,4R,5S, 6S)-3-Azido-1-chloro-5,6-O-isopropylidene-1-cyclohexene-4,5,6-triol 
(35) and (3S,4R,5S, 6S)-3-Azido-1-chloro-5,6-O-isopropylidene-1-cyclohexene-
4,5,6-triol (111) 
Cl 
110 
LiN3, DMF, 18 °c 
Cl 
35 
OH 
N3""·· ,,,,,,,0 
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LiN3 (8.0 g, 163.40 mmol) was added to a magnetically stirred solution of trans-
chlorohydrin 110 (12.97 g, 54.24 mmol) in dry DMF (80 mL) maintained at 18 °C 
under a nitrogen atmosphere. After 72 h the reaction mixture was treated with ether 
(200 mL) then Na2S2O3 (200 mL of a 10% w/v aq. solution). The separated aq. phase 
was extracted with ether (3 x 150 mL) and the combined organic phases were washed 
with brine (1 x 250 mL) then dried (MgSO4), filtered and concentrated under reduced 
pressure. The residue so formed was subjected to flash chromatography (silica, 
gradient elution using 20% to 25% v/v ethyl acetate/hexane) thereby providing two 
fractions, A and B. 
Concentration of fraction A (R1 0.4 in 2 : 2.5 : 5.5 v/v/v ethyl 
acetate/dichloromethane/hexane) afforded cis-azido-alcohol 35[5] (12.15 g, 91 %) as a 
white, crystalline solid, m.p. 93-94 °C (lit. [5] 93 .5-94 °C). 
1H NMR (CDCb, 300 MHz) 8 5.92 (dt, J 3.7 and 0.4 Hz, lH), 4.60 (dd, J 5.6 and 1.2 
Hz, lH) 4.40 (t, J5.6 Hz, lH), 4.24 (dt, J3.7 and 1.2 Hz, lH), 4.18 (m, lH), 2.74 (d, 
J 4.0 Hz, lH), 1.40 (s, 3H), 1.38 (s, 3H). 
13C NMR (CDCb, 75 MHz) 8 134.5 (C), 122.4 (CH), 110.7 (C), 76.0 (CH), 75.1 
(CH), 69.5 (CH), 59.0 (CH), 27.8 (CH3), 26.2 (CH3). 
IR (KBr) Vmax 3457, 2989, 2936, 2108, 1649, 13 82, 1227, 1078, 872, 654 cm-1. 
EI MS m/z (70 eV) 248 [(M+H)\ 4%] and 246 (15), 232 (21) and 230 (52), 101 
(100), 59 ( 4 7). 
HRMS Found: (M+H)\ 246.0645. C9H1235ClN3O3 requires: (M+H)\ 246.0645. 
Specific Rotation [a]n -178.1 (c 1.0, CHCb). 
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Concentration of fraction B (R1 0.3 in 2 : 2.5 : 5.5 v/v/v ethyl 
acetate/dichloromethane/hexane) afforded trans-azido-alcohol 111[5] (0.64 g, 5%) as a 
white, crystalline solid, m.p. 93 .5-95 °C (lit. [SJ 94-94.5 °C). 
1H NMR (CDCh, 300 MHz) B 5.86 (d, J2.0 Hz, lH), 4.61 (dd, J 6.4 and 1.0 Hz, lH) 
4.17 (dd, J8.5 and 6.4 Hz, lH), 3.97 (m, lH), 3.69 (dt, J8.5 and 3.1 Hz lH), 3.24 (d, 
J 3.2 Hz, lH), 1.55 (s, 3H), 1.42 (s, 3H). 
13C NMR (CDCh, 75 MHz) B 130.7 (C), 126.8 (CH), 111.5 (C), 77.9 (CH), 75.7 
(CH), 73.1 (CH), 61.3 (CH), 28.2 (CH3), 26.0 (CH3). 
IR (KBr) Vmax 3455, 2988, 2854, 2113, 1650, 1383, 1251, 1074, 869,687 cm-1. 
EI MS m/z (70 eV) 248 [(M+H)\ 2%] and 246 (11), 232 (53), 230 (100), 101 (63). 
HRMS Found: (M+H)\ 246.0646. C9H1235ClN3O3 requires: (M+H)\ 246.0645. 
Specific Rotation [a]n + 1.7 (c 0.9, CHCh). 
(3R,4R,5S,6S)-3-Azido-4-0-benzyl-1-chloro-5,6-0-isopropylidene-1-cyclohexene-
4,5,6-triol (36) 
Cl 
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BnBr, NaH, KI 
THF, 0-18 °C 
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Sodium hydride (NaH) (2.8 g of a ca. 60% suspension in paraffin, 70.00 mmol) was 
added in portions to a magnetically stirred mixture of cis-azido-alcohol 35 (11.05 g, 
44.98 mmol), benzyl bromide (BnBr) (16 mL, 134.71 mmol) and potassium iodide 
(KI) (0.3 g, 1.80 mmol) in dry THF (100 mL) maintained at 0 °C (ice-bath) under a 
nitrogen atmosphere. After stirring the resulting suspension at 0-18 °C for 24 h, it was 
treated with water (5 mL), ether (150 mL) and brine (200 mL). The separated aq. 
phase was extracted with ether (3 x 150 mL) and the combined organic phases were 
dried (MgSO4), filtered and concentrated under reduced pressure. The ensuing crude 
product was purified by flash chromatography (silica, 10% v/v ethyl acetate/hexane 
elution) to give, after concentration of the appropriate fractions (R1 0.5), the title 
compound 36[6] (15.10 g, 100%) as a clear, colourless oil. 
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1H NMR (CDCb, 300 MHz) b 7.41-7.31 (complex m, 5H), 5.95 (d, J 3.7 Hz, lH), 
4.77 (dd, J 23.3 and 12.0 Hz, lH), 4.60 (dd, J 5.6 and 1.2 Hz, lH), 4.44 (t, J 5.6 Hz, 
lH), 4.05 (d, J 3.7 and 1.2 Hz, lH), 4.05 (m, lH), 3.98 (dd, J 5.7 and 3.7 Hz, lH), 
1.42 (s, 3H), 1.40 (s, 3H). 
13C NMR (CDCb, 75 MHz) b 137.3 (C), 134.5 (C), 128.5 (CH), 128.1 (CH), 127.9 
(CH), 123.1 (CH), 110.5 (C), 76.6 (CH), 75.3 (CH), 74.8 (CH), 73.5 (CH2), 57.2 
(CH), 27.7 (CH3), 26.2 (CH3). 
IR (KBr) Vmax 2988, 2935, 2103, 1651, 1382, 1225, 1076, 738,698 cm-1• 
EI MS m/z (70 eV) 322 [(M-CH3·)\ 1 %] and 320 (3), 249 (3), 191 (45), 91 (100). 
HRMS Found: (M-CH3·)\ 322.0773. C16H1s3 7ClN3O3 requires: (M-CH3·)\ 322.0772. 
Specific Rotation [a]o -111.0 (c 0.8, CHCb) [lit.[6] -113 (c 5.3, CHCb)]. 
Methyl 5-Azido-4-0-benzyl-5-deoxy-2,3-0-isopropylidene-D-mannonate (112) 
OBn 
,.,,,,,0 
.. ,,,,)< 
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i) 03, MeOH, py, -78 °C 
ii) NaBH4, -10 °C 
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A magnetically stirred solution of compound 36 (5 .08 g, 15.13 mmol) and pyridine (6 
mL, 74.18 mmol) in MeOH (100 mL) was cooled to -78 °C (acetone/dry ice bath) and 
then treated with a stream of ozone (03) (ca. 40% 0 3 in oxygen). When TLC analysis 
indicated no starting material remained (ca. 1 h), the reaction mixture was purged 
with nitrogen for ca. 0.66 h then warmed to -10 °C. This was followed by addition of 
NaBH4 (6.32 g, 167.06 mmol) in portions over 1 h. After stirring the resulting mixture 
at -10 °C for 2 h, it was treated with HCl (2.0 M solution in MeOH) so as to reduce 
the pH to ca. 4 and then NH4Cl (200 mL of a saturated aq. solution) was added. The 
separated aq. phase was extracted with ethyl acetate (3 x 150 mL) and the combined 
organic phases were washed with brine (1 x 300 mL) then dried (MgSO4) , filtered and 
concentrated under reduced pressure. The residue thus obtained was purified by flash 
chromatography (silica, 25% v/v ethyl acetate/hexane elution) thereby giving, after 
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concentration of the appropriate fractions (R1 0.4), the title compound 112 (2.46 g, 
45%) as a clear, colourless oil. 
1H NMR (CDCh/TMS, 300 MHz) 8 7.35-7.20 (complex m, 5H), 4.72 (d, J 7.2 Hz, 
lH), 4.70 (br d, J 11.6 Hz, lH), 4.60 (dd, J7.2 and 4.2 Hz, lH), 4.55 (br d, J 11.4 Hz, 
lH), 3.97 (dd, J 13.5 and 6.0 Hz, lH), 3.85 (t, J 4.6 Hz, lH) 3.78 (m, 2H), 3.57 (s, 
3H), 2.58 (br s, lH), 1.62 (s, 3H), 1.41 (s, 3H). 
13C NMR (CDCh, 75 MHz) 8 170.2 (C), 137.7 (C), 128.2 (CH), 127.5 (CH), 127.2 
(CH), 110.9 (C), 78.8 (CH), 76.7 (CH), 75.4 (CH), 73.3 (CH2), 64.0 (CH), 61.8 (CH2), 
52.2 (CH3), 26.5 (CH3), 25.5 (CH3). 
IR (KBr) Vmax 3506, 2987, 2939, 2101, 1731, 1439, 1213, 1094, 737,699 cm-1. 
EI MS m/z (70 eV) 365 (M+, 1 %), 350 (3), 336 (52), 221 (6), 159 (21), 91 (100). 
HRMS Found: (M-CH3·)\ 350.1355. C17H23N3O6 requires: (M-CH3·)\ 350.1352. 
Specific Rotation [a]o -21.1 (c 1.0, CHCh). 
Methyl 5-Azido-4-0-benzyl-6-0-tert-butyldimethylsilyl-5-deoxy-2,3-0-
isopropylidene-D-mannonate (113) 
OBn OBn 
N3 .,.,,,,,Q TBS-Cl, imidazole N3 
,,,,111\0 
.,,,,,;;< CH2Cl2, 18 °C 
""JJ;;< 
OMe OMe 
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tert-Butyldimethylsilylchloride (TBS-Cl) (438 mg, 2.91 mmol) was added to a 
magnetically stirred mixture of compound 112 (708 mg, 1.94 mmol) and imidazole 
(660 mg, 9.69 mmol) in dry dichloromethane (15 mL) maintained at 18 °C. After 
stirring for 2 h, the reaction mixture was treated with NaHCO3 (50 mL of a saturated 
aq. solution) and dichloromethane (35 mL). The separated aq. phase was extracted 
with dichloromethane (3 x 25 mL) and the combined organic phases were dried 
(MgSO4), filtered and concentrated under reduced pressure. Subjection of the ensuing 
residue to flash chromatography (silica, 6% v/v ethyl acetate/hexane elution) and 
concentration of the appropriate fractions (R1 0.5) afforded the title compound 113 
(827 mg, 89%) as a clear, colourless oil. 
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1H NMR (CDCh/TMS, 300 MHz) 8 7.34-7.24 (complex m, 5H), 4.76-4.61 (m, 3H), 
4.57 (br d, J 11.6 Hz, lH), 4.05 (dd, J 10.5 and 3.7 Hz, lH), 3.80 (m, 2H), 3.71 (m, 
lH), 3.59 (s, 3H), 1.63 (s, 3H), 1.42 (s, 3H), 0.93 (s, 9H), 0.09 (s, 6H). 
13C NMR (CDCh, 75 MHz) 8 170.1 (C), 138.0 (C), 128.2 (CH), 127.4 (CH), 127.1 
(CH), 110.6 (C), 78.8 (CH), 76.1 (CH), 75.4 (CH), 73.1 (CH2), 63.6 (CH), 62.8 (CH2), 
52.1 (CH3), 26.6 (CH3), 25.9 (CH3), 25.6 (CH3), 18.3 (C), -5.3 (CH3). 
IR (KBr) Vmax 2953, 2859, 2102, 1731, 1463, 1381, 1255, 1099, 839,698 cm-1. 
EI MS m/z (70 eV) 464 [(M-CH3·)\ 2%], 422 (13), 306 (22), 159 (17), 91 (100), 73 
(35). 
HRMS Found: (M-CH3·)\ 464.2214. C23H37N3O6Si requires: (M-CH3·)\ 464.2217. 
Specific Rotation [a]n -10.2 (c 1.3, CHCh). 
6-0-tert-Butyldimethylsilyl-5-deoxy-2,3-0-isopropylidene-D-mannolactam (114) 
OBn 0 
N3 .. ,,,,,,0 
°>< .. ,,,,,)<- 5% Pd/C, H2, EtOAc, 18 °C 0 
OMe TBSO OH 
113 114 
A magnetically stirred mixture of compound 113 (820 mg, 1.71 mmol) and 5% Pd/C 
(850 mg) in ethyl acetate (4 mL) was exposed to a balloon of hydrogen gas. After 
stirring at 18 °C for 36 h, the reaction mixture was filtered through a short pad of 
Celite™ and the filtrate was concentrated under reduced pressure. The ensuing crude 
oil was purified by flash chromatography (silica, 1.25% v/v methanol/ethyl acetate 
elution) to provide, after concentration of the appropriate fractions (R1 0.4), the title 
compound 114[4] ( 487 mg, 86%) as a white, crystalline solid, m.p. 110-111 °C (lit. [4J 
104-105 °C). 
1H NMR (CDCh, 300 MHz) 8 6.27 (s, lH), 4.57 (d, J 7.8 Hz, lH), 4.28 (t, J 7.6 Hz, 
lH), 3.96 (dd, J 10.2 and 4.0 Hz, lH), 3.65-3.50 (m, 3H), 3.35 (m, lH), 1.47 (s, 3H), 
1.37 (s, 3H), 0.86 (s, 9H), 0.05 (s, 6H). 
13C NMR (CDCh, 75 MHz) 8 168.2 (C), 110.8 (C), 78.8 (CH), 71.0 (CH), 63.5(CH2) , 
54.9 (CH), 27.3 (CH3), 25.9 (CH3), 25.1 (CH3), 18.3 (C), -5.2 (CH3). 
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IR (KBr) Vmax 3394, 2931, 2858, 1677, 1463, 1382, 1254, 1086, 839,669 cm-1. 
EI MS mlz (70 eV) 332 [(M+H)\ 7%], 316 (36), 274 (100), 216 (58), 116 (45), 75 
(67). 
HRMS Found: (M+H)\ 332.1892. C15H29NOsSi requires: (M+H)\ 332.1893. 
Specific Rotation [a]0 +15.3 (c 1.0, CHCh) [lit.[4] +18.7 (c 1.0, CHCh)]. 
6-0-tert-Butyldimethylsilyl-1,5-dideoxy-1,5-imino-2,3-0-isopropylidene-D-
mannitol (115) 
0 
TBSO OH 
X 
0 
i) BH3-DMS, THF, 18 °C 
ii) 10% Pd/C, MeOH, 18 °C 
TBSO OH 
114 115 
BH3-DMS (8 mL of 2.0 M solution in THF, 16.00 mmol) was added, dropwise, to a 
magnetically stirred solution of compound 114 (530 mg, 1.60 mmol) in dry THF (20 
mL) maintained at 18 °C under a nitrogen atmosphere. After 4.5 h MeOH (10 mL) 
was added and the resulting mixture was concentrated under reduced pressure. The 
ensuing residue was partitioned between ethyl acetate (25 mL) and NaHCO3 (25 mL 
of a saturated aq. solution). The separated aq. phase was extracted with ethyl acetate 
(3 x 15 mL) and the combined organic phases were dried (MgSO4), filtered and 
concentrated under reduced pressure. The residue so obtained was dissolved in MeOH 
(10 mL) and then treated with 10% Pd/C (120 mg). After stirring at 18 °C for 38 h, 
the reaction mixture was filtered through a short pad of Celite™ and the filtrate was 
concentrated under reduced pressure. Purification of the residue so formed by flash 
chromatography (silica, 10% v/v methanol/ethyl acetate elution) afforded, after 
concentration of the appropriate fractions (R_r 0.3), the title compound 115 (372 mg, 
73%) as a white, crystalline solid, m.p. 86-87 °C. 
1H NMR (CDCh, 300 MHz) 5 4.10 (complex m, lH), 3.91 (dd, J 7.2 and 5.4 Hz, 
lH), 3.84 (dd, J9.7 and 4.3 Hz, lH), 3.70 (dd, J9.7 and 4.1 Hz, lH), 3.57 (dd, J 10.0 
and 7.3 Hz, lH), 3.38 (dd, J 15.0 and 1.1 Hz, lH), 2.95 (dd, J 15.0 and 2.9 Hz, lH), 
2.36 (dt, J 10.0 and 4.1 Hz, lH) 1.50 (s, 3H), 1.34 (s, 3H), 0.86 (s, 9H), 0.04 (s, 6H). 
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13C NMR (CDC13, 75 MHz) 8 109.2 (C), 81.1 (CH), 74.2 (CH), 72.4 (CH), 63.6 
(CH2), 58.9 (CH), 45.8 (CH2), 28.5 (CH3), 26. 7 (CH3), 26.0 (CH3), 18.4 (C), -5.3 
(CH3). 
IR (KBr) Vmax 3307, 3120, 2931, 2858, 1471, 1438, 1378, 1239, 1087, 876, 777 cm-1. 
EI MS m/z (70 eV) 317 (M+, 3%), 302 (10), 260 ( 42), 202 (33), 172 (100), 86 (35). 
HRMS Found: M+·, 317.2018. C15H31NO4Si requires: M+, 317.2022. 
Specific Rotation [a]0 -66.0 (c 0.6, CHCb). 
1,5-Dideoxy-1,5-imino-D-mannitol Trifluoroacetate Salt (105b) 
°>< 0 
OH 
OH 
TBSO OH HO OH 
115 105b 
Compound 115 (87 mg, 0.27 mmol) was dissolved in TFA (6 mL of a 80% v/v aq. 
solution) and the resulting mixture was maintained at 18 °C. After stirring for 20 h, 
the reaction mixture was concentrated under reduced pressure. The residue so 
obtained was dissolved in water (8 mL) and the resulting solution washed with 
dichloromethane (3 x 8 mL) then filtered through a short pad of cotton. The collected 
filtrate was freeze-dried thereby giving DMJ·TFA (105b) (76 mg, 100%) as a light-
yellow solid, m.p. 175-182 °C. Comparison of the 1H and 13C NMR spectral data 
derived from this material with those obtained from the authentic samples of 
DMJ·HCl (105a) either purchased from Sigma™ or synthetized as described above 
proved a good match. 
1H NMR (D2O, 300 MHz) 8 4.22 (m, lH), 3.97 (dd, J 12.6 and 3.2 Hz, lH), 3.83 (m, 
2H), 3.67 (dd, J 9.5 and 3.0 Hz, lH), 3.39 (dd, J 13.5 and 3.0 Hz, lH), 3.22 (br d, J 
13.5 Hz, lH), 3.13 (m, lH). 
13C NMR (D2O/DMSO-d6, 75 MHz) 8 164.6 (C), 164.1 (C), 73.9 (CH), 67.4 (CH), 
67.2 (CH), 61.9 (CH), 59.6 (CH2), 49.1 (CH2). 
Specific Rotation [a]0 -10.0 (c 0.4, H2O). 
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1,2,3,4-tetra-O-Acetyl-a-L-rhamnopyranoside (121) and 1,2,3,4-tetra-O-Acetyl-P-
L-rhamnopyranoside (122) 
Me.,,,,,,,(O'COH 
HOAy)···,,,,10H 
OH 
117 
OAc 
121 
OAc 
+ 
M~X)",,DAc 
AcO i .,,,,10Ac 
OAc 
122 
L-Rhamnose monohydrate 117 (0.89 g, 4.90 mmol) was dissolved in pyridine (6 mL) 
and the resulting mixture treated acetic anhydride (2 mL). After stirring at 18 °C for 
24 h, the reaction mixture was concentrated under reduced pressure. The residue thus 
obtained was partitioned between ethyl acetate (40 mL) and NaHCO3 (40 mL of a 
saturated aq. solution). The separated organic phase was washed with NaHCO3 (2 x 
40 mL of a saturated aq. solution) then dried (MgSO4), filtered and concentrated 
under reduced pressure. Subjection of the residue so formed to flash chromatography 
(silica, gradient elution using 25 to 35% v/v ethyl acetate/hexane) afforded two 
fractions, A and B. 
Concentration of fraction A (R1 0.4 in 2 : 2.5 : 5.5 v/v/v ethyl 
acetate/dichloromethane/hexane) afforded compound 121[7J (1.15 g, 71 %) as a clear, 
colourless oil. 
1H NMR (CDCh, 300 MHz) 8 5.95 (d, J l.9 Hz, lH), 5.24 (dd, J 10.2 and 3.4 Hz, 
lH), 5.19 (m, lH), 5.06 (t, J 9.9 Hz, lH), 3.89 (m, lH), 2.12 (s, 3H), 2.11 (s, 3H), 
2.01 (s, 3H), 1.95 (s, 3H), 1.18 (d, J6.3 Hz, 3H). 
13C NMR (CDCh, 75 MHz) 8 169.9 (C), 169.6 (C), 169.6 (C), 168.2 (C), 90.6 (CH), 
70.5 (CH), 68.8 (CH), 68.7 (CH), 68.6 (CH), 21.0 (CH3), 20.9 (CH3), 20.8 (CH3), 20.8 
(CH3), 17.5 (CH3). 
IR (KBr) Vmax 2987, 2941, 1755, 1371, 1226, 1056, 974, 563 cm-1. 
EI MS mlz (70 eV) 289 [(M-CH3CO·)\ < 1 %], 273 (5), 184 (29), 157 (83), 115 (100). 
HRMS Found: (M-CH3CO2·)\ 273.0974. C14H20O9 requires: (M-CH3CO2·)\ 
273.0974. 
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Specific Rotation [a]0 -67.4 (c 0.65, CHCb) [lit.[7] -63 (c 2.3, CHCb)]. 
Concentration of fraction B (R1 0.3 1n 2 : 2.5 : 5.5 v/v/v ethyl 
acetate/dichloromethane/hexane) afforded compound 122[3] (0.38 g, 23%) as a white, 
crystalline solid, m.p. 97-98 °c (lit. [3J 98-99 °C). 
1H NMR (CDCb, 300 MHz) 8 5.81 (d, J l.2 Hz, lH), 5.44 (m, lH), 5.05 (m, 2H), 
3.64 (m, lH), 2.18 (s, 3H), 2.07 (s, 3H), 2.03 (s, 3H), 1.97 (s, 3H), 1.25 (d, J 6.2 Hz, 
3H). 
13C NMR (CDCb, 75 MHz) 8 170.2 (C), 169.8 (C), 169.7 (C), 168.4 (C), 90.3 (CH), 
71.5 (CH), 70.8 (CH), 70.3 (CH), 68.6 (CH), 21.0 (CH3), 20.9 (CH3), 20.9 (CH3), 20.7 
(CH3), 17.5 (CH3). 
IR (KBr) Vmax 2986, 2941, 1753, 1370, 1227, 1056, 977,565 cm-1. 
EI MS m/z (70 eV) 289 [(M-CH3CO·)\ < 1 %], 273 (< 1), 184 (26), 115 (100). 
HRMS Found: (M-CH3CO2-)\ 273.0976. C14H20O9 requires: (M-CH3CO2-)\ 
273.0974. 
Microanalysis Found: C, 50.36; H, 6.07; C14H20O9 requires: C, 50.60; H, 6.07%. 
Specific Rotation [a]0 + 12.5 (c 0.65, CHCb) (lit.[8] + 13 in CHCb). 
2,3,4-tri-O-Acetyl-a-L-rhamnopyranosyl Bromide (118) 
AcO 
OAc 
121 
OAc 
Route A: 
45% HBr/HOAc 
HOAc, 18 °C 
AcO 
Br 
···,,,,,OAc 
OAc 
118 
Route A: A magnetically stirred solution of compound 121 ( 485 mg, 1.46 mmol) 
in glacial acetic acid (5 mL) maintained at 18 °C was treated with hydrobromic acid 
(1.5 mL of a ca. 45% solution in acetic acid). After stirring for 1 h, dichloromethane 
(20 mL) and then ice were added and the resulting mixture was poured into cold 
NaHCO3 (35 mL of a saturated aq. solution). The separated organic phase was washed 
with cold NaHCO3 (3 x 25 mL of a saturated aq. solution) and cold water (1 x 35 mL) 
then dried (MgSO4), filtered and concentrated under reduced pressure to give bromide 
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l l8[7J ( 514 mg, 100%) as a clear, colourless oil which solidified on standing. 
Recrystallization of this material [ diethyl ether (2 mL) and hexane (2 mL) at -12 °C] 
gave the title compound ll8[7J a white, crystalline solid, m.p. 64-66 °C (lit.[7J 64.5-
65.5 °C). 
1H NMR (CDCb, 300 MHz) o 6.25 (d, J 1.1 Hz, lH), 5.65 (dd, J 10.0 and 3.5 Hz, 
lH), 5.43 (dd, J 3.5 and 1.6 Hz, lH), 5.15 (t, J 10.0 Hz, lH), 4.10 (m, lH), 2.16 (s, 
3H), 2.08 (s, 3H), 2.00 (s, 3H), 1.28 ( d, J 6.3 Hz, 3H). 
13C NMR (CDCb, 75 MHz) o 169.8 (C), 169.7 (C), 169.6 (C), 83.8 (CH), 72.6 (CH), 
71.2 (CH), 70.4 (CH), 68. (CH), 21.0 (CH3), 20.9 (CH3), 20.8 (CH3), 17.2 (CH3). 
IR (KBr) Vmax 2989, 1754, 1371, 1219, 1054, 681 cm-1. 
Specific Rotation [a]0 -176.3 (c 0.4, CHCh) [lit.[7J -173.5 (c 2.4, CHCh)]. 
Me1.D""· 0 :::••OAc 
AcO k 11110Ac 
OAc 
122 
Route B: 
45% HBr/HOAc 
HOAc, 18 °C 
Br 
.. ,,,,,,OAc 
OAc 
118 
Route B: Following the same procedure as described immediately above, 
compound 122 (226 mg, 0.68 mmol) was converted into bromide 118 (226 mg, 94%) 
which proved identical, in all respects, to the material obtained by Route A. 
N-Benzyl-1,5-dideoxy-1,5-imino-2,3-O-isopropylidene-6-O-(2-
methoxyethoxy)methyl-4-O-methoxymethy-D-mannitol (124) 
°>< 0 
MEMO OMOM 
108 
BnBr, K2C03 
MeCN, 18 °C 
MEMO OMOM 
124 
BnBr (100 µL, 0.84 mmol) and potassium carbonate (K2CO3) (133 mg, 0.96 mmol) 
was added to a magnetically stirred solution of compound 108 (215 mg, 0.64 mmol) 
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in MeCN ( 5 mL) maintained at 18 °C. After stirring for ca. 18 h, the reaction mixture 
was treated with dichloromethane (15 mL) then brine (20 mL). The separated aq. 
phase was extracted with dichloromethane (3 x 10 mL) and the combined organic 
phases were dried (MgSO4), filtered and concentrated under reduced pressure. The 
ensuing residue was subjected to flash chromatography (silica, 60% v/v ethyl 
acetate/hexane elution) to afford, after concentration of the appropriate fractions (R1 
0.4), the title compound 124 (250 mg, 92%) as a clear, colourless oil. 
1H NMR (CDCb/TMS, 300 MHz) 8 7.40-7.20 (complex m, 5H), 4.78 (d, J 6.6 Hz, 
lH), 4.73 (s, 2H), 4.70 (d, J 6.6 Hz, lH), 4.26 (m, 2H), 4.02 (t, J 4.6 Hz, lH), 3.98 (d, 
J 14.0 Hz, lH), 3.87 (dd, J 10.1 and 6.4 Hz, lH), 3.76 (dd, J 10.1 and 5.0 Hz, lH), 
3.69 (m, 2H), 3.61 (d, J 14.0 Hz, lH), 3.53 (m, 2H), 3.38 (s, 3H), 3.37 (s, 3H), 2.81 
(m, 2H), 2.63 (m, lH), 1.54 (s, 3H), 1.33 (s, 3H). 
13C NMR (CDCb, 75 MHz) 8 139.1 (C), 128.6 (CH), 128.2 (CH), 126.9 (CH), 109.1 
(C), 96.1 (CH2), 95.8 (CH2), 76.4 (CH), 73.3 (CH), 73.0 (CH), 71.8 (CH2), 66.9 
(CH2), 66.6 (CH2), 61.8 (CH2), 59.2 (CH3), 58.4 (CH), 56.0 (CH3), 49.6 (CH2), 27.4 
(CH3), 25.6 (CH3). 
IR (KBr) Vmax 2932, 2887, 1453, 1369, 1214, 1102, 1039, 860, 512 cm-1. 
EI MS m/z (70 eV) 425 (M+, < 1 %), 410 (4), 306 (100), 216 (3), 91 (67), 59 (16). 
HRMS Found: (M-CH3·)\ 410.2185. C22H35NO7 requires: (M-CH3·)\ 410.2179. 
Specific Rotation [a]o -16.0 (c 0.6, CHCb). 
2-0-Acetyl-3-0-tert-butyldiphenylsilyl-5-deoxy-4-0-methoxymethyl-D-
mannolactam (125) 
OMOM 
,,,,OTBDPS 
.. ~, 
.,,,,,,OAc 
OMe 
71 
5% Pd/C, H2, EtOAc, 18 °C 
0 
OAc 
OTBDPS 
HO OMOM 
125 
A magnetically stirred mixture of compound 71 (1.69 g, 2.87 mmol) and 5% Pd/C 
(1.52 g) in ethyl acetate (5 mL) was exposed to a balloon of hydrogen gas. After 
stirring at 18 °C for 18 h, the reaction mixture was filtered through a short pad of 
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Celite™ and the filtrate was concentrated under reduced pressure. Subjection of the 
ensuing residue to flash chromatography (silica, 1 % v/v methanol/ethyl acetate 
elution) and concentration of the appropriate fractions (R1 0.5) afforded the title 
compound 125 (1.39 g, 96%) as a white, crystalline solid, m.p. 122-123 °C. 
1H NMR (CDCh, 300 MHz) 8 7.71-7.64 (complex m, 4H), 7.48-7.31 (complex m, 
7H), 5.45 (d, J 2.3 Hz, lH), 4.38 (d, J 6.9 Hz, lH), 4.24 (m, 2H), 3.76 (m, 3H), 3.62 
(m, lH), 3.55 (m, lH), 3.17 (s, 3H), 1.92 (s, 3H), 1.07 (s, 9H). 
13C NMR (CDCh, 75 MHz) 8 170.1 (C), 168.0 (C), 136.2 (CH), 136.0 (CH), 132.7 
(C), 132.6 (C), 130.2 (CH), 129.9 (CH), 127.9 (CH), 127.5 (CH), 95.8 (CH2), 74.4 
(CH), 72.4 (CH), 69.9 (CH), 64.2 (CH2), 58.6 (CH), 55.9 (CH3), 27.1 (CH3), 20.8 
(CH3), 19.6 (C). 
IR (KBr) Vmax 3389, 2933, 2859, 1751, 1689, 1373, 1228, 1033, 704, 507 cm-1. 
EI MS m/z (70 eV) 486 [(M-CH3·)\ 5%], 444 (100), 322 (8), 241 (9), 199 (30). 
HRMS Found: (M-CH3·)\ 486.1578. C26H35N07Si requires: (M-CH3·)\ 486.1584. 
Specific Rotation [a]n + 16.8 (c 0.5, CHCh). 
2-0-Acetyl-3-0-tert-butyldiphenylsilyl-5-deoxy-6-0-methoxyisopropyl-4-0-
methoxymethyl-D-mannolactam (126) 
0 0 
CH2=CH(OMe)Me 
POCl3, CH2Cl2, 18 °C 
HO OMOM MIPO OMOM 
125 126 
Phosphoryl trichloride (POCh) ( 6 drops) was added to a magnetically stirred solution 
of compound 125 (725 mg, 1.44 mmol) in dry dichloromethane (3 mL) and 2-
methoxypropene (5 mL) maintained at 18 °C under a nitrogen atmosphere. When 
TLC analysis indicated no starting material remained (ca. 8 h), triethylamine (0.5 mL) 
was added and the resulting mixture was concentrated under reduced pressure. 
Subjection of the residue thus obtained to flash chromatography (silica, 60% v/v ethyl 
acetate/hexane elution) afforded, after concentration of the appropriate fractions (R1 
0.5), the title compound 126 (822 mg, 99%) as a clear, colourless oil. 
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1H NMR (CDCh, 300 MHz) <5 7.71-7.63 (complex m, 4H), 7.46-7.33 (complex m, 
6H), 6.12 (s, lH), 5.48 (d, J2.5 Hz, lH), 4.35 (d, J7.0 Hz, lH), 4.26 (t, J2.8 Hz, lH), 
4.18 (d, J7 .0 Hz, lH), 3.55 (m, 2H), 3.42 (m, 2H), 3.17 (s, 3H), 3.16 (s, 3H), 1.93 (s, 
3H), 1.32 (s, 3H), 1.31 (s, 3H), 1.08 (s, 9H). 
13C NMR (CDCh, 75 MHz) <5 169.9 (C), 166.4 (C), 136.2 (CH), 135.9 (CH), 132.8 
(C), 132.5 (C), 130.2 (CH), 129.9 (CH), 127.9 (CH), 127.5 (CH), 100.5 (C), 95.9 
(CH2), 74.4 (CH), 72.2 (CH), 69.8 (CH), 62.8 (CH2), 56.7 (CH), 55.9 (CH3), 48.9 
(CH3), 27.1 (CH3), 24.6 (CH3), 24.5 (CH3), 20.8 (CH3), 19.6 (C). 
IR (KBr) Vmax 3225, 2935, 2859, 1753, 1699, 1371, 1227, 1033, 704, 507 cm-1. 
EI MS mlz (70 eV) 542 [(M-CH3O·)\ 14%], 516 (8), 442 (92), 199 (34), 73 (100). 
HRMS Found: (M-CH3O·)\ 542.2580. C30H43NOsSi requires: (M-CH3O·)\ 
542.2574. 
Specific Rotation [a]0 +18.4 (c 0.5, CHCh). 
5-Deoxy-6-0-methoxyisopropyl-4-0-methoxymethyl-D-mannolactam (127) 
0 0 
OH 
TBAF, THF, 18 °C 
OH 
MIPO OMOM MIPO OMOM 
126 127 
A magnetically stirred solution of compound 126 (822 mg, 1.43 mmol) in THF (15 
mL) maintained at 18 °C was treated with TBAF (5.8 mL of a 1.0 M solution in THF, 
5.80 mmol). After 20 h the reaction mixture was concentrated under reduced pressure. 
Purification of the resulting residue by flash chromatography (silica, 3% v/v 
methanol/ethyl acetate elution) provided, after concentration of the appropriate 
fractions (R1 0.4), the title compound 127 ( 401 mg, 96%) as a white, crystalline solid, 
m.p. 130-133 °C. 
1H NMR (CDCh, 300 MHz) <5 6.37 (s, lH), 4.76 (d, J 6.9 Hz, lH), 4.68 (d, J 6.9 Hz, 
lH), 4.33 (m, lH), 4.25 (m, lH), 4.09 (m, lH), 3.80 (t, J 3.2 Hz, lH), 3.60 (m, 2H), 
3.55 (d, J9.7 Hz, lH), 3.40 (s, 3H), 3.23 (d, J2.1 Hz, lH), 3.19 (s, 3H), 1.35 (s, 6H). 
Chapter Six 162 
13C NMR (CDCh, 75 MHz) <5 171.5 (C), 100.6 (C), 96.1 (CH2), 74.3 (CH), 70.6 
(CH), 68.2 (CH), 62.1 (CH2), 56.2 (CH), 56.1 (CH3), 49.0 (CH3), 24.6 (CH3), 24.5 
(CH3). 
IR (KBr) Vmax 3329, 2943, 1674, 1381, 1214, 1035, 847 cm-1. 
EI MS m/z (70 eV) 262 [(M-CH3O·)\ 6%], 231 (14), 199 (17), 73 (100). 
HRMS Found: (M-CH3O·)\ 262.1294. C12H23NO7 requires: (M-CH3O·)\ 262.1291. 
Specific Rotation [a]0 +51.3 (c 0.3, CHCh). 
5-Deoxy-2,3-0-isopropylidene-4-0-methoxymethyl-D-mannolactam (128) and 5-
Deoxy-2,3-0-isopropylidene-6-0-methoxyisopropyl-4-0-methoxymethyl-D-
mannolactam (129) 
0 0 0 
2,2-DMP ox ox p-TsOH, 0-18 °C 
+ 
0 0 
MIPO OMOM HO OMOM MIPO OMOM 
127 128 129 
p-TsOH (75 mg, 0.39 mmol) was added to a magnetically stirred solution of 
compound 127 (401 mg, 1.37 mmol) in acetone (15 mL) and 2,2-DMP (10 mL) 
maintained at O °C (ic-bath). After stirring for 1 h, triethylamine (1 mL) was added 
and the resulting mixture was concentrated under reduced pressure. The ensuing 
residue was purified by flash chromatography (silica, gradient elution using 1.5 to 
10% v/v methanol/ethyl acetate) to give two fractions, A and B. 
Concentration of fraction A (R_r 0.3 in 8 : 1 v/v ethyl acetate/methanol) afforded 
compound 128 (53 mg, 15%) as a clear, light-yellow oil. 
1H NMR (CDCh, 300 MHz) <5 7.63 (s, lH), 4.90 (d, J 6.5 Hz, lH), 4.70 (d, J 6.6 Hz, 
lH), 4.58 (d, J 7.8 Hz, lH), 4.43 (dd, J 7.8 and 6.5 Hz, lH), 3.86 (m, 2H), 3.75 (m, 
2H), 3.41 (m, 4H), 1.48 (s, 3H), 1.38 (s, 3H). 
13C NMR (CDCh, 75 MHz) <5 170.3 (C), 111.0 (C), 96.4 (CH2), 78.6 (CH), 73.8 
(CH), 72.9 (CH), 60.9 (CH2), 56.3 (CH3), 55.0 (CH), 27.1 (CH3), 25.2 (CH3). 
IR (KBr) Vmax 3330, 2987, 2898, 1678, 1375, 1214, 1031, 861 cm-1. 
EI MS mlz (70 eV) 262 [(M+H)\ 9%], 261 (2),- 246 (100), 199 (71), 73 (46). 
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HRMS Found: M+, 261.1214. C11H19NO6 requires: M+·, 262.1212. 
Specific Rotation [a]o +82.4 (c 0.5, CHCb). 
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Concentration of fraction B (R10.4 in 8 : 1 : 3.5 v/v/v ethyl acetate/methanol/hexane) 
afforded compound 129 (304 mg, 67%) as a clear, colourless oil. 
1H NMR (CDCb, 300 MHz) 8 6.21 (s, lH), 4.90 (d, J 6.6 Hz, lH), 4.64 (d, J 6.6 Hz, 
lH), 4.55 (d, J 7.5 Hz, lH), 4.40 (t, J 7.5 Hz, lH), 3.74 (dd, J 9.3 and 3.6 Hz, lH), 
3.69 (dd, J 8.2 and 6.4 Hz, lH), 3.51 (m, lH), 3.38 (m, 4H), 3.17 (s, 3H), 1.49 (s, 3H), 
1.37 (s, 3H), 1.32 (s, 6H). 
13C NMR (CDCb, 75 MHz) 8 168.2 (C), 110.8 (C), 100.5 (C), 96.1 (CH2), 78.2 (CH), 
74.2 (CH), 72.9 (CH), 61.1 (CH2), 56.3 (CH3), 53.0 (CH), 49.0 (CH3), 27.1 (CH3), 
25.2 (CH3), 24.5 (CH3), 24.4 (CH3). 
IR (KBr) Vmax 3220, 2989, 1687, 1381, 1213, 1034, 851 cm-1. 
EI MS m/z (70 eV) 334 [(M+H)\ 3%], 318 (5), 244 (21), 231 (44), 73 (100). 
HRMS Found: (M+H)\ 334.1866. C15H27NO7 requires: (M+H)\ 334.1866. 
Specific Rotation [a]0 +64.8 (c 0.4, CHCb). 
1,5-Dideoxy-1,5-irnino-2,3-O-isopropylidene-6-O-methoxyisopropyl-4-O-
methoxymethyl-D-mannitol (130) 
0 
°x 
0 
LiAlH4, THF, 18 °C ox 
0 
MIPO OMOM MIPO OMOM 
129 130 
LiAlH4 (0.8 mL of a 1.0 M solution in THF, 0.80 mmol) was added, dropwise, to a 
magnetically stirred solution of compound 129 (114 mg, 0.34 mmol) in dry THF (5 
mL) maintained at 18 °C under a nitrogen atmosphere. After stirring for 20 h, the 
reaction mixture was treated with dichloromethane (10 mL) and then NaOH (10 mL 
of a 2.0 N aq. solution). The separated aq. phase was extracted with dichloromethane 
(2 x 10 mL) and the combined organic phases were dried (MgSO4), filtered and 
concentrated under reduced pressure. The residue so obtained was subjected to flash 
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chromatography (silica, 6% v/v methanol/ethyl acetate elution) to afford, after 
concentration of the appropriate fractions (R1 0.3), the title compound 130 (93 mg, 
86%) as a white, crystalline solid, m.p. 55-56 °C. 
1H NMR (CDCh, 300 MHz) o 4.89 (d, J 6.3 Hz, lH), 4.65 (d, J 6.3 Hz, lH), 4.14 (m, 
lH), 4.00 (dd, J 6.8 and 5.3 Hz, lH), 3.66 (dd, J 9.l and 2.9 Hz, lH), 3.53 (dd, J 10.0 
and 6.8 Hz, lH), 3.39 (m, 5H), 3.18 (s, 3H), 2.95 (dd, J 14.7 and 2.8 Hz, lH), 2.51 
(m, lH), 1.92 (br s, lH), 1.52 (s, 3H), 1.35 (s, 3H), 1.31 (s, 6H). 
13C NMR (CDCh, 75 MHz) o 109.1 (C), 100.0 (C), 96.4 (CH2), 80.4 (CH), 76.3 
(CH), 74.3 (CH), 60.1 (CH2), 58.0 (CH), 56.1 (CH3), 48.8 (CH3), 45.9 (CH2), 28.2 
(CH3), 26.8 (CH3), 24.7 (CH3), 24.5 (CH3). 
IR (KBr) Vmax 2988, 2940, 1451, 1380, 1216, 1039, 853, 517 cm-1. 
EI MS m/z (70 eV) 319 (M+·, 3%), 304 (31), 288 (21), 272 (41), 216 (100), 73 (76). 
HRMS Found: (M-CH3·)\ 304.1755. C15H29NO6 requires: (M-CH3·)\ 304.1761. 
Specific Rotation [a]0 -28.8 (c 0.5, CHCh). 
N-Benzyl-1,5-dideoxy-1,5-imino-2,3-O-isopropylidene-6-O-methoxyisopropyl-4-
O-methoxymethyl-D-mannitol (131) 
ox 
0 
MIPO OMOM 
130 
BnBr, K2C03 
MeCN, 18 °C ox 
0 
MIPO OMOM 
131 
A magnetically stirred solution of compound 130 (85 mg, 0.27 mmol) in MeCN ( 4 
mL) maintained at 18 °C was treated with BnBr (42 µL, 0.35 mmol) and K2CO3 (55 
mg, 0.40 mmol). After stirring for ca. 16 h, the reaction mixture was treated with 
dichloromethane (15 mL) then brine (20 mL). The separated aq. phase was extracted 
with dichloromethane (3 x 10 mL) and the combined organic phases were then dried 
(MgSO4), filtered and concentrated under reduced pressure. The ensuing residue was 
subjected to flash chromatography (silica, 35% v/v ethyl acetate/hexane elution) 
thereby affording, after concentration of the appropriate fractions (R1 0.4), the title 
compound 131 (102 mg, 94%) as a clear, colourless oil. 
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1H NMR (CDCh/TMS, 300 MHz) D 7.40-7.20 (complex m, 5H), 4.72 (dd, J21.3 and 
6.6 Hz, 2H), 4.29 (m, 2H), 4.04 (t, J 3.8 Hz, lH), 4.00 (d, J 13.9 Hz, lH), 3.70 (dd, J 
9.7 and 7.0 Hz, lH), 3.61 (d, J 13.9 Hz, lH), 3.55 (m, lH), 3.38 (s, 3H), 3.20 (s, 3H), 
2.79 (ddt, J 13.0, 3.8 and 1.5 Hz, 2H), 2.68 (dd, J 13.0 and 3.6 Hz, lH), 1.53 (s, 3H), 
1.34 (s, 3H), 1.33 (s, 6H). 
13C NMR (CDCh, 75 MHz) D 139.4 (C), 128.5 (CH), 128.1 (CH), 126.8 (CH), 109.0 
(C), 100.0 (C), 95.8 (CH2), 75.7 (CH), 73.1 (CH), 72.8 (CH), 62.3 (CH), 60.0 (CH2), 
59.1 (CH2), 55.9 (CH3), 49.5 (CH2), 48.8 (CH3), 27.2 (CH3), 25.6 (CH3), 24.6 (CH3), 
24.6 (CH3). 
IR (KBr) Vmax 2938, 2891, 1453, 1370, 1212, 1151, 1045, 860, 512 cm-1. 
EI MS mlz (70 eV) 409 (M+, 11 %), 394 (8), 320 (20), 306 (100), 91 (54), 73 (34). 
HRMS Found: M+, 409.2462. C22H35NO6 requires: M+, 409.2464. 
Specific Rotation [a]0 -17.5 (c 0.6, CHCh). 
N-Benzyl-1,5-dideoxy-1,5-imino-2,3-0-isopropylidene-4-0-methoxymethyl-D-
mannitol (119) 
°x 0 PPTS, MeOH, 18 °C ox 0 
MIPO OMOM HO OMOM 
131 119 
A magnetically stirred solution of compound 131 (150 mg, 0.37 mmol) in MeOH (4 
mL) maintained at 18 °C was treated with PPTS (52 mg, 0.21 mmol). After stirring 
for ca. 36 h, triethylamine (0.5 mL) was added and the resulting mixture was 
concentrated under reduced pressure. The ensuing residue was subjected to flash 
chromatography (silica, 35% v/v ethyl acetate/hexane elution) to give, after 
concentration of the appropriate fractions (R10.4), the title compound 119 (119 mg, 
96%) as a clear, colourless oil. 
1H NMR (CDCh/TMS, 300 MHz) D 7.33-7.21 (complex m, 5H), 4.91 (d, J 6.6 Hz, 
lH), 4.70 (d, J 6.6 Hz, lH), 4.29 (m, lH), 4.20 (t, J 6.l Hz, lH), 3.97 (m, 2H), 3.81 
(ddd, J 26.5, 11.4 and 4.3 Hz, 2H), 3.62 (d, J 13.5 Hz, lH), 3.41 (s, 3H), 2.93 (dd, J 
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14.1 and 4.3 Hz, lH), 2.82 (br s, lH), 2.70 (dd, J 14.1 and 4.0 Hz, lH), 2.64 (t, J 4.3 
Hz, lH), 1.53 (s, 3H), 1.34 (s, 3H). 
13C NMR (CDCb, 75 MHz) B 138.5 (C), 128.9 (CH), 128.5 (CH), 127.3 (CH), 109.3 
(C), 96.6 (CH2), 77.8 (CH), 74.4 (CH), 72.6 (CH), 63.4 (CH), 60.3 (CH2), 57.2 (CH2), 
56.2 (CH3), 49.4 (CH2), 27.7 (CH3), 25.7 (CH3). 
IR (KBr) Vmax 3469, 2933, 1453, 1380, 1215, 1151, 1036, 734, 513 cm-1. 
EI MS m/z (70 eV) 322 [(M-CH3·)\ 8%], 306 (89), 206 (21), 164 (15), 91 (100). 
HRMS Found: (M-CH3·)\ 322.1653. C18H27N05 requires: (M-CH3·)\ 322.1654. 
Specific Rotation [a]o+20.4 (c 0.5, CHCb). 
N-Benzyl-1,5-dideoxy-1,5-imino-2,3-0-isopropylidene-4-0-methoxymethyl-6-0-
(2,3,4-tri-O-acetyl-a-L-rhamnopyranosyl)-D-mannitol (132) 
HO 
Br 
... ,,,,,OAc 
OAc 
118 
+ 
ox 
0 
OMOM 
119 
AgOTf, CH2Cl2 
PhMe,MS4A 
-10 °c MXXO 
AcO , '''110Ac 
OAc 
132 
ox 
0 
OMOM 
A suspension of silver trifluoromethanesulfonate (AgOTf) (94 mg, 0.37 mmol) in dry 
toluene (5 mL) was added to a magnetically stirred mixture of bromide 118 (139 mg, 
0 0.39 mmol), compound 119 (96 mg, 0.28 mmol) and 4A molecular sieves (0.5 g) in 
dry dichloromethane (12 mL) maintained at -10 °C (ice-bath) under a nitrogen 
atmosphere. After stirring for 0.5 h, triethylamine (1 mL) and then dichloromethane 
( 40 mL) were added. The resulting mixture was filtered through a short pad of 
Celite™ and then concentrated under reduced pressure. Subjection of the ensuing 
residue to flash chromatography (silica, 50 % v/v ethyl acetate/hexane elution) and 
concentration of the appropriate fractions (R1 0.4) provided the title compound 132 
(110 mg, 63%) as a clear, colourless oil which solidified on standing. 
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1H NMR (CDCb/TMS, 300 MHz) o 7.37-7.17 ( complex m, 5H), 5.27 (m, 2H), 5.06 
(t, J 9.9 Hz, lH), 4.79 (d, J 6.6 Hz, lH), 4.71 (s, lH), 4.69 (d, J 6.6 Hz, lH), 4.30 (m, 
2H), 4.06 (m, lH), 4.03-3.84 (ddm, J 10.l and 7.5 Hz, 3H), 3.59 (m, 2H), 3.39 (s, 
3H), 2.89 (m, lH), 2.76 (m, 2H), 2.14 (s, 3H), 2.06 (s, 3H), 1.99 (s, 3H), 1.53 (s, 3H), 
1.33 (s, 3H), 1.19 ( d, J 6.3 Hz, 3H). 
13C NMR (CDCb, 75 MHz) o 170.1 (C), 170.0 (C), 169.8 (C), 139.1 (C), 128.4 (CH), 
128.3 (CH), 126.9 (CH), 109.1 (C), 97.5 (CH), 96.0 (CH2), 75.4 (CH), 72.8 (CH), 
72.5 (CH2), 71.1 (CH), 70.1 (CH), 69.3 (CH), 66.8 (CH2), 66.7 (CH), 61.7 (CH), 59.2 
(CH2), 56.0 (CH3), 49.5 (CH2), 27.2 (CH3), 25.4 (CH3), 21.2 (CH3), 21.1 (CH3), 21.0 
(CH3), 17.6 (CH3). 
IR (KBr) Vmax 2984, 2936, 1750, 1371, 1245, 1223, 1136, 1051, 734 cm-1. 
EI MS m/z (70 eV) 609 (M+, 8%), 594 (60), 548 (24), 506 (18), 306 (100), 91 (37). 
HRMS Found: M+, 609.2765. C3oH43NO12 requires: M+·, 609.2785. 
Specific Rotation [a]n-40.3 (c 0.3, CHCb). 
N-Benzyl-1,5-dideoxy-1,5-imino-6-0-(2,3,4-tri-O-acetyl-a-L-rhamnopyranosyl)-
D-mannitol (133) 
ox 
0 
OMOM 
OAc 
132 
M&X:CO 
AcO , .,,,110Ac 
OAc 
133 
OH 
OH 
A magnetically stirred solution of compound 132 (110 mg, 0.18 mmol) in 
dichloromethane (6 mL) maintained at 18 °C was treated with TFA (2 mL). After 
stirring for 32 h, the reaction mixture was concentrated under reduced pressure. 
Purification of the resulting residue by flash chromatography (silica, 2% v/v 
methanol/ethyl acetate elution) provided, after concentration of the appropriate 
fractions (Rt 0.5), the title compound 133 (68 mg, 72%) as a white, crystalline solid, 
m.p. 59-61 °C. 
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1H NMR (CDCb/TMS, 300 MHz) 8 7.35-7.21 (complex m, 5H), 5.30 (m, 2H), 5.05 
(t, J 9.5 Hz, lH), 4.77 (s, lH), 4.19 (m, 2H), 3.80 (m, 4H), 3.35 (m, 3H), 2.94 (dd, J 
12.2 and 3.6 Hz, lH), 2.71 (br s, 2H), 2.37 (d, J 9.2 Hz, lH), 2.27 (d, J 12.2 Hz, lH), 
2.14 (s, 3H), 2.03 (s, 3H), 2.00 (s, 3H), 1.15 ( d, J 6.3 Hz, 3H). 
13C NMR (CDCb, 75 MHz) 8 170.3 (C), 170.2 (C), 169.9 (C), 138.3 (C), 128.8 (CH), 
128.6 (CH), 127.3 (CH), 98.2 (CH), 76.1 (CH), 70.9 (CH), 69.8 (CH), 69.7 (CH), 69.4 
(CH), 68.0 (CH), 66.9 (CH), 65.7 (CH), 65.2 (CH2), 56.9 (CH2), 55.4 (CH2), 21.2 
(CH3), 21.0 (CH3), 21.0 (CH3), 17.6 (CH3). 
IR (KBr) Vmax 3431, 2926, 1749, 1371, 1225, 1135, 1085, 1051, 733 cm-1. 
EI MS m/z (70 eV) 525 (M+·, 4%), 508 (1), 494 (25), 422 (30), 222 (100), 91 (61). 
HRMS Found: (M-OH·)\ 508.2188. C25H35N011 requires: (M-OH·)\ 508.2183 . 
Specific Rotation [a]0 -90.0 (c 0.2, CHCb). 
N-Benzyl-1,5-dideoxy-1,5-imino-6-0-a-L-rhamnopyranosyl-D-mannitol (134) 
OH 
0 OH 
OH NaOMe/MeOH, 18 °C 
OAc 
133 
Me,,,,, .. (o"f'o 
HO~··,,,,,OH 
OH 
134 
OH 
OH 
Sodium methoxide (5 mL of a 0.2 M solution in MeOH) was added to compound 133 
(90 mg, 0.17 mmol) and the resulting mixture was maintained at 18 °C under a 
nitrogen atmosphere. After stirring for 2 h, the reaction mixture was cooled to O °C 
(ice-bath) and then treated with Amberlite IR-120 (H+) (0.5 g) for ca. 0.5 h. After 
filtration, the collected filtrate was treated with triethylamine (0.5 mL) and then 
concentrated under reduced pressure. The ensuing residue was purified by flash 
chromatography (silica, 20 % v/v methanol/ethyl acetate elution) to afford, after 
concentration of the appropriate fractions (RJ 0.4), the title compound 134 (57 mg, 
84%) as a white, crystalline solid, m.p. 89-93 °C. 
1H NMR (D20, 300 MHz) 8 7.40-7.26 (complex m, 5H), 4.75 (s, lH), 4.22 (d, J 10.3 
Hz, lH), 4.06 (d, J 13.5 Hz, lH), 3.95 (m, lH),_3.85-3.71 (complex m, 3H), 3.69-3.60 
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(complex m, 2H), 3.46-3.34 (complex m, 3H), 2.82 (dd, J 12.9 and 3.3 Hz, lH), 2.29 
(d, J9.5 Hz, lH), 2.22 (d, J 13.2 Hz, lH), 1.20 (d, J 6.3 Hz, 3H). 
13C NMR (D2O/DMSO-d6, 75 MHz) 8 138.9 (C), 131.4 (CH), 130.2 (CH), 129.2 
(CH), 102.4 (CH), 76.0 (CH), 73.6 (CH), 72.0 (CH), 71.7 (CH), 70.6 (CH), 69.5 
(CH), 69.2 (CH), 67.1 (CH), 66.4 (CH2), 58.5 (CH2), 56.4 (CH2), 18.2 (CH3). 
Specific Rotation [a]0 -63.2 (c 0.4, MeOH). 
N-Benzyl-4-0-benzyl-6-0-tert-butyldimethylsilyl-1,5-dideoxy-1,5-imin o-2,3-0-
isopropylidene-D-mannitol (135) 
TBSO OH 
115 
0 )< 
BnBr, NaH, KI 
THF, 0-18 °C 
0 )< 
TBSO OBn 
135 
NaH (63 mg of a ca. 60% suspension in paraffin, 1.58 mmol) was added in portions to 
a magnetically stirred mixture of compound 115 (101 mg, 0.32 mmol), BnBr (115 µL, 
0.97 mmol) and KI (15 mg, 0.09 mmol) in dry THF (10 mL) maintained at 0 °C (ice-
bath) under a nitrogen atmosphere. After stirring the resulting mixture at 0-18 °C for 
18 h, NaH (24 mg, 0.60 mmol), BnBr (50 µL, 0.42 mmol) and KI (10 mg, 0.06 mmol) 
were added. Stirring was continued for 18 h and then the reaction mixture was treated 
with water (10 drops), ethyl acetate (25 mL) and brine (25 mL). The separated organic 
phase was washed with brine (1 x 25 mL) then dried (MgSO4), filtered and 
concentrated under reduced pressure. Subjection of the residue so formed to flash 
chromatography (silica, 10% v/v ethyl acetate/hexane elution) afforded, after 
concentration of the appropriate fractions (R1 0.3), the title compound 135 (141 mg, 
89%) as a clear, colourless oil. 
1H NMR (CDCb/TMS, 300 MHz) 8 7.41-7.20 (complex m, l0H), 4.68 (dd, J 24.0 
and 11.7 Hz, 2H), 4.34 (m, 2H), 4.05 (d, J 14.1 Hz, lH), 3.91 (m, 2H), 3.81 (dd, J 
10.3 and 4.5 Hz, lH), 3.61 (d, J 14.1 Hz, lH), 2.87 (dd, J 13.0 and 3.4 Hz, lH), 2.75 
(m, lH), 2.69 (dd, J 10.3 and 4.5 Hz, lH), 1.57 (s, 3H), 1.36 (s, 3H), 0.92 (s, 9H), 
0.07 (s, 6H). 
Chapter Six 170 
13C NMR (CDCb, 75 MHz) 8 139.5 (C), 138.6 (C), 128.5 (CH), 128.4 (CH), 128.2 
(CH), 127.7 (CH), 127.6 (CH), 126.8 (CH), 109.0 (C), 76.6 (CH), 75.4 (CH), 73.1 
(CH), 72.1 (CH2), 63.6 (CH), 62.0 (CH2), 58.9 (CH2), 50.0 (CH2), 27.3 (CH3), 26.2 
(CH3), 25.6 (CH3), 18.5 (CH3), -5.1 (CH3). 
IR (KBr) Vmax 2929, 2856, 1454, 1379, 1215, 1072, 836,732,512 cm-1. 
EI MS m/z (70 eV) 497 (M+·, 5%), 482 (40), 440 (11), 376 (61), 352 (100), 73 (8) . 
HRMS Found: M+·, 497.2931. C29H43NO4Si requires: M+, 497.2961. 
Specific Rotation [a]o -22.8 (c 0.5, CHCb). 
4-0-Benzyl-5-deoxy-2,3-0-isopropylidene-D-mannolactam (136) 
OBn 0 
N3 
.,,,1\\0 0 
. .,,,,,)< PPh3, H20, THF, 18 °C )< 
OMe HO OBn 
112 136 
Triphenylphosphine (PPh3) (840 mg, 3 .20 mmol) was added to a magnetically stirred 
solution of compound 112 (780 mg, 2.14 mmol) in THF (15 mL) and water (0.5 mL) 
maintained at 18 °C. After stirring for 24 h, the reaction mixture was concentrated 
under reduced pressure and the residue was partitioned between ethyl acetate (100 
mL) and brine (100 mL). The separated aq. phase was extracted with ethyl acetate (3 
x 25 mL) and the combined organic phases were dried (MgSO4), filtered and 
concentrated under reduced pressure. Subjection of the ensuing residue to flash 
chromatography (silica, 2% v/v methanol/ethyl acetate elution) provided, after 
concentration of the appropriate fractions (R10.5), the title compound 136 (605 mg, 
92%) as a white, crystalline solid, m.p. 126-127 °C. 
1H NMR (CDCb/TMS, 300 MHz) 8 7.79 (s, lH), 7.37-7.25 (complex m, SH), 4.84 
(d, J 11.4 Hz, lH), 4.65 (d, J 11.4 Hz, lH), 4.57 (d, J 7.9 Hz, lH), 4.50 (dd, J 7.9 and 
5.9 Hz, lH), 4.18 (br s, lH), 3.92 (br d, J 11.1 Hz, lH), 3.72 (m, lH), 3.59 (dd, J 9.4 
and 5.9 Hz, lH), 3.40 (m, lH), 1.48 (s, 3H), 1.40 (s, 3H). 
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Be NMR (CDCh, 75 MHz) 8 170.6 (C), 137.6 (C), 128.4 (CH), 127.9 (CH), 127.8 
(CH), 111.0 (C), 79.2 (CH), 76.4 (CH), 72.8 (CH), 72.6 (CH2), 60.9 (CH2), 54.6 
(CH2), 27.0 (CH3), 25.2 (CH3). 
IR (KBr) Vmax 3338, 2896, 1678, 1455, 1381, 1213, 1082, 698 cm-1. 
EI MS m/z (70 eV) 307 (M+, 16%), 292 (15), 276 (16), 201 (53), 91 (100). 
HRMS Found: M+, 307.1425. C16H21NOs requires: M+·, 307.1420. 
Specific Rotation [a]n+93.0 (c 0.2, CHCh). 
4-0-Benzyl-5-deoxy-2,3-0-isopropylidene-6-0-methoxyisopropyl-D-
mannolactam (137) 
0 0 
°x 
CH2=CH(OMe)Me ox POCl3, CH2Cl2, 18 °C 
0 0 
HO OBn MIPO OBn 
136 137 
POCh (8 drops) was added to a magnetically stirred solution of compound 136 (656 
mg, 2.13 mmol) in dry dichloromethane (10 mL) and 2-methoxypropene (10 mL) 
maintained at 18 °C under a nitrogen atmosphere. When TLC indicated no starting 
material remained (ca. 3 h), the reaction mixture was treated with triethylamine (1 .5 
mL) and then concentrated under reduced pressure. The residue thus obtained was 
purified by flash chromatography (silica, 0.5% v/v methanol/ethyl acetate elution) 
thereby giving, after concentration of the appropriate fractions (R1 0.4), the title 
compound 137 (782 mg, 97%) as a clear, colourless oil. 
1H NMR (CDCh/TMS, 300 MHz) 8 7.41-7.27 (complex m, SH), 6.18 (s, lH), 4.86 
(d, J l l.6 Hz, lH), 4.62 (d, J 11.6 Hz, lH), 4.60 (d, J7.8 Hz, lH), 4.51 (dd, J7.8 and 
6.0 Hz, lH), 3.74 (dd, J9.5 and 3.1 Hz, lH), 3.52 (m, 2H), 3.26 (dd, J9.5 and 8.1 Hz, 
lH), 3.16 (s, 3H), 1.54 (s, 3H), 1.42 (s, 3H), 1.31 (s, 3H), 1.30 (s, 3H). 
Be NMR (CDCh, 75 MHz) 8 168.5 (C), 137.3 (C), 128.5 (CH), 128.4 (CH), 128.0 
(CH), 127.9 (CH), 110.8 (C), 100.4 (C), 78.9 (CH), 76.8 (CH), 72.9 (CH), 72.4 (CH2), 
60.7 (CH2), 52.4 (CH), 48.9 (CH3), 27.1 (CH3), 25.1 (CH3), 24.4 (CH3), 24.3 (CH3). 
IR (KBr) Vmax 3214, 2989, 1689, 1455, 1381, 1212, 1086, 853, 699 cm-1. 
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EI MS m/z (70 eV) 380 [(M+H)\ 2%], 362 (9), 348 (51), 277 (38), 91 (82), 73 (100). 
HRMS Found: (M+H)\ 380.2070. C20H29N06 requires: (M+H)\ 380.2073. 
Specific Rotation [a]n +65.1 (c 0.8, CHCh). 
4-0-Benzyl-1,5-dideoxy-1,5-imino-2,3-0-isopropylidene-6-0-methoxyisopropyl-
D-mannitol (138) 
MIPO 
0 
OBn 
137 
°>< 0 LiAIH4, THF, 18 °C 
MIPO OBn 
138 
°>< 0 
LiAlH4 (2.7 mL of a 1.0 M solution in THF, 2.70 mmol) was added, dropwise, to a 
magnetically stirred solution of compound 137 ( 420 mg, 1.10 mmol) in dry THF (10 
mL) maintained at 18 °C under a nitrogen atmosphere. After stirring for 9 h, the 
reaction mixture was treated with dichloromethane (40 mL) and then NaOH (10 mL 
of a 2.0 N aq. solution). The separated aqueous phase was extracted with 
dichloromethane (3 x 10 mL) and the combined organic phases were dried (MgS04), 
filtered and concentrated under reduced pressure. The residue so obtained was 
subjected to flash chromatography (silica, 5% v/v methanol/ethyl acetate elution) thus 
affording, after concentration of the appropriate fractions (R1 O.3), the title compound 
138 (327 mg, 81 %) as a clear, colourless oil. 
1H NMR (CDCh/TMS, 300 MHz) b 7.40-7.25 (complex m, 5H), 4.90 (d, J 11.6 Hz, 
lH), 4.56 (d, J 11.6 Hz, lH), 4.17 (m, 2H), 3.65 (dd, J 9.0 and 2.8 Hz, lH), 3.44 (m, 
3H), 3.18 (s, 3H), 2.97 (dd, J 14.8 and 2.5 Hz, lH), 2.54 (ddd, J 10.0, 5.4 and 2.8 Hz, 
lH), 1.90 (s, lH), 1.54 (s, 3H), 1.40 (s, 3H), 1.32 (s, 3H), 1.31 (s, 3H). 
13C NMR (CDCh, 75 MHz) b 138.5 (C), 128.3 (CH), 127.9 (CH), 127.6 (CH), 109.1 
(C), 99.9 (C), 80.9 (CH), 78.5 (CH), 74.4 (CH), 72.8 (CH2), 61.0 (CH2), 58.0 (CH), 
48.7 (CH3), 46.1 (CH2), 28.4 (CH3), 26.8 (CH3), 24.7 (CH3), 24.5 (CH3). 
IR (KBr) Vmax 2988, 2937, 1454, 1379, 1216, 1055, 860, 698 cm-1. 
EI MS m/z (70 eV) 366 [(M+H)\ 5%], 350 (7), 318 (34), 262 (97), 91 (100), 73 (91). 
HRMS Found: (M+H)\ 366.2282. C2oH31NOs requires: (M+H)\ 366.2280. 
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Specific Rotation [a]n -25.0 (c 0.5, CHCb). 
N-Benzyl-4-0-benzyl-1,5-dideoxy-1,5-imino-2,3-0-isopropylidene-6-0-
methoxyisopropyl-D-mannitol (139) 
MIPO OBn 
138 
°>< 0 
BnBr, K2C03 
MeCN, 18 °C ox 
0 
MIPO OBn 
139 
173 
A magnetically stirred solution of compound 138 (327 mg, 0.89 mmol) in MeCN (10 
mL) maintained at 18 °C was treated with BnBr (140 µL, 1.18 mmol) and K2CO3 (185 
mg, 1.34 mmol). After stirring for ca. 16 h, the reaction mixture was concentrated 
under reduced pressure and the residue was partitioned between ethyl acetate (50 mL) 
and brine (50 mL). The separated aq. phase was extracted with ethyl acetate (2 x 25 
mL) and the combined organic phases were then dried (MgSO4), filtered and 
concentrated under reduced pressure. Subjection of the residue to flash 
chromatography (silica, 35% v/v ethyl acetate/hexane elution) afforded, after 
concentration of the appropriate fractions (R1 0.5), the title compound 139 ( 407 mg, 
100%) as a clear, colourless oil. 
1H NMR (CDCb/TMS, 300 MHz) 8 7.39-7.17 (complex m, l0H), 4.64 (dd, J26.4 
and 11.9 Hz, 2H), 4.30 (m, 2H), 4.00 (d, J 14.0 Hz, lH), 3.82 (m, lH), 3.69 (dd, J 9.7 
and 6.6 Hz, lH), 3.61 (d, J 14.0 Hz, lH), 3.55 (dd, J9.7 and 5.1 Hz, lH), 3.15 (s, 3H), 
2.83 (m, 2H), 2.70 (m, lH), 1.54 (s, 3H), 1.33 (s, 3H), 1.31 (s, 3H), 1.30 (s, 3H). 
13C NMR (CDCb, 75 MHz) 8 139.4 (C), 138.4 (C), 128.6 (CH), 128.3 (CH), 128.2 
(CH), 127.9 (CH), 127.6 (CH), 126.8 (CH), 109.0 (C), 100.0 (C), 76.3 (CH), 75.4 
(CH), 73.9 (CH), 71.8 (CH2), 61.5 (CH), 60.1 (CH2), 58.9 (CH2), 49.8 (CH2), 48.8 
(CH3), 27.9 (CH3), 25.6 (CH3), 24.7 (CH3), 24.6 (CH3). 
IR (KBr) Vmax 2989, 2937, 1454, 1379, 1212, 1075, 734,698 cm-1. 
EI MS mlz (70 eV) 454 [(M-H·)\ < 2%], 440 (41), 352 (98), 252 (13), 91 (100), 73 
(38). 
HRMS Found: (M-H·)\ 454.2603. C27H37NOs requires: (M-H·)\ 454.2594. 
Specific Rotation [a]n -10.3 (c 1.0, CHCb). 
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N-Benzyl-4-O-benzyl-1,5-dideoxy-1,5-imino-2,3-O-isopropylidene-D-mannitol 
(120) 
0 ;;< 
Method A: 
TBAF, THF, 18 °C 
0 ;;< 
TBSO OBn HO OBn 
135 120 
174 
Method A: A magnetically stirred solution of compound 135 (282 mg, 0.57 mmol) 
in THF (5 mL) was treated with TBAF (0.7 mL of a 1.0 M solution in THF, 0.70 
mmol). After stirring at 18 °C for 2 h, the reaction mixture was concentrated under 
reduced pressure. Subjection of the resulting residue to flash chromatography (silica, 
35% v/v ethyl acetate/hexane elution) afforded, after concentration of the appropriate 
fractions (R_r0.4), the title compound 120 (216 mg, 99%) as a clear, colourless oil. 
1H NMR (CDCh/TMS, 300 MHz) 8 7.36-7.21 (complex m, l0H), 4.83 (d, J 11.6 Hz, 
lH), 4.64 (d, J 11.6 Hz, lH), 4.29 (m, 2H), 3.96 (d, J 13.5 Hz, lH), 3.77 (ddm, J 11.4 
and 4.1 Hz, 3H), 3 .57 ( d, J 13 .5 Hz, 1 H), 2.91 ( dd, J 14.1 and 4.3 Hz, 1 H), 2.69 (m, 
3H), 1.53 (s, 3H), 1.35 (s, 3H). 
13C NMR (CDCh, 75 MHz) 8 138.5 (C), 138.1 (C), 128.8 (CH), 128.4 (CH), 127.9 
(CH), 127.7 (CH), 127.2 (CH), 109.1 (C), 78.0 (CH), 76.8 (CH), 72.8 (CH2), 72.3 
(CH), 62.9 (CH), 60.6 (CH2), 57.3 (CH2), 49.4 (CH2), 27.7 (CH3), 25.7 (CH3). 
IR (KBr) Vmax 3468, 2933, 1454, 1380, 1215, 1070, 736, 512 cm-1. 
EI MS m/z (70 eV) 382 [(M-H·)\ 11 %], 368 (6), 352 (87), 252 (15), 91 (100). 
HRMS Found: (M-H·)\ 382.2008. C23H29N04 requires: (M-H·)\ 382.2018. 
Specific Rotation [a]n+l0.5 (c 1.0, CHCh). 
°x 0 
Method B: 
PPTS, MeOH, 18 °C 
0 ;;< 
MIPO OBn HO OBn 
139 120 
Method B: A magnetically stirred solution of compound 139 (352 mg, 0.77 mmol) 
in MeOH ( 4 mL) was treated with PPTS (108 mg, 0.43 mmol). After stirring at 18 °C 
for ca. 20 h, triethylamine (0.5 mL) was . added. The resulting mixture was 
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concentrated under reduced pressure and the residue was partitioned between ethyl 
acetate (15 mL) and NaHCO3 (15 mL of a saturated aq. solution). The separated aq. 
phase was extracted with ethyl acetate (2 x 10 mL) and the combined organic phases 
were dried (MgSO4), filtered and concentrated under reduced pressure. The residue 
thus obtained was subjected to flash chromatography (silica, 35% v/v ethyl 
acetate/hexane elution) to afford, after concentration of the appropriate fractions (R1 
0.4), the title compound 120 (274 mg, 94%) which proved identical, in all respects, to 
the material obtained by Method A. 
N-Benzyl-4-O-benzyl-1,5-dideoxy-1,5-imino-2,3-O-isopropylidene-6-O-(2,3,4-tri-
O-acetyl-a-L-rhamnopyranosyl)-D-mannitol (140) 
Me,,,,, 
'·· 
HO 
Br 
···,,,,,OAc 
OAc 
118 
+ 
OBn 
120 
AgOTf, CH2Cl2 
PhMe, MS 4A 
-10 °c 
Me,,,,,,,(0"(O 
AcO~··,,,,,OAc 
OAc 
140 
ox 
0 
OBn 
A mixture of AgOTf (203 mg, 0.79 mmol) in dry toluene (5 mL) was added to a 
magnetically stirred mixture of bromide 118 (297 mg, 0.84 mmol), compound 120 
0 (253 mg, 0.66 mmol) and 4A molecular sieves (2.0 g) in dry dichloromethane (20 
mL) maintained at -10 °C (ice-bath) under a nitrogen atmosphere. After stirring for 
0.5 h, triethylamine (1.5 mL) and dichloromethane (50 mL) were added. The resulting 
mixture was filtered through a short pad of Celite™ and then concentrated under 
reduced pressure. Subjection of the ensuing residue to flash chromatography (silica, 
30 % v/v ethyl acetate/hexane elution) gave two fractions, A and B. 
Concentration of fraction A (R1 0.5 1n 4 2.5 5.5 v/v/v ethyl 
acetate/dichloromethane/hexane) afforded compound 140 (377 mg, 92% at 94% 
conversion) as a white foam. 
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1H NMR (CDCh/TMS, 300 MHz) 8 7.37-7.17 (complex m, l0H), 5.25 (m, 2H), 5.04 
(t, J9.9 Hz, lH), 4.71 (d, J 11.7 Hz, lH), 4.61 (ds, J 11.7 Hz, 2H), 4.30 (m, 2H), 3.96 
(dm, J 14.0 Hz, 2H), 3.82 (m, 2H), 3.62 (d, J 14.0 Hz, lH), 3.54 (dd, J 10.0 and 4.9 
Hz, lH), 2.87 (m, 2H), 2.75 (m, lH), 2.13 (s, 3H), 2.04 (s, 3H), 1.99 (s, 3H), 1.55 (s, 
3H), 1.34 (s, 3H), 1.14 (d, J 6.3 Hz, 3H). 
13C NMR (CDCb, 75 MHz) 8 169.9 (C), 169.8 (C), 169.7 (C), 139.0 (C), 138.2 (C), 
128.4 (CH), 128.3 (CH), 128.2 (CH), 127.8 (CH), 127.6 (CH), 126.8 (CH), 109.0 (C), 
97.5 (CH), 76.5 (CH), 75.2 (CH), 72.8 (CH), 72.2 (CH2), 71.0 (CH), 69.9 (CH), 69.2 
(CH), 66.7 (CH2), 66.5 (CH), 60.8 (CH), 58.7 (CH2), 49.9 (CH2), 27.4 (CH3), 25.5 
(CH3), 21.1 (CH3), 21.0 (CH3), 20.9 (CH3), 17.5 (CH3). 
IR (KBr) Vmax 2985, 2936, 1750, 1454, 1371, 1223, 1136, 1053, 735 cm-1. 
EI MS m/z (70 eV) 655 (M+, 6%), 640 (41), 596 (6), 352 (100), 91 (61). 
HRMS Found: M+·, 655.2971. C35H45N011 requires: M+·, 655.2993. 
Specific Rotation [a]o-42.5 (c 1.0, CHCh). 
Concentration of fraction B (R1 0.4 in 4 : 2.5 : 5.5 v/v/v ethyl 
acetate/dichloromethane/hexane) afforded the starting material 120 (14 mg, 6% 
recovery) which proved identical, in all respects, to the authentic material. 
N-Benzyl-4-O-benzyl-1,5-dideoxy-1,5-imino-6-O-(2,3,4-tri-O-acetyl-a-L-
rhamnopyranosyl)-D-mannitol (141) 
M&X:XO 
AcO = '''10Ac 
OAc 
140 
OBn 
°>< 0 
Me,,,,,,,(o'(o 
Ac0~··,,,,,1OAc 
0Ac 
141 
OBn 
A magnetically stirred solution of compound 140 (327 mg, 0.50 mmol) in 
dichloromethane maintained at 18 °C (18 mL) was treated with TFA (2 mL). After 
stirring for 24 h, the reaction mixture was concentrated under reduced pressure. The 
ensuing residue was subjected to flash chromatography (silica, 2% v/v methanol/ethyl 
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acetate elution) thus providing, after concentration of the appropriate fractions (R1 
0.4), the title compound 141 (279 mg, 91 %) as a clear, colourless oil which solidified 
on standing. 
1H NMR (CDCh/TMS, 300 MHz) b 7.39-7.20 (complex m, l0H), 5.31 (dd, J 10.1 
and 3.5 Hz, lH), 5.21 (dd, J 3.4 and 1.7 Hz, lH), 5.01 (t, J 10.0 Hz, 2H), 4.64 (d, J 
11.4 Hz, lH), 4.54 (s, 1H), 4.14 (m, 2H), 3.71 (m, 3H), 3.58 (m, 2H), 3.34 (d, J 13.5 
Hz, lH), 2.92 (dd, J 12.3 and 4.2 Hz, lH), 2.77 (br s, lH), 2.63 (br s, lH), 2.45 (d, J 
7.7 Hz, lH), 2.23 (d, J 12.3 Hz, lH), 2.14 (s, 3H), 2.01 (s, 3H), 2.00 (s, 3H), 1.05 (d, J 
6.2 Hz, 3H). 
13C NMR (CDCb, 75 MHz) b 169.9 (C), 169.9 (C), 169.8 (C), 138.3 (C), 138.3 (C), 
128.6 (CH), 128.5 (CH), 128.3 (CH), 127.9 (CH), 127.6 (CH), 127.1 (CH), 97.7 (CH), 
77.7 (CH), 75.9 (CH), 74.5 (CH2), 70.8 (CH), 69.8 (CH), 69.1 (CH), 68.0 (CH), 66.8 
(CH), 65.4 (CH2), 64.4 (CH), 57.0 (CH2), 54.5 (CH2), 21.0 (CH3), 20.9 (CH3), 20.8 
(CH3), 17.4 (CH3). 
IR (KBr) Vmax 3476, 2936, 1759, 1453, 1371 , 1225, 1135, 1053, 734 cm-1. 
EI MS mlz (70 eV) 615 (M+·, 6%), 598 (1), 512 (40), 354 (50), 312 (100), 91 (64). 
HRMS Found: M+, 615.2656. C32H41N011 requires: M+, 615.2680. 
Specific Rotation [a]0 -37.0 (c 0.9, CHCb). 
N-Benzyl-4-0-benzyl-1,5-dideoxy-1,5-imino-6-0-a-L-rhamnopyranosyl-D-
mannitol (142) 
O OBn 
.. ,,,,,OAc 
0Ac 
141 
NaOMe/MeOH, 18 °c 
0 OBn 
···,,,,,OH 
OH 
142 
OH 
OH 
Sodium methoxide (5 mL of a 0.2 M solution in MeOH) was added to compound 141 
(279 mg, 0.45 mmol) and the resulting mixture was maintained at 18 °C under a 
nitrogen atmosphere. After stirring for 2 h, the reaction mixture was filtered through a 
short pad of cotton and then concentrated under reduced pressure. The residue so 
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formed was purified by flash chromatography (silica, 10 % v/v methanol/ethyl acetate 
elution) to deliver, after concentration of the appropriate fractions (R1 0.5), the title 
compound 142 (195 mg, 88%) as a white, crystalline solid, m.p. 76-77 °C. 
1H NMR (CDCh/TMS, 300 MHz) 8 7.29-7.18 (complex m, l0H), 4.81 (d, J l l.3 Hz, 
lH), 4.67 (s, lH), 4.57 (m, 2H), 4.22 (d, J 9.l Hz, lH), 3.91 (m, 4H), 3.68 (m, 6H), 
3.46 (m, 4H), 2.86 (m, lH), 2.39 (d,J7.6, lH), 2.19 (d,Jll.6, Hz, lH), 1.21 (d,J6.2 
Hz, 3H). 
13C NMR (CDCh, 75 MHz) 8 138.2 (C), 137.2 (C), 129.1 (CH), 128.5 (CH), 127.9 
(CH), 127.9 (CH), 127.4 (CH), 100.3 (CH), 77.7 (CH), 74.9 (CH), 74.2 (CH2), 73.0 
(CH), 71.3 (CH), 71.2 (CH), 68.9 (CH), 67.9 (CH), 64.4 (CH2), 63.0 (CH), 57.2 
(CH2), 54.2 (CH2), 17.9 (CH3). 
IR {KBr) Vmax 3401, 2912, 1759, 1453, 1383, 1130, 1073, 910, 733 cm-1. 
ESI MS m/z (70 eV) 490 [(M+H)\ 100%]. 
HRMS (FAB) Found: (M+H)\ 490.2419. C26H35N08 requires: (M+H)\ 490.2435. 
Specific Rotation [a]0 -46.7 (c 0.3, CHCh). 
1,5-Dideoxy-1,5-imino-6-0-a-L-rhamnopyranosyl-D-mannitol (116) 
0 OH 
5% Pd/C, MeOH, 18 °C 
OH 
··,,,,,,OH 
OH OH 
134 116 
Method A: A magnetically stirred mixture of compound 134 (52 mg, 0.13 mmol) 
and 5% Pd/C ( 50 mg) in MeOH (2 mL) was exposed to a balloon of hydrogen gas. 
After stirring at 18 °C for ca. 24 h, the reaction mixture was filtered through a short 
pad of Celite™ and then concentrated under reduced pressure. The ensuing residue 
was dissolved in water (10 mL) and the resulting mixture was washed with 
dichloromethane (4 x 8 mL) then filtered through a short pad of Celite™. The 
collected filtrate was freeze-dried thereby affording Rha-DMJ 116[9] (38 mg, 95%) as 
a light-grey solid. 
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1H NMR (D2O, 500 MHz) c> 4.60 (d, J 1.6 Hz, lH), 3.90 (m, lH), 3.81 (q, J 1.8 Hz, 
lH), 3.76 (dd, J 10.4 and 2.7 Hz, lH), 3.62 (dd, J 9.7 and 3.5 Hz, lH), 3.56 (t, J 9.7 
Hz, lH), 3.49 (m, 2H), 3.42 (dd, J 9.6 and 3.1 Hz, lH), 3.24 (t, J 9.6 Hz, lH), 2.95 
(dd, J 14.0 and 2.5, Hz, lH), 2.75 (d, J 14.0 Hz, lH), 2.66 (m, lH), 1.10 (d, J 6.3 Hz, 
3H). 
13C NMR (D2O/DMSO-d6, 125 MHz) c> 101.9 (CH), 75.2 (CH), 73.6 (CH), 71.8 
(CH), 71.5 (CH), 70.4 (CH), 69.5 (CH), 68.7 (CH), 66.9 (CH2), 60.5 (CH), 49.8 
(CH2), 18.3 (CH3). 
ESI MS m/z (70 eV) 310 [(M+H)\ 90%], 164 (100). 
HRMS (FAB) Found: (M+H)\ 310.1495. C12H23NO8 requires: (M+H)\ 310.1496. 
Specific Rotation [a]n-51.7 (c 0.6, H2O) [lit.[9] [a]n-42.6 (c 0.33, H2O)]. 
OH 
0 OBn 
5% Pd/C, MeOH, 18 °C 
O OH 
OH OH 
142 116 
Method B: Following the same procedure as described immediately above, 
compound 142 (185 mg, 0.38 mmol) was converted into Rha-DMJ 116 (116 mg, 
99%) which proved identical, in all respects, to the material obtained by Method A. 
Chapter Six 180 
6.6 References 
[1] W. C. Still, M. Kahn, A. Mitra, J. Org. Chem., 1978, 43, 2923. 
[2] D. D. Perrin, W. L. F. Amarego, Purification of Laboratory Chemicals, 3rd 
Edition, Pergamon Press, 1988. 
[3] J. Kopf, P. Koell, Acta Crystallogr., Sect. B: Struct. Crystallogr. Cryst. Chem. 
1981,37, 1127. 
[ 4] G. W. J. Fleet, N. G. Ramsden, D. R. Witty, Tetrahedron Lett., 1988, 29, 
2871. 
[5] T. Hudkicky, J. Rouden, H. Luna, S. Allen, J. Am. Chem. Soc., 1994, 116, 
5099. 
[ 6] M. Banwell, C. De Savi, K. Watson, J. Chem. Soc., Perkin Trans. 1, 1998, 
2251. 
[7] G. M. Bebault, G. G. S. Dutton, C. K. Warfield, Carbohydr. Res., 1974, 34, 
174. 
[8] V. Pozsgay, A. Neszemelyi, Carbohydr. Res., 1980, 80, 196. 
[9] N. Asano, K. Yasuda, H. Kizu, A. Kato, J. Q. Fan, R. J. Nash, G. W. J. Fleet, 
R. J. Molyneux, Eur. J. Biochem., 2001, 268, 35. 
Appendices 
Appendix 1 Fold-out Schemes 
A 1.1 Scheme 2.1: Synthesis of Ketone 53 
A 1.2 Scheme 3.1: Synthesis of Differentially Protected 
D-Talose Derivatives 
A 1.3 Scheme 4.1: Total Synthesis ofDMJ (105): 
1st Approach 
A 1.4 Scheme 4.2: Total Synthesis of DMJ (105): 
2nd Approach 
A 1.5 Scheme 5.1: First Total Synthesis of Rha-DMJ (116): 
1st Approach 
A 1.6 . Scheme 5.2: First Total Synthesis of Rha-DMJ (116): 
2nd Approach 
Appendix 2 X-ray Crystallographic Data 
A 2.1 X-ray Structure Report for Compound 60 
A 2.2 X-ray Structure Report for Compound 61 
A 2.3 X-ray Structure Report for Compound 67 
A 2.4 X-ray Structure Report for Compound 98 
A2.5 X-ray Structure Report for Compound 100 
Appendix 3 Copies of Publications Arising Out of Work Conducted 
During the Period of PhD Candidature 
181 
182 
183 
184 
185 
186 
187 
188 
189 
190 
199 
209 
218 
227 
235 
Appendices 182 
Appendix 1 
A 1.1 Scheme 2.1: Synthesis of Ketone 53 
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A 1.1 Scheme 2.1: Synthesis of Ketone 53 
Reagents and conditions: (i) TBDPS-Cl (1. 1 mol equiv.), imidazole (2.7 mol equiv.) , CH2Ch, 18 °C, 1 
h; (ii) Ac2O (2.0 mol equiv.), DMAP (cat.) , py, 18 °C, 2 h; (iii) m-CPBA (1.0 mol equiv.), CH2Ch, 0-
18 °C, 18 h; (iv) Method A: LiCI (5 .0 mol equiv.) , EAA (3.0 mol equiv.) , THF, 44-46 °C, 86 h; 
Method B: LiCl (5 .0 mol equiv.), HOAc (3 .0 mol equiv.), THF, 18 °C, 70 h; (v) CH2(OMe)2, P20 s, 18 
°C, 0.5 h; (vi) LiN3 (3.0 mol equiv.), DMF, 18 °C, 96 h; (vii) 0 3, py (10.0 mol equiv.) , MeOH, -78 °C, 
1 h then NaI (6.1 mol equiv.), -78----0 °C, 1 h then NaBH4 (15.7 mol equiv.) , 0 °C, 4 h; (viii) MEM-Cl 
(8. 1 mol equiv.), DIPEA (10.0 mol equiv.), CH2Ch, 18 °C, 16 h; (ix) H2 (1 atm), 5% Pd/C, (Boc)2O 
(3.0 mol equiv.), EtOAc, 18 °C, 36 h; (x) NaBH4 (excess) , MeOH, 18 °C, 30 h; (xi) TBAF (1.1 mol 
equiv.), THF, 18 °C, 1 h; (xii) 2,2-DMP, p-TsOH (cat.), 18 °C, 2 h; (xiii) DMP (5.0 mol equiv.), 
CH2Ch, 18 °C, 2 h; (xiv) LiAlf4 (8.2 mol equiv.), THF, -78 °C, 6 h; (xv) TBAF (1.2 mol equiv.), THF, 
18 °C, 0.5 h; (xvi) 2,2-DMP,p-TsOH (cat.), 18 °C, 0.5 h; (xvii) H2 (1 atm), 5% Pd/C, (Boc)2O (1.3 mol 
equiv.), EtOAc, 18 °C, 13 h. 
A 1.2 Scheme 3.1: Synthesis of Differentially Protected D-Talose Derivatives 
·•' 
,,,,OH 
3 steps 
p~ 
HOyo~O 
LJ'''1,,H 
AcO,.. \~OTBDPS 
99 
I 
IV 
l V 
Appendices 
·•' 
,,,OTBDPS 
p~ 
0~o~o 
LJ'''1,,H 
Ac6.. ·,,,~OTBDPS 
97 
___ A ___ _ 
( \ 
P-k o ~ 
AcO~o~O Ac011,, .. ("v~ \_J :_-1,,H + LJ ,,,/,IH 
Ac6.· .\.OAc Ac6.. ~bAc 
~ 100 __ 1_0_1 --~ y 
V1 
l 
111 
9H 
,,,,OTB DPS 
.,, 
OH 
o~O~OH 
LJ .,,;H 
AcO., \.~OTBDPS 
96 
___ A __ _ 
( OAc OAc ~ 
AcOi,,, .. OAc 
I. H 
AcO __ . .\.OAc 
102 
AcO Ac 
AcO~~OAc 
+ u·,,/,IH 
OAc AcO... \.~OAc 
+ ,. 
AcO''''' 
103 104 
~---- ----~ y 
I ~i 
D-Talose (92) 
184 
A 1.2 Scheme 3.1: Synthesis of Differentially Protected D-Talose Derivatives 
Reagents and conditions: (i) H3PO4 ( cat.), 3 : 1 v/v THF/H2O, 18 °C, 40 h; (ii) 0 3, py, MeOH, -78 °C, 1 
h then NaI (3.1 mol equiv.), -78~66 °C, 3 h then NaBI-Li (19.8 mol equiv.), -60~-40 °C, 6 h; (iii) 2,2-
DMP, p-TsOH (cat.), 18 °C, 3 h; (iv) diisoamylborane (8.7 mol equiv.), THF, 0-18 °C, 72 h; (v) TBAF 
(1.2 mol equiv.) , 18 °C, 0.5 h then Ac2O, DMAP (cat.), py, 18 °C, 14 h; (vi) TFA, 4 : 1 v/v THF/H2O, 
0-18 °C, 20 h then Ac2O, DMAP (cat.), py, 0-18 °C, 23 h; (vii) Ac2O, py, 0-18 °C, 18 h. 
A 1.3 Scheme 4.1: Total Synthesis of DMJ (105): 1st Approach 
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A 1.3 Scheme 4.1: Total Synthesis of DM
J (105): 1st Approach 
Reagents and conditions: (i) TF A, CH2CI2, o 
0 c, 3 h; (ii) L~ (5.0 mol equiv.), THF, 18 °C, 2
4 h; 
(iii) 2.0 M HCl/MeOH, 18 °C, 7 h; (iv) H2 (1 atm),
 5% Pd/C, EtOAc, 18 °C, 18 h; (v) TBAF (3.4 mol
 
equiv.) THF, 18 °C, 18 h; (vi) 2,2-DMP, p-TsOH (
cat.), 18 °C, 2 h. 
• 
A 1.4 Scheme 4.2: Total Synthesis of DMJ (105): 2nd Approach 
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A 1.4 Scheme 4.2: Total Synthesis of DMJ (105): 2nd Approach 
Reagents and conditions: (i) 2,2-DMP, p-TsOH (cat.), 18 °C, 1 h; (ii) m-CPBA (1.0 mol equiv.), 
CH2Ch, 0-18 °C, 18 h; (iii) HOAc (3.0 mol equiv.), LiCl (5.0 mol equiv.), THF, 18 °C, 19 h; (iv) LiN3 
(3.0 mol equiv.), DMF, 18 °C, 72 h; (v) BnBr (3.0 mol equiv.) , NaH (1.6 mol equiv.), KI (cat.), THF, 
0-18 °C, 24 h; (vi) 0 3, py (4.9 mol equiv.), MeOH, -78 °C, 1 h then NaBH.i (11.0 mol equiv.), -10 °C, 3 
h; (vii) TBS-Cl (1.5 mol equiv.), imidazole (5.0 mol equiv.), CH2Ch, 18 °C, 2 h; (viii) H2 (1 atm), 5% 
Pd/C, EtOAc, 18 °C, 36 h; (ix) BHrDMS (10.0 mol equiv.), THF, 18 °C, 4 .5 h then 10% Pd/C, MeOH, 
18 °C, 38 h; (x) 80% v/v TFAJH20, 18 °C, 20 h. 
A 1.5 Scheme 5.1: First Total Synthesis of Rha-DMJ (116): 1st Approach 
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A 1.5 Scheme 5.1: First Total Synthesis of Rha-DMJ (116): 1st Approach 
Reagents and conditions: (i) H2 (1 atm), 5% Pd/C, EtOAc, 18 °C, 18 h; (ii) CH2=C(OMe)Me, POCl3 
(cat.), CH2Ch, 18 °C, 8 h; (iii) TBAF (4.1 mol equiv.), THF, 18 °C, 20 h; (iv) 2,2-DMP, p-TsOH (cat.), 
0 °C, 1 h; (v) L~ (2.4 mol equiv.), THF, 18 °C, 20 h; (vi) BnBr (1.3 mol equiv.), K2CO3 (1.5 mol 
equiv.), MeCN, 18 °C, 16 h; (vii) PPTS (0.6 mol equiv.), MeOH, 18 °C, 36 h; (viii) AgOTf (0.9 mol 
equiv.)), PhMe, MS 4A, CH2Ch, -10 °c, 0.5 h; (ix) 1 : 3 v/v TFA/CH2Ch, 18 °c , 32 h; (x) 0.2 M 
NaOMe in MeOH, 18 °C, 2 h; (xi) H2 (1 atm), 5% Pd/C, MeOH, 18 °C, 24 h. 
A 1.6 Scheme 5.2: First Total Synthesis ofRha-DMJ (116): 2nd Approach 
·•' 
,,,,\OH 
.,,,,,10H 
B;:;cx 
i 0 
TBSO OBn 
135 l ii B;;co 
l j< 
HO OBn 
118 
+ 
120 
120 
vm 
Mei,,,, 
'·· 
Appendices 
OBn 
N3 .,,,\\0 
6 steps 
.. ,,,,j< 
OMe 
112 
l 3 steps 
1 P.J< path 
a TBSO OH 
Vll 
MIP 
OBn 
•• ,,,,10Ac 
OAc 
140 
115 
J< 
OBn 
139 
IX 
XI 
0 
J< 111 path 
b HO OBn 
136 l iv 
°>< 0 
MIPO OBn 
137 l V 
P.J< VI 
MIPO OBn 
138 
OH 
OAc 
141 
OH 
Me/,XX'' O 
HO .... , ... ,,"OH 
OBn 
OH 
142 
A 1.6 Scheme 5.2: First Total Synthesis of Rha-DMJ (116): 2nd Approach 
188 
Reagents and conditions: (i) BnBr (4.3 mol equiv.), NaH (6.8 mol equiv.) , KI (0.5 mol equiv.), THF, 0-
18 °C, 36 h; (ii) TBAF (1.2 mol equiv.), THF, 18 °C, 2 h; (iii) PPh3 (1.5 mol equiv.) , THF, H2O, 18 °C, 
24 h; (iv) CH2=C(OMe)Me, POCl3 (cat.), CH2Ch , 18 °C, 3 h; (v) LiAlH4 (2.4 mol equiv.), THF, 18 °C, 
9 h; (vi) BnBr (1.3 mol equiv.), K2CO3 (1.5 mol equiv.), MeCN, 18 °C, 16 h; (vii) PPTS (0 .6 mol 
equiv.), MeOH, 18 °C, 20 h; (viii) AgOTf (0.9 mol equiv.), PhMe, MS 4A., CH2Ch, -10 °C, 0.5 h; (ix) 
1 : 9 v/v TFA/CH2Ch, 18 °C, 24 h; (x) 0.2 M NaOMe in MeOH, 18 °C, 2 h; (xi) H2 (1 atm) , 5% Pd/C, 
MeOH, 18 °C, 24 h. 
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Appendix 2 
Appendices 
A 2.1 X-ray Structure Report for Compound 60a 
C16 
C6 
~ \ / 
,,....,., ·. 
ca 
a X-ray crystal data are presented as provided by Dr A. J. Edwards at The Australian National 
University. 
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Abstract 
Comment 
The rnosaic spread of all exa1nined crystals was observed to be large and highly anisotropic. 
In addition; significant diffuse scatter was observed between Bragg peaks. These features were 
evident across a selection of crystc1ls. The high anisotropic displacement pararneters obtained in 
the firrnl re:6.nen1ent cycles may have their origin in these features . The absolute structure value 
does not r efine unainbiguously and this too is likely due to in1precision in the data extraction 
resulting from these systematic features 
Experimental 
Cryst(J,l rlata 
C24H21Cl04Si 
.!VI,. = 443.015 
Ortl10rh<m1bic 
P212121 
a = 0.7:32S (7) A 
h = 9.772fl (7) A 
c = 2fi.180 (2) A 
V = 2:394 .9 (:1) A 3 
Z = 4 
D x: = 1.229 IVIg .111 - 3 
Dm not 1neasured 
1\!Io Ka radiation 
,\ = 0.71073 A 
Cdl parameters from 150G9 refiectious 
0 = 2.546- 25.028° 
J.l = 0.2~-36 111111 - l 
T = 200 K 
Prism 
Colourless 
0.54 x 0.50 x 0.36 nun 
Crystal source: local laboratory 
Data collect'iun 
KappaCCD diffractometer 
CCD scans 
Absorption correction: 
by integTation Gaussian by integTation 
(Coppens , 1970) 
Trnin = 0.871 , Tmax = 0.929 
16120 measured reflections 
4063 independent reflections 
Refinem ent 
Refinement on F 
R = 0.0611 
wR = 0.0704 
S = 1.0696 
2935 reflections 
272 parameters 
H-atorn parameters not refined 
Chebychev polynomial with 3 parameters, 
Carruthers & "\iVatkin , 1979, 1.67 0.G63 
0.679 
2935 reflections with 
>3.00a(l) 
Rint = 0.066 
Bmax = 25.13° 
h = -11 - 10 
k = - 11 - 11 
l = - 27 - 29 
( 6 / CJ )max = 0.000083 
0 - .'3 6-Pmax = 0.72 e A 
0 -3 6-Prnin = - 0. 70 e A 
Extinction correction: none 
Scattering factors frmn International Tables 
for X-ray Crystallography (Vol. IV) 
Absolute structure: F lack, 1930 Friedel-pairs 
Flack p c1ran1cter = 0.33(1 5) 
0 
Table 1. Selected geometric parameters ( A , 0 ) 
Cll- C4 1.733 (6) C7- C8 1.526 (9) 
Si12 - 08 1. 65 1 (3) Cll - C12 1.. 398 (6 ) 
Si 12- C11 1.881 (4) Cll- C16 1. 386 (6) 
Si1 2 - C21 1. 881 (4) C 12- C13 1.381 ( 6) 
S i1 2- C31 1.889 (4 ) C13- C14 1..401 (7) 
07- Cl 1..416 (G) C14- C15 1.35 7 (7) 
0 7- CG 1. 414 (7 ) C l 5- C16 1..391 (6 ) 
08- C2 1.43,5 (.5 ) C2 1- C22 1.382 (6) 
00- C3 1.455 (6) C21 - C26 1.398 (6) 
09- C7 1.333 (9 ) C22- C23 1.39.5 (7 ) 
010- C7 1.1 82 (8 ) C 23- C24 1.374 (8 ) 
Cl - C2 1.4 76 (7) C24- C25 1.355 (7 ) 
Cl - C6 1.448 (7) C25- C2 6 1. 381 (7 ) 
C2- C3 1.539 (6 ) C 31 - C32 1.534 (7) 
C3- C4 1.5 32 (8 ) C31- C33 1.536 (8 ) 
C4- C5 1.346 (9 ) C.31- C34 1. 516 (7) 
C.5 - C6 1.404 (9) 
O8- Sil2-Cll 108_.l 7 (16 ) O9- C7--O10 126.2 (6) 
O8 - Sil2--C21 110.33 (17) O9-C7- C8 111.2 (6) 
Cll- S il2 --C21 109.43 (18 ) O10- C7- C8 122.6 (8) 
O8- Sil2- C31 104.46 (19) Sil2- Cll - C12 120.1 (3 ) 
Cll- Sil2- C31 114.93 (19 ) Sil2- -Cll - C16 122.0 (3) 
C21 - Si l2- C31 109.38 (19) C12- Cl 1- C16 117.4 (4) 
C l - O7-C6 61.5 (3) C ll- Cl2- Cl3 121.3 (4) 
Si12 - O8- C2 123 .6 (2 ) C12- C l 3- Cl4 119.7 (4 ) 
C3 - O9- C7 115.4 (5) C13-C14-C15 119.7 (4) 
O7- Cl - C2 118.8 (5) C14-Cl5 - Cl6 120.4 (5) 
O7-C l - CG 59.2 (3) Cll - Cl6- -Cl.5 121.5 ( 4 ) 
C2 - Cl - C6 119.5 (.'S) Sil2--C21 - C22 121.5 (3) 
O8- C2-- Cl 11 3.1 (4) S il2 - C21 - C26 121.5 (3) 
O8- C2- C3 107.9 (4) C22 --- C21- C26 116.9 (4) 
Cl - C2- C.3 114.3 (4) C21- C22- C23 121 .9 (.5 ) 
O9- C3- C2 108.3 (3) C22-C23-C24 119.3 (5) 
O9- C3- - C4 106.2 (4) C23- C24-- C25 120.0 ( 4) 
C2- C3- C4 110.6 (5) C24--C25- C26 120 .9 (.5) 
Cll - C4- C3 112 .4 (6) C21- C2Ei- C25 121.0 (5) 
Cll - C4- C5 124. 3 (5) Sil2- C.31--C32 112.4 (.'3) 
C3- C4-- Cfi 123. :-3 (5) Sil2-C31 - C33 109.7(4 ) 
C4 - C:-i - C6 120.4 ( S) C32- C31- C33 108.2 (5) 
O7- C6- C l 59 .3 (3) Sil2-C31·-C34 108 .3 (3 ) 
O.7- C6- C.':i 118.7 (6) C32- C31- C34 106.1 (.'S) 
Cl--C6 - C5 120.2 (G) C.'33-C.'31-C34 112.3 (6) 
Data collection: COLLECT (Nonius BV, 1997) Cell refinen1ent: HKL Scalepack (Otwinowski 
& Nlinor 1997). Data reduction: Denzo and Scalepak (Otwinowski & Minor, 1997). ProgTmn(s) 
used to solve structure: SIR-92 (Alton1are et al) . Program(s) used to refine structure: CRYS-
TALS Issue 10 (Watki1~, Prout , Carruthers & Betteridge, 1996) + 1na.-xus(:rviackay et al. ; 1999) 
. iv1olecular graphics: CAIVIER.ON (Watkin , Prout & P earce , 1996) . Software used to prepare 
1naterial for publication: CRYSTALS Issue 10 (Watkin 1 Prout , Carruthers & Betteridge, 1996) 
+ n1axus(ivfackay et al., 1999) . 
Supplementary data for th.is paper are available fron1 the IUCr electronic archives (Reference: ). 
Services for accessing these data are described at the back of the journal. 
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Supplem e ntary data 
The tables of da,ta shown below are not normally printed in Acta Cryst. Section C but the data 
will be available electronically via the online contents pages at 
http: / /journals.iucr.org/ c/journalhornepage.html 
J Table Sl . Fractional atomic coordinates and equi·valt:.nt isotrop'ic displacement parameters ( A 2 ) 
u - ( 1;3) uiJ i J eq - I\I;1 a a ai.aj. 
X y z Ueq 
Cll -0.30437 (18) -0.0793 (3) 0.11006 (6) 0.1309 
Sil2 -0.25141 (1 2) -0.1317 (1) 
-0.14601 ( 4) 0.0523 
07 -0.0358 (3) - 0.3312 (.5) 
-0.00452 (17) 0.0995 
08 - 0.1802 (3) -0.1248 (3) 
-0.08655 (11) 0.0585 
09 -0.0919 (3) - 0.0372 (,5) 0.00867 (16) 0.0888 
010 -0. 1815 (5) 0.1633 (5) - 0.0176 (3) 0.1321 
Cl 
-0.1620 (5) -0.3298 (6) -0.0325 (2) 0 .0786 
C2 -0.2317 ( 4) -0. 1976 (4) 
-0.04127 (16) 0.0619 
C3 -0.2272 (5) 
- 0.1003 (6) 0 .00674 (18) 0.0800 
C4 -0.2431 (6) - 0.1803 (9) 0 .05869 (19) 0.0966 
C5 
-0.2109 (6) -0 .3138 (9) 0.0636 (2) 0.0980 
C6 - 0.1537 (5) -0.3855 (8) 0.0206 (2) 0 .0947 
C7 - 0.0865 (6) 0.0926 (8) -0•.0075 (3) 0.1043 
cs 0.0618 (7) 0.1417 (8) -0.0124 (4) 0.1461 
Cll - 0.2946 (4) - 0.3155 ( 4) - 0.16073 (15) 0.0554 
C l2 
-0.1896 (5) -0.4101 ( 4) -0.17014 (19) 0.0671 
Cl3 -0.2170 (5) - 0.5482 (4) -0.1749 (2) 0.0787 
Cl4 
-0.3524 (6) -0.5954 (5) -0.1699 (2 ) 0.0824 
Cl5 
- 0.4554 (6) - 0.5048 (5) - 0.1608 (2) 0.0823 
Cl6 
-0 .4272 (5) -0.3658 ( 4) -0. 15597 (19) 0.0670 
C21 -0.4129 (4) -0.0262 ( 4) -0.14759 (18) 0.0581 
C22 
- 0.5031 (5) -0.0326 (5) -0.18992 (19) 0.0695 
C23 
-0.6182 (5) 0.0521 (6) - 0 .1932 (2) 0.0809 
C24 
- 0.6466 (5) 0.1402 (5) -0. 1521 (2) 0 .0753 
C25 
-0.5604 (5) 0.1477 (4) -0.1099 (2) 0.0748 
C26 
- 0.4436 (5) 0.0678 (4) -0. 10742 (19) 0.0651 
C31 -0 .1194 (5) - 0.0529 (4) -0.19170 (19) 0.0655 
C32 0.0231 (5) -0.1179 (6) -0.1852 (3) 0.0896 
C33 
-0.1645 (7) -0.0712 (9) - 0.2497 (2) 0.1215 
C34 
-0 .1029 (8) 0.0965 (5) -0 .1767 (4) 0.1302 
Hll 
- 0.1939 (5) -0.3645 (6) -0.0678 (2) 0.0921 
H21 
-0.3293 (4) - 0.2259 (4) -0.04714 (16) 0.0749 
H31 
-0.3021 (5) -0.0310 (6) 0.00274 (18) 0.0938 
H51 
-0 .2265 (6) -0.3611 (9) 0.0983 (2) 0.1168 
H61 
-0.1798 (5) - 0.4753 (8) 0 .0368 (2) 0.1129 
H81 0.0644 (7) 0.2392 (8 ) -0.0245 (4) 0.1777 
H82 0.1083 (7) 0.1338 (8) 0.0229 (4) 0.1777 
H83 0.1104 (7) 0.0828 (8) -0.0389 (4 ) 0.1777 
Hl21 
-0.0928 (5) - 0.3772 ( 4) -0.17375 (19) 0.0779 
Hl31 
-0._1406 (5) -0.6145 ( 4) -0 .1814 (2) 0 .0932 
Hl41 -0.3736 (6) -0.6950 (5) -0. 1737 (2) 0.0985 
Hl51 -0.5521 (6) -0.5380 (5) - 0.1574 (2) 0.0997 
Hl61 -0.5041 (5) -0.3005 (4) -0.14886 (19) 0 .0803 
H221 -0.4846 (5) -0 .0991 (5) -0.21926 (19) 0.0826 
H231 -0.6800 (5) 0.0475 (6) -0.2248 (2) 0.0940 
H241 -0.7305 (5) 0.1991 (5) -0 .1532 (2) 0 .0907 
H251 -0.5815 (5) 0.2121 (4) . -0 .0801 (2) 0 .0895 
H261 
-0.3791 (5) 0.0782 (4) - 0.07676 (19) 0.0787 
H321 0.0884 (5) -0.0730 (6) -0.2104 (3) 0.1055 
H322 0.0177 (5) -0.2180 (6) -0.1932 (3) 0.1055 
H323 0.0562 (5) -0.1047 (6) -0 .1479 (3) 0.1055 
H331 -0.0936 (7) -0.0297 (9) -0.2736 (2) 0.1418 
H332 -0 .1738 (7) -0.1709 (9) -0.2580 (2) 0 .1418 
H333 -0.2547 (7) -0.0247 (9) -0.2555 (2) 0.1418 
H341 -0.0333 (8) 0.1398 (5) - 0.2006 (4) 0.1532 
H342 -0.1932 (8) 0.1440 (.5) -0.1811 (4) 0.1532 
H343 -0.0718 (8) 0.1045 (-5 ) -0.1390 ( 4) 0 .1532 
-
Table S2. An:isotropic displacement parameters (A2 ) 
U11 U22 U33 U12 U13 U23 
Cll 0.0979 (11) 0.226 (2) 0.0683 (9) -0.0122 (12) 0.0174 (7) -0.0353 (11) 
Sil2 0.0606 (5) 0.0445 (5) 0.0517 (5) -0.0006 (5) 0.0043 (5) 0.0019 (4) 
07 0.0606 (18) 0.149 (4) 0.089 (3) 0.002 (2) - 0.0032 (18) 0.016 (2) 
08 0.0598 (15) 0.0.5 58 (15) 0.0598 (15) - 0.0056 (12) 0.0022 ( 12) -0.0047 (13) 
09 0.0646 (19) 0.112 (3) 0.090 (2) -0.0105 (19) -0.0056 (18) -0.028 (2) 
010 0.084 (3) 0.089 (3) 0 .223 (6) - 0.007 (2) 0.013 (3) - 0.050 (3) 
Cl 0.069 (3) 0.097 ( 4) 0.070 (3) 0.005 (3) - 0.006 (2) 0.019 (3) 
C2 0.052 (2) 0.078 (3) 0.055 (2) - 0.009 (2) 0.0010 (18) -0.0001 (18) 
C3 0.056 (3) 0.124 (4) 0.060 (3) -0.002 (2) 0.007 (2) -0.013 (2) 
C4 0.056 (2) 0 .175 (6) 0.059 (3) -0.020 (4) 0.007 (2) - 0.010 (3) 
C5 0.081 ( 4) 0.141 (6) 0.072 ( 4 ) -0.00 1 (3) -0 .014 (:3) 0.026 (3) 
C6 0.068 (3) 0.149 (6) 0.067 (3 ) 0.009 (3) -0.002 (2) 0.030 (3) 
C7 0.070 (3) 0.109 (5) 0.134 (5) - 0.006 (3) 0.012 ( 4) -0.060 (4) 
cs 0.089 (4) 0.107 (5) 0.24 (1) -0.025 (4) 0.028 (5) - 0.065 (6) 
Cll 0.069 (2) 0.0433 (18) 0.053 (2) 0.0009 (16) 0.0017 (17) -0 .0031 (15) 
Cl2 0.068 (3) 0 .052 (2) 0.082 (3) 0.0031 (19) 0 .005 (2) 0.0036 (19) 
Cl3 0.090 ( 4) 0.0384 (19) 0.108 ( 4) 0.002·9 (19) 0.019 (3) - 0 .002 (2) 
C14 0.096 ( 4) 0.046 (2) 0.105 ( 4) - 0.009 (2) 0 .023 (3) -0.003 (2) 
Cl5 0.082 (3) 0 .060 (3) 0.105 ( 4) -0 .009 (2) 0.014 (3) -0 .006 (3) 
Cl6 0.071 (3) 0.053 (2) 0.078 (3) 0.002 (2) 0 .015 (2) -0.008 (2) 
C21 0.066 (2) 0 .0463 (18) 0.062 (2) 0.0031 (16) 0.007 (2) 0.0038 (18) 
C22 0.069 (3) 0.073 (3) 0.066 (3) 0.001 (2) 0.004 (2) 0.008 (2) 
C23 0.065 (3) 0.096 (4) 0.082 (3) -0.002 (3) - 0.006 (2) 0.021 (3) 
C24 0.072 (3) 0.060 (2) 0.095 (3) 0.009 (2) 0.016 (3) 0.019 (3) 
C25 0.081 (3) 0 .049 (2) 0.094 (3) 0.004 (2) 0.021 (3) 0.001 (2) 
C26 0.071 (3) 0.052 (2) 0 .072 (3) -0.001 (2) 0.010 (2) 0.001 (2) 
C31 0.070 (3) 0.055 (2) 0.071 (3) - 0.0021 (19) 0.016 (2) 0.007 (2) 
C32 0.073 (3) 0.085 (4) 0.111 (4) 0.000 (3) 0.022 (3) 0.014 (3) 
C33 0.096 (4) 0 .195 (8) 0 .073 (3) - 0.01 7 (5) 0.014 (3) 0.042 ( 4) 
C34 0.139 (6) 0.053 (3) 0.199 (8) -0.014 (3) 0.089 (6) 0.001 (4) 
0 
Table 83. Geometric parameters ( A ) 0 ) 
Cll-C4 1.733 (6) Cl3-Cl4 1.401 (7) 
Sil2-O8 1.651 ( 3) Cl3-Hl31 1.000 
Sil2-Cll 1.881 ( 4) Cl4-Cl5 1.357 (7) 
Sil2- C21 1.881 ( 4) Cl4-Hl41 1.000 
Sil2- C3 1 1.889 ( 4) C l5-Cl6 1.391 (6) 
O7- Cl 1.416 (6) Cl5- Hl51 1.000 
O7-C6 1.414 (7) Cl6-Hl61 1.000 
O8-C2 1.435 "(5) C21-C22 1.382 ( 6) 
O9- C3 1.455 ( 6) C21-C26 1.398 (6) 
O9- C7 1.333 (9) C22-C23 1.395 (7) 
O10- C7 1.182 (8) C22-H221 1.000 
Cl-C2 1.476 (7) C23-C24 1.374 (8) 
Cl- C6 1.448 (7) C23-H231 1.000 
Cl-Hll 1.000 C24-C25 1.355 (7) 
C2-C3 1.539 ( 6) C24-H241 1.000 
C2- H21 1.000 C25-C26 1.381 (7) 
C3-C4 1.532 (8) C25- H251 1.000 
C3-H31 1.000 C26-H261 1.000 
C4- C5 1.346 (9) C31-C32 1.534 (7) 
C5- C6 1.404 (9) C31- C33 1.536 (8) 
C5- H51 1.000 C31-C34 1.516 (7) 
C6-H61 1.000 C32-H321 1.000 
C7-C8 1.526 (9) C32-H322 1.000 
C8-H81 1.000 C32-H323 1.000 
C8- H82 1.000 C33-H331 1.000 
C8-H83 1.000 C33- H332 1.000 
Cll-Cl2 1.398 (6) C:33- H333 1.000 
Cll- Cl6 1.386 ( 6) C34-H341 1.000 
Cl2- Cl3 1.381 ( 6) C34-H342 1.000 
C l2- Hl21 1.000 C34- H343 1.000 
O8-Sil2-Cll 108.17 (16) Cl2-Cl3-Cl4 119.7 ( 4) O8-Sil2-C21 110.33 (17) Cl2-Cl3-Hl31 120.3 (3) Cll- Si 12-C21 109.43 (18) Cl4- Cl3-Hl31 120.0 (3) O8-Sil2-C31 104.46 ( 19) Cl3-Cl4- Cl5 119.7 ( 4) Cll-Sil2- C31 114.93 (19) Cl3-Cl4- Hl41 120.4 (3) C21-Sil2-C31 109.38 (19) Cl5-Cl4-Hl41 119.9 (3) Cl-O7-C6 61.5 (3) Cl4-Cl5-Cl6 120.4 (5) Sil2- O8-C2 123.6 (2) Cl4-Cl5-Hl51 119.9 (3) C3-O9-C7 115.4 (5) Cl6-Cl5- . Hl51 119.7 (3) O7-Cl-C2 118.8 (-5) Cll-Cl6-Cl.5 121.5 (4) O7-Cl-C6 59.2 (3) Cll-Cl6-Hl61 119.1 (2) C2-Cl-C6 119.5 (5) Cl5--C'l6-Hl61 119.4 (3) O7- Cl-Hll 135.1 (3) Si 12-C21-C22 121.5 (3) C2- Cl-Hll 91.2 ( :3) Sil2-C21- C26 121.5 (3) C6-Cl-Hll 135.4 (4) C22-C21-C26 116.9 ( 4) O8-C2- Cl 113.1 ( 4) C21-C22-C23 121.9 (5) O8-C2-C3 107.9 (4) C21- C22-H221 119.0 (3) Cl- C2-C3 114.3 ( 4) C23--Cl22- H221 119.1 (3) O8-C2- H21 110.6 (2) C22-C23-· C24 119.3 (5) Cl-C2-H21 102.5 (3) C22-C23-H231 120.2 (3) C3- C2-H21 108.3 (2) C24- C23-H231 120.5 (3) O9-C3- C2 108.3 (3) C23-C24- C25 120.0 (4) O9-C3- C4 106.2 ( 4) C23-C24-H241 120.2 (3) C2- C3-C4 110.6 (-5) C25-C24-H241 119.8 (3) O9- C3-H31 112.1 (3) C24- C25-C26 120.9 (5) C2- C3- H31 108.6 (3) C24- C25-H2.51 119.6 (3) C4-C3- H31 111.0 (3) C26- C25-H2-51 119.5 (3) Cll- C4-C3 112.4 (6) C21-C26-C25 121.0 (5) Cll-C4-C.5 124.3 (5) C21-C26-H261 119.4 (3) C3-C4- C5 123.3 (5) C25-C26-H261 119.6 (3) C4- C5-C6 120.4 (5) Sil2- C31- C32 112.4 (3) C4- C5-H51 119.5 (3) Si 12-C 31- C :33 109.7 (4) C6-C5- H51 120.l ( 4 ) C32-C31-C33 108.2 (5) O7- C6- Cl 59.3 (3) Sil2- C31- C34 108.3 (3) O7- C6-C5 118.7 (6) C32-C31- C34 106.1 (5) Cl-C6- C5 120.2 (6) C33- C31-C34 112.3 (6) O7-C6- H61 135.9 (3) C31-C32-H321 108.9 (3) Cl- C6-H61 133 .8 ( 4 ) C31-C32- H322 109.7 (3) C5-C6- H61 91.4 ( 4) H321-C32- H322 109.476 O9-C7- O10 126.2 (6) C31-C32-H323 109.8 (3) O9-C7-C8 111.2 (6) H321-C32-H323 109.476 O10- C7-C8 122.6 (8) H322-C32-H323 109.476 C7-C8- H81 ll0.4 (5) C31- C33-H331 109.1 (3) C7-C8- H82 109 .3 (5) C31-C33- H332 109 .7 ( 4) H81-C8-H82 109.476 H33 l-C33-H332 109.476 C7-C8-H83 108 .7 ( 4 ) C3 l -C33-H333 109.7 (3) H81- C8-H83 109.476 H33 l -C33-H333 109.476 H82-C8-H83 109.476 H332-C33-H333 109.476 Sil2-Cll-Cl2 120.l (3) C31-C34- H341 109 .2 (3) Sil2-Cll- Cl6 122.0 (3) C31-C34-H342 109 .l ( 4) Cl2-Cll- Cl6 117.4 ( 4) H341-C34-H342 109.476 Cll-Cl2- Cl3 121.3 ( 4) C31-C34-H343 110.l ( 4) Cll- Cl2-Hl21 ll9.5 (2) H341-C34-H343 109.476 Cl3-Cl2-Hl21 119.2 (3) H342-C34-H343 109.476 
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b X-ray crystal data are presented as provided by Dr A. C. Willis at The Australian National University. 
Abstract 
Comment 
Experimental 
Crystal data 
C24H2sCbO4~E 
JvI, . = 479.47 
Orthorhombic 
P212121 
a = 10.0331 (1) A 
b = 10.2913 (1) A 
c = 24.2234 (3) A 
V = 2501.15 (4) A. 3 
Z =4 
Dx = 1.273 rvig 111 - 3 
Dm not rneasured 
l\!Io Ka radiation 
" 
,\ = 0.7107 A 
Cell parc1n1eters from 68975 reflections 
0 = 4.076- 27.485° 
µ = 0.334 111111- 1 
T = 200.0 K 
Tablet 
Colourless 
0.49 x 0.40 x 0.26 rrnn 
Data collection 
Nonius KappaCCD diffracto111eter 
w scans with CCD 
10 - 10.1900 -1010.:300001 0 0.1500 
0 -1 0 0.2500 0 0 1 0.1300 0 0 -1 
0.1300 -1 0 -1 0.2300 0 -1 -1 0.2000 
0 1 -1 0 .1300 Absorption correction: 
multi-scan 
Tmin = 0.853, T'inax = 0.918 
57346 measured reflections 
Refinement 
5715 independent reflections 
4671 reflections with 
I> 2.00vffd9) 
Rint = 0.04348 
0max = 27.48° 
h = - 12 --+ 13 
k = -13--+ 13 
l = - 31 --+ 31 
every O reflections 
intensity decc1y: none 
Refinement on F Scattering factors from International Tables 
R = 0.0298 for Crystallography (1992 , Vol. C, Table 
wR=0.0345 6.1.1.2) 
S = 0.931 (H) 
4671 reflections Absolute st:ructure: Reflections with Friedel 
283 parameters nrntes: 2411 F(H)=F(- H) reflections: 72 
H atcnns t reated by a nuxture of independent Reflections without Friedel in.ates: 7 4 7 
and constrained refinement Flack parn,n1eter = -0.012 (2) 
" Table l. Selected geometric parameters (A , 0 ) 
Cl(30) - C( 4) 1.821 (2) C(9)- C(10) 1.389 (2) 
Cl(3 l )- C(6) 1.7:39 (2) C(9)- C(14) 1.;390 (2) 
Si(S)--O(7) 1.652 (1) C(l0)--C(ll) 1.389 (3) 
Si(8)- C(9) 1.870 (2) C(ll)- C(12) 1.381 (3) 
Si(8)-- C(15) 1.871 (2) C(12)- C(13) 1.365 (3) 
Si(8)- C(21) 1.883 (2) C(l3)- C(14) 1.386 (3 ) 
O(7) - C(2) 1.416 (2) C(l5)-C(16) 1.397 (:3) 
O(25)- C(l) 1.443 (2) C(15)- C(20) 1.398 (3 ) 
O(25)- C(26) 1.362 (2) C(l6)-C(17) 1.386 (3) 
O(27)- C(26) 1.192 (2) C(17)- C(18) 1.369(4) 
O(29)- C(3) 1.407 (2) C(l8)- C(l9) 1.366(4) 
C(l)- C(2) 1.525 (2) C(19)-C(20) 1.388 (3) 
C(l)- C(6) 1.500 (2) C(21)-C(22) 1.530 (3) 
C(2)- C(3) 1.530 (2) C(21)-C(2:3 ) 1.527 (3) 
C(3)- C( 4) 1.519 (3) C(21)-C(24) 1.535 (3) 
C(4)- C(5 ) 1.488 (3) C(26)-C(28) 1.482 (3) 
C(5)-C(6) 1.305 (3) 
O(7)- Si(8 )- C(9) 110.80 (7) Si(8 )---C(9)- C( 14) 119.0 (1) 
O(7) - Si(8)·-C(15) 109.61 (7) C(10)- C(9)- C(14) 116 .7 (2) 
O(7) - Si(8 )- C(21) 103.99 (7) C(9)- C(10)- C(ll) 121.9 (2) 
C(9 )- Si(8)- C( 15) 107.15 (8) C(l0)- C(ll)- C(12) 119.6 (2) 
C(9)- Si(8)- C(21) 115.45 (8) C(ll)- C(12)- C(13) 119.8 (2 ) 
C( 15)- Si(8)- C(21) 109.79 (8) C( 12)-C(13)- C(14) 120.1 (2) 
Si(8)- O(7)--C(2) 128.2 ( 1) C(9 )- C( 14)-C( 13) 121.9 (2) 
C(l)-O(25) - C(26) 117.2 (1) Si(8)- C( 15)- C(16) 121.8 (2) 
0(25 )- C( 1 )--C(2) 108.8 ( 1) Si(8 )- C(15)-C(20) 121.5(1) 
0(25 )- C( 1 )--C( 6) 106.7 ( 1) C( 16)--C(15 )- C(20) 116.5 (2) 
C(2)- C(l)- C(6) 110. 9 (1) C( 15)- C(l6)- C(l 7) 121.4 (2) 
O(7)- C(2) - C( 1) 108.8 (1) C(l6)- C(l 7) - C( 18) 120.3 (2) 
O(7)- C(2)- C(3) 111.9 (1) C(l 7)- C(18)- C(l9) 120.1 (2) 
C(l)- C(2)- C(3) 108.4 (1) C( 18)- C( 19)--C(20) 119.9 (2) 
O(29)- C(;1)- C(2) 115.0 (1) C(15)- C(20) - C(l9) 121.7 (2) 
O(29)- C(3)- C( 4) 112.4 (2) Si(8)- C(21)- C(22) 111.9 (1) 
C(2)- C(3)- C( 4) 108 .7 (1) Si(8)-. C(21)- C(23) 110.1 (1) 
Cl(30)- C( 4)- C(3) 109.7 (1) Si(8)- C(21 )- C(24) 108.3 ( 1) 
Cl(30)- C( 4)- C(5) 109 .9 (1) C( 22 )--C(21 )- C ( 2:1) 109.4 (2) 
C(3)- C( 4)- C(5) 112.7 (2) C(22)- C(21)--C(24) 108.1 (2) 
C( 4 )- C( 5 )--C( G) 121.3 (2) C(23)--C(21)- C(24) 108.9 (2) 
Cl(31)- C(G)- C(l) 11:3.9 ( 1) 0(2[) )- C(26) - O(27) 123.3 (2) 
Cl(3 l )- C( 6)- C( 5) 120. 7 (1) O(2S)- C(26)- C(28) 110.8 (2) 
C(l)--C(6)- C(5) 12:S.3 (2) O(27)- C(26)- C(28) 125.8 (2) 
Si(8)--C(9)- C(l0) 124.2 (1) 
Data collection: KappaCCD. Cell refinement: HKL Scalepack (Otwinowski & l\!Iinor 1997) . Data 
reduction: Denzo and Scalepak (Otwinowski & Minor, 1997). Prograrn(s) used to solve structure: 
SIR92 (Altomare, et al. 1994) . Prograin(s) used to refine structure: teXsan (l\lISC, 1992-1997) . 
Software used to prepare niaterial for publication: teXsan (l\lISC, 1992-1997). 
Supplementary data for this paper are available fr0111 the IUCr electronic archives (Reference: ). 
Services for accessing these data are described at the back of the journal. 
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Supplementary data 
The tables of data shown below are not nonnally printed in Acta Oryst. Sect-ion C but the data 
will be available electronically via the online contents pages at 
http://journals.iucr.org/c/jour11alho111epage.html 
Ti:l.ble S1. Fract·ional atomic cuord,inates anrl erru'i'ualent isotrupic displacement parameters ( A2 ) 
U: - (1/'') . .uij i J . . eq - 0 ~ -i ~J a a a 2 .a 1 . 
X y z Ueq Cl(30) 0.70462 (5) 0.51824 (6) 0.72107 (2) 0.0602 (2) Cl (31) 0.24462 (7) 0.56058 (6) 0.63237 (2) 0.0662 (2) Si(8) 0.40588 (5) 0 .48902 (5) 0.89261 (2) 0.0283 (1) 0(7) 0.3608 (1) 0.4366 (1) 0.83092 (5) 0.03 12 (3) 0 (25) 0.2143 (1) 0.3838 (1) 0.73929 (5) 0.0372 (4) 0(27) 0.0603 (1) 0.5042 (1) 0.78335 (7) 0.0581 (5) 0(29 ) 0 .5959 (2) 0 .3058 (1) 0 .79511 (6) 0.0493 (4) 
C(l ) 0.3052 (2) 0 .4925 (2) 0.73788 (7) 0.0328 ( 4) C(2) 0.4174 (2) 0 .4679 (2) 0.77905 (7) 0.0302 ( 4) 
C(3) 0.5048 (2) 0.3579 (2) 0.75685 (8) 0.0354 (5) C(4) 0.5723 (2) 0.4037 (2) 0.70420 (8) 0.0432 (5) 
C(5) 0.4774 (2) 0.4642 (2) 0.66461 (8) 0.0446 (6) 
C (6) 0.3-58:3 (2) 0.5000 (2) 0.68007 (7) 0.0403 (5) 
C(9) 0.5911 (2) 0.5155 (2) 0.89578 (7) 0.0322 ( 4) 
C ( lO) 0.6828 (2) 0 .4200 (2) 0.90981 (8) 0.0389 (5) 
C(ll) 0 .8192 (2) 0.4415 (2 ) 0.90698 (9) 0.0475 (6 ) 
C(l2) 0 .8664 (2) 0 .5608 (2) 0.8897 (1) 0.0527 (6) 
C( l 3) 0.7787 (2) 0.6570 (2) 0.8760 (1) 0.0550 (7) 
C(l4) 0.6426 (2) 0.6347 (2) 0.87917 (9) 0.0432 (5) 
C(l5) 0.3247 (2) 0 .6492 (2) 0.90687 (8) 0.0339 (5) 
C(l6) 0.3661 (2) 0.7289 (2) 0.95027 (9) 0.0528 (7) 
C(l7) 0.3003 (3) 0.8436 (2) 0.9627 (1) 0.0679 (8) 
C(l8 ) 0.1923 (3) 0.8818 (2) 0.9322 (1) 0 .0684 (8) 
C(19) 0.1492 (2) 0.8070 (2) 0.8892 (1) 0.0540 (6 ) 
C(20) 0.2139 (2) 0.6913 (2) 0.87682 (8) 0.0394 (5) 
C(21) 0.3385 (2) 0.3623 (2) 0.94125 (8) 0.0357 (5) 
C(22) 0.3793 (2) 0.2248 (2) 0.9240 (1) 0.0514 (6) 
C(23) 0.3872 (3) 0 .3888 (2) 0.99991 (8) 0.0525 (6 ) 
C(24) 0.1857 (2) 0.3699 (3) 0.9403 (1) 0.0611 (7) 
C(26) 0.0956 (2) 0.4019 (2) 0.76546 (9) 0.0440 (5) 
C(28) 0.0206 (2) 0.278 1 (2) 0.7693 (1) 0.0662 (8) 
H ( l ) 0.651 (2) 0.363 (2) 0.804 (1) 0.059 
H (2) 0.2595 0.5704 0.7470 0.039 
H(3) 0.4696 0.5445 0.7826 0.036 
H(4) 0.4464 0.2892 0.7467 0.043 
H(5) 0.6116 0.3304 0.6868 0.052 
H(6) 0.5041 0.4771 0.6274 0.053 
H(7) 0.6512 0.3375 0.9217 0.047 
H(8) 0.8798 0.3745 0.9169 0.057 
H(9) 0.9596 0..5760 0.8874 0.063 
H ( l0) 0.8109 0.7392 0.8642 0.066 
H(ll) 0.5829 0.7028 0.8697 0.052 
H(l2) 0.4411 0.7040 0.9717 0.063 
H(l3) 0.3:302 0.8960 0.9925 0.082 
H(14) 0.1473 0.9603 0.9410 0.082 
H(l5) 0.0750 0.8341 0.8677 0.065 
H(l6) 0.1820 0.6395 0.8472 0.047 
H(l 7) 0.3481- 0. 2079 0.8877 0.062 
H( l 8) 0.4737 0.2176 0. 9248 0.062 
H(l9)· 0.3416 0.1637 0.9489 0.062 
H(20) 0.4819 0.3905 1.0003 0.063 
H(21) 0.3563 0 .322 1 1.0238 0.063 
H(22) 0.3538 0.4703 1.0121 0.063 
H(23) 0.1576 0.4482 0 .9574 0.073 
H(24) 0.1496 0.2978 0.9.597 0.073 
H(25) 0.1554 0.3684 0.9031 0.073 
H(26) 0.0591 0.2249 0.7971 0.079 
H(27) -0.0697 0.2959 0.7784 0.079 
H(28) 0.0244 0.2343 0.7348 0.079 
Table 82. Anisotropic d·isplacement parameters (A. 2 ) 
U11 U22 U33 U12 U13 U23 
Cl(30) 0.0504 (3) 0.0702 (4) 0.0599 (3) -0.0176 (3) 0.0150 (3) -0.0111 (3) 
Cl(31) 0.0929 (5) 0.0622 (4) 0 .0435 ( 3) -0 .0062 (3) -0 .0275 (3) 0.0110 (3) 
Si(8) 0.0299 (2) 0.0285 (2) 0.0266 (2) -0.0006 (2) 0.0018 (2) 0.0009 (2) 
0 (7) 0.0331 (6) 0.0349 (7) 0.0257 (6) -0.0025 (5) 0.0019 (5) 0.0000 (5) 
0(2-5) 0.0400 (7) 0.0309 (7) 0.0406 (7) -0 .0028 (6) -0.0034 (6) -0.0042 (6) 
0(27) 0.0424 (8) 0.0493 (9) 0.083 (1) 0.0087 (7) 0.0042 (7) -0.0122 (9) 
0(29) 0.0496 (9) 0.0444 (9) 0 .0.538 (9) 0.0136 (7) · -0 .0053 (8) 0 .0006 (7) 
C(l) 0.0409 (9) 0.0243 (8) 0.0333 (9) -0.0007 (8) -0.0039 (7) -0.0010 (8) 
C(2) 0.0366 (9) 0.0276 (9) 0.0262 (8) - 0.0012 (7) 0.0026 (7) -0.0011 (7) 
C(3) 0.039 (1) 0.030 (1) 0.037 (1) 0.0024 (8) 0.0019 (8) -0.0040 (8) 
C(4) 0.05 1 (1) 0.039 (1) 0.040 (1) -0.0030 (8) 0.0115 (8) -0.0106 (8) 
C(5) 0.067 (1) 0.038 (1) 0 .029 (1) -0.011 (1) 0.0070 (9) -0.0054 (8) 
C(6) 0.059 (1) 0.031 (1) 0.0309 (9) -0.0101 (9) -0.0091 (8) 0.0003 (8) 
C(9) 0.0337 (8) 0.0357 (9) 0.0273 (8) -0.0024 (7) 0.0009 (7) 0.0010 (8) 
C(lO) 0.0351 (9) 0.036 (1) 0.046 (1) - 0.0019 (8) 0.0014 (9) 0.0016 (9) 
C(ll ) 0.034 (1) 0.049 (1) 0.059 (1 ) 0.0048 (9) -0.0003 (9) 0 .000 (1) 
C( l 2) 0.033 (1) 0.068 (1) 0.057 (1) -0.0088 (9) 0 .005 (1) 0.010 (1) 
C(l3) 0.044 (1) 0.055 (1) 0.066 (2) - 0.0140 (9) 0.004 (1) 0.022 (1) 
C(l4) 0.0385 (9) 0.043 (1 ) 0.048 (1) - 0.0049 (9) -0.0032 (9) 0.014 (1) 
C( l5) 0.039 (1) 0.0297 (9) 0.033 (1) -0.0025 (7) 0.0101 (8) 0.0004 (7) 
C(l6) 0.070 (2) 0.044 (1) 0.045 (1) 0.000 (1) -0.003 (1) -0 .009 (1) 
C ( l7) 0.101 (2) 0.044 (1) 0.058 (2) -0.003 (1) 0.010 (1) -0 .019 (1) 
C( l8 ) 0.075 (2) 0.035 (1) 0.096 (2) 0.009 (1) 0.035 (1) - 0 .012 (1) 
C ( 19 ) 0.041 ( 1) 0.039 (1) 0.082 (2) 0.0089 (9) 0.015 (1) 0.006 (1) 
C(20) 0.032 (1) 0.033 (1) 0.053 (1) -0.0015 (8) 0.0095 (8) 0.0023 (9) 
C (21 ) 0.0383 (9) 0 .034 (1) 0.035 (1) -0.0033 (8) 0.0054 (8) 0.0073 (8) 
C(22) 0.062 ( 1) 0 .032 (1) 0.060 (1) -0.008 (1) 0.005 (1) 0.006 (1) 
C (23) 0.077 (2) 0.048 (1) 0.033 (1) 0.000 (1) 0.009 (1) 0.0080 (9) 
C(24) 0.040 (1) 0.064 (2) 0.079 (2) -0.008 (1) 0.014 (1) 0.024 (1) 
C(26) 0.037 (1) 0.045 (1) 0.049 (1) 0.0013 (9) -0.0086 (9) -0.0013 (9) 
C(28) 0.051 (1) 0 .055 (1) 0.093 (2) -0.014 (1) 0.005 (1) -0.003 (1) 
0 Table S3. Geometr-ic parameters ( A , 0 ) 
Cl(30) - C( 4) 1.821 (2) C (l3)-C(l4) l .386 (3) Cl(31)-C(6) 1.739 (2) C(l3)-H(l0) 0.95 Si (8)-O(7) 1.652 (1) C (l4) - H (ll ) 0.95 
Si (8)-C (9) 1.879 (2) C (l5)-C(l6) 1.397 ( 3) Si (8)-C(l5 ) 1.871 (2) C (l5)-C(20) 1.398 (3) Si (8)-C(21 ) 1.883 (2) C (l6)-C(l7) 1.386 (3) O(7)-C(2 ) 1.416 (2) C (l6)-H (l2) 0.95 
O(25)-C(l ) 1.443 (2) C(l7)-C(l8) 1.369 ( 4) 
O(25)-C(26) 1.362 (2) C(l 7)-H(l3) 0.95 
O(27)-C(26) 1.192 (2) C(l8)-C(l9) 1.366 ( 4) 
O(29 )-C(3) 1.407 (2) C (l8)-H(l4) 0.95 
O(29)-H(l ) 0.83 (2) C(l9)-C(20) 1.388 (3) 
C(l )-C(2) 1.525 (2) C (l9)-H(l5) 0.95 
C(l) - C(6) 1.500 (2) C (20)-H( 16) 0.95 
C(l )-H(2) 0.95 C(21 )-C(22) 1.530 (3) 
C(2)-C(3) 1.530 (2) C (21)-C(23) 1.527 ( 3) 
C(2)- H(3) 0.95 C(21)-C (24) 1.535 (3) 
C(3)-C(4) 1.519 (3) C (22)- H (l 7) 0.95 
C(3)-H(4) 0.95 C (22)- H( l8) 0.95 
C(4)-C(5) 1.488 (3) C(22)-H(l9) 0.95 
C(4)- H(5) 0.95 C(23)-H(20) 0.95 
C(5)- C(6) 1.305 (3 ) C(23)-H(21) 0.95 
C(5)-H(6) 0.95 C(23)-H(22) 0.95 
C(9)-C(l0) 1.389 (2) C(24)- H(23) 0.95 
C(9)-C(l4) 1.390 (2) C (24)-, H(24) 0.95 
C( lO)-C (ll ) 1.389 (3) C (24)-H(25) 0.95 
C(10)- H(7) 0.95 C(26)-C(28) 1.482 (3) 
C(ll)-C( l2) 1.381 (3) C (28)- H (26) 0.95 
C(ll)-- H(8) 0.95 C (28) - H(27) 0.95 
C(l2)-C(l3 ) 1.365 (3) C (28)-H(28) 0.95 
C(l2) - H(9) 0.95 
O(7)-Si(8)-C (9) 110.80 (7) C(9)-C( l4)--C(13) 121.9 (2) 
O(7)-Si(8)-C(l5) 109 .61 (7) C(9)-C(l4)-H(ll ) 119.0 
O(7)-Si(8)-C (21) 10:3.99 (7) C( 13)--C( l4)-H(ll) 119.0 
C( 9 )- Si ( 8 )-C ( 15) 107.15 (8) Si( 8)-C( l-5)- C(l6) 121.8 (2) 
C(9)-Si(8)-C(21) 115.45 (8) Si( 8)-C(l-5)----C(20) 121.S (1) 
C( 15)-Si (8)-C(21 ) 109.79 (8) C ( 16)--C( l 5)-C(20) 116.5 (2) 
Si (8)-O (7)-C(2) 128.2 ( 1) C (l 5)-C( l6)-C( l7) 121.4 (2) 
C( l )-O (25)-C(26) 117.2 ( 1) C (l -5)-C( l6)-H( 12) 119.3 
C(:3)-O(29)-H (l ) 109 (2) C (l 7)-C( l6)-H( l2) 119 .3 
O(25)-C(l)----C( 2) 108.8 (1) C(l6)-C(l7)-C(l8) 120.3 (2) 
O(2-5 )-C( l )-C (6) 106.7 (1) C( l 6)-C(l 7)-H(l3) 119 .9 
0 ( 2-5 )-C( l )-H (2) 110. l C(l8)-C(l 7)-H(l3) 119.8 
C(2)-C(l)----C(6) 110.9 (1) C (17)-C(l8)-C(l9) 120.1 (2) 
C(2)-C(l)-H(2) 110.1 C(l7)-C(l8)- H(14) 120 .0 
C(6)-C( l )-H(2) 110.1 C( 19)---C( 18)-H( 14) 120.0 
O(7)- C(2)-C (l ) 108.8 (1) C( 18)-C( 19 )-----C(20) 119 .9 (2) 
O(7)-C (2)----C (3) 111.9 (1) C(l8)-C(l9)-H(l5) 120.0 
O(7)-C(2)-H (3) 109.2 C(20)-C(l9)-H(l5) 120.0 
C( l )- C(2)-C(3) 108.4 (1) C(l5)-C(20)-C(l9) 121.7 (2) 
C( l )-C(2)-H(3) 109.2 C ( 15 )-C ( 20 )-H ( 16) 119.1 
C(3)-C(2)- H(3) 109.2 C( 19)-C(20)-H(l6) 119.1 
O(29)-C(3)-C(2) 115.0 (1) Si(8)-C(21)-C(22) 111.9 (1) 
O(29)- C(3)-C( 4) 112.4 (2) Si(8)-C (21 )----C (23) 110.1 (1) 
O(29)- C(3)-H(4) 106.7 Si(8)-C(21)-C (24) 108.3 (1) 
C(2)-C(3)----C(4) 108.7 (1) C( 22)-C ( 21 )-----C (23) 109.4 (2) 
C(2)-C(3)-H( 4) 106.7 C(22)-C(21)-C(24) 108.1 (2) 
C( 4)-C(3)-H( 4) 106.7 C(23 )~(21 )-C(24) 108.9 (2) 
Cl (30)-C( 4)-C(3) 109.7 (1) C (21)- C(22)- H (l7) 109.-5 
Cl(30)-C( 4)-C(-5) 109.9 (1) C(21)- C(22)-H(l8) 109.5 
Cl(30) - C( 4)-H( 5) 108.1 C(21)-C(22)-H(l9) 109 .5 
C(3) - C( 4)-C(5) 112.7 (2) H(l7)-C(22)-H(l8 ) 109.5 
C(3)-C( 4)- H(5) 108.l H( l 7)-C(22)-H( 19 ) 109.5 
C( 5)-C( 4)-H( 5) 108. l H( l8)-C(22)-H(l9 ) 109.5 
C(4)- C(5 )-C(6) 121.3 (2) C (2 1 )-C ( 23 )-H ( 20 ) 109.5 
C( 4) - C(5)-H(6) 119 .4 C(21)-C(23) - H(2 1) 109.5 
C(6)-C(5)-H(6) 119 .4 C(21) ----C(23)-H (22) 109.5 
Cl(31)-C(6)-C( l ) 113.9 (1) H (20)-C(23)-H(21) 109.5 
Cl(31)-C(6)-C(5) 120 .7 (1) H (20)-C(23) - H(22 ) 109.5 
C( l )-C(6)-C(5) 125.3 (2) H(21)-C (23)-H(22) 109.5 
Si(8)-C(9)- C(l0 ) 124.2 (1) C(21)-C(24)-H(23) 109 .5 
Si(8)-C(9)-C( l4) 119 .0 (1) C(21 )-C(24)-H(24) 109.5 
C(10)-C(9)-C( l4) 116 .7 (2) C(21)-C(24)-H (25) 109.5 
C(9)-C(10)-C(ll) 121.9 (2) H ( 23 )-----C ( 24)- H( 24) 109.5 
C( 9)-C( 10)-H(7) 119.l H (23 )-C ( 24 )-H ( 25) 109.5 
C( 11)-C( 10)- H(7) 119.l H (24 )-C ( 24 )-H ( 25) 109.5 
C ( 10 )-C ( 11 )-C ( 12) 119.6 (2) O(25)-C(26)-O(27) 123.3 (2) 
C( 10)-C( ll)-H(8) 120.2 0 ( 25 )-C( 26 )-C ( 28) 110 .8 (2) 
C(l2)-C( 11)-H(S) 120.2 O (27)-C(26)-C(28) 125 .8 (2) 
C(ll)-C( 12)-C( l3) 119.8 (2) C (26 )-----C(28)-H(26) 109.5 
C( 11)-C( 12)-H(9) 120.l C(26)-----C(28)-H(27) 109.5 
C(13)-C ( l2)-H(9) 120.1 C(26)-C(28)-H(28) 109.5 
C( 12)-C( 13)-C( 14) 120.1 (2) H (26)-C( 28)-H(27) 109.5 
C(l2)-C(l3)-H(10) 120 .0 H ( 26 )-C ( 28 )-H ( 28) 109.5 
C(l4)-C( 13)-H(lO) 120.0 H(27 )-C(28)-H (28) 109.5 
Cl(30)-C(4)-C(:3)- O (29) 
Cl(30)-C( 4)-C(3)-C(2) 
Cl(30)-C( 4)-C(5)-C(6) 
Cl( 31)-C( 6)-C( 1)-0(25) 
Cl(31)-C(6)-C( l)-C(2) 
Cl(31)-C(6)- C( 5)-C( 4) 
Si(8)-O(7)-C(2)_:c( 1) 
Si(8 )-O(7)--C(2)--C(3) 
Si(8 )- C(9)-C(l0)-C(ll) 
Si(8)-C (9)- C(l4)-C (13) 
Si(8)-C(l5)-C(l6)-C (l7) 
Si (8)-C(l5)-C(20)-C (l9) 
O(7)-Si(8)--C(9 )-C( 10) 
O(7)- Si(8)-C(9)-C(l4) 
O(7)- Si (8)-C(l5)-C(l6) 
O(7)-Si(8)-C(l5)-C (20) 
O(7)-Si(8)-C(21)- C(22) 
O(7)-Si (8)-C(21)-C(23) 
O(7)- Si(8)-C(21 )-C(24) 
O(7)-C(2)- C(l)-O(25) 
O(7)-C(2)-C( l )-C(6) 
0 ( 7)- C (2 )-C (3 )-0( 29) 
O(7)- C(2)-C(3)- C (4) 
O(25)-C(l)-C(2)-C(3) 
O(25)-C(l)-C(6)-C(5) 
O(27)-C(26)- O(25)- C (l ) 
0 (29 )- C( 3 )-C( 2)- C( 1) 
O(29)-C(3)-C( 4)-C(5) 
C( 1 )- 0 ( 25 )- C( 26)- C( 28) 
C( 1 )-C( 2 )-C( 3 )-C ( 4) 
C( 1 )-C( 6 )-C( 5)-C ( 4) 
C(2)-O(7)-Si(8)-C(9) 
C( 2) - O(7)-Si ( 8 )-C ( 15 ) 
Cl(31) · · ·O (29i ) 
Cl(31) · · -C(23'.'. ) 
0(27) -. -C(281ll ) 
-54.7 (2) 
73.8 (2) 
- 107.6 (2) 
74.3 (2) 
-167.4 (1) 
- 175.7 (1) 
- 136.6 (1) 
103.6 (1) 
174.4 (2) 
- 174.4 (2) 
-176.0 (2) 
176.6 (1) 
-87.9 (2) 
86.9 (2) 
- 166.1 (2) 
18 .0 (2) 
51. 1 (2) 
173.1 (1) 
- 67.9 (2) 
- 51.8 (2) 
-168.8 (1) 
- 47.5 (2) 
- 174.5 (1) 
70.2 (2) 
-104.9 (2) 
5.6 (3) 
- 167.5 (1) 
- 177.4 (1) 
- 173.2 (2) 
65.5 (2) 
3.5 (3) 
- 33.4 (2) 
84.6 (1) 
C(2)-0(7)- Si (8)-C(21 ) 
C(2)---C (l )-O(25)-C(26 ) 
C(2)-C( 1)-C( 6 )-C( 5) 
C(2)-C(3)-C(4)- C(5) 
C (3)---C (2)-C(l )-C (6) 
C ( 3 )-C ( 4 )-C ( 5 )-C ( 6) 
C(6)-C( 1)-0(25 )-C(26) 
C(9)-Si (8)-C( 15 )-C (l6) 
C(9)-Si (8)-C(l5)-C (20 ) 
C (9)-Si (8)-C(21 )-C(22) 
C (9)-Si(8)-C(21)-C (23 ) 
C(9) - Si(8)-C(21)-C (24) 
C (9)-C( 10)--C( 11 )---C( 12) 
C (9)-C(l4)-C (l3)-C(l2) 
C(10)-C(9)-Si (8)-C(l5) 
C (l0)-C(9)-Si (8)-C(21 ) 
C ( 10 )---C ( 9 )--C ( 14)-C(l3) 
C( 10 )--C ( 11 )--C( 12)-C( l3) 
C (ll)-C (10)--C(9)-C(l4) 
C( 11 )-C(l2)-C ( 13)-C(l4) 
C(14)- C(9) - Si(8)- C (l5) 
C ( 14)-C(9)-Si (8)-C (21 ) 
C (l 5)-Si(8)-C(21)-C(22) 
C(l5)-Si(8)-C(21 )-C(23) 
C ( 15)-Si( 8)--C(21 )-C(24) 
C(l5)-C(l6)-C(l 7)--C( l8) 
C( 15 )--,--C(20 )--C( 19 )-C (18) 
C( 16)-C( 15)-Si( 8)-C(21) 
C(l6)-C( l 5)--C(20)-C(l9) 
C (l6)-C( l 7)-C(l 8)-C( l9) 
C ( 17 )-C ( 16)-C( 15 )-C (20 ) 
C (l 7)-C(l8)--C(l9 )-C(20) 
C (20)-C (l5 )-Si( 8)-C(21) 
Table 84. Contact distances ( 11) 
3.467 (2) 0 (27)·. -C (12iv) 
3.5 10 (2) 0 (29) - - -C (6v ) 
3.199 (3) 0(29) · · -C(l V) 
-158.1 (1) 
104.9 (2) 
13.4 (3) 
-48.9 (2) 
-46.9 (2) 
15.0 (3) 
-135 .4 (2) 
- 45.8 (2) 
138.3 (1) 
-70 .5 (2) 
51.5 (2) 
170.5 (1) 
- 0.1 (3) 
-0.5 ( 4) 
152.6 (2) 
29.9 (2) 
0.8 (3) 
0.5 (3) 
-0.6 (3) 
- 0.2 ( 4) 
- 32.6 (2) 
-155.2 ( 1) 
168.3 (1) 
-69.7 (2) 
49.3 (2) 
- 0.2 ( 4) 
- 1.1 (3) 
80.2 (2) 
0.6 (3) 
- 0.2 ( 4) 
0.1 (3) 
0.9 ( 4) 
- 95.6 (2) 
3.281 (3) 
3.237 (2) 
3.468 (2) 
Symmetry codes: (i) l-x , ½+Y, 1 - z; (ii ) ½-x, l-y, z-½; (iii ) -x , ½+v, ~ -z; (iv) x - 1, y, z ; (v) 1- x, y- ½, ~ -z. 
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a X-ray crystal data are presented as provided by Dr A. J. Edwards at The Australian National 
University. 
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Abstract 
Comment 
The con1pound for which this structure has been detennined is an ison1er of that described on the 
sub1nission form . The relative and absolute stereoche1nistries are demonstrated in the diagram. 
Determination of the absolute sterochen1istry fron1 the experimental anomalous dispersion 
data is unambiguous. 
Experimental 
Crystal dato, 
C25H30Cb05Si 
1VJ1, = S21.513 
Orthorhombic 
P212121 
a = 8.73950 (10) A 
b = 15.8G37 (2) A 
0 
c = 20.1971 (3) A 
V = 2798.38 (6) A. 3 
Z=4 
Dx = 1.238 Tvig ru-3 
Dm not measured 
l\!Io Ka. radiation 
0 /\ = 0. 71073 A 
Cell paran1eters from 25801 reflections 
0 = 2.910- 27.48S 0 
fl = Q. 31 llllll - l 
T = 200 K 
Prisrn 
Colourless 
0.43 X 0.36 X 0.24 111111 
Crystal source: local laboratory 
Data collection 
KappaCCD diffractometer 
CCD scans 
Absorpt ion correction: 
by integration Gaussian by integration 
(Coppens ) 1970) 
32854 measured reflections 
6415 independent reflections 
Refinem ent 
Refinement on F 
R = 0.0400 
wR = 0.0470 
S = 1.0148 
4982 reflections 
308 paran1eters 
H-at01n parameters not refined 
Chebychev polynomial with 3 paran1eters1 
Carruthers & vVatkin 1 1979, 0. 629 0.409 
0.327 
4982 reflections with 
>3 .00o-(1) 
Rim= 0.05 .5 
0max = 27.48° 
h = - 11 ----+ 11 
k = - 20 - : 20 
l = - 24 -- 26 
( 6 / o-) max = 0.000662 
6.Pmax = 0.55 e },.,_ - 3 
6.Pmin = - 0.42 e A -3 
Extinction correction: none 
Scatt ering factors from International Tr1,bles 
for X -ray Crystallography (Vol. IV) 
Absolute structure: Flack 1 2750 Friedel-pairs 
Flack paramet er = 0.08 (6) 
a 
Table 1. Selected geometri,c parameters (A, OJ 
Cll- C2 1.811 (2) C.'5-C6 1.::i25 (3) 
C!2--C4 1. 743 (2) C 7-C8 1.477 (4 ) 
S il -O5 Ui5.'.30 (16) C9-C10 1. 49 1 (3) 
Sil-Cll 1.8.'59 (2) Cl l - C1 2 1. 3!)8 (4 ) 
Si l - C l ? 1.889 (3) C ll - C16 1. 400 (4) 
Sil - C2 1 1.881 (3) C12-C13 1.383 (5 ) 
O 1 - C5 1.438 (3) Cl3 - C14 1.362 (8) 
O 1-C7 1.3:39 (3) C 14-C15 1.384 (7) 
O2- C7 1.194 (3) C15-C16 1.386 (5) 
O3-C6 1.443 (:2 ) C17-C18 1.531 (:'S ) 
O3-C9 1.352 (3) C17-C19 1.536 (4 ) 
O4-C9 1.:200 (3) Cl 7-C20 1.540 (5) 
O5-Cl 1.408 (3) C21-C22 1.389 (4 ) 
C l -C2 1.524 (3) C21-C26 1.377 (4 ) 
C l -CG 1.521 (3) C22-C23 1.390 (4 ) 
C2 - C3 1A83 (3) C23-C24 1.345 (5 ) 
C3- C -1 1. 307 ( 4) C24-C25 1.366 (6) 
C4-C5 1. -504 (3) C25-C26 1.393 (6) 
O5 - Sil - Cll 107:5 -( 1) O2 - C7- C8 128.2 (3) 
O.5 - Sil - Cl 7 105 .28 (11 ) O3- C9- O4 122.9 (2 ) 
Cll - S il- Cl 7 107.63 (13) O3-C9- C10 110.81 (19 ) 
O5 - Sil - C21 109.18 (9) O4- C9- C l0 126.3 (2) 
Cl 1-Sil - C21 110.31 (11 ) Sil - Cll- C 12 120.2 (2 ) 
Cl 7- S il - C21 116.52 (14) Sil - Cll - Cl6 122.2 (2) 
C5 - O1 - C7 118 .7 (2) C 12- Cll-ClG 117 .. 3 (3) 
C6 - O3 - C9 116.61 (16 ) Cll-C12- Cl3 121.1 ( 4 ) 
Sil - O5 - Cl 129 .87 (13) C12-C13- C 14 120.4 ( 4 ) 
O5 - C l - C2 107.36 (18 ) C13- C 14- Cl:'5 120.5 (3) 
O5 - Cl - C6 111.21 (1 7) C14- Cl5-C16 119.4 (4) 
C2 - Cl - C6 108.47 (17) Cl l - C16 _..:._Cl5 121.3 (4) 
Cll - C2 - Cl 108.17 (1S) Sil-Cl 7- C18 107.6 (2) 
Cll- C2 - C3 108.59 (1 7) S il- Cl 7-C19 110.1 (2) 
Cl - C2- C3 115.1 (2) Cl8- Cl 7- Cl9 109.4 (3) 
C2 - C3- C4 122.1 (2) Sil - Cl 7- C20 113.2 (2) 
C l2- C4- C3 121.8 (2) C18- Cl 7 - C20 106.0 (3) 
Cl2- C4- C.S ll.'3.81 (19) C19- Cl 7- C20 110.2 (3) 
C3- -C4-C5 124.3 (2) Sil-C21- C22 119.38 (19 ) 
O1- C5- C4 105.94 (HJ) Si1 - C21 - C26 124.5 (:3) 
O1 - C5 - CG 10'1.G6 (17) C22 --C21--C26 116.0 (.3) 
C4- C.5 - C6 108.81 (19) C21- C22 - C2:3 122.3 (3) 
O3 - C6-Cl 107.16 (15) C22-C23- C24 119.9 (3) 
O3--C6- C5 108.76 (17) C23- C24- C2.'5 11 9.9 (3) 
Cl -C6- C5 110.37 (18) C24- C25- C26 120.1 (3) 
O1 - C7- O2 12 2.5 (2) C21 --C26- C25 121.7 (4) 
CH-C7- C8 109 .2 (2) 
Data collection: COLLECT (Non.ius, 2001). Cell refinenient: HKL Scalepack (Otwinowski & 
Niinor 1997). Data reduction: Denzo and Scalepak (Otwinowski & 1\!Iinor, 1997) . Program(s) 
used to solve structure: SIR97 (Altomare et al. 1999) . ProgTan1(s) used to refine structure: 
CRYSTALS (Watkin et al.2001) . I'v1olecular graphics: CA1vIERON (Watkin et al.1996) . Software 
used to prepare material for publication: CRYSTALS (\Natk.in et al.2001) + maXus(Niackay et 
al., 1999) . 
Supplen1entary data for this paper are. available fr01n the IUCr electronic archives (Reference: ). 
Services for accessing these data are described at the back of the journal. 
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Supplementary data 
The tables of data shown below are not nonnally printed in Acta Cryst. Section C but the data 
will be available electronically via the online contents pages at 
http: //journals.iucr.org/ c/journalhornepage.htrnl 
:, Table Sl . Fractional atomic coord-inates and eq-ui11alent isotropic displacement pu,ramet ers ( A 2 ) 
u - (1/3) uiJ i j eq - L i~J a a ai .a j . 
X y z Ueq Cll 1.16437 (8) 0.44813 (5) 0.66541 ( 4) 0.0708 
Cl2 0.8712 (1) 0.176.55 (6) 0.72744 (.5) 0.0912 
Si l 0.88300 (7) 0.55109 (3) 0.51464 (3) 0.0437 
01 0 .68195 (18) 0.34656 (11 ) 0.68906 (8) 0.0493 
02 0.4517 (2) 0.28835 (14) 0 .67225 ( 11) 0.0706 
03 0.65772 (17) 0 .38252 (9) 0 .55491 (7) 0.0412 
04 0.5937 (2) 0.2643 (1) 0 .5006 (1) 0.0640 
0 5 0.9466.5 (17) 0 .45808 (9) 0.53933 (8) 0 .0448 
Cl 0.9085 (2) 0.41071 (12) 0 .59593 ( 11) 0.0395 
C2 1.0551 (3) 0.36944 (14) 0.62086 (12) 0.0457 
C3 1.0324 (3) 0.29545 (17) 0.66468 (14) 0.0558 
C4 0.8982 (3) 0 .26084 ( 16) 0.67328 (12) 0.0554 
C5 0.7530 (3) 0.29167 (14) 0 .. 64142 ( 12) 0.0464 
C6 0 .7939 (2) 0 .34164 ( 12) 0.57940 (11) 0.0383 
C7 0. 5305 (3) 0.33675 (18) 0.70207 (12) 0.0523 
C8 0.4866 (4) 0 .3930 (2) 0 .75719 (14) 0 .0738 
C9 0.5659 (3) 0.33603 ( 14) 0.51525 (12) 0.0466 
ClO 0.4298 (3) 0.38586 (17) 0.49398 (16) 0 .0605 
Cll 0.7613 (3) 0.53329 (16) 0.44041 (12) 0.0516 
Cl2 0 .7770 (4) 0.4593 (2) 0.40333 (13) 0.0680 
C l 3 0.6989 (6) 0.4486 (3) 0 .34438 (18) 0.1019 
Cl4 0.6049 (6) 0.5104 ( 4) 0.3212 (2) 0.1199 
C15 0.5833 (5 ) 0.5838 ( 4) 0.3570 (2) 0 .1044 
C l 6 0.6623 ( 4) 0.5953 (2) 0.41588 (16) 0.0722 
Cl7 1.0586 (3) 0.61091 (19) 0 .48703 ( 17) 0.0687 
Cl8 1.1347 ( 4) 0.5598 (3) 0.43176 (19) 0.0888 
C l 9 1.0129 (5) 0.6981 (2) 0.4603 (2) 0.0992 
C20 1.1799 (4) 0.6202 (3) 0. 5419 (2) 0.1009 
C21 0 .7671 (3) 0.60019 (14) 0.58305 (12) 0.0528 
C22 0.6125 ( 4) 0.58118 (16) 0.58836 (15) 0.0635 
C23 0. 5233 (4) 0. 60945 (19 ) 0.64086 (17) 0.0734 
C24 0.5861 (5) 0.6579 (2) 0.68829 (16) 0.0794 
C25 0.7371 (6) 0.6796 (3) 0.68453 ( 19) 0.1061 
C26 0.8268 (4) 0.6505 (3) 0.63232 (18) 0.0875 
Hll 0 .8617 (2) 0.44869 (12) 0.62987 (11) 0.0474 
H21 1.1092 (3) 0.34755 (14) 0.58077 (12 ) 0.0550 
H31 1.1228 (3) 0.27122 ( 17) 0.68835 (14) 0.0670 
H51 0 .6835 (3) 0 .24429 (14) 0.62861 (12) 0.0 ,557 
H61 0.8382 (2) 0 .30202 (12) 0.54598 ( 11) 0.0460 
H81 0.3751 (4) 0 .3859 (2) 0.76686 (14) 0.0885 
H82 0.5475 (4 ) 0.3782 (2) 0.79747 (14) 0.0885 
H83 0.5074 (4 ) 0.4529 (2) 0.74456 (14) 0.0885 
Hl0l 0.3636 (3) 0.35036 (17) 0.46476 (16) 0.0726 
Hl02 0.3702 (3) 0.40369 (17) 0 .53387 ( 16) 0.0726 
Hl03 0.4643 (3) 0.43695 (17) 0.46907 (16) 0.0726 
Hl21 0.8459 (4 ) 0.4135 (2) 0.41966 (13) 0.0816 
Hl31 0.7115 (6 ) 0.3951 (3) 0.31868 (18) 0.1221 
Hl41 0.5510 (6) 0.5026 (4) 0.2779 (2) 0.1438 
Hl51 0.5114 (5) 0.6282 (4) 0.3406 (2) 0.1257 
Hl 61 0.6482 (4) 0.6488 (2) 0 .44132 ( 16) 0.0866 
Hl81 1.2284 (4) 0.5900 (3) 0.41609 (19) 0.1066 
Hl82 1.1639 (4) 0.5029 (3) 0.4490.S (19) 0.1066 Hl83 1.0615 (4) 0..5.531 (3) 0.39406 (19) 0.1066 Hl91 1.1066 (5) 0.7293 (2) 0.4458 (2) 0.1190 Hl92 0.9601 (5) 0 .7307 (2) 0.4960 (2) 0.1190 
Hl93 0.9422 (-5) 0.6910 (2) 0.4218 (2) 0.1190 H201 1.2697 ( 4) 0 .6522 (3) 0.5244 (2) 0.1205 
H202 1.1348 (4) 0.6513 (3) 0.5803 (2) 0.1205 
H203 1.2139 ( 4) 0.5629 (3) 0.5567 (2) 0.120.s 
H221 0.5636 (4) 0.54592 (16) 0.55318 (15) 0.0761 
H231 0.4126 (4) 0.59372 (19) 0.64336 (17) 0.0880 
H241 0.5223 (5) 0.6780 (2) 0.72622 (16) 0.0952 
H251 0.7834 (6) 0.7164 (3) 0.71941 (19) 0.1278 
H261 0.937:3 (4) 0.6666 (3) 0.63054 (18) 0.1052 
Taule S2 . Anisutrop-ic displacement pararneters (A 2 ) 
U11 U22 U:3.3 U12 U13 U23 Cll 0.0604 ( 4) 0.0692 (4) 0.0828 (4) - 0.0012 (:3) -0.0286 (3) - 0.0050 (3) Cl2 0.0738 (5) 0.0908 (5) 0.1089 (6) 0.0106 ( 4) 0.0030 (-5) 0.0603 (-5) Sil 0.0447 (3 ) 0.0:362 (2) 0.0502 (3) - 0.0022 (2) -0.0082 (3) 0.0044 (2) 0 1 0.0436 (8) 0.0576 (9) 0.0467 (8) 0.0039 (7) 0.0045 (7) -0.0010 (7) 02 0.052 (1) 0.0830 (14) 0.0771 (13) - 0.004 (1) 0.002 (1) - 0.0035 (11) 
03 0.0420 (8) 0.0348 (6) 0.0467 (8) 0.0027 (6) -0.0074 (6) -0.0016 (6) 
04 0.0666 (11) 0.0476 (9) 0.0778 (12) 0.0006 (8) - 0.0161 (9) - 0 .0187 (8) 
05 0.0445 (8) 0 .0399 (8) 0.0500 (8) 0.0036 (6) 0.003:3 (6) 0.0061 (6) Cl 0.0381 (11) 0.0369 (9) 0.0434 (11) 0.0058 (8) -0.0009 (8) 0.0014 (8) 
C2 0.0:399 (11) 0.0458 (11) 0.0515 ( 12) 0.0061 (9) -0.0056 (9) - 0.0016 (9) 
C3 0.0472 (14) 0.0566 (14) 0.0636 (15) 0.0133 (11 ) - 0.0042 (11 ) 0.0128 (12) 
C4 0.0587 (14) 0.0502 (12) 0.0574 (14) 0.0130 (11) 0.0005 ( 11 ) 0.015 (1) 
C5 0.0473 (12) 0.0421 (11) 0 .0497 (12) 0.0052 (9) 0.001 (1) 0.0038 (9) 
C6 0 .037 (1) 0.0:332 (9) 0.0445 (11) 0.0061 (8) -0.0032 (8) - 0.0004 (8) 
C7 0.0465 (13) 0.0665 (15) 0.0438 (12) 0.0074 (11) - 0.000 (1) 0.0086 (11) 
C8 0.0586 (16) 0.111 (3) 0.0523 (15) 0 .0189 (16) 0.0004 (12) - 0 .0108 (15) 
C9 0.0473 (11) 0 .041 (1) 0.0514 ( 12) - 0.0034 (9) -0.007 (1) - 0.003 (1) 
ClO 0.0460 (13) 0.0556 (13) 0.0800 (18) - 0.0017 (11 ) - 0.0188 (12) -0.0014 (13) 
Cll 0.0505 (13) 0.0570 (13) 0.0473 (12 ) - 0.0060 (11) -0.005 (1) 0.007 (1) 
Cl2 0.0769 (19) 0.0744 (18) 0.0525 (14) -0.0182 (15) 0.0047 (12) - 0.0075 (13) 
Cl3 0.127 (3) 0.119 (3) 0 .0591 (18) - 0.050 (3) - 0.008 (2) -0.013 (2) 
Cl4 0.123 (4) 0.176 (5) 0.061 (2) - 0.067 ( 4 ) - 0.033 (2) 0 .024 (3) 
Cl5 0.078 (2) 0.144 (4 ) 0.091 (3) - 0.019 (2) -0.033 (2) 0.049 (3) 
Cl6 0.0641 (17) 0.0802 (19) 0.0724 (18) 0.0001 (14) -0 .0157 (15) 0 .0194 (15) 
Cl7 0.0593 (15) 0.0648 (15) 0.0820 (19) - 0.0213 (13) -0.0130 (15) 0.0256 (15) 
C18 0.0553 (17) 0 .114 (3) 0.098 (2) - 0.0068 (19) 0.0143 (16) 0.035 (2) 
Cl9 0.101 (3) 0.066 (2 ) 0.131 (3) - 0.0297 (19) -0.008 (2) 0.038 (2) 
C20 0.073 (2) 0.118 (3) 0.111 (3) - 0.049 (2) -0.029 (2) 0.032 (2) 
C21 0.0691 (16) 0.0366 (11 ) 0.0527 (13) 0.013 (1) -0.0172 (12) -0.0014 (9) 
C22 0.0732 (18) 0.0466 (12 ) 0.0706 (16) - 0.0072 (12) 0.0106 (14) - 0.0114 (11) 
C23 0.087 (2) 0.0563 (16 ) 0.0770 (19 ) 0.0034 (15) 0.0139 (16) -0.0054 (14) 
C24 0.099 (3) 0.084 (2) 0.0558 (16) 0.0297 (19) - 0 .0057 (16) -0.0082 (14) 
C25 0.112 (:3) 0.136 ( 4) 0.070 (2) 0.026 (3) -0 .037 (2) -0.053 (2) 
C26 0.075 (2) 0.108 (3) 0.079 (2) 0.0208 (18) -0.03:37 (17) - 0.040 (2) 
0 Table ~•3_ Geometric parameters ( A ) 0 ) 
Cll-C2 1.811 (2) Cll-Cl6 1.400 ( 4) Cl2- C4 1.743 (2) Cl2-Cl3 1.383 ( 5) Sil-O5 1.6530 (16) Cl2-Hl21 1.000 Sil-Cll 1.859 (2) Cl3-Cl4 1.362 (8) Sil-Cl7 1.889 (3) Cl3-Hl31 1.000 Sil- C21 1.881 (3) C14-Cl5 1.384 (7) O1-C.5 1.438 (3) Cl4-Hl41 1.000 O1-C7 1.3.59 (3) Cl5-Cl6 · 1.386 (-5) O2- C7 1.194 (3) Cl5- Hl51 1.000 O3-C6 1.443 (2) Cl6-Hl61 1.000 O3-C9 1.352 (3) Cl7-Cl8 1.531 (5) O4-C9 1.200 (3) Cl7-Cl9 1.536 ( 4) O5-Cl 1.408 ( .3 ) Cl7-C20 1.540 (5) Cl- C2 1.524 (3) Cl8-Hl81 1.000 Cl- C6 1.521 (3) Cl8-Hl82 1.000 Cl-Hll 1.000 Cl8-Hl83 1.000 C2-C3 1.483 (3) Cl9- Hl91 1.000 C2- H21 1.000 Cl9-Hl92 1.000 C3- C4 1.307 ( 4) Cl9-Hl93 1.000 C3- H31 1.000 C20-H201 1.000 C4-C5 1.504 (3) C20-H202 1.000 C5-C6 1.525 (3) C20-H203 1.000 C5- H51 1.000 C21-C22 1.:389 (4) C6- H61 1.000 C21-C26 1.377 (4) C7-C8 1.477 (4) C22-C23 1.390 (4) C8-H81 1 .000 C22-H221 1.000 C8- H82 1.000 C23-C24 1.345 (5) C8-H83 1.000 C23-H231 1.000 C9-Cl0 1.491 (3) C24-C25 1.366 (6) Cl0- Hl0l 1.000 C24- H241 1.000 Cl0- Hl02 1.000 C25-C26 1.393 (6) Cl0-Hl03 1.000 C25-H251 1.000 Cll- Cl2 1.398 ( 4) C26- H261 1.000 
O5-Sil-Cll 107. 5 (1) C l2- Cll-Cl6 117.3 (3) 
O5-Sil-Cl7 10-5.28 (11) Cll-Cl2-Cl3 121.1 ( 4) 
Cll-Sil- Cl? 107.63 (13) C ll-C l2-Hl21 119.47 (17) 
O5-Sil-C21 109.18 (9) C l3-C l2-Hl21 ll9.4 (:3) 
Cll-Sil-C21 ll0.31 (11 ) Cl2- Cl3-Cl4 120.4 ( 4) 
Cl 7- Sil-C21 ll6. -52 (14) Cl2- Cl3- Hl3 1 119.8 (3) 
C5- Ol-C7 ll8 .7 (2) Cl4-Cl3- Hl31 119.8 (3) 
C6- O3-C9 ll6.61 (16) Cl3-Cl4-Cl5 120.5 (3) 
Sil- O5- Cl 129.87 (13) Cl3-Cl4- _ Hl41 119.7 (3) 
O5- C'l- C2 107.36 (18) Cl5-Cl4- Hl41 ll9.8 (3) 
O5- Cl- C:6 111 .21 (17) Cl4-Cl5-Cl6 119 .4 (4) 
C2-C l-C6 108.47 (17) Cl4-Cl5-Hl.Sl 120.3 (3) 
O5-Cl-Hll 109.4 (1) C 16-C 15- H 151 120 .3 (3) 
C2-Cl-Hll 112.09 (12) Cll-Cl6-Cl5 121.3 (4) 
C6-Cl - Hll 108.32 (ll ) Cll-Cl6- Hl61 ll9 .33 (18) 
Cll- C2- Cl 108 .17 ( 15) Cl5-Cl6-Hl61 ll9 .4 (3) 
Cll- C2- C3 108.59 (17) Sil-Cl 7-Cl8 107.6 (2) 
Cl-C2-C3 ll5.l (2) Sil- Cl7- Cl9 110 .l (2) 
Cll- C2- H21 113.07 (8) Cl8-Cl 7-Cl9 109.4 (:3) 
Cl- C2- H21 106.21 (12) Sil- Cl7- C20 113.2 (2) 
C3- C2-H21 105.78 (14) Cl8-Cl 7-C20 106.0 (3) 
C2- C3-C4 122 .1 (2) Cl9-Cl 7-C20 110 .2 ( 3) 
C2- C3- H31 118.94 (13) Cl 7-Cl8- Hl81 109.44 (17) 
C4- C3- H31 118.97 (14) Cl 7- Cl8- Hl82 109.47 (17) 
Cl2- C4-C3 121.8 (2) Hl81-Cl8- Hl82 109.476 
Cl2- C4-C.5 113 .81 (19) Cl7-Cl8-Hl83 109.50 (17) 
C3- C4- C 5 124.3 (2) H 181---;-C 18- H 183 109.476 
Ol-C5- C4 105.94 (19 ) Hl82- Cl8-Hl83 109.476 
Ol- C5-C6 109 .66 (17) Cl 7-Cl9-Hl91 109.58 (19) 
C4-C5-C6 108.81 (19) Cl7- Cl9- Hl92 109 .4 (2) 
Ol- CS- H -5 1 111.44 (12) Hl91- Cl9- Hl92 109.476 
C4-C5-H51 112.26 (13) Cl 7- Cl9-Hl93 109 .4 (2) 
C6- C5- H -51 108. 67 (12) Hl91- Cl9-Hl93 109.476 
O3- C6- Cl 107 .16 (1.5 ) Hl92-Cl9- Hl93 109.476 
O3-C6- C 5 108.76 (17) Cl 7-C20- H201 109.45 (18) 
Cl- C6- C5 110 .37 (18) Cl7-C20- H202 109 .5 (2) 
O3-C6- H6 1 111.7 (1) H20 l - C20- H202 109.475 
C1-C6-H61 110.20 (11) Cl7- C20- H203 109 .4 (2) 
C5- C6- H61 108.60 (11 ) H201- C20-H203 109.476 
Ol- C7- O2 122.5 (2) H202- C20-H203 109.476 
Ol-C7-C8 109.2 (2) Sil-C21-C22 119.38 (19) 
O2- C7- · CS 128 .2 (:3) Sil- C21- C26 124.5 (:3) 
C7- C8- H81 109.39 (17) C22-C21- C26 116 .0 (3) 
C7- C8- H82 109 .50 (15) C21- C22-C23 122 .3 (3) 
H81- C8- H82 109.476 C21-C22-H221 118 .84 (15) 
C7-C8-H83 109.52 (18) C23-C22- H221 118 .8 (2) 
H81-C8-H83 109.476 C22-C23-C24 119 .9 (3) 
H82-C8-H83 109.476 C 22-C23- H231 120.0 (2) 
O3- C9-O4 122.9 (2) C24- C23- H231 120. 1 (2) 
O3-C9-Cl0 110.81 (19) C23-C24-C25 119.9 (3) 
O4- C9-Cl 0 126 .3 (2) C23-C24-H241 120.0 (2) 
C9- Cl0- H101 109.48 (13) C25- C24-H241 120 .0 (2) 
C9-Cl0- Hl02 109 .44 (16) C24- C 25-C26 120.1 (:3) 
Hl01-Cl 0-Hl02 109 .476 C24-C 25- H2-51 119 .9 (2) 
C9-Cl0- H103 109 .48 (14) C26-C25- H251 120 .0 (2) 
H101-Cl0- H103 109.476 C 21-C26-C25 121.7 ( 4) 
Hl 02-Cl0- Hl03 109.476 C21-C 26- H26 1 119.2 (2) 
Sil-Cll-Cl2 120.2 (2) C 25-C26- H261 119.1 (2) 
Sil-Cll-C l 6 1-:>·) ·, (")) 
....J...l • "-J ..J 
Appendices 
A 2.4 X-ray Structure Report for Compound 98a 
a X-ray crystal data are presented as provided by Dr A. J. Edwards at The Australian National 
University. 
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Abstract 
Comment 
The structure corresponds to a dichloro con1pound, not the dihydroxy species indicated at tirne 
of submission. The substitution pattern of the cyclohexene ring is as indicated , with the second 
chloride substituting for the hydroxide nearest the chloride. The absolute and relative stereo-
chemistries are as indicated on the subrnission forrn and the absolute stereochenlistry is una1n-
biguously deterrnined fron1 the anomalous dispersion effects observed in this experi1nent. 
A simple hydrogen bonding involving both intra and inter n1olecular interactions is observed 
for the hydroxyl gToup. 
Experimental 
Crystal data 
C24H2sCl2O4Si 
]VJ,. = 479.476 
Orthorhombic 
P212121 
a = 10.06920 (10) A 
b = 10.45860 (10) A 
0 
c = 23.9372 (:3) A 
V = 2520.82 (5) A·3 
Z=4 
Dx = 1.263 Nig m-3 
Dm. not measured 
Nio Ka. radiation 
0 
,,\ = 0. 71073 A 
Cell parameters from 27053 reflections 
g = 2.910-- 27.485° 
µ = 0.33 lillil -l 
T = 200 K 
Prism 
Colourless 
0.20 x 0.18 x 0.17 mn1 
Crystal source: local lal>oratory 
Data collection 
KappaCCD diffractometer 
CCD scans 
Absorption correction: 
by integration Gaussian by integra tion 
(Coppens, 1970) 
Tmin = 0.940 , T'inax = 0.956 
30616 n1easured reflections 
5767 independent reflections 
Refinement 
Refinen1ent on F 
R = 0.0290 
wR = 0.0301 
S = l.0799 
4200 reflections 
285 paraineters 
H atorns treated by a mixture of independent 
and constrained refi11en1e~nt 
Chebychev polynon1ial with 3 paranieters, 
Carruthers & vVatkin , 1979, 0.297 0.487 E-
010 .909.E-01 
4200 reflections with 
>3 .00o- ( 1) 
Rint = 0.042 
0max = 27.48° 
h = - 13 --+ L1 
k= - 13--+ 12 
l = -27--+ :31 
(.6.. / o-)max = 0.000645 
0 -3 
.0..Pmax = 0.24 e A · 
.0..fJmin = - 0.38 e A - 3 
Extinction correctiou: none 
Scattering factors frorn International Tables 
for X-ray Crystallography (Vol. IV) 
Absolute structure: Flack, 2400 Friedel-pairs 
Flack para111eter = -0.02 (5) 
0 
Table 1. Selt:.cted geometric parameters (A, o) 
Cll - C3 1.808 (2 ) C7--C8 1.490 (3) 
Cl2- C.5 1.737 (2) Cll- Cl2 1. 399 (3) 
Sil -O4 1. 6584 (13) Cll ·-C16 1. 394 (.3) 
Sil - Cll 1.8687 (El) C12- C13 1..39:; (3) 
Sil - C1 7 1. 885 (2) C13- C14 1.374 ( 4) 
Sil - C21 1.8723 (17) C l 4- Cl 5 1. 383 (4) 
Ol - C2 1.424 (2) Cl5- C16 1.395 (3) 
O2 - CG 1.449 (2 ) Cl7-C18 1. 540 (3) 
O2 - C7 1.361 (2) C17- C19 l.53~ (3) 
O3-C7 1.198 (2) C1 7- C20 1..538 (3) 
O4- C l 1.425 (2) C21 - C22 1.401 (J) 
C1-C2 1. 522 (2) C2 1- C26 1.397 (3) 
Cl - C6 1.529 (2) C22-C23 1.390 (3) 
C2- C3 1..521 (3) C23-C24 1.372 (3) 
C3-C4 1. 480 (3) C24-C25 1.376 (3) 
C4-C5 1..323 (3) C25-C26 1.389 (3) 
C5 - C6 1.496 (3 ) 
O4--Sil - Cl 1 109:50 (8 ) O2- C7- C8 110.98 (18 ) 
O4 - Sil - Cl7 104.13 (8) O3- C7- C8 125.8 (2 ) 
Cll - Sil - Cl 7 109.66 (9) Sil - Cll- C12 120.77 (15 ) 
O4- Sil - C21 108.85 (7) Sil - Cll- Cl6 121.77 (17) 
Cll - Sil - C21 108.28 (8) C 12- Cl l - C16 117.30 (19 ) 
C17- Sil - C2 1 116 .24 (8) Cll- C12 - C13 121.4 (2) 
C6- O2- C7 116.8.'i (14) C l2- Cl.'3 - Cl4 120.2 (2) 
Sil ·-O4- Cl 125.38 (1 1) C 13- C14 - Cl.S 119.7 (2) 
O4- C l - C2 110.17 (14 ) Cl4·-Cl.S - C16 120.2 (2) 
O4- Cl- C6 108.08 (13) Cl 1- Cl6- C15 121. 3 (3) 
C2- C l - C6 112 .50 (15) Sil- Cl 7- Cl8 108.32 (15) 
O1 - C2-Cl 112.50 (16) Sil - Cl7- C l 9 109.69 (14) 
O1 - C2- C3 106.60 (16) C18·- Cl 7- C19 108.9 (2) 
Cl-C2- C3 110.86 (16) Sil - C l 7--C20 112 .39 (15 ) 
Cll--C.'3 - C2 109.85 (14) C18- Cl 7- C20 108.3 (2) 
Cll - C3- C4 109.44 (1.'5) C19- C17- C20 1.09.14 (18) 
C2 - C3- C4 114.02 (17) Sil- C,21 - C22 118.67 (14) 
C3- C4- C5 121.95 (18) Sil-- C21-C26 124.09 (14 ) 
Cl2-C5- C4 120.54 (16) C22- C21 - C26 116.81 (16) 
Cl2- C5- C6 11 3 .97 (15 ) C21--C22·-C23 121.5 (2) 
C4- C5- C6 125 .49 (18) C22- C23- C24 120.0 (2) 
O2- C6- Cl 110.12 (14 ) C23- C24--C25 120.04 (19) 
O2 -- C6- C5 107.44 ( 14) C24- C25-C26 120 .0 (2) 
Cl - C6--C5 111.26 ( 15) C21- C26- C25 121.56 (El) 
O2--C7- O3 123.25 (19) 
Data collection: COLLECT (Nonius: 2001). Cell refinement: HKL Scalcpack (Otwiuowski & 
1vlinor 1997). Data reduction: Denzo and Scalepak (Otwinowski & 1vlinor , 1997). Program(s) 
used to solve structure: SIR97 (Altomare et al. 1999) . Prograin(s) used to refine structure: 
CRYSTALS (Watkin et al.2001) PLATON(Spek 1990). Molecular graphics: CA1vlERON (Watkin 
et al.1996) . Software used to prepare material for publication: CRYSTALS (VVatkin et al.2001) 
+ n1aXus(1vlackay et al., 1999) . 
Supplementary data for this paper are available fr-0111 the IUCr electrouic archives (Reference: ). 
Services for accessing these data are described at the back of the journal. 
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Table Sl. Fract-iunal atornic coordinates and equi-ualent 'isotropic displacement parameters ( A2 ) 
U - (1 3) U'iJ i J eq - / I:,ir,j a a a .;, .aj. 
X y z Ueq 
Cll 0.25963 (5) 0.47668 (5) 0.22435 (2) 0.0525 
Cl2 0.70980 (7) 0.46683 (7) 0.12812 (2) 0.0680 
Sil 0.57927 (5) 0.50-579 (.5) 0.397718 (19) 0.0279 
01 0.51251 (18) 0.74907 ( 13) 0.26358 (7) 0.0446 
02 0.75978 (13) 0.61036 (11) 0.24203 (5) 0.0339 
03 0.91407 (15) 0.47231 (14) 0.27377 (8) 0.0554 
04 0.62334 (12) 0.55576 ( 12) 0.33463 (5) 0.0304 
Cl 0.55774 (16) 0.52357 (16) 0.28381 (7) 0.0267 
C2 0.4553 (2) 0.62525 (17) 0.26925 (9) 0.0350 
C3 0.3881 (2) 0.59508 (19) 0.21389 (9) 0.0408 
C4 0.4804 (2) 0.5507 (2) 0 .16981 (8) 0.0440 
cs 0.6029 (2) 0.51:34 (2) 0.18132 (8) 0.0401 
C6 0.66327 (17) 0.50795 (18) 0'.23837 (7) 0.0314 
C7 0.8817 (2) 0.5795 (2) 0.26254 (9) 0.0397 
C8 0.9660 (2) 0.6957 (2) 0.26894 (13) 0.0582 
Cll 0.6587 (2) 0 .34777 (18) 0.41226 (8) 0.0341 
Cl2 0.7709 (2) 0.30823 (19) 0.38239 (9) 0.0400 
Cl3 0.8371 (2) 0.1951 (2) 0.39563 (12) 0.0538 
Cl4 0.7926 (3) 0.1195 (2) 0.43865 (12) 0.0639 
C15 0.6815 ( 4) 0.1559 (2) 0.46871 (11) 0.0659 
Cl6 0.6151 (3) 0.2690 (2) 0.4555 (1) 0.0492 
Cl7 0.64938 (19) 0.6305 (2) 0.44637 (9) 0.0357 
Cl8 0.8018 (2) 0 .6184 (3) 0.44614 (12) 0.0578 
Cl9 0.5981 (3) 0.6069 (2) 0.50604 (9) 0.0500 
C20 0.6128 (3) 0.7672 (2) 0.4284 (1) 0.0501 
C21 0.39473 (16) 0 .48410 ( 17) 0.39938 (7) 0.0310 
C22 0.3414 (2) 0.3671 (2) 0 .38181 (9) 0.0421 
C23 0.2054 (2) 0.3505 (2) 0.3748 (1) 0.0513 
C24 0.1199 (2) 0.4495 (2) 0.3858 (1) 0.0496 
C25 0.1686 (2) 0.5651 (2) 0.4042 (1) 0.0471 
C26 0.:3046 (2) 0.5821 (2) 0.41091 (9) 0.0402 
Hl 0.594 ( 4) 0.754 (3) 0.2691 (16) 0.098 (12) 
Hll 0.50810 (16) 0.44120 (16) 0.28757 (7) 0.0320 
H21 0.3903 (2) 0.62491 (17) 0.30084 (9) 0.0420 
H31 0.3494 (2) 0.67753 (19 ) 0.20035 (9) 0.0490 
H41 0.4491 (2) 0.5488 (2) 0. 13017 (8) 0.0527 
H61 0.70630 (17) 0.42285 (18) 0.24429 (7) 0.0377 
H81 1.0549 (2) 0.6706 (2) 0.28403 (13) 0.0699 
H82 0.9222 (2) 0.7566 (2) 0.29534 (13) 0.0699 
H83 0.9776 (2) 0.7377 (2) 0.23174 (13) 0.0699 
Hl21 0.8042 (2) 0.36218 (19) 0.35087 (9) 0.0480 
Hl31 0.9173 (2) 0.1690 (2) 0.37376 (12) 0.0646 
Hl41 0.8402 (3) 0.0385 (2) 0.44817 (12) 0.0767 
Hl51 0.6488 (4) 0.1010 (2) 0.50003 ( 11) 0.0791 
Hl61 0 .5347 (3) 0.2940 (2) 0.4774 (1) 0.0590 
Hl81 0.8408 (2) 0.6839 (3) 0.47176 (12) 0.0696 
Hl82 0.8276 (2) 0.5310 (3) 0.45913 ( 12) 0.0696 
Hl83 0 .8359 (2) 0.6325 (3) 0.40738 (12) 0.0696 
Hl91 0.6355 (3) 0.6732 (2) 0.53172 (9) 0.0601 
Hl92 0.6266 (3) 0.520 1 (2) 0.51881 (9) 0.0601 
Hl93 0.4990 (3) 0.6121 (2) 0.50635 (9) 0.0601 
H201 0.6520 (3) . 0.8297 (2) 0.4554 (1) 0.0602 H202 0.5140 (3) 0.7767 (2) 0.4281 (1) 0 .0602 H203 0 .6485 (:3 ) 0. 7840 (2) 0.3902 (1) 0.0602 H221 0.4025 (2) 0 .2938 (2) 0.37414 (9) 0 .0506 
H231 0 .1699 (2) 0.2663 (2) 0.3617 (1) 0.0616 
H241 0.0222 (2) 0.4377 (2) 0.3805 (1) 0. 0596 
H25 1 0.1062 (2) 0.6368 (2) 0.4127 (1) 0.0566 
H261 0.3386 (2) 0.6665 (2 ) 0.42432 (9) 0.0483 
Table S2 . An-isotrup-ic displacemf:.nt parameters (,L\.2 ) 
U11 U22 U33 U12 U13 U2 3 Cll 0.0382 (3) 0.0551 (3) 0 .0643 (3) -0.0088 (2) - 0.0109 (2) 0 .0096 (3) Cl2 0.0751 ( 4) 0.0888 (5) 0 .0403 (3) -0 .0143 ( 4) 0.0177 (3) - 0.0173 (3) Sil 0.0285 (2) 0.0277 (2) 0.0274 (2) - 0.0008 (2) -0.00272 (19) - 0.0014 (2) 
01 0.0511 (9) 0.0251 (7) 0.058 (1) 0 .0023 (6) -0.0096 (8) 0.0031 (7) 02 0.0322 (7) 0 .0292 (6) 0 .0402 (7) -0.0022 (5) - 0.0002 (6 ) 0.0032 (.5 ) o-~ 0.0397 (8) 0.0440 (9) 0.0827 ( 12) 0.0083 (7) -0.0050 (8) 0 .0103 (8) ,) 
04 0.0312 (6 ) 0.0307 (6 ) 0.0294 (6) - 0.003-5 (5) -0.0039 (5) 0.0000 (-5) Cl 0.0298 (8 ) 0.0246 (8) 0.0258 (8) - 0.0012 (7) -0 .0037 (6 ) 0.0017 (7) 
C2 0.039 (1) 0.0278 (9) 0 .038 (1) 0.002.5 (8) - 0.0035 (8) 0 .0031 (8) 
C3 0.0434 (11) 0.035 (1) 0 .0441 (11 ) -0.0037 (8 ) - 0 .0123 (9) 0.0107 (9) 
C4 0.0548 (13) 0.04-50 (12) 0.032 (1) - 0.014 (1) -0.0088 (9) 0.0073 (9 ) 
C5 0.0527 (12) 0.0377 (11 ) 0.0298 (9) - 0.012 (1) 0.0048 (8 ) - 0.0014 (8) 
C6 0.0358 (9) 0.0246 (8 ) 0 .0339 (9) - 0 .0037 (8 ) 0 .0021 (7) 0 .0005 (8) 
C7 0.033 (1) 0.0410 (11 ) 0.0449 (11 ) 0.0008 (8 ) 0.0042 (9) 0.0007 (9 ) 
cs 0.0395 (12) 0.0501 (13) 0.0849 (19) -0.009 (1) - 0.0089 (13 ) 0.0033 (U) 
Cll 0.0404 (11 ) 0.0290 (9 ) 0 .033 (1) - 0.0002 (8) -0.0106 (8) - 0.0028 (7) 
Cl2 0.0342 (11) 0 .035 (1 ) 0.0504 ( 12) - 0.0002 (8) - 0.0102 (9) - 0.0028 (9) 
Cl3 0.0400 (12) 0 .0413 (11 ) 0.0802 (17) 0.0077 (9) - 0.0195 (12) - 0.0106 (12) 
Cl4 0.0734 (19 ) 0.0382 (l3 ) 0 .0802 (19 ) 0.0093 (12) -0.0377 ( 16) 0.0017 (13) 
Cl5 0.106 (2) 0.0391 (13) 0.0525 (15) - 0.0045 (14) -0.0206 (15) 0 .0146 (11) 
Cl6 0.0683 (16) 0.0414 (1 2) 0.0378 (11) 0.0027 (11) - 0.0032 (11 ) 0 .0032 (9) 
C17 0.034 ( 1) 0.035 (1 ) 0.0:383 (11) - 0.0027 (8) - 0.0043 (8) - 0.0072 (8) 
Cl8 0.0365 (12) 0.0628 (16) 0 .0741 (17) - 0.0065 (11) -0.0135 (11) - 0.0220 (13) 
Cl9 0.0665 (16) 0.0491 (13) 0 .0345 (11 ) - 0.0029 (12) -0.0079 (11 ) - 0.0111 (9) 
C20 0.0602 (1-5) 0 .0345 (11 ) 0.05.57 (14) - 0.008 (1) - 0.0067 (12) - 0.005 (1) 
C21 0.0 320 (9) 0.0334 (9) 0.0276 (8) - 0.0047 (7) - 0 .0003 (7) - 0.0013 (8) 
C22 0.0371 (11 ) 0.0425 (11 ) 0.0468 (12) - 0.0040 (9) -0.0025 (9 ) - 0.0085 (9) 
C23 0.0430 (13 ) 0.0533 (13) 0 .0577 (14) - 0.015 (1) -0.0033 (11) - 0.0144 (11 ) 
C24 0.031 (1) 0.0672 (15) 0.0508 (13) - 0.007 (1) - 0.0044 (9) - 0.0031 (11 ) 
C25 0.034 ( 1) 0.0517 (12) 0 .0554 (13) 0.00-50 (9) - 0.002 (1) - 0.0044 (11 ) 
C26 0.037 (1) 0.0397 (11 ) 0.0438 (11) - 0.0008 (8) - 0 .0006 (9) - 0 .0026 (9) 
J Table 83. Geometric parameters ( A , 0 ) 
Cll-C3 1.808 (2) Cl3- Cl4 1.374 ( 4) Cl2-C5 1.737 (2) Cl3-Hl31 1.000 Sil- O4 1.6584 ( 13) Cl4-Cl.S 1.383 ( 4) 
Sil- Cll 1.8687 (19) Cl4-Hl41 1.000 
Sil-Cl7 1.885 (2) Cl.S-Cl6 1.:395 (3) Sil-C21 1.8723 ( 17) Cl5-Hl51 1.000 
Ol-C2 1.424 (2) Cl6-Hl61 1.000 
O1- Hl 0.83 ( 4) Cl7-Cl8 1.540 ( 3) 
O2-C6 1.449 (2) Cl7-Cl9 1.539 (3) 
O2-C7 1.361 (2) Cl7-C20 1.538 (3) 
O3-C7 1.198 (2) Cl8-Hl81 1.000 
O4- Cl 1.425 (2) Cl8-Hl82 1.000 
Cl- C2 1..522 (2) Cl8-Hl83 1.000 
Cl-C6 1.529 (2) Cl9- Hl91 1.000 
Cl-Hll 1.000 Cl9-Hl92 1.000 
C2- C3 1.521 (3) Cl9-Hl93 1.000 
C2-H21 1.000 C20-H201 1.000 
C3-C4 1.480 (3) C20-H202 1.000 
C3- H31 1.000 C20-H203 1.000 
C4- C5 1.323 (3) C21-C22 1.401 (3) 
C4-H41 1.000 C21-C26 1.397 (3) 
C5-C6 1.496 (3) C22- C23 1.390 (3) 
C6-H61 1.000 C22-H221 1.000 
C7- C8 1.490 (3) C23-C24 1.372 (3) 
C8- H81 1.000 C23-H231 1.000 
C8-H82 1.000 C24-C25 1.376 (3) 
C8- H83 l.000 C24-H241 1.000 
Cll-Cl2 1.399 ( 3) C25-C26 1.389 (3) 
Cll-Cl6 1.394 (3) C25- H2.Sl 1.000 
Cl2- Cl3 1.395 (3) C26- H261 1.000 
Cl2-Hl21 1.000 
O4- Sil-Cll 109·. 50 (8) C12-Cl3- Cl4 120.2 (2) 
O4-Si 1-C 1 7 104.13 (8) C12-Cl3- H131 119.90 (15) 
Cll-Sil-Cl7 109.66 (9) C 14- C 13- H 131 119.92 (16) 
O4-Sil-C21 108.85 (7) Cl3-Cl4-Cl5 119.7 (2) 
Cll--Sil-C:21 108.28 (8) Cl3- Cl4--Hl41 120.14 (16) 
Cl7--Sil--C21 116.24 (8) Cl5-Cl4--Hl41 120.15 (1.5) 
C2- Ol--Hl 116.3 (24) Cl4-Cl5-Cl6 120.2 (2) 
C6--O2- C7 116.85 (14) Cl4- Cl5--Hl51 119.90 (15) 
Sil- O4--Cl 125.38 (11 ) Cl6- Cl .5--Hl51 119.92 (17) 
O4- Cl-C:2 110.17 (14) C 11-C 16-C 15 121.3 (3) 
O4-Cl-C:6 108.08 (13 ) Cll-Cl6- Hl61 119.38 (13) 
C2- Cl- C6 112.50 (1-5 ) C 15-C 16--H 161 119.36 (17) 
O4- Cl-Hll 111.00 (8) Sil-Cl 7-Cl8 108.32 (1-5) 
C2--Cl-Hll 106.48 (9) Sil- Cl7-Cl9 109.69 (14) 
C6-Cl-Hll 108.62 (9) Cl8- Cl7-Cl9 108.9 (2) 
Ol- C2- Cl 112.,50 (16) Sil-Cl7- C20 112.39 (1.5) 
Ol- C2- C3 106.60 (16) Cl8-Cl7-C20 108.3 (2) 
Cl-C2-C3 110.86 (16) Cl9- Cl 7-C20 109.14 (18) 
O1- C2-H21 109.89 (11) Cl7- Cl8-Hl81 109.46 (12) 
Cl- C2- H21 105.5 ( 1) Cl 7-Cl8-H182 109.47 (14) 
C3- C2-H21 111.54 (11) Hl81-Cl8- Hl82 109 .476 
Cll-C3-C2 109.85 (14) Cl7- Cl8- Hl83 109.47 (14) 
Cll-C3-C4 109.44 (15) Hl81-Cl8- Hl83 109.476 
C2-C3-C4 114.02 (17) Hl82-C l 8-Hl83 109.476 
Cll- C3- H31 110.91 (7) Cl 7-Cl9-Hl91 109.47 (11) 
C2- C3- H31 106.0 (1) C17-Cl9- Hl92 109.47 (12) 
C4- C3-H31 106 .49 (11 ) Hl91- ·Cl9- Hl92 109.476 
C3- C4- C5 121.9,5 (18) Cl 7- C19--Hl93 109.46 (12) 
C3- C4- H41 119.03 (11) H191-Cl9- Hl93 109.476 
C5--C4--H41 119.02 (12) H 192-C 19--H 193 109.476 
Cl2-C5-C4 120. 54 (16) Cl7- C20- H201 109.47 (12) 
Cl2- C5- C6 113.97 (15) Cl 7- C20-H202 109.46 (12) 
C4--C5- C6 125 .49 ( 18) H201-C20--H202 109.476 
O2-C6-Cl 110.12 (14) Cl7- C20- H203 109.47 (13) 
O2- C6- C5 107.44 (H ) H201- C20-H203 109.476 
Cl-C6-C5 111.26 (15) H202- C20-H203 109.476 
O2-C6- H61 111.02 (9) Sil-C21- C22 118.67 (14) 
Cl- C6-H61 107 .18 (9) Sil-C21- C26 124.09 (14) 
C5- C6- H61 109.86 (11 ) C22- C21-C26 116.81 (16) 
O2- C7- O3 123.2,5 (19) C21- C22-C23 121.5 (2) 
O2-C7-C8 110.98 (18) C21-C22-H221 119 .23 (11) 
O3- C7-C8 125.8 (2) C23- C22- H221 119 .24 (14) 
C7- C8- H81 109.47 (13) C22-C23- C24 120.0 (2) 
C7- C8- H82 109.47 (13 ) C22- C23-H231 119.99 (14) 
H81-C8-H82 109.476 C24- C23-H231 120.00 (13) 
C7-C8-H83 109.47 (14) C23- C24-C25 120.04 (19) 
H81-C8-H83 109.476 C23- C24-H241 119.98 (13) 
H82- C8-H83 109.476 C25- C24-H241 119 .98 (13) 
Sil- Cll- Cl2 120.77 (15) C24-C25-C26 120 .0 (2) 
Sil- Cll-C:16 121.77 (17) C24-C25-H251 119 .98 (13) 
Cl2- Cll-Cl6 117.30 (19) C26-C25- H251 119 .99 (13) 
Cll- Cl2-Cl3 121.4 (2) C21-C26-C25 121.56 (19) 
Cll-Cl2-H121 119 .31 (12) C21- C26-H261 119.22 (11 ) 
Cl3-Cl2-Hl21 119.31 (15) C25- C26-H26 l 119.21 (1 ~) 
Appendices 
A 2.5 X-ray Structure Report for Compound 100a 
(\__ 
{' }):\,-"• lllllli; ---
010 ~t) 
r, J i, /-;;;,/,/) 0 1 J)L"' ',-~r'_µz .... i!"""' 
(,..;;;~~;~,--.... 
01, .. c-r 
. '"" \'-.":;,,,,,.~ 7~,) 
014 /,._-_'.}:S~.J 
l I..,,."-'\,;; 
c*z_, 
7----,,."_,,_'::} -, __ ,, ... ,. .......... ~ ..... -· (_.> 
0 18 //' i\ ·, 
(::::::::\\}_._'.,'j 
"'"(,,,,,,,••• .•y• .. 
. .,.,.,. .... ,._ 
cjiJi;;~, 
a X-ray crystal data are presented as provided by Dr A. J. Edwards at The Australian National 
University. 
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Abstract 
Comment 
Experimental 
Crystal data 
C1sH220g 
!VI,. = 346.332 
:Nionoclinic 
C2 
a = Hi5808 (:3) A 
b = 5.732:30 (10) A. 
c = 19.0387 (5) A 
/3 = 109.5197 (9) 0 
V = 1705.G5 (6) A_ :3 
Z= 4 
D,r. = l. :349 l\!Ig m - 3 
Dm not 111.easurc.d 
Data c:ollect'ion 
KappaCCD diffractometer 
CCD scans 
Absorption correction: 
by integration Gaussian by integTation 
( Coppens, 1970) 
T mill = 0.959 , Trnax = 0.988 
18908 measured reflections 
2155 independent reflections 
l\!lo Ka radiation 
0 
>. = 0.71073 A 
Cell paraineters from 13077 reflections 
f) = 2.910- 27.485° 
µ = 0 .112 llllil - l 
T = 200 K 
Prisn1 
Colourless 
0.:39 x 0.32 x 0.11 nun 
Crystal source: local laboratory 
1307 reflections with 
> 2.00o-(1) 
Rint = 0.083 
Brnax = 27.48° 
h = - 21 --+ 21 
k=-7--+7 
l = - 24 --+ 24 
Refinement 
Re:finern.ent on F 
R = 0.0349 
wR = 0.0389 
S = 1.0604 
1:307 reflections 
217 para111eters 
H-atom parameters not refined 
Chebychev polynomial with :-3 paran1eters1 
Carruthers & Watkin , 1979, 0.292 0.180 
0.361£-01 
(6/0")max = 0.003255 
0 -3 6Pmax = 0.28 e A 
6Prnin = -0.19 e A - 3 
Extinction correction: none 
Scattering factors fron1 International Tables 
for X~ray Crystallography (Vol. IV) 
~ Table 1. Selected geometr·ic parameters ( A, 0 ) 
O1 - C2 1.415 (4) O2 1- C7 1.430 ( 4 ) 
O1 - C5 1.4 .5 1 (4) O21---'-C22 1.423 ( 4) 
O8 - C2 1.439 ( 4) C2- C3 1.503 (4 ) 
O8 - C9 1.373 ( 4) C3-- C4 1.518 (5) 
O10- Cfl 1.195 (4) C4 - C5 1..519 (5) 
O12- C3 1.447 (4) C.5 - C6 1..515 (4) 
O12 - C13 l..'34 :3 (4) C6- C7 1 "?." (") • d.;.J,) .J 
O14- Cl3 1.193 (5 ) C0- Cll 1.491 (5) 
O16- C4 1.442 (4) Cl3- Cl5 1.495 (5) 
OlG --Cl 7 1.3:56 (4) Cl7- C19 1.492 (-5) 
O18--Cl 7 1.191 (5) C22- C23 1.516 (4 ) 
O20 - CG 1.428 (4) C22- C24 1..502 (5 ) 
O20 - C22 1.449 (4 ) 
C2-O1- C5 
C2 - O8- C9 
C3- O12- Cl3 
C4- O 16-C17 
C6- O20- C22 
C7- O21-C22 
O1- C2- O8 
O1-C2-C3 
O8-C2-C3 
O12- C3- C2 
O12- C3- C4 
C2- C.'l- C4 
O16- C4- C3 
O16- C4- C5 
C3 - C 4- C5 
O1- C5-- C4 
O1- C5 - C6 
C4- C5- C6 
O20- C6- C5 
110 .0 (2 ) 
11 5 .4 (3) 
118 .2 (3) 
115 .8 (3) 
108 .8 (2 ) 
10-5.7 (3) 
110.2 (2 ) 
106.2 (3) 
106.3 (3) 
105. l (3) 
108.7 (3) 
100.5 (3) 
113.7 (2) 
109.2 (.3) 
101.9 (3) 
103 .9 (3) 
110.7 (2) 
11 5.5 (3) 
11 2.0 (3) 
O20- C6-C7 104.3 (2) 
C.S - C6- C7 114.5 (3) 
O2 1- C7- C6 103 .5 (3 ) 
O8- C9- O 10 122 .. s (:::l) 
O8-C9- Cll 11 1.0 (3) 
O 10- C9- Cll 126 .. '5 (3) 
O12- Ci:3-O14 123. 7 (4 ) 
O 12- C1 3-C15 109.7 (3 ) 
O 14-- C13- C15 126.6 (3) 
O 16- C17-O18 123 .4 (3) 
O16- Cl 7- C19 111.9 (3) 
O18- C l 7--:-- C19 124 .7 (4) 
O2 0- C22- O2 1 104. 5 (3) 
O 20- C22- C23 110.0 (3) 
021 - C22- C23 111.!'i (3 ) 
O20- C22 - C24 108.7 (3) 
O2 1- C22- C24 109.1 (3) 
C23- C22- C24 11 2.7 (.3) 
Data collection: COLLECT (Nonius BV, 1997) . Cell re£nen1ent: HKL Scalepack (Otwinowski & 
1'viinor 1997). Data reduction: Denzo and Scalepak (Otwinowski & Minor , 1997). Progrmn(s) used 
to refine structure: CRYSTALS (\tVatkin et al.2001) + n1c:1Xus(1'vlackay et al. , 1999) . 1'vlolecular 
graphics: CAl'vfERON (\tVatkin et al.1996) . Software used to prepare material for publication: 
CRYSTALS (vVatkin et al.2001) + m aXus(1'vlackay et al. , 1999) . 
Supplementary data for this paper are available fron1 the IUCr electronic archives (Reference: ). 
Services for accessing these data are described at the back of the journal. 
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0 Table Sl. Fractional atomic coordinates and equivalent isotropic di.splacement parameters ( A 2 ) 
u - (1/3) uiJ i j eq - I:iI:j a a a i. a j. 
X y z Ueq 
01 0.29737 (14) 0 .6776 (4) 0.30419 (12) 0.0387 
08 0.28217 (14) 0.3027 (4) 0.34680 (11) 0.0379 
010 0.29586 (17) 0.4760 (5) 0.45641 (13) 0.0515 
012 0.12836 ( 13) 0.6174 (4) 0.20018 (12) 0.0404 
014 0.04178 (17) 0.3765 (.5) 0.11585 (17) 0.0639 
016 0.22859 (15) 0.4732 (4) 0.11613 (12) 0.0396 
018 0.2162 (3) 0.0840 (-5) 0.10551 (16) 0.0789 
020 0.44772 ( 14) 0.4990 (4) 0.27498 (12) 0.0370 
021 0.52933 (15) 0.8219 (5) 0.31576 (14) 0.0463 
C2 0.2379 (2) 0.5067 (6) 0 .30912 (18) 0.0365 
C3 0.1898 (2) 0.4330 (6) 0.23046 (17) 0.0364 
C4 0.26002 (19) 0.4497 (6) 0 .19611 (16) 0.0335 
C5 0.3053 (2) 0.6735 (6) 0,23055 (16) 0.0360 
C6 0.39826 (19) 0 .6916 (7) 0.23575 (17) 0.0372 
C7 0.4447 (2) 0.9057 (6) 0.2777 (2 ) 0.0454 
C9 0.3076 (2) 0.3098 (7) 0.42321 (17) 0.0374 
Cll 0.3501 (2) 0.0874 (7) 0.45639 (19) 0.0453 
Cl3 0.0581 (2) 0.5669 (7) 0.14211 (19) 0.0453 
Cl5 0.0064 (2) 0.7834 (8) 0.1161 (2 ) 0.0570 
Cl7 0.2059 (2) 0 .2718 (7) 0.07717 (19) 0.0476 
Cl9 0.1659 (3) 0.3153 (9) -0.00443 (18) 0.0588 
C22 0.5194 (2) 0.5875 (6) 0.33609 (18) 0.0374 
C23 0.4992 (2) 0.5765 (8) 0.40803 (18) 0.0464 
C24 0.5980 (2) 0.4508 (7) 0.3398 (2) 0.0457 
H21 0.2004 (2) 0.5718 (6) 0.33604 (18) 0.0443 
H31 0.1600 (2) 0.2786 (6) 0.22309 (17) 0.0434 
H41 0.29647 (19) 0.3064 (6) 0.20630 (16) 0.0403 
H51 0.2778 (2) 0.8083 (6) 0.19803 (16) 0 .0441 
H61 0.39504 (19) 0.6983 (7) 0.18240 (17) 0.0452 
H71 0.4170 (2) 0.9642 (6) 0.3136 (2) 0.0562 
H72 0.4461 (2) 1.0333 (6) 0.2424 (2) 0.0562 
Hlll 0.3680 (2) 0.0964 (7) 0.51195 (19) 0.0556 
H112 0.4016 (2) 0 .0607 (7) 0.44121 (19) 0.0556 
H113 0.3089 (2) - 0.0445 (7) 0.43813 (19) 0.0556 
Hl51 - 0.0459 (2) 0.7471 (8) 0.0727 (2) 0.0648 
H152 -0.0108 (2) 0.8476 (8) 0.1579 (2) 0.0648 
Hl53 0.0419 (2) 0.9012 (8) 0.1009 (2) 0.0648 
H231 0.5487 (2) 0.6381 (8) 0.45011 (18) 0.0553 
H232 0.4883 (2) 0.4104 (8) 0.41821 (18) 0.0553 
H233 0.4471 (2) 0.6721 (8) 0.40311 (18) 0.0553 
H241 0.6481 (2) 0.5106 (7 ) 0.3816 (2) 0.0584 
H242 0.5885 (2) 0.2826 (7) 0.3486 (2) 0.0584 
H243 0.6094 (2) 0.4675 (7) 0.2917 (2) 0.0584 
Hl91 0.1647 (3) 0.4872 (9) -0.01370 (18) 0 .0700 
H192 0.1995 (3) 0. 2363 (9) -0.03249 (18) 0.0700 
Hl93 0.1060 (3) 0.2533 (9) -0.02159 (18) 0.0700 
Table S2. An·isotrop-ic displacement parameters (A.2 ) 
U11 U22 U33 U12 U13 U 23 
01 0.0407 (11) 0.0384 (13) 0.0361 (11 ) -0.0009 (11) 0 .0116 (9) -0 .0047 (11 ) 
08 0.0426 (12) 0.0380 (13) 0.0324 (11 ) 0.0053 (11) 0.0117 (9) 0. 001 (1) 
010 0.0632 (15) 0.0499 (16) 0.0407 ( 14) 0.0100 ( 14) 0.0163 (12) - 0 .0035 (12) 
012 0.0325 (11 ) 0.0392 (14) 0.0431 ( 12) 0.005 (1) 0.0040 (9) -0.0033 (11 ) 
014 0.0515 (16) 0.0512 (17) 0.0696 ( 18) - 0.0001 (14) -0.0056 (14) -0.0097 (15) 
016 0.0465 (12) 0.0385 (13) 0.0284 ( 11) 0.0023 (11) 0.0055 (9) 0.00-5 (1) 
018 0.136 (3) 0. 0393 (16) 0.0435 (16) 0.0162 (19 ) 0 .0063 (17) -0 .0035 (15) 
020 0.0353 (11) 0 .0341 (13) 0.038.5 (13) 0.002 (1) 0.008 (1) - 0.001 (1) 
021 0.0416 (13) 0.0384 (14) 0.0.567 (15 ) - 0.0057 (12) 0.0135 (11) 0.0019 (13) 
C2 0.0364 (15) 0.0362 (18) 0.0358 (16) 0.0025 (14) 0.0106 ( 13) 0 .0012 (15) 
C3 0.0340 (15) 0 .0344 (18) 0.0374 (16) 0.00.50 (14) 0.0072 (13) 0 .0038 (14) 
C4 0.0365 (14) 0.0335 (17) 0.0278 (14) 0.0032 (14) 0.0069 (12) 0.0023 (13) 
C5 0.0417 (16) 0.0344 (17) 0.0311 (15) 0.0048 (15) 0.0111 (13) 0.0039 (14) 
C6 0.0383 (16) 0.0362 (17) 0.0352 (16) 0.0003 (16) 0.0098 (13) 0.0040 (16) 
C7 0.0456 (19) 0.0309 (18) 0.057 (2) -0.0008 (15) 0.0131 (17) 0.0060 (16) 
C9 0.0356 (16) 0.043 (2) 0.0332 (17) -0 .0010 (16) 0.0112 (13) 0.0014 (16) 
Cll 0.050 (2) 0.044 (2) 0.0410 (17) 0.0022 (18) 0.0150 (15) 0.0050 (18) 
Cl3 0.0354 (18) 0.049 (2) 0.0449 (19) - 0.0002 (16) 0 .0052 (15) -0.0001 (18) 
C15 0.045 (2) 0.053 (3) 0.059 (2) 0.0097 (18) 0 .0002 (17) 0.003 (2) 
Cl7 0.061 (2) 0.044 (2) 0 .0341 (18) 0.0092 (19) 0.0115 (16) - 0.0047 (17) 
Cl9 0.069 (2) 0.066 (3) 0.0338 (18) 0.008 (2) 0.0065 (17) -0.001 (2) 
C22 0.0366 (16) 0.0331 (17) 0.0407 (17) - 0.0025 (15) 0 .0104 (13) -0.0013 (16) 
C23 0.0417 (17) 0.057 (2) 0.0401 (18) 0.0023 (17 ) 0.0128 (14) 0.0030 (19) 
C24 0.0340 (16) 0 .048 (2) 0.055 (2) 0.0042 (17) 0.01.50 (15) 0.0022 (18) 
Table S3 . Geometric parameters ( A, 0 ) 
Ol- C2 1.415 ( 4) C6-H\3l 1.000 
Ol-C5 1.45 1 (4) C7-H71 1.000 
O8- C2 1.439 ( 4) C7-H72 1.000 
O8- C9 1.373 ( 4) C9-Cll 1.491 (5) 
O10-C9 1.195 (4) Cll-Hlll 1.000 
O12- C3 1.447 ( 4) Cll-Hll2 1.000 
O12-Cl 3 1.343 ( 4) Cll-Hll:3 1.000 
O14-Cl3 1.193 (5) C13-Cl5 1.495 (5) 
O16- C4 1.442 ( 4) Cl5- Hl51 1.000 
O16- Cl7 1.356 ( 4) Cl5- Hl52 1.000 
O18-Cl7 1.191 (5) Cl5-Hl53 1.000 
O20-C6 1.428 ( 4) Cl7-Cl9 1.492 ( 5) 
O20- C22 1.449 ( 4) Cl9- Hl91 1.000 
O21-C7 1.430 ( 4) Cl9-Hl92 1.000 
O21- C22 1.423 ( 4) Cl9-Hl93 1.000 
C2-C3 1.503 ( 4) C22-C23 1.516 ( 4) 
C2-H21 1.000 C22-C24 1.502 ( 5) 
C3-C4 1.518 (5) C23-H231 1.000 
C3- H31 1.000 C23-H232 1.000 
C4-C5 1.519 (.5) C23- H233 1.000 
C4-H41 1.000 C24- H241 1.000 
C5-C6 1.515 ( 4) C24- H242 1.000 
C5-H51 1.000 C24-H243 1.000 
C6-C7 1.525 (5) 
C2- O1-C.5 110.0 (2) O10- C9- Cll 126.5 (3) 
C2- O8-C9 115.4 (3) C9- Cll-Hlll 109.58 (19) C3- O12-Cl3 118.2 (3) C9- Cll-Hll2 109.68 (19) 
C4- O16- Cl7 115.8 (3) Hlll-Cll-Hll2 109.476 
C6-O20-C22 108.8 ( 2) C9-Cll- Hll3 109.14 (19) C7-O21-C22 10.5.7 (3) Hlll--Cll-Hll3 109.476 
O1-C2- O8 110.2 (2) H112-Cll-Hll3 109.475 
O l - C2- C3 106 .2 (3) O12-Cl3-O14 123.7 ( 4) 
O8-C2-C3 106.3 ( 3) O12- Cl:3-. Cl5 109.7 (3) 
Ol-C2-H21 109.95 (16) O14-Cl3-Cl5 126.6 (3) 
O8-C2-H21 110.41 (15) Cl3-Cl5-Hl 51 ll0.l (2) 
C3-C2-H21 11:3.69 (17) Cl3-Cl5-Hl52 109.1 (2) 
O12- C3-C2 10.s.1 (3) Hl51-Cl5- Hl52 109.477 
O12-C3-C4 108.7 (3) Cl3- Cl5- Hl53 109.2 (2) 
C2-C3-C4 100.5 (3) Hl51-Cl5-Hl53 109.475 
O12-C3-H31 110.02 (16) Hl52--<::15-Hl53 109.476 
C2- C3- H31 117.47 (19) O16-Cl7- O18 123.4 (3) 
C4-C3-H31 114.14 (18) O16- C l 7-Cl9 lll .9 (3) 
O16- C4- C3 113.7 (2) O18-Cl 7-Cl9 124.7 ( 4) 
O16-C4-C.5 109.2 (3) Cl 7-Cl9-Hl91 108.9 (2) 
C3- C4-C5 101.9 (3) Cl7-Cl9- Hl92 110.3 (2) 
O16- C4-H41 105 .27 (17) Hl91- Cl9-H192 109.476 
C3- C4- H41 lll.45 (18) Cl7-Cl9-H193 109.2 (2) 
C5- C4- H41 115.52 (17) H 191-C 19-H 193 109.476 
O1-C5- C4 103.9 (3) Hl92-Cl9- Hl93 109.476 
Ol-C5- C6 110.7 (2) O20-C22- O21 104.5 (3) 
C4- C5- C6 115.5 (3) O20- C22-C23 110.0 (3) 
O1-C5-H51 114.58 ( 16) O21-C22-C23 111.5 (3) 
C4-C5-H51 109.16 (16) O20-C22- C24 108.7 (3) 
C6- C5- H51 103 .34 (18) O21- C22-C24 109.1 (3) 
O20-C6- C5 112.0 (3) c23--<::22-C24 112.7 (3) 
O20-C6-C7 104.3 (2) C22-C23-H231 109.85 (19) 
C.5- C6- C7 114.5 (3) C22- C23- H232 108 .9 (2) 
O20-C6- H61 112.77 (16) H23 l -C23- H232 109.475 
C5-C6-H61 103.20 (16) C22-C23-H233 109.69 (19) 
C7- C6- H61 110.37 (19) H231-C23-H233 109.476 
O21-C7- C6 103.5 (3) H232- C23- H233 109.477 
O21- C7- H71 111.4 (2) C22- C24- H241 109.7 (2) 
C6- C7- H71 111.17 (19) C22-C24-H242 109.2 (2) 
O21-C7- H72 110.33 (18) H241-C24- H242 109.476 
C6-C7-H72 110.91 (18) C22-C24- H243 109.54 (19) 
H71- C7-H72 109.467 H241-C24-H243 109.476 
O8- C9- O10 122.5 (3) H242-C24-H243 109.476 
O8-C9- Cll 111.0 (3) 
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Introduction 
D-Talose [D-talo-hexose, (1 )], one of the rarer D-
aldohexoses, as well as certain deoxy-derivatives, represent 
key residues associated with a range of biologically 
significant entities. The first reported occurrence of this 
hexose was by Hesse who, in 1902, described the isolation of 
a hydrate as a hydrolysis product of cocacitrin_PJ More 
recently, D-talose has been identified[2] as the central motif 
associated with the aminoglycoside hygromycin B 
(produced by S. hygroscopicus) which acts as a broad 
spectrum antibiotic and is used in veterinary medicine as an 
anthelmintic, especially against acaridsYJ 6-Deoxy-o-talose 
(D-talomethylose) is obtained by hydrolysis of the capsular 
polysaccharide of Gram-negative bacteria. [4l It has also been 
identified in an extracellular polysaccharide produced by the 
ruminal bacterium Butyrivibrio fibrisolvens X6C6 l [5] and in 
the serotype c polysaccharide antigen from Actinbacillus 
actinomycetemcomitans. [6l An O-acetylated homopoly-
saccharide of 6-deoxy-D-talose (6-deoxy-a-D-talan poly-
mer) has recently been isolated from Burkholderia (Pseudo-
monas) plantarii DSM 65357 while 3-O-methyl-6-deoxy-D-
talose has been identified in lipopolysaccharides of 
Rhodopseudomonas palustris. [SJ D-Talose has found use as a 
bulking and/or browning agent in food preparation. [9] 
Further, since it also has the same natural taste as sucrose, 
D-talose can be used as a low-calorie sweetening agent. [9] 
The 'all-cis' arrangement of the non-anomeric hydroxy 
groups in the pyranose form of compound ( 1) has a number 
of useful implications in molecular recognition processes[IOJ 
and may be responsible for the capacity of this sugar to 
reduce molybdenum inhibition of the growth of the yeast 
Saccharomyces cerevisiae. [l lJ 
Given the foregoing it is not surprising that some effort 
has been directed to the preparation of the title compound 
and various derivatives. The most common and perhaps 
obvious route to D-talose has been by C2 epimerization of the 
more abundant D-galactose, a conversion that can be 
achieved directly through the agency of various molybdenum 
species, [l 2] or by multi-step sequences. [I3] A practical and 
recently reported synthesis of D-talose involves a stannylene 
acetal-mediated epimerization process_[14] The dihydroxy-
lation of D-galactal provides another route to target (1 ).[ 15l 
Paulsen has also reported[ 16] a simple synthesis of D-talose 
by acetoxonium rearrangement of D-galactose. In related 
work, 1,6-anhydro-~-o-talopyranose has been prepared from 
the C2 epimeric 1,6-anhydro-~-D-galactopyranose by an 
oxidation/reduction sequence. [ 17] 
A concise syntheses of D-talose has recently been 
developed by O'Doherti18] and involves the asymmetric 
dihydroxylation of furfural. * The synthesis of differentially 
protected talose derivatives has also been the subject of some 
effort with the work just described providing access to such 
species on route to the final target, i.e. (1 ). Not surprisingly, 
the selective manipulation ofo-talose itself has also provided 
methods for accessing useful derivatives,(2 1] while regimes 
involving manipulations (including inversion at C2) of a 
"' The concise synthesis of L-talose from non-carbohydrate sources was achieved using asymmetric epoxidation methodology (see reference 19 and 
references therein). More recent syntheses have been reported by Vogel, Marshall, and Ogasawara (see reference 20). 
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galactose derivative have also been reported. [22J Chain-
extension approaches employing the Henry reaction of D-
lyxose and its derivatives have provided efficient syntheses 
of various amino-deoxy-o-talose derivatives. [23J 
CHO CHO 
HO H 
!~)''OH HO H HO H HO H 
HO H •II, H OH OH 
H OH Cl H OH 
OH OH 
( 1 ) (2) (3) 
For sometime now, we have been engaged in a program 
directed toward the synthesis of novel and/or rare 
carbohydrates from non-carbohydrate precursors. Two types 
of precursors have been exploited in this work, namely ring-
fused . gem-dibromocyclopropanes[24J and 3-halo-cis-1,2-
dihydrocatechols (2). l25J* Both types of compound are 
available in either enantiomeric form, the first by resolution 
of the racemate, and the second through whole-cell 
biotransformation of the corresponding aromatic. A key 
chemical step in the elaboration of each of these precursors 
to the target carbohydrate is the ozonolytic cleavage of the 
appropriate halocycloalkene followed by reductive workup, a 
strategy pioneered by Hudlicky and coworkers in their 
seminal studies on the conversion of 3-halo-cis-1,2-
dihydrocatechols (2) into various aldohexoses, particularly 
derivatives of D-mannose (3). [26,27Jt As part of our efforts in 
this general area we now report on the preparation of a range 
of previously unreported and differentially protected D-
talose derivatives from compound (2) (X = Cl). The relative 
ease of access to such compounds afforded by the present 
work should assist in general investigations into the chemical 
and biological properties of this rare type of D-aldohexose. 
Further, since 2H, 13C and/or 17O-labelled cis-1 ,2-dihydro-
catechols are rather easily produced, the correspondingly 
labelled D-talose derivatives will also be readily available by 
the pathway described here. t 
Results and Discussion 
The elaboration of the cis-1 ,2-dihydrocatechol (2) into 
various D-talose derivatives is shown in Scheme l. In 
keeping with earlier work[25dJ on its iodo-congener, 
chlorodiol (2) was selectively mono-protected at the less 
sterically hindered hydroxy group using tert-
butyldipheny1silyl chloride (TBDPS-Cl) so as to give the 
mono-ol (4) together with small amounts of its regio-isomer. 
This unstable mixture was immediately O-acetylated under 
standard conditions to afford the differentially protected cis-
1,2-dihydrocatechol (5) [78% from (2)] which could be 
readily separated from its co-produced regioisomer [16% 
M. G. Banwell et al. 
from (2)]. Since, like precursor (4), compound (5) was 
particularly prone to elimination processes (leading to 
aromatic products) it was immediately subject to the next 
step of the reaction sequence, namely selective epoxidation 
of the non-chlorinated double-bond using m-
chloroperbenzoic acid (m-CPBA). In this manner, the 
diastereoisomeric and chromatographically separable 
epoxides (6) (58%) and (7) (18%) were obtained, with the 
predominance of the former product being determined by the 
steric demands of the TB DPS and (to a lesser extent) acetyl 
moieties that direct epoxidation to the less congested ~-face 
of the non-chlorinated double-bond with compound (5). The 
appearance of three additional signals [ relative to the 18 seen 
in isomer (6)] in the low-field region of the 13C NMR 
spectrum of the minor isomer (7) is attributed to the 
restricted rotation of the aromatic rings associated with the 
TBDPS group in this highly congested 'all-cis' substituted 
cyclohexene. Confirmation of the structure of products ( 6) 
and (7) follows from a single-crystal X-ray analysis of the 
latter (see Fig. 1, Tables 1, 2 and Experimental Section). 
In keeping with earlier observations, [2sJ reaction of 
epoxide (7) with aqueous acid results in the opening of the 
three-membered ring by a pathway involving nucleophilic 
attack at the allylic carbon, so as to form the required 
conduritol derivative (9). However, the choice of acid 
catalyst for this conversion was critical. Thus, when HCI in 
aqueous tetrahydrofuran (THF) was employed only minor 
amounts (12%) of the required compound, (9), were 
obtained, with the corresponding chlorohydrin (see 
Experimental) being the predominant product (55%) . In 
contrast, when phosphoric acid was employed as catalyst 
then target (9) predominated (71 % ), although significant 
amounts (20%) of a product, (8), incorporating the elements 
of THF, were obtained. Compound (9) embodies the 
necessary stereochemical array of hydroxy residues for 
elaboration to D-talose derivatives. To this end, the alkenyl 
halide residue within substrate (9) was subjected to reaction 
with ozone at - 78°C and the intermediate hydroperoxy 
species[25eJ reduced by workup with sodium borohydride. In 
this way the D-talonic acid y-lactone (10) was obtained, albeit 
in a modest yield of 54%. Compound (10) was readily 
converted by standard methods into the corresponding and 
more easily handled acetonide (11 ) (82% ), which was 
subject to full analytical and spectroscopic characterization. 
The elaboration of compound ( 11 ) to protected forms of 
o-talose was straightforward and involved reduction of the 
lactone carbonyl. This could be achieved using 
diisoamylborane[29J and in this manner lactol ( 12) (83 % ) was 
obtained as a ca. 2: 3 mixture of the a- and ~-anomers. 
Reaction of this mixture with tetra-n-butylammonium 
fluoride (TBAF) resulted in removal of the TBDPS group 
and the ensuing material was immediately subjected to 
exhaustive acetylation under standard conditions . The 
resulting triacetates (13) (40%) and (14) (47%) could be 
* For an excellent overview on the production and synthetic utility of cis-1 ,2-dibydrocatechols see reference 26. 
t For a very useful review on the synthesis of monosaccharides from non-carbohydrate sources see reference 27 b. 
t For useful discussions on the value of carbohydrates incorporating such labels see reference 25d. 
A Chemoenzymatic Synthesis of Differentially Protected D-Talose Derivatives 97 
(2) 
lTBDPS-CI 
0 
~:,,OTBDPS 
Y•10Ac 
• m-CPBA 
-----•• 
.,,OR 
Cl 
(6) 
+ 
(8) 
+ 9\,0TBDPS 
Cl 
Ac20, 1 (4) R = H 
pyridine ~ (5) R = OAc 
0 
:-9''· .\,OTBDPS 
~ ., 10Ac 
OH Hov· ,\,OTBDPS 
~ ., 10Ac 
HO O ft ~
~ ~ 
diisoamyl-
borane 
• 
Cl 
(7) 
,,· ·-=--
2,2-DMP, 
fr TsOH 
• 
Cl 
(9) 
I (i) 0 3 then Nal t (ii) NaBH4 
OH 
0 0 ::-
~-~---OH \__j '"H ~ 
AcO OTBDPS AcO OTBDPS 
'°. ·-:, 
AcO OTB DPS 
(12) (11) (10) 
~ ~:?):~AF 
~c20, pyridine 
__________ A ________ _ 
( \ 
Acov0y(t Aco,,,(oy(t 
\__j -,,H .,. + \_./ .,. H .,. 
,,· ·~ 
AcO OAc 
~· ·,,, 
AcO OAc 
(13) (14) 
Scheme 1 
separated by flash chromatography on silica, and the 
structure of the former was confirmed by single-crystal X-
ray analysis (see Fig. 2, Tables 3, 4 and Experimental 
Section). 
Efforts were made to chemically correlate triacetates (13) 
and (14) with known derivatives ofD-talose. Thus, a mixture 
of these compounds was subjected to reaction with aqueous 
trifluoroacetic acid so as to effect global deprotection and 
thereby generate D-talose itself (Scheme 2). The crude 
product obtained by this means was then exhaustively 
acetylated with acetic anhydride in the presence of pyridine. 
Thin-layer chromatography (TLC) analysis of the resulting 
material revealed the presence of at least three fractions with 
two able to be isolated by flash chromatographic techniques. 
One fraction (the less mobile) contained a ca. 2: 1 mixture of 
two penta-0-acetates (53% combined yield), whilst the other 
provided a single compound (22%) of the same composition. 
Two of these three compounds were presumed to correspond 
to the ex-forms of penta-0-acetyl-o-talopyranose, (15) and 
( 16), respectively, while the remaining material was thought 
to be the isomeric ~-penta-0-acetyl-D-talofuranose based 
on, amongst other things, the I H nuclear magnetic resonance 
(NMR) chemical shift (8 6.42) and coupling (d, J 4.5 Hz) 
observed for the anomeric proton in this material. Support 
for these conclusions came from the preparation of authentic 
samples of compounds (15) and ( 16) from D-talose itself. 
Thus, such studies established that the two-component 
fraction contained a ca. 2: 1 mixture of the penta-0-acetyl-
~-D-talofuranose and compound (15) whilst the more mobile 
fraction contained pure samples of compound (16). 
Conclusions 
The concise and chemoenzymatic nature of the routes to the 
D-talose derivatives described above offer a rather flexible 
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Fig. 1. ADEP (with 50% probability ellipsoids) of compound (7) 
derived from X-ray crystallographic data. 
entry into this rare class of carbohydrate that should facilitate 
further studies in the appropriate areas of glycobiology and 
molecular recognition. 
Experimental 
Melting points were recorded with a Kofler hot stage apparatus and are 
uncorrected. Proton (1H) and carbon (13C) NMR spectra were recorded 
with a Varian Unity 300 or Varian Gemini 300 spectrometer operating 
at 300 MHz for proton and 75 MHz for carbon. All such spectra were 
recorded in deuteriochloroform (CDC13) solution at 22°C. The degree 
of protonation of each carbon atom observed in the 13 C NMR spectra 
was determined by attached proton test (APT) experiments. Infrared 
(IR) spectra (vmaJ were recorded with either a Perkin-Elmer 983G 
infrared spectrophotometer or a Perkin-Elmer 1800 Series FTIR 
instrument. Samples were analysed either as thin films on sodium 
chloride plates (for liquids) or as potassium bromide disks (for solids). 
Low-resolution electron-impact mass spectra (LREI-MS) (m/z) were 
Table 1. Bond lengths (A) for (7), C24H27ClO4Si 
Atom Atom Distance Atom Atom Distance 
Cll C4 1.733(6) C7 C8 1.526(9) 
Sil2 08 1.651(3) Cl 1 C12 1.398(6) 
Si12 Cll 1.881(4) Cl 1 Cl6 l .386(6) 
Sil2 C21 1.881(4) Cl2 Cl3 1.381(6) 
Sil2 C3 l 1.889(4) Cl3 C14 1.401 (7) 
07 Cl 1.416(6) Cl4 C15 1.357(7) 
07 C6 1.414(7) Cl5 Cl6 1.391(6) 
08 C2 1.435(5) C21 C22 1.382(6) 
09 C3 1.455(6) C21 C26 1.398(6) 
09 C7 1.333(9) C22 C23 1.395(7) 
010 C7 1.182(8) C23 C24 1.374(8) 
Cl C2 1.476(7) C24 C25 1.355(7) 
Cl C6 1.448(7) C25 C26 1.381(7) 
C2 C3 1.539(6) C31 C32 1.534(7) 
C3 C4 1.532(8) C31 c..,.., .).) 1.536(8) 
C4 cs 1.346(9) C31 CJ_4 1.516(7) 
cs C6 1.404(9) 
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Table 2. Bond angles (degrees) for (7), C24H27CIO4Si 
Atom Atom Atom Angle Atom Atom Atom Angle 
08 Sil2 Cl 1 108.17(16) 09 C7 010 126.2( 6) 
08 Sil2 C21 110.33(17) 09 C7 C8 111.2(6) 
Cl 1 Sil2 C21 109.43(18) 010 C7 C8 122.6(8) 
08 Sil2 C31 104.46(19) Sil2 Cl 1 C12 120.1(3) 
Cl 1 Sil2 C31 114.93(19) Sil2 Cl 1 Cl6 122.0(3) 
C21 Sil2 C31 109.38(19) C12 Cl 1 C16 117.4( 4) 
Cl 07 C6 61.5(3) Cl 1 Cl2 CI3 121.3( 4) 
Si 12 08 C2 123.6(2) Cl2 C13 C14 119.7(4) 
C3 09 C7 115 .4(5) C13 Cl4 Cl5 119.7(4) 
07 Cl C2 118.8(5) Cl4 Cl5 C16 120.4(5) 
07 Cl C6 59.2(3) Cl 1 Cl6 Cl5 121.5(4) 
C2 Cl .C6 119.5(5) Sil2 C21 C22 121.5(3) 
08 C2 CI 113.1( 4) Si12 C21 C26 121.5(3) 
08 C2 C3 107.9(4) C22 C21 C26 116.9(4) 
Cl C2 C3 114.3(4) C21 C22 C23 121.9(5) 
09 C3 C2 108.3(3) C22 C23 C24 119.3(5) 
09 C3 C4 106.2(4) C23 C24 C25 120.0( 4) 
C2 C3 C4 110.6(5) C24 C25 C26 120.9(5) 
Cll C4 C3 112.4(6) C21 C26 C25 121.0(5) 
Cll C4 cs 124.3(5) Si 12 C31 C32 112.4(3) 
C3 C4 cs 123.3(5) Si 12 C31 C33 109.7(4) 
C4 cs C6 120.4(5) C32 C31 C33 108.2(5) 
07 C6 Cl 59.3(3) Sil2 C31 C34 108.3(3) 
07 C6 cs 118.7(6) C32 C31 C34 106.1(5) 
Cl C6 cs 120.2(6) C33 C31 C34 112.3(6) 
recorded at 70 eV on either a VG Micromass 7070F mass spectrometer 
or a JEOL AX-505H mass spectrometer. High-resolution mass spectra 
were recorded with a VG Micromass 7070F instrument. Optical 
rotations were measured at 20°C with a Perkin- Elmer 241 polarimeter 
at the sodium D-line (589 nm) using spectroscopic grade chloroform 
(Merck) and at the concentration (c) (g/100 mL) indicated. The 
measurements were carried out in a cell with a path length of l dm. 
Specific rotations ([a]5°) were calculated using the equation 
[a]o = (100.a)/(c.1) and are given in units of 10-1 .deg.cm2.g- 1. THF 
was distilled, under nitrogen, from sodium benzophenone ketyl. 
Dichloromethane was distilled from calcium hydride and methanol 
from magnesium methoxide. 
(1 S, 6S)-2-Chloro-6-{ [(], 1-dimethylethyl)diphenylsilyl] oxy}-2, 4-cyclo-
hexadien-1-ol (4) and (1S,2S)-3-Chloro-2-{[(1,l-dimethylethyl)di-
phenylsilyl] oxy }-3,5-cyclohexadien-l-ol 
A magnetically stirred solution of compound (2) (17.0 g, 116.0 mmol) 
and imidazole (21.0 g, 308.5 mmol) in dichloromethane (100 mL) 
maintained at l 8°C under a nitrogen atmosphere was treated, dropwise 
over a period of0.5 h, with TBDPS-Cl (Aldrich, 32.5 mL, 124.2 mmol) . 
The ensuing mixture was stirred for a further 1.0 h then diluted with 
water (500 mL) and extracted with dichloromethane (3 x 150 mL). The 
combined organic phases were washed with brine (2 x 150 mL) then 
dried (MgSO4), filtered and concentrated under reduced pressure to 
give a ca. 4 : 1 mixture ( as judged by I H NMR analysis) of the title 
compounds as a clear colourless oil. Since this material was 
exceptionally prone to decomposition it was used immediately in the 
next step of the reaction sequence. 
(1 S, 6S)-2-Chloro-6-{ [(], 1-dimethylethyl)diphenylsilyl] oxy} -2, 4-cyclo-
hexadien-1-ol Acetate (5) and (IS,6S)-5-Chloro-6- {[(l,J-dimethyl-
ethyl)diphenylsilyl}oxy}-2,4-cyclohexadien-l-ol Acetate 
The 4: 1 mixture of compound (4) and its regio-isomer (44.65 g, 
116.0 mmol), obtained as described immediately above, was dissolved 
in pyridine (30 mL) and the resulting solution treated with acetic 
anhydride (22 mL, 233.2 mmol) and 4-dimethylaminopyridine 
(DMAP) (1 .40 g, 11.6 mmol) while being stirred magnetically and 
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Fig. 2. ADEP (with 50% probability ellipsoids) of compound (13) 
derived from X-ray crystallographic data. 
Table 3. Bond lengths (A) for (13), C15H22O9 
Atom Atom Distance Atom Atom Distance 
01 C2 1.415(4) 021 C7 1.430( 4) 
01 cs 1.451(4) 021 C22 1.423(4) 
08 C2 1.439(4) C2 C3 1.503(4) 
08 C9 1.373(4) C3 C4 1.518(5) 
010 C9 1.195(4) C4 cs 1.519(5) 
012 C3 l .447(4) cs C6 1.515(4) 
012 Cl3 1.343(4) C6 C7 1.525(5) 
014 Cl3 1.193(5) C9 Cl I 1.491(5) 
016 C4 1.442(4) Cl3 Cl5 1.495(5) 
016 Cl7 1.356(4) C17 Cl9 1.492( 5) 
018 Cl7 1.191 ( 5) C22 C23 1.516(4) 
020 C6 1.428(4) C22 C24 1.502(5) 
020 C22 1.449(4) 
maintained at l 8°C under a nitrogen atmosphere. After 2 h the reaction 
mixture was concentrated under reduced pressure and the residue 
subjected to flash chromatography (silica gel, gradient elution using 
1.25 to 1.5% v/v hexane/ethyl acetate) thereby affording two fractions , 
A and B. 
Concentration of fraction A (RF 0.5) afforded compound (5) (38.54 
g, 78%) as a clear colourless oil, [a] 0 - 107.4 (c, 1.75) (Found: M+•, 
(i3) 0 OAc (i) TF NH2O AcO 
+ 
(14) 
(ii) Ac2O, pyridine A OAc 
OAc 
(15) 
+ 
Table 4. Bond angles (degrees) for (13), C15H22O9 
Atom Atom Atom Angle Atom Atom Atom Angle 
C2 01 cs 110.0(2) 020 C6 C7 104.3(2) 
C2 08 C9 115.4(3) cs C6 C7 114.5(3) 
C3 012 C13 118.2(3) 021 C7 C6 103 .5(3) 
C4 016 Cl7 115.8(3) 08 C9 010 122.5(3) 
C6 020 C22 108.8(2) 08 C9 Cl 1 111.0(3) 
C7 021 C22 105.7(3) 010 C9 C 11 126.5(3) 
01 C2 08 110.2(2) 012 Cl3 014 123 .7(4) 
01 C2 C3 106.2(3) 012 Cl3 Cl5 109.7(3) 
08 C2 C3 106.3(3) 014 Cl3 Cl5 126.6(3) 
012 C3 C2 105.1(3) 016 Cl7 018 123.4(3) 
012 C3 C4 108.7(3) 016 C17 Cl9 111.9(3) 
C2 C3 C4 100.5(3) 018 C17 Cl9 124.7(4) 
016 C4 C3 113 .7(2) 020 C22 021 104.5(3) 
016 C4 cs 109.2(3) 020 C22 C23 110.0(3) 
C3 C4 cs 101.9(3) 021 C22 C23 111.5(3) 
01 cs C4 103.9(3) 020 C22 C24 108.7(3) 
01 cs C6 110.7(2) 021 C22 C24 109.1(3) 
C4 cs C6 115.5(3) C23 C22 C24 112.7(3) 
020 C6 cs 112.0(3) 
426.1421. C24H2735ClO3Si requires M+•, 426.1418). 1 H NMR ( CDC13, 300 MHz) 8 7.75-7.70, complex m, 4H; 7.50-7.38, complex m, 6H; 
6.17, d,JS.9 Hz, lH; 5.75, ddd,J9.0, 5.9 and2.4 Hz, IH; 5.61, dd,J 
9.0 and 2.4 Hz, lH; 5.56, d, J6.6 Hz, lH; 4.72, dt, J6.6 and 2.4 Hz, lH; 
2.15, s, 3H; 1.09, s, 9H. 13C NMR (CDC13, 75 MHz) 8 170.2, 136.0, 
135.9, 133.7, 132.8, 130.7, 130.4, 130.1, 130.1, 127.9(1), 127.8(7), 
125.3, 121.9, 71. 1, 70.5, 26.9, 21.0, 19.2. Vmax (KBr) 2958, 2932, 2858, 
1747, 1427, 1226, 112,868,821,702 cm- 1• EI MS m/z (70 eV) 428 and 
426 (M+•, both< 1%), 384 (< 1) and 386 (< 1), 368 (< 1) and 366 (2) , 
84 (100). 
Concentration of fraction B (RF 0.4) afforded (IS,6S)-5-chloro-6-
{ [(I , 1-dimethylethyl)diphenylsilyl] oxy}-2,4-cyclohexadien-1-ol ace-
tate (7.90 g, 16%) as a clear colourless oil, [a] 0 +5 .3 (c, 1.03) (Found: 
M+•, 426.1417. C24H2/ 5C1O3Si requires M+•, 426.1418). 1H NMR (CDC13, 300 MHz) 8 7.77-7.70, complex m, 4H; 7.45- 7.37, complex 
m, 6H; 6.18, d, J 5.2 Hz, lH; 5.95, ddd, J9.7, 5.7 and 3.1 Hz, IH; 5.81 , 
ddm, J9.7 and 3.1 Hz, IH; 5.28, m, lH; 4.26, d, J 5.7 Hz, lH; 1. 77, s, 
3H; 1.08, s, 9H. 13C NMR (CDC13, 75 MHz) 8 170.2, 136.2, 136.2, 
135.3, 133.6, 132.7, 130.0, 129.8, 127.7, 127.5, 126. 1, 124.0, 123 .3, 
72.5, 71.4, 26.9, 20.9, 19.9. Ymax (KBr) 2931, 2857, 1738, 1427, 1369, 
1233, 1112, 1049, 702,505 cm- 1• EI-MS mlz (70 eV) 428 and 426 (M+•, 
both< 1%), 384 (< 1) and 386 (< 1), 311 (33) and 309 (63), 293 (45) 
and 291 (80), 241 (87), 199 (100). 
[JS-(] a ,2a,3a, 6a)]-4-Chloro-2-{[(J, J-dimethylethyl)dipheny lsily l]-
oxy)-7-oxabicylco [4.1. 0 j hept-4-en-3-ol Acetate (6) and [IR-(Ja,2~,-
3~, 6a)]-4-Chloro-2-{ [(I ,1-dimethylethyl)diphenylsilyl} oxy) - 7-oxa-
bicyclo [4. J.0]hept-4-en-3-ol Acetate (7) 
A magnetically stirred solution of compound (5) (2 .08 g, 4.87 mmol) in 
dichloromethane (25 mL) maintained at 0- 5°C (ice bath) under a 
nitrogen atmosphere was treated, in one portion, with m-CPBA 
(technical grade, Aldrich, ca. 70% peracid, 1.26 g, 5. 11 mmol peracid). 
AcO OAc 
_ ..,0, )--I A~O. pyridine 
AcOu·,,H ----- (1) 
~ -:... AcO OAc 
(16) 
Scheme 2 
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Stirring was continued overnight during which time the ice bath and 
reaction mixture were allowed to warm to ca. l8°C. The resulting 
mixture was then washed with sodium metabisulfite (3 x 60 mL of an 
15% w/v aqueous solution), sodium bicarbonate ( 1 x 60 mL of a 
saturated aqueous solution) and water ( 1 x 60 mL) before being dried 
(MgSO4), filtered and concentrated under reduced pressure. The 
ensuing light-yellow oil was subjected to flash chromatography (silica 
gel, gradient elution using 2-3% v/v ethyl acetate/hexane) thereby 
affording two fractions, A and B. 
Concentration of fraction A (RF 0.5) afforded compound (6) (1.25 g, 
58%) as a clear colourless oil, [a]0 +34.6 (c, 1.1) (Found: M+•, 
442.1363 . C24H2/ 5ClO4Si requires M+•, 442.1367). 1H NMR (CDC13, 
300 MHz) 8 7.75-7.65, complex m, 4H; 7.50-7.40, complex m, 6H; 
6.30, dd, J 4. l and 2.2 Hz, lH; 5.38, m lH; 4.55, m, lH; 3.41, m IH; 
3.35, m, lH; 1.94, s, 3H; 1.11, s, 9H. 13 C NMR (CDC13, 75 MHz) 8 
170.1, 136.5, 136.3, 135.9, 133.6, 133.3, 130.7, 130.5, 128.4, 128.1, 
122.8, 69.4, 68.4, 53.7, 48.6, 27.3, 21.0, 20.0; Ymax (KBr) 2957, 2858, 
2932, 1751, 1369, 1225, 1112, 703, 506 cm- 1• EI-MS mlz (70 eV) 444 
and 442 (M+•, both< 1 %), 241 (100), 199 (80). 
Concentration of fraction B (RF 0.3) afforded compound (7) (0.38 g, 
18%) as a white crystalline solid, melting point (m.p.) 156-158°C, [a]u 
- 156.9 (c, 1. 1) (Found: C, 64.8; H, 6.1; Cl, 7.9%; [M - C4H9·t, 385.0663. C24H 2735CIO4Si requires C, 65.1, H, 6.1, Cl, 8.0%; [M-
C4H9" t, 385.0663). 1H NMR (CDC13, 300 MHz) 8 7.81, m, 2H; 7.77, 
m, 2H; 7.50-7.37, complex m, 6H; 6.25, d,J4.4 Hz, lH; 5.86, dd,J5.7 
and 1.9 Hz, 1H; 4.31, dd, J 5.7 and 1.2 Hz, lH; 3.17, t, J 4.2 Hz, lH; 
3.03, m, lH; 2.24, s, 3H; 1.09, s, 9H. 13C NMR (CDCl3, 75 MHz) 8 
170.7, 135 .9, 135.8, 134.9, 134.7, 133.3, 132.1, 130.3, 130.2, 129.6, 
128.1, 128.0, 127.7, 126.7, 70.6, 70.0, 54.9, 47.8, 26.7, 21.2, 19.2. Ymax 
(K.Br) 2931, 2858, 1743, 1427, 1370, 1233, 1112, 706, 507 cm- 1. EI-
MS m/z (70 eV) 444 and 442 (M+•, both < 1%), 241 (53), 199 (100). 
(1 S,2S,3S, 6R)-4-Chloro-2-{ [ (1, 1-dimethylethyl)diphenylsilyl] oxy}-6-
( 4 '-hydrmybutoxy)-4-cyclohexene-1,3-diol 3-Acetate (8) and (JR,2S,-
3S, 4S)-5-Chloro-3-{ [(I, 1-dimethylethyl)diphenylsilyl] oxy}-5-cyclo-
hexene-1,2,4-triol 4-Acetate (9) 
A magnetically stirred solution of epoxide (7) (1.08 g, 2.44 mmol) in 
THF (15 mL) and water (5 mL) was treated with phosphoric acid 
(0.5 mL of a 93% aqueous solution, M & B) whilst being maintained 
under a nitrogen atmosphere. The resulting mixture was stirred at l 8°C 
for 40 h then concentrated under reduced pressure and the residue 
partitioned between ethyl acetate (30 mL) and brine (30 mL). The 
separated aqueous phase was extracted with ethyl acetate (3 x 30 mL) 
and the combined organic phases were then dried (MgSO4), filtered and 
concentrated under reduced pressure. The resulting light-yellow oil was 
subject to flash chromatography (silica gel, gradient elution using 30 to 
50% v/v ethyl acetate/hexane) thereby affording two fractions, A and B. 
Concentration of fraction A (RF 0.5 in 8: 2.5: 5.5 v/v/v ethyl 
acetate/dichloromethane/hexane) then afforded compound (8) (265 mg, 
20%) as a light-yellow oil, [a]u - 87.2 (c, 1.0) (Found: [M - C4H9·t, 
475.1345. C28H3} 5CIO6Si requires [M - C4H9.]+, 475.1344). 1H NMR (CDC13, 300 MHz) 8 7.75- 7.70, complex m, 4H; 7.45- 7.38, complex 
m, 6H; 6.07, br d, J 4.0 Hz, lH; 5.61, br d, J 4.0 Hz, lH; 4.28, m, lH; 
4.03, br, t, J 4.0 Hz, lH; 3.64--3.54, complex m, 3H; 3.41, m, lH; 3.25, 
m, lH; 2.43, s, 2H; 1.88, s, 3H; 1.52, m, 4H; 1.08, s, 9H. 13C NMR 
(CDC13, 75 MHz) 8 169.8, 136.1, 136.0, 132.9, 132.8, 131.7, 130.2, 
129.9, 127.9, 127. 7, 126.5, 77.4, 70.8, 70.5, 69.9, 62.5, 29.5, 26.9, 26.5, 
20.7, 19.5 ( one signal obscured or overlapping). vmax (KBr) 3429, 2932, 
2858, 1747, 1370, 1228, 1112, 1045, 740, 704, 507 cm- 1. EI-MS m/z 
(70 eV) 477 (1%) and 475 (2) [M - C4H9·t, 241 (78), 199 (100), 181 
(52), 101 (90). 
Concentration of fraction B (RF 0.7 in 8: 2.5 : 5.5 v/v/v ethyl acetate/ 
dichloromethane/hexane) then afforded compound (9) (795 mg, 71%) 
as a clear, colourless oil, [a]o - 59.1 (c, 1.0) (Found: [M - C4H9·t, 
403.0763. C24H2/ 5C1O5Si requires[M- C4H9"]+, 403.0769). 1H NMR (CDC13, 300 MHz) 8 7.75-7 .65, complex m, 4H; 7.50-7.38, complex 
m, 6H; 6.02, m lH; 5.48, m, lH; 4.50, m, lH; 4.30, m, lH; 3.51, dd, J 
6.5 and 1.6 Hz, lH; 2.74, s, 2H; 1.69, s, 3H; 1.08, s, 9H. 13 C NMR 
(CDC13, 75 MHz) 8 170.0, 136.2, 136.1, 132.9, 132.5, 130.9, 130.3, 
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129.8, 128.5, 128.0, 127.5, 74.4, 72.3, 70.8, 70.4, 27.0, 20.5, 19.8. Ymax 
(KBr) 3429, 2931, 2857, 1747, 1227, 1159, 1112, 1040, 738, 703,508 
cm-
1
• EI-MS mlz (70 eV) 405 (2%) and 403 (7) [M - C4H9"t, 267 (20) 
and 265 (50), 241 (60), 199 (100), 181 (60) . 
(JS,2S,3S, 6R)-4, 6-Dichloro-2-{ [(1, l-dimethylethyl)diphenylsilyl]-
oxy}-4-cyclohexene-1,3-diol 3-Acetate and (JR,2S,3S,4S)-5-Chloro-3-
{ [(1 ,1-dimethylethyl)diphenylsilyl] oxy }-5-cyclohexene-1,2,4-triol 4-
Acetate (9) 
A solution of compound (7) ( 457 mg, 1.03 mmol) and water (2 mL) in 
THF ( 6 mL) was treated with H Cl (1 mL of a 1 M aqueous solution) and 
the ensuing mixture allowed to stand at 18°C for 24 hand then treated 
with NaOH (2.5 mL of a 1 M aqueous solution) and dichloromethane 
(10 mL). The separated aqueous phase was extracted with 
dichloromethane (3 x 8 mL) and the combined organic phases were 
washed with brine (1 x 10 mL) then dried (MgSO4), filtered and 
concentrated under reduced pressure to give a light-yellow oil. 
Subjection of this material to flash chromatography (silica gel, gradient 
elution using 3 to 30% v/v ethyl acetate/hexane) afforded three 
:fractions, A-C. 
Concentration of fraction A (RF 0.6 in 1 : 2.5: 5.5 v/v/v ethyl 
acetate/dichloromethane/hexane) afforded starting material (7) (68 mg, 
15% recovery), identical, in all respects, with authentic material. 
Concentration of fraction B (RF 0.5 in 1 : 2.5: 5.5 v/v/v ethyl acetate/ 
dichloromethane/hexane) afforded (JS, 2S, 3S, 6R)-4, 6-dichloro-2-
{ [(1,1-dimethylethyl)diphenylsilyl] oxy}-4-cyclohexene-l, 3-diol 3-ace-
tate (231 mg, 47 at 85% conversion) as a white crystalline solid, m.p. 
135.5-137°C, [a]o - 131.4 (c, 0.9) (Found: C, 59.6; H, 5.8; Cl, 14.7%; 
[M-C4H9·t, 421.0427. C24H2/ 5Cl2O4Si requires C, 60.1; H, 5.9; Cl, 
14.8%; [M - C4H9.]+, 421.0430) . 1H NMR (CDC13, 300 MHz) 8 7.75-
7.65, complex m, 4H; 7.50-7.38, complex m, 6H; 6.07, d, J 4.4 Hz, IH; 
5.70, d, J 4.4 Hz, lH; 4.56, br t, J 4.4 Hz, lH; 4.37, m, lH; 3.72, m, lH; 
2.70, br s, lH; 1.98, s, 3H; 1.09, s, 9H. 13C NMR (CDC13, 75 MHz) 8 
169.5, 136.1, 136.0, 132.6, 132.5, 130.4, 130.2, 128.1 , 127.9, 126.8, 
73.4, 70.2, 69.2, 56.6, 27.0, 20.7, 19.5 (one signal obscured or 
overlapping). Ymax (KBr) 2932, 2858, 1751, 1226, 1113 , 1048, 
736, 702, 508 cm-1. EI-MS mlz (70 eV) 425 (< 1 %), 423 (2) and 421 
(4) [M-C4H9"]+, 250 (35) and 248 (78), 241 (88), 199 (100) . 
Concentration of fraction C (RF 0.7 in 8: 2.5: 5.5 v/v/v ethyl acetate/ 
dichloromethane/hexane) afforded dial (9) (50 mg, 10 at 85% 
conversion), identical, in all respects, with material obtained as 
described immediately above. 
3-O-[(1,1-Dimethylethyl)diphenylsilyl]-D-talonic acid y-Lactone 2-
Acetate (JO) 
A magnetically stirred solution of diol (9) (830 mg, 1.80 mmol) and 
pyridine (2 mL) in methanol (35 mL) was cooled to - 78°C (acetone/ 
dry-ice bath) then treated with a stream of ca. 40% ozone in oxygen 
(produced by a Wallace & Tiernan ozonator) for 1.0 h, at which point 
TLC anaiysis indicated the complete consumption of the starting 
material. The reaction mixture was purged with nitrogen and then 
treated with sodium iodide (840 mg, 5.60 rnmol) . After 3 h the now red-
brown reaction mixture was warmed to - 66°C and treated with sodium 
borohydride (1.35 g, 35.69 mmol) . The reaction mixture was 
maintained between -60 and --40°C for 6 h and then treated with 
sufficient 2 M HCI in methanol so as to reduce the pH to ca. 3.5. The 
ensuing mixture was concentrated under reduced pressure and the 
residue partitioned between ethyl acetate (25 mL) and brine (25 mL). 
The separated aqueous phase was extracted with ethyl acetate 
(3 x 20 mL) and the combined organic phases were dried (MgSO4), 
filtered and concentrated under reduced pressure . Subjection of the 
resulting light-yellow oil to flash chromatography (silica gel, 60% v/v 
ethyl acetate/hexane elution) and concentration of the appropriate 
fractions (RF 0.4) then afforded lactone (10) ( 450 mg, 54%) as a clear, 
colourless oil, [o:Jo +19.1 (c, 0.6) (Found: [M - C4H9·t, 401.1041. 
C24H30O7Si requires [M - C4H9"]+, 401.1057). 1H NMR (CDC13, 300 
MHz) 8 7.62- 7.58, complex m, 4H; 7.50-7 .37, complex m, 6H; 5.62, 
d, J 5.6 Hz, lH; 4.61, d, J 5.6 Hz, lH; 4.13, br s, lH; 3.42, dd, J 11.3 
and 8.0 Hz, lH; 3.31, dd, J 11.3 and 4.1 Hz, lH; 3.15, m, lH ; 2.55 , br 
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s, 2H; 2.10, s, 3H; 1.07, s, 9H. 13C NMR (CDC13, 75 MHz) 8 172.8, 
170.2, 135 .8, 135.7, 132.9, 132.2, 130.5, 130.5, 128.2, 128.1, 86.3, 
71.8, 70.5, 69.2, 63.1, 26.8, 20.6, 19.4. Vmax (KBr) 3467, 2930, 2857, 
1796, 1753, 1375, 1232, 1113, 1104, 703,508cm- 1.EI-MSm/z(70eV) 
401 [M - C4H9"t (15%), 199 (100). 
3-0-[(1, I-Dimethylethyl)diphenylsilyl]-5, 6-0-(1-methylethylidene)-D-
talonic Acid y-Lactone 2-Acetate (I I) 
A solution of compound (10) (100 mg, 0.22 mmol) in 
2,2-dimethoxypropane (7 mL) was treated with p-toluenesulfonic 
acid (25 mg, 0.13 rnmol) and the resulting mixture stirred at l 8°C 
for 3 h, treated with triethylamine (2 mL) and then concentrated 
under reduced pressure. Then residue thus obtained was subject to 
flash chromatography (silica gel, 15% v/v ethyl acetate/hexane 
elution) and concentration of the appropriate fractions (Rp 0.4) 
then afforded compound (I I) (90 mg, 82%) as a white crystalline solid, 
m.p. 106- 107.5°C, [a]o +16.0 (c, 1.0) (Found: C, 63.2; H, 6.5%; [M-
C4H9"t, 441.1371. C27H34O7Si requires C, 65.0; H, 6.9%; [M-
C4H9"t, 441.1370). 1H NMR (CDC13, 300 MHz) 8 7.70-7.60, 
complex m, 4H; 7.55- 7.38, complex m, 6H; 5.58, d, J5.5 Hz, lH; 4.62, 
d, J 5.5 Hz, lH; 4.06, s, IH; 3.72, m, 2H; 3.45, t, J7.3 Hz, lH; 2.15, s, 
3H; 1.25, s, 3H; 1.23, s, 3H; 1.07, s, 9H. 13 C NMR (CDC13, 75 MHz) 8 
172.3,, 169.9, 135.9, 135.7, 132.9, 132.1, 130.5, 128.2, 128.1, 110.6, 
83.6, 74.2, 71.9, 69.2, 65.2, 26.7, 25 .6, 25.5, 20.6, 19.4 (one signal 
obscured or overlapping) . vmax (KBr) 2933, 2859, 1803, 1752, 1373, 
1225, 1137, 1113, 1096, 703, 507 cm- 1. EI-MS m/z (70 eV) 483 [M -
CH3"t, (30%), 441 [M - C4H9°t, (33), 383 (100), 341 (50), 241 (80), 
199 (94). 
3-0-[ (I ,l-Dimethylethyl)diphenylsilyl]-5,6-0-(J-M ethylethylidene)-
D-talo-furanose 3-Acetate (12) 
A solution of diisoamylborane in THF was prepared by treating BH3-
dimethyl sulfide complex (2 mL of a 2 M solution in THF, 4 mmol, 
Aldrich) maintained at 0°C under a nitrogen atmosphere with 
2-methylbut-2-ene (4 mL of a 2 M solution in THF, 8 mmol). After 
stirring the ensuing mixture for 3 hat 0°C it was treated with a solution 
of lactone (11) (231 mg, 0.46 mmol) in THF (5 mL) . After 3 days at 
18°C, the reaction mixture was quenched with water (1 mL) and sodium 
bicarbonate (10 mL of a saturated aqueous solution) added. This was 
followed by the addition of hydrogen peroxide (0 .5 mL of a 30% 
aqueous solution) and the resulting mixture then concentrated under 
reduced pressure. The residue was partitioned between water (20 mL) 
and dichloromethane (20 mL) and the separated aqueous phase was 
then extracted with dichloromethane (3 x 20 mL) . The combined 
organic phases were dried (MgSO4), filtered and concentrated under 
reduced pressure to afford a light-yellow oil. Subjection of this material 
to flash chromatography (silica gel, 15% v/v ethyl acetate/hexane) and 
concentration of the appropriate fractions (RF 0.3) then afforded a ca. 
2: 3 mixture of the a- and ~-forms of facto! (12) (192 mg, 83%) as a 
clear colourless oil, [ a] 0 - 30.2 (c, 0.5) (Found: [M - C4H9']+, 443 .1523. 
C H O S. · [ • + 13 27 36 7 1 reqmres M - C4H9 ] , 443 . 1526). C NMR (CDC13, 
75 MHz) 8 169.9(9), 169.9(5), 136.0, 135 .9, 135.8, 135.7, 133.4, 132.6, 
132.4, 131.9, 130.5, 130.3, 130.2, 128.1(3), 128.0(5), 127.9(6), 
127.9(2), 109.8, 109.6, 100.0, 96.4, 83.4, 82.0, 77.5, 75.2, 74.3, 74.0, 
72.6, 72.4, 66.0, 65 .2, 30. 1, 27 .1, 27.0, 26. 1, 25.7, 22.1, 21.3 , 21.2, 
21.0, 19.3 (one signal overlapping or obscured). vmax (KBr) 3443, 2933, 
2859, 1748, 1371 , 1235, 1113, 1062, 703, 505 cm- 1• EI-MS m/z (70 eV) 
485 [M - CH3·t, (23%), 443 [M - C4H9·t, (38), 325 (45), 341 (50), 
241 (68), 199 (100), 101 (84). 
5 ,6-0-(1-M ethylethylidene)-a-D-talofuranose Triacetate (13) and 
5,6-0-(1-Methylethylidene)-~-D-talofuranose Triacetate (14) 
Method A. A magnetically stirred mixture of compound (12) 
(67 mg, 0.13 mmol) in THF (4 mL) maintained under a nitrogen 
atmosphere at l 8°C was treated with tetra-n-butylammonium fluoride 
(150 µL ofa l M solution in THF, 0.15 mmol). After 0.5 h the reaction 
mixture was treated with pyridine (6 mL), acetic anhydride (0.5 mL, 
5.30 mmol) and DMAP (13 mg, 0.11 mmol) and then stirring continued 
at l 8°C for 14 h. The resulting light-yellow solution was treated with 
ammonium chloride (20 mL of a saturated aqueous solution) and ethyl 
acetate ( 15 mL). The separated aqueous phase was extracted with 
ethy 1 acetate (2 x 10 mL) and the combined organic phases were 
washed with brine (1 x 15 mL) and then dried (MgSO4), filtered and 
concentrated under reduced pressure to give a light-yellow oil. 
Subjection of this material to flash chromatography (silica gel, gradient 
elution using 20 to 25% v/v ethyl acetate/hexane) afforded two 
fractions, A and B. 
Concentration of fraction A (RF 0.5 in 4: 2.5 : 5.5 v/v/v ethyl 
acetate/dichloromethane/hexane) afforded compound (I 3) (18 mg, 
40%) as a light-yellow and crystalline solid, m.p. 96-98°C, [a]o + 11.2 
(c, 0.25) (Found: C, 52.0; H, 6.1%; [M - CH3·t, 331.1029. C 15H22O9 
requires C, 52.0; H, 6.4%; [M-CH3"t, 331.1030). 1H NMR (CDC13, 300 MHz) 8 6.43, d, J 4.5 Hz, lH; 5.34, dd, J 5.9 and 2.1 Hz, lH; 5.28, 
m, lH; 4.30, m, lH; 4.24, m, lH; 4.02, t, J 6.7 Hz, lH; 3.91, m, lH; 
2.13, s, 3H; 2.11, s, 3H; 2.07, s, 3H; 1.39, s, 3H; 1.36, s, 3H. 13C NMR 
(CDC13, 75 MHz) 8 170.3, 169.7, 169.3, 110.1, 94.4, 83.2, 75.3, 71.1 , 
70 .3, 65.2, 26.2, 25.8, 21.3, 21.0, 20.6. V max (KBr) 2988, 2925, 1750, 
1372, 1222, 1111, 1065, 1011, 939 cm- 1• EI-MS mlz (70 eV) 331 [M -
CH30]+, (80%), 287 (15), 169 (60), 127 (29), 101 (100). 
Concentration of fraction B (RF 0.4 in 4: 2.5: 5.5 v/v/v ethyl acetate/ 
dichloromethane/hexane) afforded compound (14) (22 mg, 47%) as a 
clear colourless oil, [a]o -54.0 (c, 0.25) (Found: [M - CH3"t, 
331.1029. C15H22O9 requires [M-CH3"t, 331.1030). 1H NMR (CDC13, 300 MHz) 8 6.18, d, J 1.8 Hz, lH; 5.44--5.32, complex m, 2H; 
4.26-4.14, complex m, 2H; 4.03, m, lH; 3.84, m, lH; 2.12, s, 3H; 2.09, 
s, 3H; 2.08, s, 3H; 1 .40, s, 3H; 1.38, s, 3H. 13C NMR (CDC13, 75 MHz) 8 169.7, 169.4, 169.2, 110.0, 98.1, 80.9, 75.3, 74.3, 71.1, 65.2, 26.3, 
25.8, 21.3, 20.8, 20.8. Vmax (KBr) 2988, 2925, 1752, 1372, 1219, 1062, 
970 cm- 1. EI-MS mlz (70 eV) 331 [M - CH3"t, (53%), 287 (12), 169 (57), 127 (40), 101 (100). 
Method B. A magnetically stirred solution of compound (12) 
(51 mg, 0.10 mmol) and DMAP (15 mg, 0.12 mmol) in pyridine 
(2.5 mL) maintained under a nitrogen atmosphere at l 8°C was treated 
with acetic anhydride (0.5 mL). After 3 h the reaction mixture was 
treated with dichloromethane (8 mL) and ammonium chloride (15 mL 
of a saturated aqueous solution). The separated organic phase was 
washed with ammonium chloride ( 15 mL of a saturated aqueous 
solution) and brine (1 x 15 mL) and then dried (MgSO4), filtered and 
concentrated under reduced pressure to give a light-yellow oil. This 
material was dissolved in THF (2.5 mL) and then treated with tetra-n-
butylammonium fluoride (90 µL of a 1 M solution in THF, 0.09 mmol) . 
After 0.5 h the reaction mixture was treated with pyridine ( 4 mL), acetic 
anhydride (0.5 mL) and DMAP (6 mg, 0.05 mmol), and maintained at 
18°C with stirring for 14 h. The resulting light-yellow solution was 
treated with sodium bicarbonate ( 15 mL of a saturated aqueous 
solution) and ethyl acetate ( 10 mL) . The separated aqueous phase was 
extracted with ethyl acetate (3 x 5 mL) and the combined organic 
phases were washed with brine ( 1 x 15 mL) and then dried (MgSO4), 
filtered and concentrated under reduced pressure to give a light-yellow 
oil. Subjection of this material to flash chromatography (silica gel, 
gradient elution using 20 to 25% v/v ethyl acetate/hexane) afforded two 
fractions, A and B. 
Concentration of fraction A (RF 0.5 in 4: 2.5 : 5 .5 v/v/v 
ethy 1 acetate/dichloromethane/hexane) afforded compound ( 13) 
(22 mg, 63 %) identical, in all respects, with the chromatographically 
more mobile product obtained by Method A as described immediately 
above. 
Concentration of fraction B (RF 0.4 in 4 : 2.5 : 5.5 v/v/v ethyl acetate/ 
dichloromethane/hexane) afforded compound ( 14) (6 mg, 17%) 
identical, in all respects, with the chromatographically less mobile 
product obtained by Method A as described immediately above. 
a-Penta-0-acetyl-D-talopyranose (15) a-Penta-0-acetyl-D-talofura-
nose (16) 
Method A. A magnetically stirred solution of authentic D-talose 
(1 53 mg, 0 .85 mrnol) in pyridine (4 mL) was cooled to 0°C (ice-
bath) and then treated with acetic anhydride (2 mL). The resulting 
solution was stirred at O-l8°C for 18 h, and then treated with 
102 
NaHC03 (20 mL of a saturated aqueous solution) and ethyl acetate 
(20 mL). The separated organic phase was washed with NaHC03 (I x 20 mL of a saturated aqueous solution), and NH4Cl (2 x 20 mL 
of a saturated aqueous solution), and then dried (MgS04), filtered 
and concentrated under reduced pressure to give a light-yellow oil. 
Subjection of this material to flash chromatography (silica gel, 
gradient elution using 25 to 35% v/v ethyl acetate/hexane) afforded 
two fractions, A and B. 
Concentration of fraction A (RF 0.26 in 4 : 2.5 : 5.5 v/v/v ethyl 
acetate/dichloromethane/hexane) afforded compound (15) (259 mg, 
78%) as light-yellow crystalline solid, m.p. 104-106°C (lit.[3o1 107°C), (a.Jo +74.8 (c, 0.5) (lit.£3°1 +70.2 in CHC13) (Found: C, 49.3; H, 5.3%; [M - CH3co·t, 347.0969. Cale. for C16H220 11 : C, 49.2; H, 5.7%; [M-
CH3co·J+, 347.0978). 1H NMR (CDC13 , 300 MHz) 8 6.08, br s, lH; 
5.3, hrs, lH; 5.25, t,J3.7 Hz, lH; 5.25, m, lH; 4.26, br t,J6.9 Hz, lH; 
4.10, m, 2H; 2.10(3), s, 3H; 2.10(1), s, 3H; 2.09, s, 3H; 1.98, s, 3H; 1.95, 
s, 3H. 13 C NMR (CDC13, 75 MHz) 8 170.2, 169.9, 169.5, 169.5, 167.9, 
91.4, 68 .8, 66.3, 65.3, 65.1, 61.5, 21.0, 20.9, 20.8, 20.7(4), 20.6(6). 
Vrnax (KBr) 2974, 1749, 1372, 1226, 1143, 1045, 1002, 732 cm- 1. EI-
MS mlz (70 eV) 347 [M - CH3co·t, (11%), 331 (M-CH3C02.]+, (24), 
242 (45), 200 (35), 157 (78), 115 (100), 98 (65). 
Concentration of fraction B (RF 0.32 25:75 v/v ethyl acetate/hexane) 
afforded compound (16) (40 mg, 12%) as a clear colourless oil, [a] 0 
+38.6 (c, 0.5) (Found: [M - CH3co·t, 347.0969. Cale for C16H220 11 : [M - CH3CO"]+, 347 .0978). 1H NMR (CDC13, 300 MHz) 8 6.12, s, IH; 
5.31, m, 2H; 5.18, m, lH; 4.34, m, lH; 4.27, dd, J 11.9 and 4.5 Hz, lH; 
4.14, dd, J 11.9 and 6.6 Hz, lH; 2.12, s, 3H; 2.11(3), s, 3H; 2.10(9), s, 
3H; 2.05, s, 6H. 13C NMR (CDC13, 75 MHz) 8 170.4, 169.9, 169.5, 
169.4, 168.8, 97.7, 79.3, 74.0, 70.0, 69.7, 62.5, 21.2, 21.0, 20.9, 20.7, 
20.6. vmax (KBr) 1749, 1372, 1219, 1045, 967,895,602 cm- 1• EI-MS 
m/z (70 eV) 347 [M - CH3CO"t, (2%), 331 [M-CH3C02·]+, (30), 245 (100), 200 (35) , 143 (92). 
Method B. A magnetically stirred solution of a mixture of 
compounds (13) and (14) ( 40 mg, 0.12 mmol, obtained by either one of 
the two methods described immediately above) in THF/water (4 mL of 
a 1 : 1 v/v mixture) was treated with trifluoroacetic acid (TFA) (0.4 mL). 
The resulting mixture was stirred at 0-18°C for 20 h and then 
concentrated under reduced pressure. The ensuing light-yellow oil was 
dissolved in pyridine ( 4 mL ), the resulting solution cooled to ca. 0°C 
(ice-bath) and then treated with acetic anhydride (1 mL) and DMAP 
(7 mg, 0.06 mmol). The reaction mixture was stirred at 0°C for 1 hand 
then at l 8°C for 23 h before being poured into a mixture of ethyl acetate 
(10 mL) and ammonium chloride (15 mL of a saturated aqueous 
solution). The separated organic phase was washed with NH4Cl (2 x 15 mL of a saturated aqueous solution) then dried (MgS04), 
filtered and concentrated under reduced pressure to give a light-yellow 
oil. Subjection of this material to flash chromatography (silica gel, 
gradient elution using 25 to 35% v/v ethyl acetate/hexane) afforded two 
fractions, A and B. 
Concentration of fraction A (RF 0.26 in 4 : 2.5: 5.5 v/v/v 
ethyl acetate/dichloromethane/hexane) afforded a ca. 2: 1 mixture of a 
penta-0-acetyl-D-talofuranose and compound ( 15) (24 mg, 53%) as a 
light-yellow oil which solidified on standing. Comparison of the 1H and 
13C NMR data derived from this material with those obtained from 
authentic samples of compound ( 15) provided a good match. The 
following additional signals, attributed to the penta-0-acetyl-~-D-
talofuranose, were observed: 1H NMR (CDC13, 300 MHz) 8 6.42, d, J 
4.5 Hz, lH; 5.30, m, partially obscured, lH; 5.23, m, lH; 5.15, m, lH; 
4.46, t, J2.9 Hz, lH; 4.31, dd, J 11.7 and 4.8 Hz, lH; 4.16, m, lH 
[signals due to acetate methyl groups overlapping with those due to 
equivalent groups in compound (15)]; 13C NMR (CDC13, 75 MHz) 8 
170.4, 169.9, 169.8, 169.7, 169.3, 93.9, 82.0, 77.4, 69.9, 69.8, 62.1, 
29.9, 21.3, 21.1, 20.5 (one signal obscured or overlapping). 
Concentration of fraction B (RF 0.32 in 4: 2.5 : 5.5 v/v/v 
ethyl acetate/dichloromethane/hexane) afforded compound (16) 
( 10 mg, 22%) as a clear colourless oil. This material was identical, in 
all respects, with the material prepared as described above from D-
talose. 
Crystallography 
Crystal Data 
M. G. Banwell et al. 
Compound (7). C24H27Cl04Si, M 443.015, T 200 K, 
orthorhombic, space group ?212121 , a 9.7325(7), b 9.7726(7), c 
25.180(2) A, V2394.9(3) A3, De (Z 4) 1.229 g cm-3, F(00O) 936, µ(Mo 
Ka) 0.236 A, 4063 unique data (20rnax 50.05°), 2935 with I > 3a(I), R 
0.0611, mR 0.0704, S 1.0696. 
Compound (13). C15H22 0 9, M 346.332, T 200 K, monoclinic, 
space group C2, a 16.5808(3), b 5.73230(10), c 19.0387(5) A, ~ 
109.5197(9) 0 , V 1705.55(6) A3, De (Z 4) 1.349 g cm-3, F(000) 736, 
µ(Mo Ka) 0.112 A, 2155 unique data (20rnax 54.96°), 1307 with I > 
2a(I) , R 0.0349, mR 0.0389, S 1.0604. 
Structure Determination 
Intensity data w_ere collected using a Nonius Kappa CCD diffractometer 
and extracted from diffraction images using the DENZ0[311 package. 
Analytical absorption corrections were applied. (321 Both structures were 
solved by direct methodsl33J and expanded using Fourier techniquesJ34J 
Full matrix least-squares refinement was on F, non-hydrogen atoms 
were refined anisotropically while hydrogen atoms were included at 
geometrically determined positions and ride on the carbon of 
attachment. ADEP's of (7) and (13) were generated using CAMERON 
software. l35l 
Atomic coordinates, bond lengths and angles, and displacement 
parameters have been deposited with the Cambridge Crystallographic 
Data Center (CCDC Nos 185848 and 185849 for compounds (7) and 
(13), respectively). 
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The naturally occurring sugar mimetic alkaloids 1-deoxy-
mannojirimycin (DMJ, 1) and 6-0-a-L-rhamnopyranosyl-
DMJ (2) have each been prepared in a completely 
stereoselective manner from the cis-1,2-dihydrocatechol 3, 
itself obtained in enantiomerically pure form by microbial 
oxidation of chlorobenzene. 
The alkaloid 1-deoxymannojirimycin (DMJ, 1) has been 
isolated from the seeds of Lonchocarpus sericeus 1 and L. 
costaricensis (Leguminosae) 2 as well as from cultures of 
Streptomycese lavendulae .3 Like a number of other naturally 
occurring polyhydroxylated piperidines,4 this compound 
displays various rather important biological properties. In 
particular, it is a potent inhibitor of several a-mannosidases.5 
Interestingly, derivatisation of DMJ can result in significant 
enhancement of its enzyme inhibiting properties. For example, 
one of us has recently reported 6 the isolation of 6-O-a-L-
rhamnopyranosyl-DMJ (Rha-DMJ, 2), as well as DMJ itself,6b 
from the bark of Anglyocalyx pynaertii (Leguminosae) and 
shown that this first naturally occurring glycoside of DMJ is 
a significantly more potent inhibitor of a-L-fucosidase than 
parent 1. Given the therapeutic potential arising from a 
capacity to control glycosylation,7 DMJ and its derivatives have 
attracted attention as agents for the treatment of, inter alia, 
cancer, diabetes and viral infections.7•8 As a result various 
ingenious synthetic routes to polyhydroxylated piperidines, 
including DMJ, have been developed.4•9 One of the most 
elegant and effective methods has been described by Hudlicky 
and co-workers 10 who were able to convert the cis-1 ,2-dihydro-
catechol 3 into various endo-nitrogenous aza sugars including 
( + )-kifunensine and mannojirimycin. A great attraction of this 
approach is that compound 3 11 is available in large quantity 
and enantiomerically pure form via microbial oxidation of 
chlorobenzene and it can be readily elaborated to various 
differentially protected and, therefore, synthetically valuable 
forms of several aza sugars. Here we report on the application 
of this approach to the preparation of DMJ and a differentially 
protected derivative that has been exploited in the (first) total 
synthesis of 6-O-a-L-rhamnopyranosyl-DMJ (2). Since various 
disaccharide derivatives of DMJ have been identified as poten-
tial cancer remedies 12 the present work should provide useful 
methods for accessing members of this interesting class of 
pseudo-tri saccharide. 
The synthesis of DMJ from cis-1,2-dihydrocatechol 3 is 
shown in Scheme 1 and follows the early steps of Hudlicky's 
mannojirimycin synthesis. Thus, the readily available acetonide 
derivative 10 of diol 3 was subject to epoxidation with m-CPBA 
and the resulting epoxide 4 10 (81 % from 3) converted, in a 
completely regioselective fashion , into the chlorohydrin 5 (98%) 
upon reaction with lithium chloride. Treatment of the last 
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Cl OH 
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compound with lithium azide resulted in an SN2-type displace-
ment and formation of the previously reported 10 cis-azido-
alcohol 6 (91%, mp 93- 94 °C) which was O-benzylated under 
standard conditions to give the expected ether 7 t { 100%, [a]0 
-111 .0 (c 0.8) t}. Ozonolytic cleavage of a methanolic solution 
of this last compound followed by reductive work-up with 
sodium borohydride and subsequent protection of the ensuing 
1°-alcohol using TBS-Cl then afforded the azido-ether 8 {89%, 
[a]0 -10.2 (c 1.3)}. Two-fold hydrogenolysis of this last 
compound using 5% Pd on C as catalyst resulted in formation 
oflactam 9 13 {86%, mp 110- 111 °C, [a]n + 15.3 (c 1.0)} which 
was converted into the corresponding piperidine 10 13 {73%, mp 
86- 87 °C, [a]0 -66 (c 0.6)} upon exposure to the borane-
dimethyl sulfide complex followed by cleavage of the resulting 
borane- amine complex with methanol in the presence of 10% 
palladium on carbon. 14 Treatment of compound 10 with 80% 
v/v trifl.uoroacetic acid (TFA)-H2O at 18 °C for 18 h then gave 
the TFA salt, 1 ·TFA, of DMJ. The spectral and physical data 
derived from this material proved an excellent match with those 
obtained on an authentic sample. 
The differentially protected DMJ derivative 10 served as 
an effective precursor to 6-O-a-L-rhamnopyranosyl-DMJ 
(2) (Scheme 2). Thus, the former compound was N- and O-
benzylated under standard conditions and the TBS-ether 
moiety then cleaved with tetra-n-butylammonium fluoride 
(TBAF) to give the 1 °-alcohol 11 15 {89% from 10, [a] 0 + 10.5 (c 1.0)} which could be coupled with the L-rhamnopyranosyl 
bromide 12 16 in the presence of silver triflate.17 Coupling 
product 13 {87%, [a]0 -42.5 (c 1.0)} was deprotected in a step-
wise fashion by sequential exposure to TFA (resulting in 
removal of the acetonide group), methanolic sodium methoxide 
(to remove the acetate groups) and dihydrogen in the presence 
of 5% Pd on C. The sample of Rha-DMJ (2) {80% from 13, [a]n 
- 51.7 (c 0.6, H2O)} thus obtained after this final deprotection 
step gave spectral data in full accord with the assigned structure 
and in excellent agreement with those derived from the natural 
material.00 
Synthetic 2 was evaluated for its glycosidase inhibitory 
activity (Table 1) and shown to be 5- 10 times less active than 
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Scheme 1 Reagents and conditions: (i) 2,2-DMP, p-TsOH·H2O (cat.), 18 °C, 1 h; (ii) m-CPBA (1.0 mole equiv.), CH2Cl2 , 0- 18 °C, 11 h; (iii) LiCl (5 mole equiv.), HOAc (3 mole equiv.), THF, 18 °C, 17 h; (iv) LiN3 (3 mole equiv.), DMF, 18 °C, 72 h; (v) BnBr (3.0 mole equiv.), Kl (0.04 mole equiv.), NaH (1.6 mole equiv.), THF, 0- 18 °C, 24 h; (vi) 0 3 (excess), pyridine (4.9 mole equiv.), MeOH, -78 °C, I h then NaBH4 (11 mole equiv.), 
-10 °C, 3 h; (vii) TBS-Cl (1 .5 mole equiv.), imidazole (5 mole equiv.), CH2Cl2 , 18 °C, 2 h; (viii) H2 (I atm), 5% Pd on C (cat.), EtOAc, 18 °C, 36 h; (ix) BH1·DMS (10 mole equiv.), THF, 18 °C, 4.5 h then 10% Pd on C, MeOH, 18 °C, 38 h; (x) 80% v/v TFA- H2O, 18 °C, 20 h. 
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Scheme 2 Reagents and condiiions: (i) BnBr (4.3 mole equiv.), KI (0 .5 mole equiv.), NaH (6.8 mole equiv.), THF, 18 °C, 24 h; (ii) TBAF (1 .2 mole equiv.) , THF, 18 °C, 2 h; (iii) AgOTf (1.2 mole equiv,), 4 A 
molecular sieves, CH2C1 2, - 10 °C, 0.5 h; (iv) I : 5 v/v TFA- CH2CI2, 18 
°C, 24 h; (v) NaOMe (0.2 M solution in MeOH), 18 °C, 2 h; (vi) H 2 (1 atm), 5% Pd on C (cat.), EtOH, H 2O (trace), 18 °C, 48 h. 
the natural product. These results call into question the 
previously reported 6 glycosidase inhibitory activity of the 
naturally occurring 2 which may have been compromised by 
contamination of the assay sample with a more powerful 
inhibitor like ~-L-homofuconojirimycin. Despite this, com-
pound 2 must still be regarded as a rather potent inhibitor 
of bovine epididymis-derived a-fucosidase. 
Experimental 
Compound 13 
A solution of silver triflate (203 mg, 0. 79 mmol) in toluene 
(5 mL) was added dropwise to a magnetically stirred solution 
of alcohol 11 (253 mg, 0.66 mmol) and bromide 12 (297 mg, 
0.84 mrnol) in CH2Cl2 (20 mL) containing activated 4 A 
molecular sieves (2 g) and maintained under a nitrogen 
atmosphere at -10 °C. After 0.5 h the reaction mixture was 
treated with Et3N (1.5 mL) then CH2Cl2 (50 mL). The ensuing 
mixture was filtered through a 2 cm deep pad of Celite™ and 
the filtrate concentrated under reduced pressure. The light-
Table 1 Comparison of the glycosidase inhibitory properties of 
synthetic and natural samples of compound 2 ° 
Enzyme 
a-Fucosidase 
Bovine epididyrnis 
Human placenta 
Rat epididyrnis 
a-Mannosidase 
Rat epididymis 
a-L-Rhamnosidase 
Penicillium decumbens 
Synthetic 
2.8 
23 
28 
>1000 
>1000 
Natural 
0.5 
4.6 
3.2 
460 
740 
0 The enzymes a-L-fucosidases from bovine epididymis and human 
placenta, and a-L-rhamnosidase from Penicillium decumbens were 
purchased from Sigma Chemical Co. The rat epididymal fluid prepared 
from rat epididymis according to the method of Skudlarek et al. 18 was 
used as the enzyme source of rat epididymis glycosidases. The glyco-
sidase activities were determined using an appropriate p-nitrophenyl 
glycoside as substrate at the optimum pH of each enzyme. The reaction 
was stopped by adding 400 mM Na2 CO3• The released p-nitrophenol 
was measured spectrometrically at 400 nm. 
yellow oil thus obtained was subjected to flash chromatography (silica, 25- 35% v/v ethyl acetate- hexane gradient elution) and 
concentration of the appropriate fractions (Rr 0.5 in 4 : 2.5 : 5.5 
v/v/v ethyl acetate- CH2Cl2- hexane) afforded glycoside 13 (377 mg, 87%) as a white foam (Found: M +·, 655.2971. 
C35H 45N011 requires M +•, 655.2993). vmax (NaCl)/cm- 1 2985, 
2936, 1750, 1371, 1223, 1053, 735, 699; OH (300 MHz, CDC1 3) 
7.40- 7.10 (10 H, complex m), 5.32- 5.18 (3 H, complex m), 5.04 (1 H, t, J 9.8 Hz), 4.72 (1 H, d, J 11. 7 Hz), 4.64 (1 H, broad s), 
4.63 (1 H, d, J 11.7 Hz, partially obscured), 4.30 (2 H, broad s), 
4.04-3.90 (2 H, complex m), 3.81 (2 H, m), 3.62 (1 H, d, J 14.0 
Hz), 3.54 (1 H, dd, J 10.0 and 4.8 Hz), 2.88 (1 H, m), 2.74 (1 H, 
broad d, J 14.0 Hz), 2.13 (3 H, s), 2.04 (3 H, s), 1.99 (3 H, s), 
1.55 (3 H, s), 1.34 (3 H, s), 1.14 (3 H, d, J 6.3 Hz); be (75 MHz, 
CDC13) 169.9, 169.8, 169.7, 139.0, 138.2, 128.4, 128.3, 128.2, 
127.8, 127.6, 126.8, 109.0, 97.5, 76.5, 75.2, 72.8, 72.1, 71.0, 69.9, 
69.2, 66.7, 66.5, 60.8, 58.7, 49.9, 27.4, 25.5, 21.1, 21.0, 20.9, 
17.5; m/z (EI) 655 (<1 %, M +·), 640 (5), 352 (100), 91 (60). 
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